1	}	NN	O	}	_	0	SENT_1	[p1l97t103r120b428],
2	IV	CD	NUMBER	iv	num	1	SENT_1	[p1l97t103r120b428],
3	"	``	O	"	punct	4	SENT_1	[p1l97t103r120b428],
4	lf13SVAOICl	NN	O	lf13svaoicl	dep	1	SENT_1	[p1l97t103r120b428],
5	}	CD	NUMBER	}	num	4	SENT_1	[p1l97t103r120b428],
6	IV3	NN	O	iv3	dep	1	SENT_1	[p1l97t103r120b428],

1	Dose-Related	NNP	O	Dose-Related	nn	2	SENT_2	[p1l263t296r771b358],
2	Efficacy	NNP	O	Efficacy	_	0	SENT_2	[p1l804t296r1090b379],
3	of	IN	O	of	_	0	SENT_2	[p1l1121t296r1196b358],
4	Aspirin	NNP	O	Aspirin	prep_of	2	SENT_2	[p1l1226t297r1514b378],
5	After	IN	O	after	dep	2	SENT_2	[p1l1546t296r1743b358],
6	Coronary	JJ	O	coronary	amod	7	SENT_2	[p1l1774t298r2127b379],
7	Surgery	NN	O	surgery	pobj	5	SENT_2	[p1l264t398r560b479],
8	in	IN	O	in	_	0	SENT_2	[p1l591t397r666b457],
9	Patients	NNS	O	patient	prep_in	7	SENT_2	[p1l698t397r997b458],
10	With	IN	O	with	dep	2	SENT_2	[p1l1030t396r1216b458],
11	PIAZ	NNP	O	PIAZ	nn	14	SENT_2	[p1l1249t384r1403b457],
12	Polymorphism	NN	O	polymorphism	nn	14	SENT_2	[p1l1435t396r1995b479],
13	(	NN	O	(	nn	14	SENT_2	[p1l265t496r829b565],
14	NCTO0262275	NN	O	ncto0262275	pobj	10	SENT_2	[p1l265t496r829b565],
15	)	CD	NUMBER	)	dep	14	SENT_2	[p1l265t496r829b565],

1	Eric	NNP	PERSON	Eric	nn	2	SENT_3	[p1l261t613r348b649],
2	Lim	NNP	PERSON	Lim	_	0	SENT_3	[p1l367t613r467b656],
3	,	,	O	,	_	0	SENT_3	[p1l367t613r467b656],
4	MS	NN	O	m	conj_and	2	SENT_3	[p1l487t615r567b656],
5	,	,	O	,	_	0	SENT_3	[p1l487t615r567b656],
6	FRCS	NN	O	frc	nn	9	SENT_3	[p1l587t614r853b656],
7	(	CD	NUMBER	(	num	9	SENT_3	[p1l587t614r853b656],
8	C-Th	NN	O	c-th	nn	9	SENT_3	[p1l587t614r853b656],
9	)	NN	O	)	conj_and	2	SENT_3	[p1l587t614r853b656],
10	,	,	O	,	_	0	SENT_3	[p1l587t614r853b656],
11	Sebastian	NNP	PERSON	Sebastian	nn	12	SENT_3	[p1l873t611r1091b649],
12	Carballo	NNP	PERSON	Carballo	conj_and	2	SENT_3	[p1l1111t611r1316b656],
13	,	,	O	,	_	0	SENT_3	[p1l1111t611r1316b656],
14	PhD	NNP	O	PhD	conj_and	2	SENT_3	[p1l1335t614r1436b656],
15	,	,	O	,	_	0	SENT_3	[p1l1335t614r1436b656],
16	Jacqueline	NNP	PERSON	Jacqueline	nn	17	SENT_3	[p1l1453t611r1693b662],
17	Cornelissen	NNP	PERSON	Cornelissen	conj_and	2	SENT_3	[p1l1713t611r1993b656],
18	,	,	O	,	_	0	SENT_3	[p1l1713t611r1993b656],
19	PhD	NNP	O	PhD	conj_and	2	SENT_3	[p1l2013t614r2114b656],
20	,	,	O	,	_	0	SENT_3	[p1l2013t614r2114b656],
21	Ziad	NNP	PERSON	Ziad	nn	23	SENT_3	[p1l261t668r363b705],
22	A.	NNP	PERSON	A.	nn	23	SENT_3	[p1l380t669r428b705],
23	Ali	NNP	PERSON	Ali	conj_and	2	SENT_3	[p1l447t668r525b713],
24	,	,	O	,	_	0	SENT_3	[p1l447t668r525b713],
25	MRCS	NNP	ORGANIZATION	MRCS	conj_and	2	SENT_3	[p1l545t672r690b712],
26	,	,	O	,	_	0	SENT_3	[p1l545t672r690b712],
27	MRCP	NNP	O	MRCP	conj_and	2	SENT_3	[p1l710t672r857b712],
28	,	,	O	,	_	0	SENT_3	[p1l710t672r857b712],
29	Robert	NNP	PERSON	Robert	nn	30	SENT_3	[p1l877t668r1030b705],
30	Grignani	NNP	PERSON	Grignani	conj_and	2	SENT_3	[p1l1049t669r1262b718],
31	,	,	O	,	_	0	SENT_3	[p1l1049t669r1262b718],
32	PhD	NNP	O	PhD	conj_and	2	SENT_3	[p1l1282t671r1383b712],
33	,	,	O	,	_	0	SENT_3	[p1l1282t671r1383b712],
34	Sarah	NNP	PERSON	Sarah	nn	35	SENT_3	[p1l1404t668r1533b705],
35	Bellm	NNP	PERSON	Bellm	conj_and	2	SENT_3	[p1l1551t668r1693b713],
36	,	,	O	,	_	0	SENT_3	[p1l1551t668r1693b713],
37	BS	NNP	O	BS	conj_and	2	SENT_3	[p1l1712t672r1777b712],
38	,	,	O	,	_	0	SENT_3	[p1l1712t672r1777b712],
39	and	CC	O	and	_	0	SENT_3	[p1l1798t668r1883b705],
40	Stephen	NNP	PERSON	Stephen	nn	44	SENT_3	[p1l262t724r448b775],
41	Large	JJ	PERSON	large	amod	44	SENT_3	[p1l467t726r607b775],
42	,	,	O	,	_	0	SENT_3	[p1l467t726r607b775],
43	FRCS	NNP	O	FRCS	dep	44	SENT_3	[p1l627t728r742b762],
44	Departments	NNP	O	Departments	conj_and	2	SENT_3	[p1l260t803r459b836],
45	of	IN	O	of	_	0	SENT_3	[p1l472t802r501b827],
46	Cardiothoracic	JJ	O	cardiothoracic	amod	47	SENT_3	[p1l513t802r737b827],
47	Surgery	NN	O	surgery	prep_of	44	SENT_3	[p1l750t803r870b836],
48	and	CC	O	and	_	0	SENT_3	[p1l882t802r938b827],
49	Clinical	JJ	O	clinical	amod	50	SENT_3	[p1l951t802r1067b827],
50	Pharmacology	NN	O	pharmacology	conj_and	47	SENT_3	[p1l1079t802r1303b836],
51	,	,	O	,	_	0	SENT_3	[p1l1079t802r1303b836],
52	Papworth	NNP	ORGANIZATION	Papworth	nn	53	SENT_3	[p1l1316t802r1463b836],
53	Hospital	NNP	ORGANIZATION	Hospital	conj_and	47	SENT_3	[p1l1475t802r1611b836],
54	,	,	O	,	_	0	SENT_3	[p1l1475t802r1611b836],
55	Cambridge	NNP	LOCATION	Cambridge	conj_and	47	SENT_3	[p1l1625t802r1802b836],
56	,	,	O	,	_	0	SENT_3	[p1l1625t802r1802b836],
57	and	CC	O	and	_	0	SENT_3	[p1l1816t802r1873b827],
58	Department	NNP	ORGANIZATION	Department	conj_and	47	SENT_3	[p1l1885t803r2069b836],
59	of	IN	ORGANIZATION	of	_	0	SENT_3	[p1l2082t802r2111b827],
60	Cardiovascular	NNP	ORGANIZATION	Cardiovascular	nn	61	SENT_3	[p1l261t838r491b863],
61	Medicine	NNP	ORGANIZATION	Medicine	prep_of	58	SENT_3	[p1l502t838r652b868],
62	,	,	O	,	_	0	SENT_3	[p1l502t838r652b868],
63	Wellcome	NNP	ORGANIZATION	Wellcome	nn	65	SENT_3	[p1l664t838r816b863],
64	Trust	NNP	ORGANIZATION	Trust	nn	65	SENT_3	[p1l829t839r909b863],
65	Centre	NNP	ORGANIZATION	Centre	appos	61	SENT_3	[p1l922t839r1024b863],
66	for	IN	ORGANIZATION	for	_	0	SENT_3	[p1l1036t838r1079b863],
67	Human	JJ	ORGANIZATION	human	amod	68	SENT_3	[p1l1091t839r1206b863],
68	Genetics	NNP	ORGANIZATION	Genetics	prep_for	65	SENT_3	[p1l1219t839r1358b868],
69	,	,	O	,	_	0	SENT_3	[p1l1219t839r1358b868],
70	University	NNP	ORGANIZATION	University	dep	2	SENT_3	[p1l1371t839r1529b872],
71	of	IN	ORGANIZATION	of	_	0	SENT_3	[p1l1542t838r1571b863],
72	Oxford	NNP	ORGANIZATION	Oxford	nn	77	SENT_3	[p1l1582t838r1696b868],
73	,	,	O	,	_	0	SENT_3	[p1l1582t838r1696b868],
74	Oxford	NNP	LOCATION	Oxford	appos	77	SENT_3	[p1l1710t838r1824b868],
75	,	,	O	,	_	0	SENT_3	[p1l1710t838r1824b868],
76	United	NNP	LOCATION	United	appos	77	SENT_3	[p1l1837t838r1941b863],
77	Kingdom	NNP	LOCATION	Kingdom	prep_of	70	SENT_3	[p1l1953t838r2094b872],

1	Background	NN	O	background	_	0	SENT_4	[p1l90t1037r546b1119],
2	.	.	O	.	_	0	SENT_4	[p1l90t1037r546b1119],

1	To	TO	O	to	aux	2	SENT_5	[p1l601t1040r698b1098],
2	evaluate	VB	O	evaluate	purpcl	27	SENT_5	[p1l753t1038r1063b1098],
3	the	DT	O	the	det	4	SENT_5	[p1l1116t1038r1231b1098],
4	impact	NN	O	impact	dobj	2	SENT_5	[p1l1285t1038r1538b1118],
5	of	IN	O	of	_	0	SENT_5	[p1l1591t1037r1666b1098],
6	the	DT	O	the	det	8	SENT_5	[p1l1716t1038r1831b1098],
7	genetic	JJ	O	genetic	amod	8	SENT_5	[p1l1884t1039r2151b1119],
8	polymorphisms	NNS	O	polymorphism	prep_of	4	SENT_5	[p1l10t1137r600b1218],
9	affecting	VBG	O	affect	partmod	8	SENT_5	[p1l632t1137r954b1218],
10	aspirin	NN	O	aspirin	nn	11	SENT_5	[p1l985t1138r1246b1218],
11	response	NN	O	response	dobj	9	SENT_5	[p1l1275t1157r1604b1218],
12	using	VBG	O	use	xcomp	9	SENT_5	[p1l1635t1138r1842b1218],
13	platelet	NN	O	platelet	nn	14	SENT_5	[p1l1871t1137r2153b1218],
14	aggregation	NN	O	aggregation	dobj	12	SENT_5	[p1l11t1239r451b1319],
15	and	CC	O	and	_	0	SENT_5	[p1l488t1238r624b1299],
16	the	DT	O	the	det	17	SENT_5	[p1l661t1238r776b1299],
17	response	NN	O	response	dobj	12	SENT_5	[p1l813t1258r1143b1319],
18	to	TO	O	to	_	0	SENT_5	[p1l1180t1245r1249b1299],
19	diﬁerent	JJ	O	diﬁerent	amod	21	SENT_5	[p1l1287t1238r1611b1299],
20	aspirin	NN	O	aspirin	nn	21	SENT_5	[p1l1647t1239r1908b1319],
21	doses	NNS	O	dose	prep_to	12	SENT_5	[p1l1945t1238r2150b1299],
22	after	IN	O	after	_	0	SENT_5	[p1l11t1338r182b1399],
23	cardiopulmonary	JJ	O	cardiopulmonary	amod	24	SENT_5	[p1l204t1339r852b1420],
24	bypass	NN	O	bypass	prep_after	12	SENT_5	[p1l872t1339r1152b1420],
25	,	,	O	,	_	0	SENT_5	[p1l872t1339r1152b1420],
26	we	PRP	O	we	nsubj	27	SENT_5	[p1l1174t1359r1280b1399],
27	performed	VBD	O	perform	_	0	SENT_5	[p1l1305t1338r1699b1419],
28	a	DT	O	a	det	29	SENT_5	[p1l1724t1359r1761b1399],
29	subanalysis	NN	O	subanalysis	dobj	27	SENT_5	[p1l1785t1339r2152b1420, p1l10t1439r105b1499],
30	of	IN	O	of	_	0	SENT_5	[p1l133t1438r207b1499],
31	the	DT	O	the	det	32	SENT_5	[p1l231t1438r346b1499],
32	results	NNS	O	result	prep_of	29	SENT_5	[p1l372t1438r619b1499],
33	from	IN	O	from	_	0	SENT_5	[p1l646t1438r825b1499],
34	a	DT	O	a	det	36	SENT_5	[p1l851t1458r888b1499],
35	randomized	JJ	O	randomized	amod	36	SENT_5	[p1l913t1438r1362b1499],
36	trial	NN	O	trial	prep_from	27	SENT_5	[p1l1387t1438r1539b1499],
37	evaluating	VBG	O	evaluate	partmod	36	SENT_5	[p1l1567t1438r1961b1519],
38	lowand	NN	O	lowand	nn	40	SENT_5	[p1l1985t1438r2152b1499, p1l11t1539r147b1600],
39	medium-dose	NN	O	medium-dose	nn	40	SENT_5	[p1l178t1539r692b1600],
40	aspirin	NN	O	aspirin	dobj	37	SENT_5	[p1l725t1540r986b1620],
41	and	CC	O	and	_	0	SENT_5	[p1l1019t1539r1155b1600],
42	clopidogrel	NN	O	clopidogrel	dobj	37	SENT_5	[p1l1188t1539r1633b1620],
43	.	.	O	.	_	0	SENT_5	[p1l1188t1539r1633b1620],

1	Methods	NNS	O	method	_	0	SENT_6	[p1l88t1638r426b1699],
2	.	.	O	.	_	0	SENT_6	[p1l88t1638r426b1699],

1	Blood	NN	O	blood	nsubjpass	3	SENT_7	[p1l454t1638r674b1699],
2	was	VBD	O	be	auxpass	3	SENT_7	[p1l696t1659r839b1699],
3	collected	VBN	O	collect	_	0	SENT_7	[p1l865t1638r1194b1699],
4	from	IN	O	from	_	0	SENT_7	[p1l1218t1638r1397b1699],
5	consenting	VBG	O	consent	prepc_from	3	SENT_7	[p1l1421t1640r1830b1720],
6	patients	NNS	O	patient	dobj	5	SENT_7	[p1l1853t1640r2150b1719],
7	and	CC	O	and	_	0	SENT_7	[p1l11t1738r147b1799],
8	DNA	NN	O	dna	dobj	5	SENT_7	[p1l188t1741r387b1799],
9	extracted	VBN	O	extract	partmod	6	SENT_7	[p1l427t1738r780b1799],
10	.	.	O	.	_	0	SENT_7	[p1l427t1738r780b1799],

1	Polymerase	NN	MISC	polymerase	nn	3	SENT_8	[p1l823t1738r1253b1819],
2	chain	NN	O	chain	nn	3	SENT_8	[p1l1295t1738r1497b1799],
3	reaction	NN	O	reaction	nsubjpass	11	SENT_8	[p1l1537t1739r1835b1799],
4	and	CC	O	and	_	0	SENT_8	[p1l1877t1738r2013b1799],
5	restriction	NN	O	restriction	nn	9	SENT_8	[p1l2054t1758r2152b1799, p1l10t1840r317b1900],
6	fragment	NN	O	fragment	nn	9	SENT_8	[p1l369t1839r709b1920],
7	length	NN	O	length	nn	9	SENT_8	[p1l758t1839r998b1920],
8	polymorphism	NN	O	polymorphism	nn	9	SENT_8	[p1l1048t1839r1604b1920],
9	analysis	NN	O	analysis	conj_and	3	SENT_8	[p1l1656t1839r1956b1920],
10	was	VBD	O	be	auxpass	11	SENT_8	[p1l2007t1859r2150b1900],
11	performed	VBN	O	perform	_	0	SENT_8	[p1l10t1938r404b2019],
12	to	TO	O	to	aux	13	SENT_8	[p1l445t1945r514b1999],
13	detect	VB	O	detect	xcomp	11	SENT_8	[p1l557t1938r778b1999],
14	PIAZ	NNP	ORGANIZATION	PIAZ	dobj	13	SENT_8	[p1l819t1929r995b2011],
15	,	,	O	,	_	0	SENT_8	[p1l819t1929r995b2011],
16	C807T	NN	O	c807t	dobj	13	SENT_8	[p1l1037t1940r1291b2011],
17	,	,	O	,	_	0	SENT_8	[p1l1037t1940r1291b2011],
18	and	CC	O	and	_	0	SENT_8	[p1l1333t1938r1470b1999],
19	A842/C50T	NN	O	a842/c50t	nn	20	SENT_8	[p1l1511t1938r1918b1999],
20	polymorphisms	NNS	O	polymorphism	dobj	13	SENT_8	[p1l1958t1938r2152b2020, p1l9t2038r451b2119],
21	.	.	O	.	_	0	SENT_8	[p1l1958t1938r2152b2020, p1l9t2038r451b2119],

1	Aspirin	NN	O	aspirin	nn	2	SENT_9	[p1l502t2039r787b2119],
2	efficacy	NN	O	efficacy	nsubjpass	12	SENT_9	[p1l838t2038r1112b2119],
3	was	VBD	O	be	auxpass	4	SENT_9	[p1l1159t2058r1302b2099],
4	assessed	VBN	O	assess	_	0	SENT_9	[p1l1354t2038r1669b2099],
5	using	VBG	O	use	xcomp	4	SENT_9	[p1l1719t2039r1927b2119],
6	light	JJ	O	light	amod	9	SENT_9	[p1l1976t2038r2152b2119],
7	transmission	NN	O	transmission	nn	9	SENT_9	[p1l9t2140r491b2200],
8	platelet	NN	O	platelet	nn	9	SENT_9	[p1l519t2139r801b2220],
9	aggregometry	NN	O	aggregometry	dobj	5	SENT_9	[p1l829t2146r1362b2220],
10	,	,	O	,	_	0	SENT_9	[p1l829t2146r1362b2220],
11	and	CC	O	and	_	0	SENT_9	[p1l1392t2139r1528b2200],
12	reported	VBD	O	report	conj_and	4	SENT_9	[p1l1557t2139r1873b2220],
13	as	IN	O	as	_	0	SENT_9	[p1l1902t2159r1975b2200],
14	percentage	NN	O	percentage	nn	15	SENT_9	[p1l2003t2159r2152b2220, p1l10t2245r289b2320],
15	aggregation	NN	O	aggregation	prep_as	12	SENT_9	[p1l328t2240r768b2320],
16	and	CC	O	and	_	0	SENT_9	[p1l807t2239r943b2299],
17	EC50	NN	O	ec50	nn	18	SENT_9	[p1l982t2240r1170b2299],
18	concentrations	NNS	O	concentration	conj_and	15	SENT_9	[p1l1208t2240r1753b2299],
19	using	VBG	O	use	xcomp	12	SENT_9	[p1l1791t2239r1999b2320],
20	the	DT	O	the	det	21	SENT_9	[p1l2035t2239r2150b2299],
21	technique	NN	O	technique	dobj	19	SENT_9	[p1l9t2338r380b2419],
22	of	IN	O	of	_	0	SENT_9	[p1l414t2338r489b2399],
23	Born	NNP	O	Born	prep_of	21	SENT_9	[p1l519t2341r717b2399],
24	.	.	O	.	_	0	SENT_9	[p1l519t2341r717b2399],

1	Results	NNS	O	result	_	0	SENT_10	[p1l90t2439r381b2500],
2	.	.	O	.	_	0	SENT_10	[p1l90t2439r381b2500],

1	Of	IN	O	of	_	0	SENT_11	[p1l413t2439r510b2500],
2	90	CD	NUMBER	90	num	3	SENT_11	[p1l536t2443r614b2500],
3	patients	NNS	O	patient	prep_of	6	SENT_11	[p1l642t2440r961b2520],
4	,	,	O	,	_	0	SENT_11	[p1l642t2440r961b2520],
5	80	CD	NUMBER	80	appos	3	SENT_11	[p1l989t2443r1066b2500],
6	consented	VBD	O	consent	_	0	SENT_11	[p1l1095t2439r1470b2500],
7	to	TO	O	to	_	0	SENT_11	[p1l1497t2446r1567b2500],
8	further	JJ	O	further	amod	10	SENT_11	[p1l1595t2439r1859b2500],
9	genetic	JJ	O	genetic	amod	10	SENT_11	[p1l1884t2440r2151b2520],
10	testing	NN	O	testing	prep_to	6	SENT_11	[p1l9t2540r283b2620],
11	,	,	O	,	_	0	SENT_11	[p1l9t2540r283b2620],
12	of	IN	O	of	_	0	SENT_11	[p1l315t2538r389b2599],
13	whom	WP	O	whom	rel	18	SENT_11	[p1l417t2539r653b2599],
14	63	CD	NUMBER	63	num	15	SENT_11	[p1l684t2543r761b2599],
15	patients	NNS	O	patient	nsubjpass	18	SENT_11	[p1l792t2540r1090b2619],
16	were	VBD	O	be	auxpass	18	SENT_11	[p1l1120t2559r1300b2599],
17	randomly	RB	O	randomly	advmod	18	SENT_11	[p1l1332t2539r1696b2620],
18	assigned	VBN	O	assign	rcmod	10	SENT_11	[p1l1726t2538r2050b2620],
19	to	TO	O	to	_	0	SENT_11	[p1l2081t2546r2150b2599],
20	medium	NN	O	medium	prep_to	18	SENT_11	[p1l9t2638r350b2699],
21	-	:	O	-	_	0	SENT_11	[p1l9t2638r350b2699],
22	(	NN	O	(	nn	25	SENT_11	[p1l375t2638r520b2706],
23	325	CD	NUMBER	325	num	25	SENT_11	[p1l375t2638r520b2706],
24	mg	NN	O	mg	nn	25	SENT_11	[p1l542t2638r682b2719],
25	)	NN	O	)	dep	20	SENT_11	[p1l542t2638r682b2719],
26	or	CC	O	or	_	0	SENT_11	[p1l709t2658r784b2699],
27	low-dose	JJ	O	low-dose	amod	28	SENT_11	[p1l804t2638r1144b2699],
28	(	NN	O	(	dep	20	SENT_11	[p1l1171t2638r1314b2706],
29	100	CD	NUMBER	100	num	32	SENT_11	[p1l1171t2638r1314b2706],
30	mg	NN	O	mg	nn	32	SENT_11	[p1l1337t2638r1478b2719],
31	)	NN	O	)	nn	32	SENT_11	[p1l1337t2638r1478b2719],
32	aspirin	NN	O	aspirin	nsubj	6	SENT_11	[p1l1504t2639r1784b2719],
33	.	.	O	.	_	0	SENT_11	[p1l1504t2639r1784b2719],

1	The	DT	O	the	det	2	SENT_12	[p1l1808t2638r1951b2699],
2	PIAZ	NN	O	piaz	tmod	35	SENT_12	[p1l1975t2628r2151b2711],
3	,	,	O	,	_	0	SENT_12	[p1l1975t2628r2151b2711],
4	C807T	NN	O	c807t	tmod	35	SENT_12	[p1l11t2741r265b2812],
5	,	,	O	,	_	0	SENT_12	[p1l11t2741r265b2812],
6	and	CC	O	and	_	0	SENT_12	[p1l295t2739r432b2800],
7	A842/CSOT	NN	O	a842/csot	conj_and	2	SENT_12	[p1l461t2739r868b2800],
8	gene	NN	O	gene	nn	9	SENT_12	[p1l897t2759r1071b2820],
9	frequencies	NNS	O	frequency	nsubj	12	SENT_12	[p1l1102t2739r1536b2820],
10	were	VBD	O	be	cop	12	SENT_12	[p1l1566t2759r1745b2800],
11	30	CD	PERCENT	30	num	12	SENT_12	[p1l1776t2739r1949b2812],
12	%	NN	PERCENT	%	rcmod	2	SENT_12	[p1l1776t2739r1949b2812],
13	,	,	O	,	_	0	SENT_12	[p1l1776t2739r1949b2812],
14	66	CD	PERCENT	66	num	15	SENT_12	[p1l1979t2739r2151b2812],
15	%	NN	PERCENT	%	conj_and	12	SENT_12	[p1l1979t2739r2151b2812],
16	,	,	O	,	_	0	SENT_12	[p1l1979t2739r2151b2812],
17	and	CC	O	and	_	0	SENT_12	[p1l11t2839r147b2899],
18	21	CD	PERCENT	21	num	19	SENT_12	[p1l173t2839r347b2911],
19	%	NN	PERCENT	%	conj_and	12	SENT_12	[p1l173t2839r347b2911],
20	,	,	O	,	_	0	SENT_12	[p1l173t2839r347b2911],
21	respectively	RB	O	respectively	advmod	12	SENT_12	[p1l372t2839r843b2920],
22	,	,	O	,	_	0	SENT_12	[p1l372t2839r843b2920],
23	with	IN	O	with	_	0	SENT_12	[p1l868t2838r1039b2899],
24	no	DT	O	no	det	26	SENT_12	[p1l1065t2859r1157b2899],
25	identiﬁable	JJ	O	identiﬁable	amod	26	SENT_12	[p1l1184t2838r1614b2899],
26	differences	NNS	O	difference	prep_with	35	SENT_12	[p1l1642t2838r2050b2899],
27	in	IN	O	in	_	0	SENT_12	[p1l2078t2840r2151b2898],
28	fter	NN	O	fter	nn	30	SENT_12	[p1l186t3087r316b3149],
29	cardiac	JJ	O	cardiac	amod	30	SENT_12	[p1l359t3087r624b3149],
30	surgery	NN	O	surgery	prep_in	26	SENT_12	[p1l670t3108r971b3171],
31	,	,	O	,	_	0	SENT_12	[p1l670t3108r971b3171],
32	not	RB	O	not	neg	33	SENT_12	[p1l1016t3095r1138b3149],
33	everyone	NN	O	everyone	nsubj	35	SENT_12	[p1l1182t3108r1521b3171],
34	will	MD	O	will	aux	35	SENT_12	[p1l1564t3087r1702b3149],
35	experience	VB	O	experience	_	0	SENT_12	[p1l1747t3089r2150b3170],
36	the	DT	O	the	det	37	SENT_12	[p1l222t3191r339b3253],
37	benefit	NN	O	benefit	nsubj	38	SENT_12	[p1l364t3190r626b3253],
38	conferred	VBD	O	confer	ccomp	35	SENT_12	[p1l651t3190r1012b3253],
39	by	IN	O	by	_	0	SENT_12	[p1l1034t3190r1127b3274],
40	aspirin	NN	O	aspirin	prep_by	38	SENT_12	[p1l1152t3194r1427b3274],
41	.	.	O	.	_	0	SENT_12	[p1l1152t3194r1427b3274],

1	It	PRP	O	it	nsubjpass	3	SENT_13	[p1l1455t3194r1510b3253],
2	is	VBZ	O	be	auxpass	3	SENT_13	[p1l1533t3194r1590b3253],
3	estimated	VBN	O	estimate	_	0	SENT_13	[p1l1617t3190r1983b3253],
4	that	IN	O	that	complm	14	SENT_13	[p1l2006t3191r2152b3253],
5	20	CD	PERCENT	20	number	9	SENT_13	[p1l8t3296r156b3358],
6	%	NN	PERCENT	%	dep	9	SENT_13	[p1l8t3296r156b3358],
7	to	TO	O	to	dep	9	SENT_13	[p1l195t3302r265b3357],
8	30	CD	PERCENT	30	number	9	SENT_13	[p1l299t3296r447b3358],
9	%	NN	PERCENT	%	nsubj	14	SENT_13	[p1l299t3296r447b3358],
10	of	IN	O	of	_	0	SENT_13	[p1l489t3294r561b3357],
11	the	DT	O	the	det	13	SENT_13	[p1l591t3294r707b3357],
12	European	JJ	MISC	european	amod	13	SENT_13	[p1l743t3297r1107b3378],
13	population	NN	O	population	prep_of	9	SENT_13	[p1l1142t3294r1551b3378],
14	carry	VBP	O	carry	ccomp	3	SENT_13	[p1l1586t3316r1776b3378],
15	a	DT	O	a	det	20	SENT_13	[p1l1810t3316r1848b3357],
16	genetic	JJ	O	genetic	amod	20	SENT_13	[p1l1884t3297r2150b3377],
17	polymorphism	NN	O	polymorphism	nn	20	SENT_13	[p1l9t3398r562b3481],
18	(	CD	NUMBER	(	num	20	SENT_13	[p1l591t3388r795b3472],
19	PIAZ	NN	O	piaz	nn	20	SENT_13	[p1l591t3388r795b3472],
20	)	NN	O	)	nsubj	35	SENT_13	[p1l591t3388r795b3472],
21	of	IN	O	of	_	0	SENT_13	[p1l825t3398r897b3459],
22	the	DT	O	the	det	26	SENT_13	[p1l920t3398r1037b3459],
23	platelet	NN	O	platelet	nn	26	SENT_13	[p1l1065t3398r1346b3480],
24	receptor	NN	O	receptor	nn	26	SENT_13	[p1l1372t3405r1685b3480],
25	GP	NN	O	gp	nn	26	SENT_13	[p1l1713t3399r1826b3459],
26	Illa	NN	PERSON	illum	prep_of	20	SENT_13	[p1l1853t3400r1978b3459],
27	that	WDT	O	that	nsubj	28	SENT_13	[p1l2006t3398r2152b3459],
28	renders	VBZ	O	render	rcmod	26	SENT_13	[p1l9t3500r295b3563],
29	them	PRP	O	they	nsubj	30	SENT_13	[p1l336t3500r529b3563],
30	resistant	JJ	O	resistant	xcomp	28	SENT_13	[p1l569t3503r889b3563],
31	to	TO	O	to	_	0	SENT_13	[p1l928t3508r998b3563],
32	its	PRP$	O	its	poss	34	SENT_13	[p1l1040t3503r1124b3563],
33	antithrombotic	JJ	O	antithrombotic	amod	34	SENT_13	[p1l1167t3500r1724b3563],
34	effects	NNS	O	effect	prep_to	30	SENT_13	[p1l1767t3500r1996b3563],
35	[	VBP	O	[	ccomp	14	SENT_13	[p1l2044t3501r2149b3574],
36	1	CD	NUMBER	1	number	37	SENT_13	[p1l2044t3501r2149b3574],
37	]	CD	NUMBER	]	dobj	35	SENT_13	[p1l2044t3501r2149b3574],
38	.	.	O	.	_	0	SENT_13	[p1l2044t3501r2149b3574],

1	The	DT	O	the	det	4	SENT_14	[p2l9t21r149b84],
2	Framingham	NNP	O	Framingham	nn	4	SENT_14	[p2l178t21r660b104],
3	Offspring	NNP	O	Offspring	nn	4	SENT_14	[p2l690t21r1044b105],
4	Study	NNP	O	Study	nsubj	5	SENT_14	[p2l1072t21r1289b105],
5	reported	VBD	O	report	_	0	SENT_14	[p2l1315t21r1639b105],
6	heterozygote	NN	O	heterozygote	nn	9	SENT_14	[p2l1666t21r2150b105],
7	and	CC	O	and	_	0	SENT_14	[p2l11t125r150b186],
8	homozygote	NN	O	homozygote	nn	9	SENT_14	[p2l178t125r636b208],
9	carriers	NNS	O	carrier	dobj	5	SENT_14	[p2l668t127r948b186],
10	of	IN	O	of	_	0	SENT_14	[p2l979t125r1052b186],
11	the	DT	O	the	det	13	SENT_14	[p2l1076t125r1192b186],
12	PIAZ	NN	ORGANIZATION	piaz	nn	13	SENT_14	[p2l1223t115r1375b185],
13	polymorphism	NN	O	polymorphism	prep_of	9	SENT_14	[p2l1404t125r1956b208],
14	having	VBG	O	have	xcomp	5	SENT_14	[p2l1985t125r2150b186, p2l9t230r128b310],
15	higher	JJR	O	higher	amod	17	SENT_14	[p2l171t227r415b310],
16	platelet	NN	O	platelet	nn	17	SENT_14	[p2l458t227r739b310],
17	aggregation	NN	O	aggregation	dobj	14	SENT_14	[p2l783t230r1226b310],
18	than	IN	O	than	_	0	SENT_14	[p2l1269t227r1437b289],
19	subjects	NNS	O	subject	prep_than	14	SENT_14	[p2l1483t227r1780b311],
20	with	IN	O	with	_	0	SENT_14	[p2l1824t227r1990b289],
21	the	DT	O	the	det	23	SENT_14	[p2l2033t227r2150b289],
22	homozygous	JJ	O	homozygous	amod	23	SENT_14	[p2l9t329r484b412],
23	P1	NN	O	p1	prep_with	19	SENT_14	[p2l520t320r670b390],
24	“	CD	NUMBER	“	number	25	SENT_14	[p2l520t320r670b390],
25	(	CD	NUMBER	(	num	28	SENT_14	[p2l709t328r1029b403],
26	normal	JJ	O	normal	amod	28	SENT_14	[p2l709t328r1029b403],
27	)	NN	O	)	nn	28	SENT_14	[p2l709t328r1029b403],
28	genotype	NN	O	genotype	dep	23	SENT_14	[p2l1066t336r1430b412],
29	,	,	O	,	_	0	SENT_14	[p2l1066t336r1430b412],
30	substantiating	VBG	O	substantiate	partmod	23	SENT_14	[p2l1468t329r2001b411],
31	the	DT	O	the	det	32	SENT_14	[p2l2033t329r2150b391],
32	association	NN	O	association	dobj	30	SENT_14	[p2l11t435r421b494],
33	between	IN	O	between	_	0	SENT_14	[p2l456t432r775b494],
34	PIAZ	NNP	ORGANIZATION	PIAZ	nn	35	SENT_14	[p2l811t423r963b493],
35	polymorphism	NN	O	polymorphism	prep_between	32	SENT_14	[p2l999t432r1551b516],
36	and	CC	O	and	_	0	SENT_14	[p2l1589t433r1728b494],
37	cardiovascular	JJ	O	cardiovascular	amod	40	SENT_14	[p2l1765t432r2150b494, p2l11t535r196b597],
38	risk	NN	O	risk	nn	40	SENT_14	[p2l219t535r359b597],
39	profile	NN	O	profile	nn	40	SENT_14	[p2l381t535r623b618],
40	[	NN	O	[	conj_and	32	SENT_14	[p2l656t535r761b608],
41	2	CD	NUMBER	2	num	42	SENT_14	[p2l656t535r761b608],
42	]	NN	O	]	dep	40	SENT_14	[p2l656t535r761b608],
43	.	.	O	.	_	0	SENT_14	[p2l656t535r761b608],

1	Two	CD	NUMBER	two	nsubj	29	SENT_15	[p2l787t537r946b597],
2	recently	RB	DATE	recently	advmod	3	SENT_15	[p2l972t535r1274b619],
3	discovered	VBN	O	discover	amod	1	SENT_15	[p2l1299t535r1703b597],
4	single	JJ	O	single	amod	6	SENT_15	[p2l1728t535r1946b618],
5	gene	NN	O	gene	nn	6	SENT_15	[p2l1974t556r2150b618],
6	polymorphisms	NNS	O	polymorphism	nsubj	9	SENT_15	[p2l9t639r597b723],
7	may	MD	O	may	aux	9	SENT_15	[p2l628t660r788b723],
8	also	RB	O	also	advmod	9	SENT_15	[p2l818t639r962b701],
9	affect	VB	O	affect	parataxis	29	SENT_15	[p2l994t639r1189b701],
10	the	DT	O	the	det	11	SENT_15	[p2l1217t639r1333b701],
11	patient	NN	O	patient	poss	13	SENT_15	[p2l1364t642r1685b722],
12	’s	POS	O	’s	_	0	SENT_15	[p2l1364t642r1685b722],
13	response	NN	O	response	dobj	9	SENT_15	[p2l1716t660r2050b722],
14	to	TO	O	to	_	0	SENT_15	[p2l2080t647r2150b701],
15	aspirin	NN	O	aspirin	prep_to	9	SENT_15	[p2l11t744r287b825],
16	,	,	O	,	_	0	SENT_15	[p2l11t744r287b825],
17	one	CD	NUMBER	one	appos	15	SENT_15	[p2l317t762r450b804],
18	that	WDT	O	that	nsubj	19	SENT_15	[p2l478t741r624b804],
19	results	VBZ	O	result	rcmod	17	SENT_15	[p2l650t741r898b804],
20	in	IN	O	in	_	0	SENT_15	[p2l925t744r997b803],
21	increased	VBN	O	increase	amod	22	SENT_15	[p2l1024t741r1383b804],
22	expression	NN	O	expression	prep_in	19	SENT_15	[p2l1411t744r1811b825],
23	of	IN	O	of	_	0	SENT_15	[p2l1839t741r1911b804],
24	platelet	NN	O	platelet	nn	25	SENT_15	[p2l1934t741r2150b825, p2l9t844r102b907],
25	GP	NN	O	gp	prep_of	22	SENT_15	[p2l161t846r274b907],
26	Ia/Ila	NN	O	ia/ila	nn	28	SENT_15	[p2l332t846r535b907],
27	collagen	NN	O	collagen	nn	28	SENT_15	[p2l595t844r907b927],
28	receptors	NNS	O	receptor	nsubj	29	SENT_15	[p2l965t852r1314b928],
29	(	VBP	O	(	_	0	SENT_15	[p2l1375t843r1601b919],
30	807T	NN	O	807t	nn	31	SENT_15	[p2l1375t843r1601b919],
31	)	NN	O	)	nsubj	51	SENT_15	[p2l1375t843r1601b919],
32	and	CC	O	and	_	0	SENT_15	[p2l1662t844r1802b907],
33	another	DT	O	another	det	36	SENT_15	[p2l1861t844r2152b907],
34	(	CD	NUMBER	(	num	36	SENT_15	[p2l11t947r255b1023],
35	C50T	NN	O	c50t	nn	36	SENT_15	[p2l11t947r255b1023],
36	)	NN	O	)	nsubj	51	SENT_15	[p2l11t947r255b1023],
37	that	WDT	O	that	nsubjpass	40	SENT_15	[p2l307t948r454b1010],
38	has	VBZ	O	have	aux	40	SENT_15	[p2l504t948r629b1010],
39	been	VBN	O	be	auxpass	40	SENT_15	[p2l680t948r863b1010],
40	reported	VBN	O	report	rcmod	36	SENT_15	[p2l914t948r1239b1031],
41	to	TO	O	to	aux	43	SENT_15	[p2l1288t955r1358b1010],
42	be	VB	O	be	auxpass	43	SENT_15	[p2l1409t948r1497b1010],
43	associated	VBN	O	associate	xcomp	40	SENT_15	[p2l1552t948r1936b1010],
44	with	IN	O	with	_	0	SENT_15	[p2l1985t948r2151b1010],
45	increased	VBN	O	increase	amod	46	SENT_15	[p2l9t1051r369b1113],
46	effectiveness	NN	O	effectiveness	prep_with	43	SENT_15	[p2l426t1051r896b1113],
47	of	IN	O	of	_	0	SENT_15	[p2l955t1051r1028b1113],
48	aspirin	NN	O	aspirin	nn	49	SENT_15	[p2l1082t1053r1339b1134],
49	(	NN	O	(	prep_of	46	SENT_15	[p2l1398t1050r1734b1135],
50	possibly	RB	O	possibly	advmod	51	SENT_15	[p2l1398t1050r1734b1135],
51	due	JJ	O	due	xcomp	29	SENT_15	[p2l1791t1051r1927b1113],
52	to	TO	O	to	_	0	SENT_15	[p2l1985t1059r2054b1113],
53	a	DT	O	a	det	54	SENT_15	[p2l2113t1072r2151b1113],
54	reduction	NN	O	reduction	prep_to	51	SENT_15	[p2l9t1154r369b1216],
55	in	IN	O	in	_	0	SENT_15	[p2l400t1157r471b1215],
56	the	DT	O	the	det	57	SENT_15	[p2l502t1154r618b1216],
57	expression	NN	O	expression	prep_in	54	SENT_15	[p2l652t1157r1051b1237],
58	of	IN	O	of	_	0	SENT_15	[p2l1084t1154r1157b1216],
59	COX-1	NN	O	cox-1	nn	60	SENT_15	[p2l1185t1153r1483b1229],
60	)	NN	O	)	prep_of	57	SENT_15	[p2l1185t1153r1483b1229],
61	.	.	O	.	_	0	SENT_15	[p2l1185t1153r1483b1229],

1	Accepted	JJ	O	accepted	_	0	SENT_16	[p2l7t1398r281b1462],
2	for	IN	O	for	_	0	SENT_16	[p2l304t1398r386b1446],
3	publication	NN	O	publication	nn	4	SENT_16	[p2l409t1398r739b1462],
4	Aug	NN	DATE	aug	prep_for	1	SENT_16	[p2l761t1400r885b1462],
5	1	CD	DATE	1	dep	1	SENT_16	[p2l909t1401r952b1456],
6	,	,	DATE	,	_	0	SENT_16	[p2l909t1401r952b1456],
7	2006	CD	DATE	2006	appos	5	SENT_16	[p2l977t1400r1117b1446],
8	.	.	O	.	_	0	SENT_16	[p2l977t1400r1117b1446],

1	Address	NN	O	address	nn	2	SENT_17	[p2l7t1482r249b1530],
2	correspondence	NN	O	correspondence	_	0	SENT_17	[p2l277t1482r740b1546],
3	to	TO	O	to	_	0	SENT_17	[p2l767t1487r821b1530],
4	Dr	NNP	O	Dr	nn	5	SENT_17	[p2l849t1484r925b1529],
5	Lim	NNP	PERSON	Lim	prep_to	2	SENT_17	[p2l951t1484r1079b1540],
6	,	,	O	,	_	0	SENT_17	[p2l951t1484r1079b1540],
7	Department	NNP	ORGANIZATION	Department	appos	2	SENT_17	[p2l1107t1484r1461b1546],
8	of	IN	ORGANIZATION	of	_	0	SENT_17	[p2l1488t1481r1544b1530],
9	Cardiothoracic	JJ	ORGANIZATION	cardiothoracic	amod	10	SENT_17	[p2l1569t1482r1999b1530],
10	Surgery	NN	ORGANIZATION	surgery	prep_of	7	SENT_17	[p2l2028t1483r2151b1530, p2l10t1580r150b1629],
11	,	,	O	,	_	0	SENT_17	[p2l2028t1483r2151b1530, p2l10t1580r150b1629],
12	Papworth	NNP	LOCATION	Papworth	nn	13	SENT_17	[p2l171t1564r453b1628],
13	Hospital	NNP	LOCATION	Hospital	appos	2	SENT_17	[p2l472t1564r733b1628],
14	,	,	O	,	_	0	SENT_17	[p2l472t1564r733b1628],
15	Papworth	NNP	PERSON	Papworth	nn	16	SENT_17	[p2l754t1564r1036b1628],
16	Everard	NNP	PERSON	Everard	appos	2	SENT_17	[p2l1055t1564r1300b1621],
17	,	,	O	,	_	0	SENT_17	[p2l1055t1564r1300b1621],
18	Cambridge	NNP	LOCATION	Cambridge	nn	20	SENT_17	[p2l1321t1564r1646b1628],
19	CB3	NN	O	cb3	nn	20	SENT_17	[p2l1668t1565r1783b1612],
20	8RE	NN	O	8re	appos	2	SENT_17	[p2l1803t1566r1931b1621],
21	,	,	O	,	_	0	SENT_17	[p2l1803t1566r1931b1621],
22	United	NNP	LOCATION	United	nn	23	SENT_17	[p2l1951t1564r2152b1612],
23	Kingdom	NNP	LOCATION	Kingdom	appos	2	SENT_17	[p2l9t1646r294b1710],
24	;	:	O	;	_	0	SENT_17	[p2l9t1646r294b1710],
25	e-mail	VB	O	e-mail	dep	23	SENT_17	[p2l321t1646r519b1694],
26	:	:	O	:	_	0	SENT_17	[p2l321t1646r519b1694],
27	eric.lim@cvsnet.org	NN	O	eric.lim@cvsnet.org	dep	23	SENT_17	[p2l546t1646r1128b1710],
28	.	.	O	.	_	0	SENT_17	[p2l546t1646r1128b1710],

1	©	RB	O	©	amod	8	SENT_18	[p2l10t1860r64b1914],
2	2007	CD	DATE	2007	tmod	1	SENT_18	[p2l91t1862r237b1914],
3	by	IN	O	by	_	0	SENT_18	[p2l262t1859r345b1933],
4	The	DT	O	the	det	5	SENT_18	[p2l370t1859r495b1914],
5	Society	NNP	O	Society	prep_by	1	SENT_18	[p2l526t1860r764b1933],
6	of	IN	O	of	_	0	SENT_18	[p2l791t1858r856b1914],
7	Thoracic	NNP	O	Thoracic	prep_of	5	SENT_18	[p2l879t1859r1165b1914],
8	Surgeons	NNPS	O	Surgeons	nsubj	9	SENT_18	[p2l1195t1860r1504b1932],
9	Published	VBN	O	publish	_	0	SENT_18	[p2l9t1940r343b1996],
10	by	IN	O	by	_	0	SENT_18	[p2l369t1940r451b2014],
11	Elsevier	NNP	ORGANIZATION	Elsevier	nn	12	SENT_18	[p2l478t1940r743b1996],
12	Inc	NNP	ORGANIZATION	Inc	prep_by	9	SENT_18	[p2l769t1943r870b1996],
13	the	DT	O	the	det	16	SENT_18	[p2l9t2036r124b2096],
14	baseline	NN	O	baseline	nn	16	SENT_18	[p2l150t2036r462b2096],
15	platelet	NN	O	platelet	nn	16	SENT_18	[p2l490t2036r771b2116],
16	aggregation	NN	O	aggregation	dep	12	SENT_18	[p2l798t2037r1256b2117],
17	.	.	O	.	_	0	SENT_18	[p2l798t2037r1256b2117],

1	Postoperatively	RB	O	postoperatively	advmod	16	SENT_19	[p2l1285t2036r1887b2117],
2	,	,	O	,	_	0	SENT_19	[p2l1285t2036r1887b2117],
3	after	IN	O	after	_	0	SENT_19	[p2l1915t2035r2086b2096],
4	5	CD	DURATION	5	num	5	SENT_19	[p2l2112t2040r2148b2096],
5	days	NNS	NUMBER	day	prep_after	16	SENT_19	[p2l11t2135r179b2216],
6	of	IN	O	of	_	0	SENT_19	[p2l206t2135r280b2196],
7	aspirin	NN	O	aspirin	prep_of	5	SENT_19	[p2l305t2136r586b2216],
8	,	,	O	,	_	0	SENT_19	[p2l305t2136r586b2216],
9	platelet	NN	O	platelet	nn	10	SENT_19	[p2l612t2135r892b2216],
10	aggregation	NN	O	aggregation	nsubjpass	27	SENT_19	[p2l917t2136r1357b2216],
11	was	VBD	O	be	auxpass	16	SENT_19	[p2l1381t2155r1523b2196],
12	consistently	RB	O	consistently	advmod	16	SENT_19	[p2l1550t2135r2000b2216],
13	but	CC	O	but	_	0	SENT_19	[p2l2022t2135r2149b2196],
14	not	RB	O	not	neg	16	SENT_19	[p2l9t2243r130b2297],
15	signiﬁcantly	RB	O	signiﬁcantly	advmod	16	SENT_19	[p2l188t2236r651b2317],
16	impaired	JJ	O	impaired	_	0	SENT_19	[p2l709t2236r1047b2317],
17	with	IN	O	with	_	0	SENT_19	[p2l1104t2236r1276b2297],
18	PIAZ	NN	ORGANIZATION	piaz	nn	21	SENT_19	[p2l1334t2226r1489b2295],
19	and	CC	O	and	_	0	SENT_19	[p2l1548t2236r1684b2297],
20	A842/C50T	NN	O	a842/c50t	conj_and	18	SENT_19	[p2l1742t2236r2149b2297],
21	carriers	NNS	O	carrier	prep_with	16	SENT_19	[p2l10t2337r284b2396],
22	and	CC	O	and	cc	21	SENT_19	[p2l320t2336r457b2396],
23	consistently	RB	O	consistently	advmod	21	SENT_19	[p2l492t2335r943b2417],
24	but	CC	O	but	_	0	SENT_19	[p2l974t2336r1101b2396],
25	not	RB	O	not	neg	27	SENT_19	[p2l1134t2343r1255b2396],
26	signiﬁcantly	RB	O	signiﬁcantly	advmod	27	SENT_19	[p2l1290t2335r1753b2417],
27	improved	VBN	O	improve	conj_but	16	SENT_19	[p2l1786t2335r2148b2416],
28	with	IN	O	with	_	0	SENT_19	[p2l8t2435r180b2497],
29	C50T	NN	O	c50t	nn	30	SENT_19	[p2l206t2437r398b2497],
30	carriers	NNS	O	carrier	prep_with	27	SENT_19	[p2l423t2436r717b2497],
31	.	.	O	.	_	0	SENT_19	[p2l423t2436r717b2497],

1	An	DT	O	a	det	3	SENT_20	[p2l743t2438r854b2496],
2	interaction	NN	O	interaction	nn	3	SENT_20	[p2l879t2436r1282b2497],
3	term	NN	O	term	nsubjpass	5	SENT_20	[p2l1306t2442r1477b2497],
4	was	VBD	O	be	auxpass	5	SENT_20	[p2l1500t2456r1643b2497],
5	identiﬁed	VBN	O	identiﬁed	_	0	SENT_20	[p2l1669t2435r2030b2497],
6	on	IN	O	on	_	0	SENT_20	[p2l2057t2456r2148b2497],
7	percentage	NN	O	percentage	nn	8	SENT_20	[p2l10t2544r412b2618],
8	aggregation	NN	O	aggregation	prep_on	5	SENT_20	[p2l437t2538r877b2618],
9	and	CC	O	and	_	0	SENT_20	[p2l901t2537r1037b2598],
10	EC50	NN	O	ec50	prep_on	5	SENT_20	[p2l1062t2539r1249b2598],
11	using	VBG	O	use	xcomp	5	SENT_20	[p2l1273t2538r1480b2618],
12	epinephrine	NN	O	epinephrine	dobj	11	SENT_20	[p2l1504t2537r1980b2618],
13	.	.	O	.	_	0	SENT_20	[p2l1504t2537r1980b2618],

1	The	DT	O	the	det	3	SENT_21	[p2l2005t2537r2147b2598],
2	interaction	NN	O	interaction	nn	3	SENT_21	[p2l10t2638r413b2697],
3	coefficient	NN	O	coefficient	nsubj	4	SENT_21	[p2l449t2636r828b2697],
4	describes	VBZ	O	describe	_	0	SENT_21	[p2l863t2637r1209b2697],
5	a	DT	O	a	det	7	SENT_21	[p2l1247t2657r1284b2697],
6	higher	JJR	O	higher	amod	7	SENT_21	[p2l1318t2637r1565b2718],
7	aggregation	NN	O	aggregation	dobj	4	SENT_21	[p2l1599t2638r2039b2718],
8	of	IN	O	of	_	0	SENT_21	[p2l2075t2636r2150b2697],
9	19	CD	PERCENT	19	num	10	SENT_21	[p2l10t2736r159b2797],
10	%	NN	PERCENT	%	nn	15	SENT_21	[p2l10t2736r159b2797],
11	(	CD	PERCENT	(	number	12	SENT_21	[p2l196t2736r369b2804],
12	95	CD	PERCENT	95	dep	13	SENT_21	[p2l196t2736r369b2804],
13	%	NN	PERCENT	%	dep	15	SENT_21	[p2l196t2736r369b2804],
14	conﬁdence	NN	O	conﬁdence	nn	15	SENT_21	[p2l403t2736r800b2797],
15	interval	NN	O	interval	prep_of	7	SENT_21	[p2l833t2736r1141b2797],
16	:	:	O	:	_	0	SENT_21	[p2l833t2736r1141b2797],
17	2	CD	NUMBER	2	number	19	SENT_21	[p2l1173t2741r1211b2796],
18	to	TO	O	to	dep	19	SENT_21	[p2l1241t2743r1310b2797],
19	36	CD	NUMBER	36	dep	7	SENT_21	[p2l1342t2741r1442b2809],
20	;	:	O	;	_	0	SENT_21	[p2l1342t2741r1442b2809],
21	p	NN	O	p	dep	19	SENT_21	[p2l1469t2757r1514b2818],
22	=	JJ	O	=	amod	24	SENT_21	[p2l1552t2757r1603b2783],
23	0.03	CD	NUMBER	0.03	tmod	22	SENT_21	[p2l1642t2736r1806b2804],
24	)	NN	O	)	dep	21	SENT_21	[p2l1642t2736r1806b2804],
25	and	CC	O	and	_	0	SENT_21	[p2l1841t2736r1978b2797],
26	less	JJR	O	less	amod	27	SENT_21	[p2l2009t2736r2147b2797],
27	inhibition	NN	O	inhibition	dep	19	SENT_21	[p2l10t2837r390b2898],
28	with	IN	O	with	_	0	SENT_21	[p2l415t2837r586b2898],
29	an	DT	O	a	det	30	SENT_21	[p2l613t2857r700b2898],
30	EC50	NN	O	ec50	prep_with	27	SENT_21	[p2l727t2839r914b2898],
31	of	IN	O	of	_	0	SENT_21	[p2l942t2837r1016b2898],
32	-2.07	CD	NUMBER	-2.07	number	33	SENT_21	[p2l1048t2841r1251b2898],
33	(	CD	NUMBER	(	num	36	SENT_21	[p2l1279t2837r1511b2905],
34	-4.19	CD	NUMBER	-4.19	number	36	SENT_21	[p2l1279t2837r1511b2905],
35	to	TO	O	to	dep	36	SENT_21	[p2l1538t2844r1606b2898],
36	0.04	CD	NUMBER	0.04	prep_of	30	SENT_21	[p2l1634t2841r1795b2910],
37	;	:	O	;	_	0	SENT_21	[p2l1634t2841r1795b2910],
38	p	NN	O	p	dep	7	SENT_21	[p2l1817t2858r1861b2918],
39	=	JJ	O	=	amod	41	SENT_21	[p2l1896t2858r1947b2884],
40	0.06	CD	NUMBER	0.06	tmod	39	SENT_21	[p2l1980t2837r2144b2905],
41	)	NN	O	)	dep	38	SENT_21	[p2l1980t2837r2144b2905],
42	in	IN	O	in	_	0	SENT_21	[p2l10t2937r84b2996],
43	patients	NNS	O	patient	prep_in	7	SENT_21	[p2l123t2937r420b3017],
44	who	WP	O	who	nsubj	48	SENT_21	[p2l460t2936r621b2997],
45	were	VBD	O	be	cop	48	SENT_21	[p2l661t2956r841b2997],
46	both	DT	O	both	det	47	SENT_21	[p2l880t2936r1052b2997],
47	PIAZ	NN	O	piaz	npadvmod	48	SENT_21	[p2l1093t2927r1248b2996],
48	positive	JJ	O	positive	rcmod	43	SENT_21	[p2l1288t2937r1585b3017],
49	and	CC	O	and	_	0	SENT_21	[p2l1627t2937r1763b2997],
50	receiving	VBG	O	receive	conj_and	48	SENT_21	[p2l1804t2937r2149b3018],
51	low-dose	JJ	O	low-dose	amod	52	SENT_21	[p2l9t3037r348b3098],
52	aspirin	NN	O	aspirin	dobj	50	SENT_21	[p2l381t3038r661b3118],
53	.	.	O	.	_	0	SENT_21	[p2l381t3038r661b3118],

1	Conclusions	NNS	O	conclusion	_	0	SENT_22	[p2l96t3137r555b3199],
2	.	.	O	.	_	0	SENT_22	[p2l96t3137r555b3199],

1	Genetic	JJ	O	genetic	amod	2	SENT_23	[p2l611t3139r898b3199],
2	polymorphisms	NNS	O	polymorphism	nsubj	10	SENT_23	[p2l948t3138r1538b3219],
3	that	WDT	O	that	nsubj	4	SENT_23	[p2l1590t3138r1734b3199],
4	affect	VBP	O	affect	rcmod	2	SENT_23	[p2l1784t3138r1983b3199],
5	the	DT	O	the	det	6	SENT_23	[p2l2032t3138r2147b3199],
6	response	NN	O	response	dobj	4	SENT_23	[p2l10t3259r339b3319],
7	to	TO	O	to	_	0	SENT_23	[p2l369t3246r439b3299],
8	aspirin	NN	O	aspirin	prep_to	4	SENT_23	[p2l471t3239r732b3319],
9	are	VBP	O	be	cop	10	SENT_23	[p2l763t3259r872b3299],
10	common	JJ	O	common	_	0	SENT_23	[p2l903t3259r1243b3299],
11	.	.	O	.	_	0	SENT_23	[p2l903t3259r1243b3299],

1	The	DT	O	the	det	3	SENT_24	[p2l1274t3238r1416b3299],
2	impaired	JJ	O	impaired	amod	3	SENT_24	[p2l1448t3239r1787b3319],
3	response	NN	O	response	nsubj	14	SENT_24	[p2l1818t3259r2147b3319],
4	of	IN	O	of	_	0	SENT_24	[p2l11t3338r85b3399],
5	persons	NNS	O	person	prep_of	3	SENT_24	[p2l106t3358r394b3419],
6	with	IN	O	with	_	0	SENT_24	[p2l417t3338r588b3399],
7	the	DT	O	the	det	9	SENT_24	[p2l610t3338r725b3399],
8	PIAZ	NN	ORGANIZATION	piaz	nn	9	SENT_24	[p2l749t3328r905b3398],
9	polymorphism	NN	O	polymorphism	prep_with	5	SENT_24	[p2l927t3338r1482b3419],
10	to	TO	O	to	_	0	SENT_24	[p2l1504t3345r1573b3399],
11	aspirin	NN	O	aspirin	prep_to	9	SENT_24	[p2l1598t3339r1859b3419],
12	may	MD	O	may	aux	14	SENT_24	[p2l1881t3358r2039b3419],
13	be	VB	O	be	cop	14	SENT_24	[p2l2059t3338r2147b3399],
14	dose	NN	O	dose	_	0	SENT_24	[p2l11t3439r179b3500],
15	related	JJ	O	related	amod	14	SENT_24	[p2l215t3439r493b3512],
16	,	,	O	,	_	0	SENT_24	[p2l215t3439r493b3512],
17	with	IN	O	with	_	0	SENT_24	[p2l527t3439r699b3500],
18	signiﬁcant	JJ	O	signiﬁcant	amod	19	SENT_24	[p2l735t3439r1125b3520],
19	improvement	NN	O	improvement	prep_with	14	SENT_24	[p2l1160t3440r1665b3520],
20	observed	VBN	O	observe	partmod	19	SENT_24	[p2l1700t3439r2038b3500],
21	in	IN	O	in	_	0	SENT_24	[p2l2074t3440r2148b3499],
22	patients	NNS	O	patient	prep_in	20	SENT_24	[p2l10t3540r307b3619],
23	using	VBG	O	use	partmod	22	SENT_24	[p2l339t3540r546b3620],
24	medium	NN	O	medium	dobj	23	SENT_24	[p2l577t3539r917b3599],
25	-	:	O	-	_	0	SENT_24	[p2l577t3539r917b3599],
26	rather	RB	O	rather	_	0	SENT_24	[p2l947t3539r1170b3599],
27	than	IN	O	than	_	0	SENT_24	[p2l1198t3539r1365b3599],
28	low-dose	JJ	O	low-dose	amod	29	SENT_24	[p2l1395t3539r1734b3599],
29	aspirin	NN	O	aspirin	conj_negcc	14	SENT_24	[p2l1767t3540r2047b3619],
30	.	.	O	.	_	0	SENT_24	[p2l1767t3540r2047b3619],

1	(	NN	O	(	nn	4	SENT_25	[p3l914t66r1100b134],
2	Ann	NNP	PERSON	Ann	nn	4	SENT_25	[p3l914t66r1100b134],
3	Thorac	NNP	PERSON	Thorac	nn	4	SENT_25	[p3l1130t66r1387b127],
4	Surg	NNP	PERSON	Surg	dep	11	SENT_25	[p3l1421t68r1594b147],
5	2007	CD	DATE	2007	num	7	SENT_25	[p3l1625t70r2028b139],
6	;	:	O	;	_	0	SENT_25	[p3l1625t70r2028b139],
7	83:134	CD	NUMBER	83:134	dep	4	SENT_25	[p3l1625t70r2028b139],
8	-9	CD	NUMBER	-9	num	9	SENT_25	[p3l2040t66r2144b134],
9	)	NN	O	)	dep	11	SENT_25	[p3l2040t66r2144b134],
10	©	CD	NUMBER	©	num	11	SENT_25	[p3l461t167r519b226],
11	2007	CD	DATE	2007	_	0	SENT_25	[p3l550t170r712b226],
12	by	IN	O	by	_	0	SENT_25	[p3l741t166r836b247],
13	The	DT	O	the	det	14	SENT_25	[p3l865t165r1008b226],
14	Society	NNP	O	Society	prep_by	11	SENT_25	[p3l1042t167r1312b247],
15	of	IN	O	of	_	0	SENT_25	[p3l1343t165r1417b226],
16	Thoracic	NNP	O	Thoracic	nn	17	SENT_25	[p3l1446t165r1768b226],
17	Surgeons	NNPS	O	Surgeons	prep_of	14	SENT_25	[p3l1802t167r2147b247],

1	In	IN	O	in	_	0	SENT_26	[p3l92t414r169b472],
2	the	DT	O	the	det	3	SENT_26	[p3l211t412r331b473],
3	dawn	NN	TIME	dawn	prep_in	9	SENT_26	[p3l378t412r586b473],
4	of	IN	O	of	_	0	SENT_26	[p3l631t412r704b473],
5	pharmacogenomics	NNS	O	pharmacogenomic	prep_of	3	SENT_26	[p3l743t412r1522b494],
6	,	,	O	,	_	0	SENT_26	[p3l743t412r1522b494],
7	little	JJ	O	little	nsubjpass	9	SENT_26	[p3l1566t412r1740b473],
8	is	VBZ	O	be	auxpass	9	SENT_26	[p3l1785t414r1843b473],
9	known	VBN	O	know	_	0	SENT_26	[p3l1887t412r2148b473],
10	about	IN	O	about	_	0	SENT_26	[p3l11t515r229b576],
11	how	WRB	O	how	advmod	13	SENT_26	[p3l285t515r448b576],
12	genes	NNS	O	gene	nsubj	13	SENT_26	[p3l504t536r723b597],
13	affect	VBP	O	affect	prepc_about	9	SENT_26	[p3l782t515r986b576],
14	the	DT	O	the	det	16	SENT_26	[p3l1041t515r1160b576],
15	individual	JJ	O	individual	amod	16	SENT_26	[p3l1219t515r1616b576],
16	response	NN	O	response	dobj	13	SENT_26	[p3l1673t536r2018b597],
17	to	TO	O	to	_	0	SENT_26	[p3l2076t522r2147b576],
18	aspirin	NN	O	aspirin	prep_to	13	SENT_26	[p3l11t621r277b702],
19	after	IN	O	after	_	0	SENT_26	[p3l321t619r498b681],
20	cardiopulmonary	JJ	O	cardiopulmonary	amod	22	SENT_26	[p3l541t619r1212b703],
21	bypass	NN	O	bypass	nn	22	SENT_26	[p3l1251t619r1515b703],
22	(	NN	O	(	prep_after	13	SENT_26	[p3l1561t618r1780b694],
23	itself	PRP	O	itself	advmod	22	SENT_26	[p3l1561t618r1780b694],
24	a	DT	O	a	det	26	SENT_26	[p3l1819t640r1857b681],
25	potent	JJ	O	potent	amod	26	SENT_26	[p3l1899t627r2150b702],
26	stimulator	NN	O	stimulator	dep	22	SENT_26	[p3l10t723r409b785],
27	of	IN	O	of	_	0	SENT_26	[p3l451t723r525b785],
28	platelets	NNS	O	platelet	prep_of	26	SENT_26	[p3l564t722r941b806],
29	)	CD	NUMBER	)	dep	26	SENT_26	[p3l564t722r941b806],
30	.	.	O	.	_	0	SENT_26	[p3l564t722r941b806],

1	To	TO	O	to	aux	2	SENT_27	[p3l985t725r1080b785],
2	evaluate	VB	O	evaluate	purpcl	15	SENT_27	[p3l1126t723r1447b785],
3	the	DT	O	the	det	4	SENT_27	[p3l1491t723r1610b785],
4	feasibility	NN	O	feasibility	dobj	2	SENT_27	[p3l1653t723r2036b807],
5	of	IN	O	of	_	0	SENT_27	[p3l2078t723r2152b785],
6	genetic	JJ	O	genetic	amod	7	SENT_27	[p3l11t829r286b909],
7	profiling	NN	O	profiling	prep_of	4	SENT_27	[p3l313t827r647b909],
8	for	IN	O	for	_	0	SENT_27	[p3l671t827r779b888],
9	targeted	VBN	O	target	dep	10	SENT_27	[p3l803t827r1125b909],
10	postoperative	JJ	O	postoperative	amod	12	SENT_27	[p3l1150t829r1679b909],
11	antiplatelet	JJ	O	antiplatelet	amod	12	SENT_27	[p3l1708t827r2150b909],
12	therapy	NN	O	therapy	prep_for	2	SENT_27	[p3l9t930r327b1013],
13	,	,	O	,	_	0	SENT_27	[p3l9t930r327b1013],
14	we	PRP	O	we	nsubj	15	SENT_27	[p3l379t951r486b991],
15	performed	VBD	O	perform	_	0	SENT_27	[p3l539t930r951b1012],
16	a	DT	O	a	det	17	SENT_27	[p3l1003t951r1041b991],
17	subanalysis	NN	O	subanalysis	dobj	15	SENT_27	[p3l1094t930r1542b1013],
18	of	IN	O	of	_	0	SENT_27	[p3l1596t930r1670b991],
19	the	DT	O	the	det	20	SENT_27	[p3l1717t930r1837b991],
20	results	NNS	O	result	prep_of	17	SENT_27	[p3l1890t930r2147b991],
21	from	IN	O	from	_	0	SENT_27	[p3l9t1033r192b1094],
22	a	DT	O	a	det	24	SENT_27	[p3l230t1054r267b1094],
23	randomized	JJ	O	randomized	amod	24	SENT_27	[p3l303t1033r770b1094],
24	trial	NN	O	trial	prep_from	15	SENT_27	[p3l804t1033r961b1094],
25	to	TO	O	to	aux	26	SENT_27	[p3l996t1040r1067b1094],
26	evaluate	VB	O	evaluate	xcomp	15	SENT_27	[p3l1106t1033r1428b1094],
27	the	DT	O	the	det	28	SENT_27	[p3l1465t1033r1584b1094],
28	impact	NN	O	impact	dobj	26	SENT_27	[p3l1621t1035r1886b1115],
29	of	IN	O	of	_	0	SENT_27	[p3l1922t1033r1996b1094],
30	the	DT	O	the	det	32	SENT_27	[p3l2027t1033r2146b1094],
31	candidate	NN	O	candidate	nn	32	SENT_27	[p3l11t1137r386b1198],
32	polymorphisms	NNS	O	polymorphism	prep_of	28	SENT_27	[p3l414t1137r1021b1220],
33	on	IN	O	on	_	0	SENT_27	[p3l1051t1158r1144b1198],
34	baseline	NN	O	baseline	nn	35	SENT_27	[p3l1169t1137r1490b1198],
35	aggregation	NN	O	aggregation	prep_on	26	SENT_27	[p3l1519t1139r1978b1219],
36	and	CC	O	and	_	0	SENT_27	[p3l2006t1137r2149b1198],
37	the	DT	O	the	det	38	SENT_27	[p3l9t1240r128b1301],
38	response	NN	O	response	prep_on	26	SENT_27	[p3l159t1261r504b1322],
39	to	TO	O	to	_	0	SENT_27	[p3l535t1247r606b1301],
40	different	JJ	O	different	amod	42	SENT_27	[p3l639t1239r967b1301],
41	aspirin	NN	O	aspirin	nn	42	SENT_27	[p3l996t1242r1264b1322],
42	doses	NNS	O	dose	prep_to	26	SENT_27	[p3l1295t1240r1507b1301],
43	after	IN	O	after	_	0	SENT_27	[p3l1539t1239r1716b1301],
44	cardiopulmonary	JJ	O	cardiopulmonary	amod	45	SENT_27	[p3l1746t1240r2147b1322, p3l10t1364r307b1426],
45	bypass	NN	O	bypass	prep_after	26	SENT_27	[p3l338t1343r623b1426],
46	.	.	O	.	_	0	SENT_27	[p3l338t1343r623b1426],

1	Material	NN	O	material	_	0	SENT_28	[p3l10t1591r361b1659],
2	and	CC	O	and	_	0	SENT_28	[p3l397t1591r549b1659],
3	Methods	NNS	O	method	conj_and	1	SENT_28	[p3l585t1591r950b1659],

1	A	DT	O	a	det	5	SENT_29	[p3l7t1749r69b1806],
2	Local	NNP	ORGANIZATION	Local	nn	5	SENT_29	[p3l106t1746r304b1808],
3	Research	NNP	ORGANIZATION	Research	nn	5	SENT_29	[p3l340t1746r679b1808],
4	Ethics	NNPS	ORGANIZATION	Ethics	nn	5	SENT_29	[p3l717t1746r941b1808],
5	Committee	NNP	ORGANIZATION	Committee	nsubj	6	SENT_29	[p3l980t1748r1394b1808],
6	approved	VBD	O	approve	_	0	SENT_29	[p3l1435t1746r1791b1828],
7	our	PRP$	O	we	poss	10	SENT_29	[p3l1828t1767r1954b1808],
8	prospective	JJ	O	prospective	amod	10	SENT_29	[p3l1989t1767r2147b1828, p3l10t1852r311b1931],
9	randomized	JJ	O	randomized	amod	10	SENT_29	[p3l341t1849r793b1911],
10	trial	NN	O	trial	dobj	6	SENT_29	[p3l821t1849r970b1911],
11	to	TO	O	to	aux	12	SENT_29	[p3l998t1856r1067b1911],
12	evaluate	VB	O	evaluate	xcomp	6	SENT_29	[p3l1100t1849r1410b1911],
13	low	JJ	O	low	amod	17	SENT_29	[p3l1440t1849r1603b1911],
14	-	:	O	-	_	0	SENT_29	[p3l1440t1849r1603b1911],
15	and	CC	O	and	_	0	SENT_29	[p3l1635t1849r1774b1911],
16	mediumdose	JJ	O	mediumdose	conj_and	13	SENT_29	[p3l1803t1849r2147b1911, p3l11t1953r180b2014],
17	aspirin	NN	O	aspirin	dobj	12	SENT_29	[p3l211t1956r468b2035],
18	and	CC	O	and	_	0	SENT_29	[p3l499t1953r638b2014],
19	clopidogrel	NN	O	clopidogrel	conj_and	17	SENT_29	[p3l667t1953r1088b2035],
20	after	IN	O	after	_	0	SENT_29	[p3l1118t1953r1288b2014],
21	primary	JJ	O	primary	amod	24	SENT_29	[p3l1315t1956r1617b2036],
22	elective	JJ	O	elective	amod	24	SENT_29	[p3l1646t1953r1926b2014],
23	coronary	JJ	O	coronary	amod	24	SENT_29	[p3l1957t1974r2147b2014, p3l10t2077r178b2139],
24	surgery	NN	O	surgery	prep_after	12	SENT_29	[p3l205t2077r505b2139],
25	.	.	O	.	_	0	SENT_29	[p3l205t2077r505b2139],

1	All	DT	O	all	det	2	SENT_30	[p3l532t2056r642b2116],
2	patients	NNS	O	patient	nsubj	3	SENT_30	[p3l668t2058r966b2138],
3	gave	VBD	O	give	_	0	SENT_30	[p3l995t2077r1164b2138],
4	written	VBN	O	write	dep	3	SENT_30	[p3l1191t2058r1461b2117],
5	informed	VBN	O	inform	amod	6	SENT_30	[p3l1487t2056r1834b2117],
6	consent	NN	O	consent	dobj	4	SENT_30	[p3l1862t2063r2149b2117],
7	for	IN	O	for	_	0	SENT_30	[p3l9t2158r114b2220],
8	genetic	JJ	O	genetic	amod	9	SENT_30	[p3l159t2161r425b2241],
9	testing	NN	O	testing	prep_for	6	SENT_30	[p3l470t2161r740b2241],
10	.	.	O	.	_	0	SENT_30	[p3l470t2161r740b2241],

1	The	DT	O	the	det	2	SENT_31	[p3l787t2159r928b2220],
2	details	NNS	O	detail	nsubjpass	8	SENT_31	[p3l977t2159r1219b2220],
3	of	IN	O	of	_	0	SENT_31	[p3l1266t2158r1338b2220],
4	our	PRP$	O	we	poss	5	SENT_31	[p3l1381t2180r1507b2220],
5	trial	NN	O	trial	prep_of	2	SENT_31	[p3l1550t2159r1700b2220],
6	have	VBP	O	have	aux	8	SENT_31	[p3l1745t2159r1920b2220],
7	been	VBN	O	be	auxpass	8	SENT_31	[p3l1965t2159r2148b2220],
8	published	VBN	O	publish	_	0	SENT_31	[p3l9t2262r385b2344],
9	[	CD	NUMBER	[	number	10	SENT_31	[p3l422t2262r527b2334],
10	3	CD	NUMBER	3	num	11	SENT_31	[p3l422t2262r527b2334],
11	]	NN	O	]	dobj	8	SENT_31	[p3l422t2262r527b2334],
12	.	.	O	.	_	0	SENT_31	[p3l422t2262r527b2334],

1	In	IN	O	in	_	0	SENT_32	[p3l562t2264r638b2322],
2	this	DT	O	this	det	3	SENT_32	[p3l669t2262r804b2323],
3	substudy	NN	O	substudy	prep_in	6	SENT_32	[p3l839t2262r1197b2345],
4	,	,	O	,	_	0	SENT_32	[p3l839t2262r1197b2345],
5	we	PRP	O	we	nsubj	6	SENT_32	[p3l1230t2283r1335b2323],
6	analyzed	VBD	O	analyze	_	0	SENT_32	[p3l1370t2262r1703b2345],
7	the	DT	O	the	det	9	SENT_32	[p3l1734t2262r1850b2323],
8	biological	JJ	O	biological	amod	9	SENT_32	[p3l1883t2262r2147b2344, p3l9t2364r136b2426],
9	efficacy	NN	O	efficacy	nsubj	24	SENT_32	[p3l172t2364r444b2447],
10	of	IN	O	of	_	0	SENT_32	[p3l478t2364r551b2426],
11	differing	VBG	O	differ	amod	13	SENT_32	[p3l583t2364r898b2446],
12	aspirin	NN	O	aspirin	nn	13	SENT_32	[p3l932t2367r1189b2447],
13	doses	NNS	O	dose	prep_of	9	SENT_32	[p3l1226t2364r1431b2426],
14	on	IN	O	on	_	0	SENT_32	[p3l1468t2386r1559b2426],
15	patients	NNS	O	patient	prep_on	13	SENT_32	[p3l1593t2367r1891b2447],
16	in	IN	O	in	_	0	SENT_32	[p3l1926t2367r1997b2425],
17	the	DT	O	the	det	19	SENT_32	[p3l2030t2364r2147b2426],
18	aspirin	NN	O	aspirin	nn	19	SENT_32	[p3l11t2470r268b2550],
19	arms	NNS	O	arm	prep_in	15	SENT_32	[p3l308t2489r489b2529],
20	who	WP	O	who	nsubj	21	SENT_32	[p3l526t2467r686b2529],
21	gave	VBD	O	give	rcmod	13	SENT_32	[p3l726t2489r896b2549],
22	written	VBN	O	write	dep	21	SENT_32	[p3l934t2470r1203b2529],
23	informed	VBN	O	inform	dep	22	SENT_32	[p3l1241t2467r1588b2529],
24	consented	VBD	O	consent	ccomp	6	SENT_32	[p3l1627t2467r2007b2529],
25	for	IN	O	for	_	0	SENT_32	[p3l2044t2467r2149b2529],
26	molecular	JJ	O	molecular	amod	28	SENT_32	[p3l9t2570r384b2632],
27	genetic	JJ	O	genetic	amod	28	SENT_32	[p3l414t2573r681b2652],
28	testing	NN	O	testing	prep_for	24	SENT_32	[p3l711t2573r981b2652],
29	.	.	O	.	_	0	SENT_32	[p3l711t2573r981b2652],

1	O003-4975	CD	NUMBER	o003-4975	_	0	SENT_33	[p3l1499t2797r1842b2851],
2	/	:	O	/	punct	10	SENT_33	[p3l1499t2797r1842b2851],
3	07	CD	NUMBER	07	dep	10	SENT_33	[p3l1849t2797r1944b2851],
4	/	:	O	/	punct	5	SENT_33	[p3l1849t2797r1944b2851],
5	$	$	MONEY	$	dep	3	SENT_33	[p3l1950t2795r2148b2858],
6	32.00	CD	MONEY	32.00	num	5	SENT_33	[p3l1950t2795r2148b2858],
7	doi	FW	O	doi	dep	5	SENT_33	[p3l982t2877r1366b2933],
8	:10.1016	CD	NUMBER	:10.1016	dep	7	SENT_33	[p3l982t2877r1366b2933],
9	/	:	O	/	punct	5	SENT_33	[p3l982t2877r1366b2933],
10	j	NN	O	j	dep	1	SENT_33	[p3l1369t2880r1386b2952],
11	.	.	O	.	_	0	SENT_33	[p3l1394t2878r2148b2933],

1	athoracsur	NN	O	athoracsur	nn	2	SENT_34	[p3l1394t2878r2148b2933],
2	.2006.08.002	NN	O	.2006.08.002	_	0	SENT_34	[p3l1394t2878r2148b2933],

1	Ann	NNP	PERSON	Ann	nn	6	SENT_35	[p3l6t3032r63b3053],
2	Thorac	NNP	PERSON	Thorac	nn	6	SENT_35	[p3l74t3031r166b3053],
3	Surg	NNP	PERSON	Surg	nn	6	SENT_35	[p3l178t3032r240b3061],
4	LIM	NN	O	lim	nn	6	SENT_35	[p3l1755t3032r1810b3053],
5	ET	NNP	O	ET	nn	6	SENT_35	[p3l1821t3032r1857b3053],
6	AL	NNP	O	AL	_	0	SENT_35	[p3l1867t3032r1906b3053],
7	135	CD	NUMBER	135	num	8	SENT_35	[p3l1977t3027r2030b3054],
8	20o7	NN	O	20o7	dep	6	SENT_35	[p3l6t3066r182b3091],
9	;	:	O	;	_	0	SENT_35	[p3l6t3066r182b3091],
10	s3	NN	O	s3	nn	15	SENT_35	[p3l6t3066r182b3091],
11	:134	CD	NUMBER	:134	num	15	SENT_35	[p3l6t3066r182b3091],
12	—	CD	NUMBER	—	num	15	SENT_35	[p3l6t3066r182b3091],
13	9	CD	NUMBER	9	num	15	SENT_35	[p3l6t3066r182b3091],
14	ASPIRIN	NNP	O	ASPIRIN	nn	15	SENT_35	[p3l1131t3065r1253b3087],
15	EFFICACY	NNP	O	EFFICACY	dep	6	SENT_35	[p3l1263t3065r1409b3087],
16	WITH	IN	O	with	_	0	SENT_35	[p3l1419t3066r1501b3087],
17	GENETIC	NNP	O	GENETIC	nn	18	SENT_35	[p3l1513t3065r1645b3087],
18	POLYMORPHISM	NNP	O	POLYMORPHISM	prep_with	15	SENT_35	[p3l1657t3065r1906b3087],

1	Table	NNP	O	Table	_	0	SENT_36	[p3l8t3230r93b3258],
2	1	CD	NUMBER	1	dep	1	SENT_36	[p3l107t3231r130b3257],
3	.	.	O	.	_	0	SENT_36	[p3l107t3231r130b3257],

1	Genotyping	NN	O	genotyping	dep	6	SENT_37	[p3l154t3230r337b3268],
2	of	IN	O	of	_	0	SENT_37	[p3l349t3229r384b3268],
3	Platelet	NN	O	platelet	prep_of	1	SENT_37	[p3l391t3229r509b3258],
4	Glycoprotein	NN	O	glycoprotein	nn	5	SENT_37	[p3l522t3230r723b3268],
5	GP	NN	O	gp	dep	6	SENT_37	[p3l738t3230r787b3258],
6	Illa	NN	O	illum	dep	17	SENT_37	[p3l798t3231r861b3263],
7	,	,	O	,	_	0	SENT_37	[p3l798t3231r861b3263],
8	In/Ila	NN	O	in/ila	dep	17	SENT_37	[p3l876t3230r971b3263],
9	,	,	O	,	_	0	SENT_37	[p3l876t3230r971b3263],
10	and	CC	O	and	_	0	SENT_37	[p3l987t3230r1045b3258],
11	Cyclooxygenuse	NN	O	cyclooxygenuse	conj_and	6	SENT_37	[p3l1060t3229r1306b3268],
12	1	CD	NUMBER	1	number	13	SENT_37	[p3l1321t3231r1335b3257],
13	(	CD	NUMBER	(	dep	6	SENT_37	[p3l1353t3229r2022b3268],
14	Prostaglandin-Endoglundin-Endoperoxide	NNP	O	Prostaglandin-Endoglundin-Endoperoxide	nn	15	SENT_37	[p3l1353t3229r2022b3268],
15	Synthase	NN	O	synthase	dep	13	SENT_37	[p3l7t3271r148b3309],
16	1	CD	NUMBER	1	num	17	SENT_37	[p3l163t3271r190b3303],
17	)	NN	O	)	_	0	SENT_37	[p3l163t3271r190b3303],

1	Restriction	NN	O	restriction	nn	2	SENT_38	[p3l1866t3344r2029b3368],
2	Alleles	NNS	O	allele	_	0	SENT_38	[p3l527t3380r631b3406],
3	Gene	NNP	O	Gene	nn	5	SENT_38	[p3l719t3381r798b3406],
4	Accession	NNP	O	Accession	nn	5	SENT_38	[p3l858t3381r1010b3406],
5	No.	NN	O	no.	dep	2	SENT_38	[p3l1022t3381r1075b3406],
6	.	.	O	.	_	0	SENT_38	[p3l1022t3381r1075b3406],

1	Oligonucleiotides	JJ	MISC	oligonucleiotides	amod	2	SENT_39	[p3l1337t3380r1605b3414],
2	Enzyme	NN	MISC	enzyme	_	0	SENT_39	[p3l1887t3381r2007b3414],

1	CARDIOVASCULAR	NN	O	cardiovascular	_	0	SENT_40	[p3l16t3465r40b3790],

1	Platelet	NN	O	platelet	nn	2	SENT_41	[p4l6t46r119b71],
2	glycoprotein	NN	O	glycoprotein	_	0	SENT_41	[p4l132t46r321b80],
3	GP	NN	O	gp	dep	2	SENT_41	[p4l334t46r380b71],
4	IIIa	NN	O	iium	nn	6	SENT_41	[p4l392t47r443b71],
5	P1	NN	O	p1	nn	6	SENT_41	[p4l499t42r574b76],
6	“	NN	O	“	dobj	3	SENT_41	[p4l499t42r574b76],
7	,	,	O	,	_	0	SENT_41	[p4l499t42r574b76],
8	P1	NN	O	p1	nn	11	SENT_41	[p4l587t42r654b71],
9	”	CD	NUMBER	”	num	11	SENT_41	[p4l587t42r654b71],
10	ITGB3	NN	O	itgb3	nn	11	SENT_41	[p4l709t46r800b71],
11	NM_000212	NN	O	nm_000212	appos	6	SENT_41	[p4l878t47r1054b75],
12	5	CD	NUMBER	5	dep	11	SENT_41	[p4l1128t46r1798b71],
13	’	SYM	O	’	dep	6	SENT_41	[p4l1128t46r1798b71],
14	-	:	O	-	_	0	SENT_41	[p4l1128t46r1798b71],
15	TGGACTTCTCTTTGGGCTCCTGTCT-3	NN	O	tggacttctctttgggctcctgtct-3	nn	17	SENT_41	[p4l1128t46r1798b71],
16	’	CD	NUMBER	’	num	17	SENT_41	[p4l1128t46r1798b71],
17	Mspl	NN	O	mspl	dep	2	SENT_41	[p4l1884t46r1957b80],

1	5	CD	NUMBER	5	_	0	SENT_42	[p4l1486t87r2154b112],
2	’	SYM	O	’	dep	1	SENT_42	[p4l1486t87r2154b112],
3	-	:	O	-	_	0	SENT_42	[p4l1486t87r2154b112],
4	CGATGGATTCTGGGGCACAGTTAT-3	NN	O	cgatggattctggggcacagttat-3	dep	1	SENT_42	[p4l1486t87r2154b112],
5	’	NN	O	’	dep	4	SENT_42	[p4l1486t87r2154b112],

1	Platelet	NN	O	platelet	nn	2	SENT_43	[p4l6t127r119b152],
2	glycoprotein	NN	O	glycoprotein	_	0	SENT_43	[p4l132t127r321b161],
3	Ial	JJ	O	ial	amod	5	SENT_43	[p4l334t128r373b152],
4	Ila	NN	O	ilum	nn	5	SENT_43	[p4l376t128r415b152],
5	C807T	NN	O	c807t	dep	2	SENT_43	[p4l499t128r593b152],
6	ITGA2	NN	O	itga2	nn	7	SENT_43	[p4l708t128r803b152],
7	NM_0O2203	NN	O	nm_0o2203	rcmod	5	SENT_43	[p4l878t128r1054b156],
8	5	CD	NUMBER	5	dep	7	SENT_43	[p4l1128t128r1804b152],
9	’	SYM	O	’	dep	7	SENT_43	[p4l1128t128r1804b152],
10	-	:	O	-	_	0	SENT_43	[p4l1128t128r1804b152],
11	TTAATTCAGTATGCCAATAATCCAA-3	NN	O	ttaattcagtatgccaataatccaa-3	dep	5	SENT_43	[p4l1128t128r1804b152],
12	’	CD	NUMBER	’	num	13	SENT_43	[p4l1128t128r1804b152],
13	Hpy188I	NN	O	hpy188us	dep	11	SENT_43	[p4l1885t128r2008b161],

1	5	CD	NUMBER	5	_	0	SENT_44	[p4l1509t168r2154b193],
2	’	SYM	O	’	dep	1	SENT_44	[p4l1509t168r2154b193],
3	-	:	O	-	_	0	SENT_44	[p4l1509t168r2154b193],
4	ACTTACCTTGCATATTGAATTGCT-3	NN	O	acttaccttgcatattgaattgct-3	dep	1	SENT_44	[p4l1509t168r2154b193],
5	’	NN	O	’	dep	4	SENT_44	[p4l1509t168r2154b193],

1	Cyclooxygenase	NNP	MISC	Cyclooxygenase	_	0	SENT_45	[p4l6t208r249b242],
2	I	PRP	O	I	nsubj	3	SENT_45	[p4l262t209r272b233],
3	C50T	VBP	O	c50t	rcmod	1	SENT_45	[p4l499t209r577b233],
4	PTGS1	NN	O	ptgs1	nn	5	SENT_45	[p4l708t209r805b233],
5	NM_000962	NN	O	nm_000962	dobj	3	SENT_45	[p4l878t209r1054b237],
6	5	CD	NUMBER	5	dep	5	SENT_45	[p4l1127t208r1779b233],
7	’	SYM	O	’	dep	5	SENT_45	[p4l1127t208r1779b233],
8	-	:	O	-	_	0	SENT_45	[p4l1127t208r1779b233],
9	AGCCCCTCATCTCTCTCCTCTGCA-3	NN	O	agcccctcatctctctcctctgca-3	dep	1	SENT_45	[p4l1127t208r1779b233],
10	’	CD	NUMBER	’	num	9	SENT_45	[p4l1127t208r1779b233],
11	Paul	NNP	PERSON	Paul	dep	9	SENT_45	[p4l1885t209r1949b233],

1	5	CD	NUMBER	5	_	0	SENT_46	[p4l1544t249r2154b274],
2	’	SYM	O	’	dep	1	SENT_46	[p4l1544t249r2154b274],
3	-	:	O	-	_	0	SENT_46	[p4l1544t249r2154b274],
4	GAGGGATGGGGCCGCCTACCT-3	NN	O	gagggatggggccgcctacct-3	dep	1	SENT_46	[p4l1544t249r2154b274],
5	’	NN	O	’	dep	4	SENT_46	[p4l1544t249r2154b274],

1	Cyclooxygenase	NNP	MISC	Cyclooxygenase	_	0	SENT_47	[p4l6t289r249b323],
2	I	PRP	O	I	nsubj	3	SENT_47	[p4l262t290r272b314],
3	A-842G	VBP	O	a-842g	rcmod	1	SENT_47	[p4l497t290r612b315],
4	PTGS1	NN	O	ptgs1	nn	5	SENT_47	[p4l708t290r805b315],
5	NM_000962	NN	O	nm_000962	dobj	3	SENT_47	[p4l878t290r1053b318],
6	5	CD	NUMBER	5	dep	5	SENT_47	[p4l1127t289r1741b315],
7	’	SYM	O	’	dep	5	SENT_47	[p4l1127t289r1741b315],
8	-	:	O	-	_	0	SENT_47	[p4l1127t289r1741b315],
9	CCTTCCGATAACTGAGCACCTA-3	NN	O	ccttccgataactgagcaccta-3	nn	11	SENT_47	[p4l1127t289r1741b315],
10	’	CD	NUMBER	’	num	11	SENT_47	[p4l1127t289r1741b315],
11	BseSI	NN	O	bsesus	dobj	3	SENT_47	[p4l1885t290r1962b315],

1	5	CD	NUMBER	5	_	0	SENT_48	[p4l1567t330r1591b355],
2	’	SYM	O	’	dep	1	SENT_48	[p4l1567t330r1591b355],
3	-	:	O	-	_	0	SENT_48	[p4l1596t330r2154b355],
4	ATCCAGACTCCACAGCTTACT-3	NN	O	atccagactccacagcttact-3	dep	1	SENT_48	[p4l1596t330r2154b355],
5	’	NN	O	’	dep	4	SENT_48	[p4l1596t330r2154b355],

1	Genotyping	NN	O	genotyping	nsubjpass	6	SENT_49	[p4l15t550r461b640],
2	of	IN	O	of	_	0	SENT_49	[p4l491t548r574b640],
3	Polymorphisms	NNP	O	Polymorphisms	nn	4	SENT_49	[p4l591t548r1182b640],
4	Blood	NNP	O	Blood	prep_of	1	SENT_49	[p4l10t660r233b722],
5	was	VBD	O	be	auxpass	6	SENT_49	[p4l267t681r413b722],
6	collected	VBN	O	collect	_	0	SENT_49	[p4l452t660r795b722],
7	from	IN	O	from	_	0	SENT_49	[p4l830t660r1014b722],
8	each	DT	O	each	det	9	SENT_49	[p4l1052t660r1226b722],
9	patient	NN	O	patient	prep_from	6	SENT_49	[p4l1262t663r1554b743],
10	,	,	O	,	_	0	SENT_49	[p4l1262t663r1554b743],
11	and	CC	O	and	_	0	SENT_49	[p4l1594t660r1737b722],
12	DNA	NN	O	dna	nsubjpass	14	SENT_49	[p4l1773t663r1970b722],
13	was	VBD	O	be	auxpass	14	SENT_49	[p4l2004t681r2149b722],
14	extracted	VBN	O	extract	conj_and	6	SENT_49	[p4l13t765r368b826],
15	using	VBG	O	use	xcomp	14	SENT_49	[p4l393t767r605b847],
16	standard	JJ	O	standard	amod	17	SENT_49	[p4l629t765r970b826],
17	techniques	NNS	O	technique	dobj	15	SENT_49	[p4l994t765r1438b847],
18	.	.	O	.	_	0	SENT_49	[p4l994t765r1438b847],

1	Informed	JJ	O	informed	amod	2	SENT_50	[p4l1466t765r1828b826],
2	consent	NN	O	consent	nsubjpass	8	SENT_50	[p4l1854t772r2151b826],
3	for	IN	O	for	_	0	SENT_50	[p4l11t869r119b931],
4	molecular	JJ	O	molecular	amod	6	SENT_50	[p4l172t870r559b931],
5	genetic	JJ	O	genetic	amod	6	SENT_50	[p4l612t872r888b952],
6	testing	NN	O	testing	prep_for	2	SENT_50	[p4l941t872r1205b952],
7	was	VBD	O	be	auxpass	8	SENT_50	[p4l1255t891r1400b931],
8	obtained	VBN	O	obtain	_	0	SENT_50	[p4l1456t870r1796b931],
9	in	IN	O	in	_	0	SENT_50	[p4l1849t872r1921b930],
10	each	DT	O	each	det	11	SENT_50	[p4l1977t870r2150b931],
11	case	NN	O	case	prep_in	8	SENT_50	[p4l13t974r193b1016],
12	.	.	O	.	_	0	SENT_50	[p4l13t974r193b1016],

1	Genotyping	VBG	O	genotype	amod	2	SENT_51	[p4l15t1132r461b1222],
2	Identification	NN	O	identification	nsubjpass	11	SENT_51	[p4l12t1242r511b1304],
3	of	IN	O	of	_	0	SENT_51	[p4l547t1242r620b1304],
4	the	DT	O	the	det	6	SENT_51	[p4l649t1242r766b1304],
5	respective	JJ	O	respective	amod	6	SENT_51	[p4l802t1245r1180b1325],
6	alleles	NNS	O	allele	prep_of	2	SENT_51	[p4l1217t1242r1449b1304],
7	in	IN	O	in	_	0	SENT_51	[p4l1485t1245r1556b1303],
8	each	DT	O	each	det	9	SENT_51	[p4l1593t1242r1761b1304],
9	gene	NN	O	gene	prep_in	6	SENT_51	[p4l1797t1263r1972b1324],
10	was	VBD	O	be	auxpass	11	SENT_51	[p4l2007t1263r2149b1304],
11	carried	VBN	O	carry	_	0	SENT_51	[p4l13t1342r274b1403],
12	out	RP	O	out	prt	11	SENT_51	[p4l305t1349r425b1403],
13	using	VBG	O	use	xcomp	11	SENT_51	[p4l454t1344r659b1424],
14	polymerase	NN	O	polymerase	nn	16	SENT_51	[p4l687t1342r1120b1425],
15	chain	NN	O	chain	nn	16	SENT_51	[p4l1153t1342r1354b1403],
16	reaction	NN	O	reaction	dobj	13	SENT_51	[p4l1384t1344r1685b1403],
17	and	CC	O	and	_	0	SENT_51	[p4l1717t1342r1856b1403],
18	restriction	NN	O	restriction	nn	25	SENT_51	[p4l1885t1344r2149b1403, p4l11t1444r159b1504],
19	fragment	NN	O	fragment	nn	25	SENT_51	[p4l219t1441r569b1525],
20	length	NN	O	length	nn	25	SENT_51	[p4l628t1442r871b1525],
21	polymorphism	NN	O	polymorphism	nn	25	SENT_51	[p4l931t1442r1495b1526],
22	analysis	NN	O	analysis	nn	25	SENT_51	[p4l1556t1442r1860b1526],
23	(	CD	NUMBER	(	num	25	SENT_51	[p4l1923t1441r2148b1517, p4l12t1541r256b1617],
24	PCRRFLP	NN	O	pcrrflp	nn	25	SENT_51	[p4l1923t1441r2148b1517, p4l12t1541r256b1617],
25	)	NN	O	)	dobj	13	SENT_51	[p4l1923t1441r2148b1517, p4l12t1541r256b1617],
26	.	.	O	.	_	0	SENT_51	[p4l1923t1441r2148b1517, p4l12t1541r256b1617],

1	Oligonucleotides	NNS	MISC	oligonucleotide	nsubjpass	3	SENT_52	[p4l310t1542r946b1624],
2	were	VBD	O	be	auxpass	3	SENT_52	[p4l994t1563r1176b1604],
3	designed	VBN	O	design	dep	14	SENT_52	[p4l1229t1542r1568b1624],
4	from	IN	O	from	_	0	SENT_52	[p4l1616t1542r1794b1604],
5	ﬂanking	VBG	O	ﬂanking	prepc_from	3	SENT_52	[p4l1843t1542r2152b1624],
6	intronic	JJ	O	intronic	amod	9	SENT_52	[p4l11t1645r301b1704],
7	and	CC	O	and	_	0	SENT_52	[p4l352t1643r491b1704],
8	exonic	JJ	O	exonic	amod	9	SENT_52	[p4l540t1645r777b1704],
9	sequence	NN	O	sequence	dobj	5	SENT_52	[p4l827t1664r1175b1725],
10	of	IN	O	of	_	0	SENT_52	[p4l1226t1643r1298b1704],
11	the	DT	O	the	det	13	SENT_52	[p4l1342t1643r1458b1704],
12	respective	JJ	O	respective	amod	13	SENT_52	[p4l1508t1645r1885b1725],
13	genes	NNS	O	gene	prep_of	9	SENT_52	[p4l1937t1664r2149b1725],
14	(	VBP	O	(	_	0	SENT_52	[p4l13t1741r244b1816],
15	Table	NNP	O	Table	dobj	14	SENT_52	[p4l13t1741r244b1816],
16	1	CD	NUMBER	1	num	15	SENT_52	[p4l283t1741r365b1816],
17	)	CD	NUMBER	)	nsubj	14	SENT_52	[p4l283t1741r365b1816],
18	.	.	O	.	_	0	SENT_52	[p4l283t1741r365b1816],

1	Digestion	NN	O	digestion	nsubj	10	SENT_53	[p4l404t1744r764b1824],
2	of	IN	O	of	_	0	SENT_53	[p4l801t1741r874b1803],
3	the	DT	O	the	det	7	SENT_53	[p4l905t1742r1021b1803],
4	105	CD	NUMBER	105	num	7	SENT_53	[p4l1060t1745r1177b1803],
5	bp	NN	O	bp	nn	7	SENT_53	[p4l1214t1742r1309b1824],
6	ITGB3	NN	O	itgb3	nn	7	SENT_53	[p4l1345t1743r1569b1803],
7	fragment	NN	O	fragment	prep_of	1	SENT_53	[p4l1608t1741r1951b1824],
8	with	IN	O	with	_	0	SENT_53	[p4l1984t1742r2150b1803],
9	Mspl	NN	PERSON	mspl	prep_with	7	SENT_53	[p4l7t1844r194b1924],
10	produced	VBD	O	produce	_	0	SENT_53	[p4l231t1841r589b1924],
11	fragments	NNS	O	fragment	dobj	10	SENT_53	[p4l629t1841r1007b1923],
12	of	IN	O	of	_	0	SENT_53	[p4l1050t1841r1123b1903],
13	67	CD	NUMBER	67	prep_of	11	SENT_53	[p4l1161t1845r1240b1903],
14	and	CC	O	and	_	0	SENT_53	[p4l1281t1841r1421b1903],
15	38	CD	NUMBER	38	num	16	SENT_53	[p4l1460t1845r1539b1903],
16	bp	NN	O	bp	conj_and	11	SENT_53	[p4l1580t1841r1675b1924],
17	only	RB	O	only	advmod	16	SENT_53	[p4l1720t1841r1881b1924],
18	in	IN	O	in	_	0	SENT_53	[p4l1920t1844r1992b1902],
19	the	DT	O	the	det	20	SENT_53	[p4l2032t1841r2149b1903],
20	presence	NN	O	presence	prep_in	16	SENT_53	[p4l11t1962r343b2023],
21	of	IN	O	of	_	0	SENT_53	[p4l375t1941r448b2002],
22	the	DT	O	the	det	24	SENT_53	[p4l472t1941r588b2002],
23	P1A2	NN	O	p1a2	nn	24	SENT_53	[p4l619t1931r787b2001],
24	allele	NN	O	allele	prep_of	20	SENT_53	[p4l817t1941r1012b2002],
25	due	JJ	O	due	_	0	SENT_53	[p4l1045t1941r1181b2002],
26	to	TO	O	to	_	0	SENT_53	[p4l1211t1948r1280b2002],
27	the	DT	O	the	det	28	SENT_53	[p4l1309t1941r1425b2002],
28	T	NN	O	t	prep_due_to	10	SENT_53	[p4l1455t1944r1505b2001],
29	to	TO	O	to	_	0	SENT_53	[p4l1532t1948r1602b2002],
30	C	NN	O	c	nn	31	SENT_53	[p4l1633t1943r1686b2002],
31	variation	NN	O	variation	prep_to	28	SENT_53	[p4l1716t1944r2050b2002],
32	in	IN	O	in	_	0	SENT_53	[p4l2079t1944r2150b2001],
33	exon	NN	O	exon	prep_in	10	SENT_53	[p4l13t2061r188b2101],
34	3	CD	NUMBER	3	num	33	SENT_53	[p4l231t2043r288b2101],
35	.	.	O	.	_	0	SENT_53	[p4l231t2043r288b2101],

1	Digestion	NN	O	digestion	nsubj	10	SENT_54	[p4l336t2042r695b2122],
2	of	IN	O	of	_	0	SENT_54	[p4l742t2039r814b2101],
3	the	DT	O	the	det	7	SENT_54	[p4l854t2040r970b2101],
4	149	CD	NUMBER	149	num	7	SENT_54	[p4l1017t2043r1136b2101],
5	bp	NN	O	bp	nn	7	SENT_54	[p4l1180t2040r1275b2122],
6	ITGA2	NN	O	itga2	nn	7	SENT_54	[p4l1319t2041r1552b2101],
7	fragment	NN	O	fragment	prep_of	1	SENT_54	[p4l1599t2039r1942b2122],
8	with	IN	O	with	_	0	SENT_54	[p4l1984t2040r2150b2101],
9	Hpy188I	NN	O	hpy188us	prep_with	7	SENT_54	[p4l9t2142r313b2222],
10	produced	VBD	O	produce	_	0	SENT_54	[p4l333t2139r693b2222],
11	fragments	NNS	O	fragment	dobj	10	SENT_54	[p4l716t2139r1093b2221],
12	of	IN	O	of	_	0	SENT_54	[p4l1121t2139r1193b2201],
13	124	CD	NUMBER	124	prep_of	11	SENT_54	[p4l1216t2143r1336b2200],
14	and	CC	O	and	_	0	SENT_54	[p4l1361t2139r1501b2201],
15	25	CD	NUMBER	25	num	16	SENT_54	[p4l1524t2143r1602b2201],
16	bp	NN	O	bp	conj_and	11	SENT_54	[p4l1628t2139r1723b2222],
17	only	RB	O	only	advmod	16	SENT_54	[p4l1752t2139r1913b2222],
18	in	IN	O	in	_	0	SENT_54	[p4l1937t2142r2008b2200],
19	the	DT	O	the	det	20	SENT_54	[p4l2032t2139r2149b2201],
20	presence	NN	O	presence	prep_in	16	SENT_54	[p4l11t2260r343b2321],
21	of	IN	O	of	_	0	SENT_54	[p4l371t2239r443b2300],
22	the	DT	O	the	det	24	SENT_54	[p4l463t2239r579b2300],
23	807C	NN	O	807c	nn	24	SENT_54	[p4l605t2240r783b2300],
24	allele	NN	O	allele	prep_of	20	SENT_54	[p4l811t2239r1006b2300],
25	in	IN	O	in	_	0	SENT_54	[p4l1032t2241r1103b2299],
26	exon	NN	O	exon	prep_in	10	SENT_54	[p4l1129t2260r1304b2300],
27	7	CD	NUMBER	7	num	26	SENT_54	[p4l1329t2243r1384b2300],
28	.	.	O	.	_	0	SENT_54	[p4l1329t2243r1384b2300],

1	Digestion	NN	O	digestion	nsubj	11	SENT_55	[p4l1411t2241r1770b2321],
2	of	IN	O	of	_	0	SENT_55	[p4l1796t2239r1868b2300],
3	the	DT	O	the	det	8	SENT_55	[p4l1888t2239r2004b2300],
4	156	CD	NUMBER	156	num	8	SENT_55	[p4l2031t2242r2150b2300],
5	bp	NN	O	bp	nn	8	SENT_55	[p4l10t2338r105b2420],
6	PTGS1	NN	O	ptgs1	nn	8	SENT_55	[p4l135t2339r375b2399],
7	CSOT	NN	O	csot	nn	8	SENT_55	[p4l412t2339r604b2399],
8	fragment	NN	O	fragment	prep_of	1	SENT_55	[p4l633t2337r976b2420],
9	with	IN	O	with	_	0	SENT_55	[p4l1004t2338r1169b2399],
10	Paul	NNP	PERSON	Paul	prep_with	1	SENT_55	[p4l1198t2340r1357b2399],
11	produced	VBD	O	produce	_	0	SENT_55	[p4l1383t2338r1742b2420],
12	fragments	NNS	O	fragment	dobj	11	SENT_55	[p4l1772t2337r2149b2420],
13	of	IN	O	of	_	0	SENT_55	[p4l13t2437r85b2499],
14	85	CD	NUMBER	85	prep_of	12	SENT_55	[p4l112t2441r188b2499],
15	and	CC	O	and	_	0	SENT_55	[p4l222t2437r362b2499],
16	71	CD	NUMBER	71	num	17	SENT_55	[p4l392t2441r467b2498],
17	bp	NN	O	bp	conj_and	12	SENT_55	[p4l499t2437r595b2520],
18	only	RB	O	only	advmod	17	SENT_55	[p4l629t2437r790b2520],
19	in	IN	O	in	_	0	SENT_55	[p4l818t2440r890b2498],
20	the	DT	O	the	det	21	SENT_55	[p4l920t2437r1036b2499],
21	presence	NN	O	presence	prep_in	17	SENT_55	[p4l1068t2458r1400b2520],
22	of	IN	O	of	_	0	SENT_55	[p4l1434t2437r1506b2499],
23	the	DT	O	the	det	25	SENT_55	[p4l1531t2437r1648b2499],
24	50C	NN	O	50c	nn	25	SENT_55	[p4l1679t2439r1817b2499],
25	allele	NN	O	allele	prep_of	21	SENT_55	[p4l1852t2437r2047b2499],
26	in	IN	O	in	_	0	SENT_55	[p4l2078t2440r2150b2498],
27	exon	NN	O	exon	prep_in	11	SENT_55	[p4l13t2558r188b2598],
28	2	CD	NUMBER	2	num	27	SENT_55	[p4l218t2540r274b2598],
29	.	.	O	.	_	0	SENT_55	[p4l218t2540r274b2598],

1	Digestion	NN	O	digestion	nsubj	11	SENT_56	[p4l308t2539r667b2619],
2	of	IN	O	of	_	0	SENT_56	[p4l699t2537r772b2598],
3	the	DT	O	the	det	8	SENT_56	[p4l798t2537r914b2598],
4	198	CD	NUMBER	198	num	8	SENT_56	[p4l947t2540r1066b2598],
5	bp	NN	O	bp	nn	8	SENT_56	[p4l1095t2537r1190b2619],
6	PTGS1	NN	O	ptgs1	nn	8	SENT_56	[p4l1221t2539r1461b2598],
7	A-842G	NN	O	a-842g	nn	8	SENT_56	[p4l1494t2538r1777b2598],
8	fragment	NN	O	fragment	prep_of	1	SENT_56	[p4l1808t2537r2151b2619],
9	with	IN	O	with	_	0	SENT_56	[p4l10t2637r175b2699],
10	BseSI	NN	O	bsesus	prep_with	1	SENT_56	[p4l206t2638r398b2699],
11	produced	VBD	O	produce	_	0	SENT_56	[p4l424t2637r784b2720],
12	fragments	NNS	O	fragment	dobj	11	SENT_56	[p4l813t2636r1191b2720],
13	of	IN	O	of	_	0	SENT_56	[p4l1225t2636r1297b2699],
14	162	CD	NUMBER	162	prep_of	12	SENT_56	[p4l1326t2640r1445b2699],
15	and	CC	O	and	_	0	SENT_56	[p4l1478t2637r1617b2699],
16	36	CD	NUMBER	36	num	17	SENT_56	[p4l1647t2640r1726b2699],
17	bp	NN	O	bp	conj_and	12	SENT_56	[p4l1757t2637r1852b2720],
18	only	RB	O	only	advmod	17	SENT_56	[p4l1887t2637r2049b2721],
19	in	IN	O	in	_	0	SENT_56	[p4l2078t2639r2150b2698],
20	the	DT	O	the	det	21	SENT_56	[p4l11t2737r127b2799],
21	presence	NN	O	presence	prep_in	17	SENT_56	[p4l157t2758r490b2820],
22	of	IN	O	of	_	0	SENT_56	[p4l522t2737r595b2799],
23	the	DT	O	the	det	25	SENT_56	[p4l620t2737r735b2799],
24	-842	CD	NUMBER	-842	num	25	SENT_56	[p4l775t2741r955b2799],
25	allele	NN	O	allele	prep_of	21	SENT_56	[p4l986t2737r1181b2799],
26	in	IN	O	in	_	0	SENT_56	[p4l1212t2740r1283b2798],
27	the	DT	O	the	det	29	SENT_56	[p4l1312t2737r1428b2799],
28	intronic	JJ	O	intronic	amod	29	SENT_56	[p4l1459t2740r1749b2799],
29	sequence	NN	O	sequence	prep_in	11	SENT_56	[p4l1781t2758r2148b2820],
30	.	.	O	.	_	0	SENT_56	[p4l1781t2758r2148b2820],

1	Fragments	NNS	O	fragment	nsubjpass	11	SENT_57	[p4l12t2839r406b2919],
2	obtained	VBN	O	obtain	partmod	1	SENT_57	[p4l466t2837r794b2898],
3	after	IN	O	after	_	0	SENT_57	[p4l851t2837r1022b2898],
4	digestion	NN	O	digestion	prep_after	2	SENT_57	[p4l1080t2837r1422b2919],
5	with	IN	O	with	_	0	SENT_57	[p4l1476t2837r1642b2898],
6	the	DT	O	the	det	9	SENT_57	[p4l1698t2837r1815b2898],
7	speciﬁc	NN	O	speciﬁc	nn	9	SENT_57	[p4l1874t2837r2150b2919],
8	restriction	NN	O	restriction	nn	9	SENT_57	[p4l11t2939r392b2998],
9	endonucleases	NNS	O	endonuclease	prep_with	2	SENT_57	[p4l431t2937r978b2998],
10	were	VBD	O	be	auxpass	11	SENT_57	[p4l1014t2958r1196b2998],
11	separated	VBN	O	separate	_	0	SENT_57	[p4l1236t2937r1601b3019],
12	on	IN	O	on	_	0	SENT_57	[p4l1638t2958r1729b2998],
13	a	DT	O	a	det	15	SENT_57	[p4l1767t2958r1805b2998],
14	3	CD	PERCENT	3	number	15	SENT_57	[p4l1841t2938r1947b3000],
15	%	NN	PERCENT	%	prep_on	11	SENT_57	[p4l1841t2938r1947b3000],
16	agaTable	JJ	O	agatable	amod	15	SENT_57	[p4l1991t2958r2149b3019, p4l13t3181r199b3243],

1	2	LS	NUMBER	2	_	0	SENT_58	[p4l227t3183r281b3242],
2	.	.	O	.	_	0	SENT_58	[p4l227t3183r281b3242],

1	Baseline	NN	O	baseline	nn	2	SENT_59	[p4l331t3181r617b3243],
2	Characteristics	NNS	O	characteristic	nsubj	10	SENT_59	[p4l650t3181r1150b3243],
3	of	IN	O	of	_	0	SENT_59	[p4l1181t3180r1256b3264],
4	the	DT	O	the	det	6	SENT_59	[p4l1275t3181r1378b3243],
5	Study	NNP	O	Study	nn	6	SENT_59	[p4l1409t3181r1604b3264],
6	Sample	NNP	O	Sample	prep_of	2	SENT_59	[p4l1636t3181r1889b3264],
7	rose	VBD	O	rise	_	0	SENT_59	[p4l9t3303r163b3343],
8	gel	NN	O	gel	dobj	7	SENT_59	[p4l188t3282r297b3364],
9	and	CC	O	and	_	0	SENT_59	[p4l320t3282r459b3343],
10	Visualized	VBN	O	visualize	conj_and	7	SENT_59	[p4l479t3282r857b3343],
11	using	VBG	O	use	xcomp	10	SENT_59	[p4l879t3284r1085b3364],
12	ethidium	NN	O	ethidium	nn	13	SENT_59	[p4l1107t3282r1446b3343],
13	bromide	NN	O	bromide	dobj	11	SENT_59	[p4l1467t3282r1804b3355],
14	,	,	O	,	_	0	SENT_59	[p4l1467t3282r1804b3355],
15	allowing	VBG	O	allow	xcomp	10	SENT_59	[p4l1830t3282r2150b3364],
16	identification	NN	O	identification	dobj	15	SENT_59	[p4l9t3380r505b3442],
17	of	IN	O	of	_	0	SENT_59	[p4l539t3380r611b3442],
18	heterozygous	JJ	O	heterozygous	amod	21	SENT_59	[p4l641t3380r1141b3463],
19	or	CC	O	or	_	0	SENT_59	[p4l1177t3401r1253b3442],
20	homozygous	JJ	O	homozygous	conj_or	18	SENT_59	[p4l1285t3380r1759b3463],
21	status	NN	O	status	prep_of	16	SENT_59	[p4l1795t3388r2010b3442],
22	for	IN	O	for	_	0	SENT_59	[p4l2044t3380r2150b3442],
23	each	DT	O	each	det	24	SENT_59	[p4l11t3481r180b3543],
24	allele	NN	O	allele	prep_for	21	SENT_59	[p4l212t3481r427b3543],
25	.	.	O	.	_	0	SENT_59	[p4l212t3481r427b3543],

1	Platelet	NN	O	platelet	nn	2	SENT_60	[p5l7t64r294b133],
2	Aggregation	NN	O	aggregation	nsubjpass	9	SENT_60	[p5l317t67r783b156],
3	The	DT	O	the	det	5	SENT_60	[p5l9t176r149b238],
4	biological	JJ	O	biological	amod	5	SENT_60	[p5l174t176r538b258],
5	effects	NNS	O	effect	dep	2	SENT_60	[p5l564t176r792b238],
6	of	IN	O	of	_	0	SENT_60	[p5l820t176r892b238],
7	aspirin	NN	O	aspirin	prep_of	2	SENT_60	[p5l915t179r1172b259],
8	were	VBD	O	be	auxpass	9	SENT_60	[p5l1196t197r1377b238],
9	assessed	VBN	O	assess	_	0	SENT_60	[p5l1405t176r1726b238],
10	using	VBG	O	use	xcomp	9	SENT_60	[p5l1751t179r1956b258],
11	light	JJ	O	light	amod	14	SENT_60	[p5l1979t176r2149b258],
12	transmission	NN	O	transmission	nn	14	SENT_60	[p5l8t278r489b337],
13	platelet	NN	O	platelet	nn	14	SENT_60	[p5l536t276r817b358],
14	aggregometry	NN	O	aggregometry	dobj	10	SENT_60	[p5l864t283r1402b359],
15	.	.	O	.	_	0	SENT_60	[p5l864t283r1402b359],

1	Our	PRP$	O	we	poss	4	SENT_61	[p5l1454t277r1602b337],
2	primary	JJ	O	primary	amod	4	SENT_61	[p5l1648t278r1950b359],
3	outcome	NN	O	outcome	nn	4	SENT_61	[p5l1997t283r2147b337, p5l11t395r206b436],
4	measure	NN	O	measure	nsubj	8	SENT_61	[p5l247t395r565b436],
5	were	VBD	O	be	cop	8	SENT_61	[p5l604t395r786b436],
6	percentage	NN	O	percentage	nn	8	SENT_61	[p5l827t382r1238b457],
7	platelet	NN	O	platelet	nn	8	SENT_61	[p5l1280t374r1560b457],
8	aggregation	NN	O	aggregation	conj_and	8	SENT_61	[p5l1599t377r2041b456],
9	at	IN	O	at	_	0	SENT_61	[p5l2083t382r2149b436],
10	baseline	NN	O	baseline	prep_at	8	SENT_61	[p5l8t475r317b537],
11	and	CC	O	and	_	0	SENT_61	[p5l349t475r489b537],
12	on	IN	O	on	_	0	SENT_61	[p5l519t496r610b537],
13	day	NN	DURATION	day	prep_on	8	SENT_61	[p5l642t475r775b559],
14	5	CD	NUMBER	5	num	13	SENT_61	[p5l803t478r839b537],
15	(	RB	O	(	advmod	16	SENT_61	[p5l872t474r1272b558],
16	expressed	VBN	O	express	partmod	13	SENT_61	[p5l872t474r1272b558],
17	as	IN	O	as	_	0	SENT_61	[p5l1302t496r1376b537],
18	percentage	NN	O	percentage	prep_as	16	SENT_61	[p5l1406t483r1818b558],
19	of	IN	O	of	_	0	SENT_61	[p5l1850t474r1923b537],
20	baseline	NN	O	baseline	nn	21	SENT_61	[p5l1947t475r2147b537, p5l9t574r173b649],
21	)	NN	O	)	prep_of	18	SENT_61	[p5l1947t475r2147b537, p5l9t574r173b649],
22	using	VBG	O	use	ccomp	16	SENT_61	[p5l206t578r411b657],
23	1.1	CD	NUMBER	1.1	num	25	SENT_61	[p5l442t579r537b636],
24	pug/mL	NN	O	pug/ml	nn	25	SENT_61	[p5l576t577r825b657],
25	collagen	NN	O	collagen	dobj	22	SENT_61	[p5l857t575r1186b657],
26	,	,	O	,	_	0	SENT_61	[p5l857t575r1186b657],
27	comparing	VBG	O	compare	dep	22	SENT_61	[p5l1220t578r1622b657],
28	the	DT	O	the	det	29	SENT_61	[p5l1651t575r1767b637],
29	results	NNS	O	result	dobj	27	SENT_61	[p5l1799t575r2046b637],
30	of	IN	O	of	_	0	SENT_61	[p5l2079t575r2152b637],
31	patients	NNS	O	patient	prep_of	29	SENT_61	[p5l9t676r307b756],
32	with	IN	O	with	prep	27	SENT_61	[p5l345t673r510b735],
33	and	CC	O	and	_	0	SENT_61	[p5l551t673r690b735],
34	without	IN	O	without	conj_and	32	SENT_61	[p5l727t673r1018b735],
35	selected	VBN	O	select	amod	37	SENT_61	[p5l1057t673r1358b735],
36	candidate	NN	O	candidate	nn	37	SENT_61	[p5l1397t673r1760b735],
37	polymorphisms	NNS	O	polymorphism	pobj	34	SENT_61	[p5l1800t673r2147b756, p5l9t774r297b856],
38	.	.	O	.	_	0	SENT_61	[p5l1800t673r2147b756, p5l9t774r297b856],

1	Assessment	NNP	O	Assessment	nsubjpass	6	SENT_62	[p5l333t776r780b835],
2	of	IN	O	of	_	0	SENT_62	[p5l816t774r888b835],
3	platelet	NN	O	platelet	nn	4	SENT_62	[p5l920t774r1201b856],
4	aggregation	NN	O	aggregation	prep_of	1	SENT_62	[p5l1237t776r1679b856],
5	was	VBD	O	be	auxpass	6	SENT_62	[p5l1713t795r1855b835],
6	undertaken	VBN	O	undertake	_	0	SENT_62	[p5l1893t774r2147b835, p5l8t873r215b935],
7	using	VBG	O	use	xcomp	6	SENT_62	[p5l257t876r462b955],
8	the	DT	O	the	det	9	SENT_62	[p5l501t873r617b935],
9	technique	NN	O	technique	dobj	7	SENT_62	[p5l659t873r1032b956],
10	of	IN	O	of	_	0	SENT_62	[p5l1077t873r1149b935],
11	Born	NNP	O	Born	dep	14	SENT_62	[p5l1186t876r1365b935],
12	[	CD	NUMBER	[	num	14	SENT_62	[p5l1413t874r1517b946],
13	4	CD	NUMBER	4	num	14	SENT_62	[p5l1413t874r1517b946],
14	]	NN	O	]	prepc_of	9	SENT_62	[p5l1413t874r1517b946],
15	.	.	O	.	_	0	SENT_62	[p5l1413t874r1517b946],

1	Secondary	JJ	O	secondary	amod	3	SENT_63	[p5l1563t873r1956b956],
2	outcome	NN	O	outcome	nn	3	SENT_63	[p5l1997t881r2147b935, p5l11t994r206b1035],
3	measures	NNS	O	measure	nsubj	6	SENT_63	[p5l251t994r606b1035],
4	were	VBD	O	be	cop	6	SENT_63	[p5l648t994r829b1035],
5	effective	JJ	O	effective	amod	6	SENT_63	[p5l876t972r1178b1035],
6	concentrations	NNS	O	concentration	_	0	SENT_63	[p5l1224t975r1772b1035],
7	of	IN	O	of	_	0	SENT_63	[p5l1817t972r1890b1035],
8	Horm	NN	O	horm	nn	9	SENT_63	[p5l1929t975r2148b1035],
9	collagen	NN	O	collagen	prep_of	6	SENT_63	[p5l11t1073r339b1155],
10	,	,	O	,	_	0	SENT_63	[p5l11t1073r339b1155],
11	adenosine	NN	LOCATION	adenosine	nn	12	SENT_63	[p5l364t1073r743b1135],
12	diphosphate	NN	O	diphosphate	conj_and	6	SENT_63	[p5l769t1073r1233b1155],
13	(	CD	NUMBER	(	num	15	SENT_63	[p5l1258t1072r1504b1147],
14	ADP	NN	ORGANIZATION	adp	nn	15	SENT_63	[p5l1258t1072r1504b1147],
15	)	NN	O	)	dep	12	SENT_63	[p5l1258t1072r1504b1147],
16	,	,	O	,	_	0	SENT_63	[p5l1258t1072r1504b1147],
17	and	CC	O	and	_	0	SENT_63	[p5l1529t1073r1669b1135],
18	epinephrine	NN	O	epinephrine	conj_and	6	SENT_63	[p5l1692t1073r2147b1155],
19	on	IN	O	on	_	0	SENT_63	[p5l11t1194r102b1235],
20	day	NN	DURATION	day	prep_on	18	SENT_63	[p5l145t1172r279b1256],
21	5	CD	NUMBER	5	num	20	SENT_63	[p5l318t1176r354b1235],
22	required	VBN	O	require	partmod	20	SENT_63	[p5l397t1172r722b1256],
23	to	TO	O	to	aux	24	SENT_63	[p5l762t1180r831b1235],
24	produce	VB	O	produce	xcomp	22	SENT_63	[p5l874t1172r1180b1256],
25	50	CD	PERCENT	50	num	26	SENT_63	[p5l1222t1174r1369b1236],
26	%	NN	PERCENT	%	iobj	24	SENT_63	[p5l1222t1174r1369b1236],
27	aggregation	NN	O	aggregation	nn	30	SENT_63	[p5l1417t1175r1860b1255],
28	(	CD	NUMBER	(	num	30	SENT_63	[p5l1903t1172r2146b1247],
29	EC50	NN	O	ec50	nn	30	SENT_63	[p5l1903t1172r2146b1247],
30	)	NN	O	)	dobj	24	SENT_63	[p5l1903t1172r2146b1247],
31	compared	VBN	O	compare	_	0	SENT_63	[p5l11t1274r385b1356],
32	with	IN	O	with	prepc_compared_with	30	SENT_63	[p5l413t1274r579b1336],
33	baseline	NN	O	baseline	pobj	30	SENT_63	[p5l609t1274r937b1336],
34	.	.	O	.	_	0	SENT_63	[p5l609t1274r937b1336],

1	Statistical	JJ	O	statistical	amod	2	SENT_64	[p5l11t1451r384b1519],
2	Methods	NNS	O	method	_	0	SENT_64	[p5l412t1450r743b1519],

1	Platelet	NN	O	platelet	_	0	SENT_65	[p5l9t1569r289b1631],
2	aggregation	NN	O	aggregation	nn	5	SENT_65	[p5l342t1572r784b1651],
3	and	CC	O	and	_	0	SENT_65	[p5l838t1569r978b1631],
4	EC50	NN	O	ec50	nn	5	SENT_65	[p5l1030t1571r1221b1631],
5	concentrations	NNS	O	concentration	dep	1	SENT_65	[p5l1275t1572r1823b1631],
6	of	IN	O	of	_	0	SENT_65	[p5l1878t1569r1950b1631],
7	heterozygous	JJ	O	heterozygous	prep_of	5	SENT_65	[p5l1999t1569r2147b1631, p5l11t1713r389b1775],

1	or	CC	O	or	cc	9	SENT_66	[p5l419t1713r495b1753],
2	homozygous	JJ	O	homozygous	amod	3	SENT_66	[p5l522t1692r996b1775],
3	carriers	NNS	O	carrier	nsubjpass	9	SENT_66	[p5l1026t1694r1305b1753],
4	of	IN	O	of	_	0	SENT_66	[p5l1336t1692r1408b1753],
5	the	DT	O	the	det	7	SENT_66	[p5l1431t1692r1547b1753],
6	candidate	NN	O	candidate	nn	7	SENT_66	[p5l1578t1692r1940b1753],
7	gene	NN	O	gene	prep_of	3	SENT_66	[p5l1971t1713r2146b1774],
8	were	VBD	O	be	auxpass	9	SENT_66	[p5l7t1813r188b1854],
9	compared	VBN	O	compare	_	0	SENT_66	[p5l237t1792r611b1875],
10	against	IN	O	against	_	0	SENT_66	[p5l657t1795r923b1874],
11	the	DT	O	the	det	12	SENT_66	[p5l967t1792r1083b1854],
12	normal	JJ	O	normal	prep_against	9	SENT_66	[p5l1130t1792r1416b1854],
13	.	.	O	.	_	0	SENT_66	[p5l1130t1792r1416b1854],

1	The	DT	O	the	det	3	SENT_67	[p5l1463t1792r1603b1854],
2	primary	JJ	O	primary	amod	3	SENT_67	[p5l1650t1795r1952b1875],
3	outcome	NN	O	outcome	nsubjpass	5	SENT_67	[p5l1997t1800r2147b1854, p5l11t1914r206b1955],
4	was	VBD	O	be	auxpass	5	SENT_67	[p5l231t1914r373b1955],
5	compared	VBN	O	compare	_	0	SENT_67	[p5l401t1893r776b1976],
6	using	VBG	O	use	xcomp	5	SENT_67	[p5l801t1895r1006b1976],
7	regression	NN	O	regression	nn	9	SENT_67	[p5l1029t1895r1418b1976],
8	(	NN	O	(	nn	9	SENT_67	[p5l1446t1892r1769b1977],
9	analysis	NN	O	analysis	dobj	6	SENT_67	[p5l1446t1892r1769b1977],
10	of	IN	O	of	_	0	SENT_67	[p5l1796t1893r1869b1955],
11	covariance	NN	O	covariance	nn	13	SENT_67	[p5l1892t1895r2147b1955, p5l11t2015r178b2057],
12	[	CD	NUMBER	[	num	13	SENT_67	[p5l222t1993r676b2069],
13	ANCOVA	NN	O	ancova	prep_of	9	SENT_67	[p5l222t1993r676b2069],
14	]	CD	NUMBER	]	num	15	SENT_67	[p5l222t1993r676b2069],
15	)	NN	O	)	nsubj	21	SENT_67	[p5l222t1993r676b2069],
16	with	IN	O	with	_	0	SENT_67	[p5l712t1994r878b2057],
17	robust	JJ	O	robust	amod	19	SENT_67	[p5l914t1994r1155b2057],
18	standard	JJ	O	standard	amod	19	SENT_67	[p5l1191t1994r1521b2057],
19	errors	NNS	O	error	prep_with	15	SENT_67	[p5l1559t2016r1778b2057],
20	to	TO	O	to	aux	21	SENT_67	[p5l1814t2002r1884b2057],
21	adjust	VB	O	adjust	infmod	9	SENT_67	[p5l1923t1994r2149b2078],
22	for	IN	O	for	_	0	SENT_67	[p5l9t2096r114b2158],
23	baseline	NN	O	baseline	nn	24	SENT_67	[p5l163t2097r472b2158],
24	Values	NNS	O	value	prep_for	21	SENT_67	[p5l524t2097r763b2158],
25	of	IN	O	of	_	0	SENT_67	[p5l817t2096r889b2158],
26	platelet	NN	O	platelet	nn	27	SENT_67	[p5l937t2097r1218b2179],
27	aggregation	NN	O	aggregation	prep_of	24	SENT_67	[p5l1270t2099r1712b2179],
28	and	CC	O	and	_	0	SENT_67	[p5l1765t2097r1905b2158],
29	EC50	NN	O	ec50	conj_and	27	SENT_67	[p5l1956t2098r2148b2158],

1	Medium-Dose	JJ	MISC	medium-dose	amod	2	SENT_68	[p5l885t2287r1104b2312],
2	Low-Dose	NN	MISC	low-dose	_	0	SENT_68	[p5l1420t2288r1574b2312],

1	Aspirin	NNP	O	Aspirin	_	0	SENT_69	[p5l937t2330r1051b2363],
2	Aspirin	NNP	O	Aspirin	dep	1	SENT_69	[p5l1440t2330r1553b2363],
3	All	NNP	O	All	rcmod	2	SENT_69	[p5l1894t2329r1939b2354],
4	Patients	NNPS	O	Patients	dep	3	SENT_69	[p5l1951t2330r2085b2355],
5	”	SYM	O	”	dep	3	SENT_69	[p5l1951t2330r2085b2355],

1	Sample	VB	O	sample	dep	118	SENT_70	[p5l8t2420r242b2490],
2	size	NN	O	size	dep	118	SENT_70	[p5l271t2423r386b2473],
3	31	CD	NUMBER	31	dep	118	SENT_70	[p5l1911t2424r1977b2473],
4	Mean	NN	O	mean	dep	118	SENT_70	[p5l6t2513r186b2563],
5	age	NN	O	age	dep	118	SENT_70	[p5l214t2528r337b2580],
6	,	,	O	,	_	0	SENT_70	[p5l214t2528r337b2580],
7	years	NNS	DURATION	year	dep	118	SENT_70	[p5l363t2528r530b2581],
8	(	VBP	O	(	dep	118	SENT_70	[p5l559t2510r696b2574],
9	SD	NN	O	sd	dep	118	SENT_70	[p5l559t2510r696b2574],
10	)	CD	NUMBER	)	dep	118	SENT_70	[p5l559t2510r696b2574],
11	66	CD	NUMBER	66	dep	118	SENT_70	[p5l1789t2514r1855b2563],
12	(	NN	O	(	dep	118	SENT_70	[p5l1877t2510r1952b2574],
13	6	CD	NUMBER	6	dep	118	SENT_70	[p5l1877t2510r1952b2574],
14	)	NN	O	)	dep	118	SENT_70	[p5l1877t2510r1952b2574],
15	Mean	NN	O	mean	dep	118	SENT_70	[p5l6t2604r186b2654],
16	height	NN	O	height	dep	118	SENT_70	[p5l213t2601r430b2671],
17	,	,	O	,	_	0	SENT_70	[p5l213t2601r430b2671],
18	m	NN	O	m	dep	118	SENT_70	[p5l457t2619r518b2653],
19	(	CD	NUMBER	(	dep	118	SENT_70	[p5l545t2601r683b2664],
20	SD	NN	O	sd	dep	118	SENT_70	[p5l545t2601r683b2664],
21	)	NN	O	)	dep	118	SENT_70	[p5l545t2601r683b2664],
22	1.75	CD	NUMBER	1.75	dep	118	SENT_70	[p5l1737t2604r1853b2654],
23	(	CD	NUMBER	(	dep	118	SENT_70	[p5l1877t2601r2040b2664],
24	0.08	CD	NUMBER	0.08	dep	118	SENT_70	[p5l1877t2601r2040b2664],
25	)	CD	NUMBER	)	dep	118	SENT_70	[p5l1877t2601r2040b2664],
26	Mean	NN	O	mean	dep	118	SENT_70	[p5l6t2693r186b2743],
27	weight	NN	O	weight	dep	118	SENT_70	[p5l211t2691r443b2761],
28	,	,	O	,	_	0	SENT_70	[p5l211t2691r443b2761],
29	kg	NN	O	kg	dep	118	SENT_70	[p5l470t2691r546b2761],
30	(	NN	O	(	dep	118	SENT_70	[p5l572t2690r710b2754],
31	SD	NN	O	sd	dep	118	SENT_70	[p5l572t2690r710b2754],
32	)	CD	NUMBER	)	dep	118	SENT_70	[p5l572t2690r710b2754],
33	82.0	CD	NUMBER	82.0	dep	118	SENT_70	[p5l1736t2694r1855b2743],
34	(	NN	O	(	dep	118	SENT_70	[p5l1877t2690r2040b2754],
35	14.2	CD	NUMBER	14.2	dep	118	SENT_70	[p5l1877t2690r2040b2754],
36	)	CD	NUMBER	)	dep	118	SENT_70	[p5l1877t2690r2040b2754],
37	Male	JJ	O	male	dep	118	SENT_70	[p5l6t2781r163b2834],
38	sex	NN	O	sex	dep	118	SENT_70	[p5l192t2799r306b2843],
39	,	,	O	,	_	0	SENT_70	[p5l192t2799r306b2843],
40	n	NN	O	n	dep	118	SENT_70	[p5l333t2799r373b2833],
41	(	CD	PERCENT	(	dep	118	SENT_70	[p5l401t2780r503b2844],
42	%	NN	PERCENT	%	dep	118	SENT_70	[p5l401t2780r503b2844],
43	)	CD	NUMBER	)	dep	118	SENT_70	[p5l401t2780r503b2844],
44	28	CD	NUMBER	28	dep	118	SENT_70	[p5l1787t2784r1855b2834],
45	(	NN	O	(	dep	118	SENT_70	[p5l1877t2780r1988b2844],
46	90	CD	NUMBER	90	dep	118	SENT_70	[p5l1877t2780r1988b2844],
47	)	CD	NUMBER	)	dep	118	SENT_70	[p5l1877t2780r1988b2844],
48	Diabetes	NNP	MISC	Diabetes	dep	118	SENT_70	[p5l6t2871r282b2924],
49	mellitus	NN	O	mellitus	dep	118	SENT_70	[p5l310t2871r581b2933],
50	,	,	O	,	_	0	SENT_70	[p5l310t2871r581b2933],
51	n	NN	O	n	dep	118	SENT_70	[p5l609t2889r648b2923],
52	(	CD	PERCENT	(	dep	118	SENT_70	[p5l676t2870r779b2934],
53	%	NN	PERCENT	%	dep	118	SENT_70	[p5l676t2870r779b2934],
54	)	CD	NUMBER	)	dep	118	SENT_70	[p5l676t2870r779b2934],
55	4	CD	NUMBER	4	dep	118	SENT_70	[p5l1822t2874r1856b2923],
56	(	NN	O	(	dep	118	SENT_70	[p5l1877t2870r1988b2934],
57	13	CD	NUMBER	13	dep	118	SENT_70	[p5l1877t2870r1988b2934],
58	)	CD	NUMBER	)	dep	118	SENT_70	[p5l1877t2870r1988b2934],
59	Hypercholesterolemia	NN	ORGANIZATION	hypercholesterolemia	dep	118	SENT_70	[p5l6t2960r727b3031],
60	,	,	O	,	_	0	SENT_70	[p5l6t2960r727b3031],
61	n	NN	O	n	dep	118	SENT_70	[p5l755t2978r794b3012],
62	(	CD	PERCENT	(	dep	118	SENT_70	[p5l822t2960r925b3024],
63	%	NN	PERCENT	%	dep	118	SENT_70	[p5l822t2960r925b3024],
64	)	CD	NUMBER	)	dep	118	SENT_70	[p5l822t2960r925b3024],
65	28	CD	NUMBER	28	dep	118	SENT_70	[p5l1787t2964r1855b3013],
66	(	NN	O	(	dep	118	SENT_70	[p5l1877t2960r1988b3024],
67	90	CD	NUMBER	90	dep	118	SENT_70	[p5l1877t2960r1988b3024],
68	)	CD	NUMBER	)	dep	118	SENT_70	[p5l1877t2960r1988b3024],
69	Hypertension	NN	O	hypertension	dep	118	SENT_70	[p5l6t3053r457b3121],
70	,	,	O	,	_	0	SENT_70	[p5l6t3053r457b3121],
71	n	NN	O	n	dep	118	SENT_70	[p5l485t3068r524b3102],
72	(	CD	PERCENT	(	dep	118	SENT_70	[p5l552t3050r654b3114],
73	%	NN	PERCENT	%	dep	118	SENT_70	[p5l552t3050r654b3114],
74	)	CD	NUMBER	)	dep	118	SENT_70	[p5l552t3050r654b3114],
75	19	CD	NUMBER	19	dep	118	SENT_70	[p5l1789t3054r1855b3103],
76	(	NN	O	(	dep	118	SENT_70	[p5l1877t3050r1988b3114],
77	61	CD	NUMBER	61	dep	118	SENT_70	[p5l1877t3050r1988b3114],
78	)	CD	NUMBER	)	dep	118	SENT_70	[p5l1877t3050r1988b3114],
79	Current	JJ	DATE	current	dep	118	SENT_70	[p5l7t3143r257b3194],
80	smokers	NNS	O	smoker	dep	118	SENT_70	[p5l283t3141r563b3204],
81	,	,	O	,	_	0	SENT_70	[p5l283t3141r563b3204],
82	n	NN	O	n	dep	118	SENT_70	[p5l590t3159r630b3193],
83	(	CD	PERCENT	(	dep	118	SENT_70	[p5l658t3141r760b3205],
84	%	NN	PERCENT	%	dep	118	SENT_70	[p5l658t3141r760b3205],
85	)	CD	NUMBER	)	dep	118	SENT_70	[p5l658t3141r760b3205],
86	3	CD	NUMBER	3	dep	118	SENT_70	[p5l1822t3144r1854b3194],
87	(	NN	O	(	dep	118	SENT_70	[p5l1877t3141r1988b3205],
88	10	CD	NUMBER	10	dep	118	SENT_70	[p5l1877t3141r1988b3205],
89	)	CD	NUMBER	)	dep	118	SENT_70	[p5l1877t3141r1988b3205],
90	Median	JJ	MISC	median	dep	118	SENT_70	[p5l6t3231r250b3283],
91	number	NN	O	number	dep	118	SENT_70	[p5l276t3231r529b3283],
92	of	IN	O	of	dep	118	SENT_70	[p5l554t3231r616b3283],
93	grafts	NNS	O	graft	dep	118	SENT_70	[p5l640t3231r832b3301],
94	,	,	O	,	_	0	SENT_70	[p5l640t3231r832b3301],
95	n	NN	O	n	dep	118	SENT_70	[p5l860t3249r900b3283],
96	(	CD	NUMBER	(	dep	118	SENT_70	[p5l928t3230r1099b3295],
97	IQR	NN	O	iqr	dep	118	SENT_70	[p5l928t3230r1099b3295],
98	)	CD	NUMBER	)	dep	118	SENT_70	[p5l928t3230r1099b3295],
99	4	CD	NUMBER	4	dep	118	SENT_70	[p5l1822t3234r1856b3283],
100	(	NN	O	(	dep	118	SENT_70	[p5l1877t3230r1929b3294],
101	3	CD	NUMBER	3	dep	118	SENT_70	[p5l1877t3230r1929b3294],
102	to	TO	O	to	dep	118	SENT_70	[p5l1950t3238r2009b3283],
103	4	CD	NUMBER	4	dep	118	SENT_70	[p5l2030t3230r2084b3294],
104	)	CD	NUMBER	)	dep	118	SENT_70	[p5l2030t3230r2084b3294],
105	Median	JJ	MISC	median	dep	118	SENT_70	[p5l6t3321r250b3373],
106	bypass	NN	O	bypass	dep	118	SENT_70	[p5l275t3321r492b3391],
107	time	NN	O	time	dep	118	SENT_70	[p5l518t3323r675b3383],
108	,	,	O	,	_	0	SENT_70	[p5l518t3323r675b3383],
109	min	NN	DURATION	min	dep	118	SENT_70	[p5l703t3323r826b3372],
110	(	CD	NUMBER	(	dep	118	SENT_70	[p5l854t3320r1025b3385],
111	IQR	NN	O	iqr	dep	118	SENT_70	[p5l854t3320r1025b3385],
112	)	CD	NUMBER	)	dep	118	SENT_70	[p5l854t3320r1025b3385],
113	73	CD	NUMBER	73	dep	118	SENT_70	[p5l1789t3324r1854b3373],
114	(	NN	O	(	dep	118	SENT_70	[p5l1877t3320r1965b3384],
115	59	CD	NUMBER	59	dep	118	SENT_70	[p5l1877t3320r1965b3384],
116	to	TO	O	to	dep	118	SENT_70	[p5l1985t3327r2044b3373],
117	85	CD	NUMBER	85	dep	118	SENT_70	[p5l2066t3320r2154b3384],
118	)	CD	NUMBER	)	_	0	SENT_70	[p5l2066t3320r2154b3384],

1	o	NN	O	o	dep	10	SENT_71	[p6l136t1094r182b1167],
2	(	CD	NUMBER	(	num	3	SENT_71	[p6l215t1088r327b1184],
3	O	NN	O	o	dep	1	SENT_71	[p6l215t1088r327b1184],
4	)	CD	NUMBER	)	number	5	SENT_71	[p6l215t1088r327b1184],
5	5	CD	NUMBER	5	num	6	SENT_71	[p6l1661t1095r1707b1167],
6	(	NN	O	(	dep	3	SENT_71	[p6l1742t1088r1854b1184],
7	6	CD	NUMBER	6	num	8	SENT_71	[p6l1742t1088r1854b1184],
8	)	NN	O	)	dep	10	SENT_71	[p6l1742t1088r1854b1184],
9	4	CD	NUMBER	4	num	10	SENT_71	[p6l133t1239r293b1334],
10	(	NN	O	(	dep	37	SENT_71	[p6l133t1239r293b1334],
11	3	CD	NUMBER	3	number	14	SENT_71	[p6l133t1239r293b1334],
12	to	TO	O	to	dep	14	SENT_71	[p6l324t1250r411b1319],
13	4	CD	NUMBER	4	number	14	SENT_71	[p6l440t1239r522b1334],
14	)	CD	NUMBER	)	dep	10	SENT_71	[p6l440t1239r522b1334],
15	4	CD	NUMBER	4	num	16	SENT_71	[p6l1660t1239r1820b1334],
16	(	NN	O	(	dep	14	SENT_71	[p6l1660t1239r1820b1334],
17	3	CD	NUMBER	3	dep	23	SENT_71	[p6l1660t1239r1820b1334],
18	to	TO	O	to	_	0	SENT_71	[p6l1851t1250r1938b1319],
19	4	CD	NUMBER	4	number	20	SENT_71	[p6l1968t1239r2049b1334],
20	)	CD	NUMBER	)	prep_to	17	SENT_71	[p6l1968t1239r2049b1334],
21	68	CD	NUMBER	68	num	22	SENT_71	[p6l85t1395r182b1469],
22	(	NN	O	(	dep	23	SENT_71	[p6l215t1389r346b1484],
23	52	CD	NUMBER	52	dep	28	SENT_71	[p6l215t1389r346b1484],
24	to	TO	O	to	_	0	SENT_71	[p6l375t1400r462b1469],
25	87	CD	NUMBER	87	num	26	SENT_71	[p6l494t1389r625b1484],
26	)	CD	NUMBER	)	prep_to	23	SENT_71	[p6l494t1389r625b1484],
27	70	CD	NUMBER	70	num	28	SENT_71	[p6l1612t1395r1709b1469],
28	(	NN	O	(	dep	37	SENT_71	[p6l1742t1389r1874b1484],
29	54	CD	NUMBER	54	number	32	SENT_71	[p6l1742t1389r1874b1484],
30	to	TO	O	to	dep	32	SENT_71	[p6l1902t1400r1989b1469],
31	84	CD	NUMBER	84	number	32	SENT_71	[p6l2021t1389r2153b1484],
32	)	CD	NUMBER	)	dep	28	SENT_71	[p6l2021t1389r2153b1484],
33	"	``	O	"	punct	34	SENT_71	[p6l68t1536r79b1545],
34	’	CD	NUMBER	’	dep	32	SENT_71	[p6l68t1536r79b1545],
35	All	DT	O	all	det	36	SENT_71	[p6l86t1535r125b1557],
36	patients	NNS	O	patient	nsubj	37	SENT_71	[p6l136t1536r242b1565],
37	include	VBP	O	include	_	0	SENT_71	[p6l253t1535r350b1557],
38	those	DT	O	those	dobj	37	SENT_71	[p6l362t1535r432b1557],
39	who	WP	O	who	nsubjpass	42	SENT_71	[p6l443t1535r499b1557],
40	were	VBD	O	be	auxpass	42	SENT_71	[p6l509t1542r574b1557],
41	randomly	RB	O	randomly	advmod	42	SENT_71	[p6l585t1535r714b1565],
42	assigned	VBN	O	assign	rcmod	38	SENT_71	[p6l725t1535r840b1565],
43	to	TO	O	to	_	0	SENT_71	[p6l851t1538r876b1557],
44	clopidogrel	NN	O	clopidogrel	prep_to	42	SENT_71	[p6l887t1535r1043b1565],
45	.	.	O	.	_	0	SENT_71	[p6l887t1535r1043b1565],

1	IQR	NN	O	iqr	_	0	SENT_72	[p6l68t1573r122b1600],
2	=	JJ	O	=	amod	4	SENT_72	[p6l135t1581r153b1588],
3	interquartile	JJ	O	interquartile	amod	4	SENT_72	[p6l166t1573r332b1602],
4	range	NN	O	range	dep	1	SENT_72	[p6l344t1580r425b1602],
5	.	.	O	.	_	0	SENT_72	[p6l344t1580r425b1602],

1	136	CD	NUMBER	136	num	2	SENT_73	[p6l224t1673r276b1698],
2	LIM	NN	O	lim	_	0	SENT_73	[p6l343t1678r396b1698],
3	ET	NNP	O	ET	nn	4	SENT_73	[p6l406t1678r440b1698],
4	AL	NNP	O	AL	dep	2	SENT_73	[p6l450t1678r487b1698],

1	ASPIRIN	NN	O	aspirin	nn	2	SENT_74	[p6l342t1710r458b1730],
2	EFFICACY	NN	O	efficacy	_	0	SENT_74	[p6l468t1710r607b1730],
3	WITH	IN	O	with	dep	2	SENT_74	[p6l616t1710r695b1730],
4	GENETIC	JJ	O	genetic	amod	5	SENT_74	[p6l706t1710r832b1730],
5	POLYMORPHISM	NN	O	polymorphism	pobj	3	SENT_74	[p6l843t1710r1081b1730],

1	Table	NNP	O	Table	_	0	SENT_75	[p6l225t1866r306b1893],
2	3	CD	NUMBER	3	dep	1	SENT_75	[p6l318t1867r341b1893],
3	.	.	O	.	_	0	SENT_75	[p6l318t1867r341b1893],

1	Genetic	JJ	O	genetic	amod	2	SENT_76	[p6l364t1867r476b1893],
2	Polymorphisms	NNS	O	polymorphism	_	0	SENT_76	[p6l487t1866r718b1903],
3	and	CC	O	and	_	0	SENT_76	[p6l732t1866r787b1893],
4	Baseline	NN	O	baseline	nn	6	SENT_76	[p6l800t1866r924b1893],
5	Platelet	NN	O	platelet	nn	6	SENT_76	[p6l935t1866r1048b1893],
6	Aggregation	NN	O	aggregation	conj_and	2	SENT_76	[p6l1057t1867r1238b1903],

1	PIA2	NN	O	pia2	_	0	SENT_77	[p6l1169t1931r1227b1958],
2	C807T	NN	O	c807t	nn	3	SENT_77	[p6l1557t1935r1647b1959],
3	A842G/C50T	NN	O	a842g/c50t	dep	1	SENT_77	[p6l1912t1935r2098b1959],

1	}	NN	O	}	_	0	SENT_78	[p6l68t1699r90b2008],
2	IV	CD	NUMBER	iv	dep	1	SENT_78	[p6l68t1699r90b2008],
3	"	``	O	"	punct	2	SENT_78	[p6l68t1699r90b2008],
4	If13SVAOIGHV3	NN	O	if13svaoighv3	dep	2	SENT_78	[p6l68t1699r90b2008],

1	Number	NN	O	number	_	0	SENT_79	[p6l224t2000r352b2029],
2	,	,	O	,	_	0	SENT_79	[p6l224t2000r352b2029],
3	na	TO	O	na	dep	1	SENT_79	[p6l365t2001r396b2024],
4	80	CD	NUMBER	80	num	5	SENT_79	[p6l1183t2002r1213b2024],
5	79	CD	NUMBER	79	dep	3	SENT_79	[p6l1587t2002r1617b2024],
6	79	CD	NUMBER	79	num	8	SENT_79	[p6l1990t2002r2020b2024],
7	Heterozygous	JJ	O	heterozygous	amod	8	SENT_79	[p6l224t2047r424b2078],
8	frequency	NN	O	frequency	dobj	5	SENT_79	[p6l436t2046r589b2078],
9	,	,	O	,	_	0	SENT_79	[p6l436t2046r589b2078],
10	n	NN	O	n	appos	8	SENT_79	[p6l601t2054r619b2070],
11	(	CD	PERCENT	(	num	12	SENT_79	[p6l632t2046r679b2075],
12	%	NN	PERCENT	%	dep	10	SENT_79	[p6l632t2046r679b2075],
13	)	CD	NUMBER	)	number	14	SENT_79	[p6l632t2046r679b2075],
14	23	CD	NUMBER	23	num	12	SENT_79	[p6l1102t2047r1132b2070],
15	(	NN	O	(	dep	5	SENT_79	[p6l1143t2046r1193b2075],
16	29	CD	NUMBER	29	dobj	15	SENT_79	[p6l1143t2046r1193b2075],
17	)	CD	NUMBER	)	number	18	SENT_79	[p6l1143t2046r1193b2075],
18	30	CD	NUMBER	30	amod	16	SENT_79	[p6l1492t2047r1523b2070],
19	(	NN	O	(	prep	16	SENT_79	[p6l1533t2046r1584b2075],
20	38	CD	NUMBER	38	num	21	SENT_79	[p6l1533t2046r1584b2075],
21	)	CD	NUMBER	)	dep	19	SENT_79	[p6l1533t2046r1584b2075],
22	14	CD	NUMBER	14	dep	23	SENT_79	[p6l1910t2047r1941b2070],
23	(	NN	O	(	advmod	16	SENT_79	[p6l1950t2046r2000b2075],
24	18	CD	NUMBER	18	num	25	SENT_79	[p6l1950t2046r2000b2075],
25	)	NN	O	)	dep	1	SENT_79	[p6l1950t2046r2000b2075],

1	Homozygous	JJ	O	homozygous	amod	2	SENT_80	[p6l7t2122r589b2217],
2	frequency	NN	O	frequency	_	0	SENT_80	[p6l626t2119r1093b2217],
3	,	,	O	,	_	0	SENT_80	[p6l626t2119r1093b2217],
4	n	NN	O	n	appos	2	SENT_80	[p6l1132t2144r1187b2191],
5	(	CD	PERCENT	(	num	6	SENT_80	[p6l1226t2118r1369b2207],
6	%	NN	PERCENT	%	dep	4	SENT_80	[p6l1226t2118r1369b2207],
7	)	CD	NUMBER	)	num	8	SENT_80	[p6l1226t2118r1369b2207],
8	Difference	NN	O	difference	dep	2	SENT_80	[p6l7t2258r458b2332],
9	in	IN	O	in	_	0	SENT_80	[p6l497t2262r581b2331],
10	percentage	NN	O	percentage	nn	11	SENT_80	[p6l617t2268r1104b2357],
11	aggregation	NN	O	aggregation	prep_in	8	SENT_80	[p6l1144t2262r1666b2356],
12	of	IN	O	of	_	0	SENT_80	[p6l1705t2258r1790b2332],
13	carriers	NNS	O	carrier	prep_of	11	SENT_80	[p6l1823t2262r2153b2332],

1	Versus	NNP	O	Versus	nn	2	SENT_81	[p6l199t2392r484b2440],
2	noncarriers	NNS	O	noncarrier	nsubj	3	SENT_81	[p6l522t2370r1026b2440],
3	(	VBP	O	(	_	0	SENT_81	[p6l1067t2366r1269b2455],
4	95	CD	PERCENT	95	number	5	SENT_81	[p6l1067t2366r1269b2455],
5	%	NN	PERCENT	%	amod	7	SENT_81	[p6l1067t2366r1269b2455],
6	CI	NN	O	ci	nn	7	SENT_81	[p6l1315t2366r1445b2455],
7	)	NN	O	)	dobj	3	SENT_81	[p6l1315t2366r1445b2455],

1	Collagen	NNP	O	Collagen	_	0	SENT_82	[p6l106t2491r498b2589],
2	1	CD	NUMBER	1	num	1	SENT_82	[p6l536t2496r576b2564],
3	p.	NN	O	p.	nn	8	SENT_82	[p6l621t2494r916b2589],
4	g/mL	NN	O	g/ml	nn	8	SENT_82	[p6l621t2494r916b2589],
5	ADP	NN	O	adp	nn	8	SENT_82	[p6l102t2622r312b2692],
6	5	CD	NUMBER	5	num	8	SENT_82	[p6l347t2624r390b2692],
7	urnol/L	NN	O	urnol/l	nn	8	SENT_82	[p6l434t2619r757b2711],
8	Epinephrine	NN	O	epinephrine	dep	1	SENT_82	[p6l105t2745r654b2843],
9	10	CD	NUMBER	10	num	11	SENT_82	[p6l694t2749r786b2818],
10	p.	NN	O	p.	nn	11	SENT_82	[p6l829t2745r1152b2837],
11	mo1/L	NN	O	mo1/l	dep	1	SENT_82	[p6l829t2745r1152b2837],

1	Difference	NN	O	difference	nsubj	9	SENT_83	[p6l7t2871r458b2944],
2	in	IN	O	in	_	0	SENT_83	[p6l497t2874r581b2943],
3	EC50	NN	O	ec50	nn	4	SENT_83	[p6l618t2872r844b2944],
4	concentration	NN	O	concentration	prep_in	1	SENT_83	[p6l883t2874r1487b2944],
5	of	IN	O	of	_	0	SENT_83	[p6l1525t2871r1611b2944],
6	carriers	NNS	O	carrier	prep_of	4	SENT_83	[p6l1645t2874r1975b2944],
7	versus	CC	O	versus	_	0	SENT_83	[p6l199t3004r484b3053],
8	noncarriers	NNS	O	noncarrier	prep_of	4	SENT_83	[p6l522t2982r1026b3053],
9	(	VBP	O	(	_	0	SENT_83	[p6l1067t2978r1270b3067],
10	95	CD	PERCENT	95	number	11	SENT_83	[p6l1067t2978r1270b3067],
11	%	NN	PERCENT	%	amod	13	SENT_83	[p6l1067t2978r1270b3067],
12	CI	NN	O	ci	nn	13	SENT_83	[p6l1315t2978r1445b3067],
13	)	NN	O	)	dobj	9	SENT_83	[p6l1315t2978r1445b3067],

1	Collagen	NNP	O	Collagen	nn	4	SENT_84	[p6l106t3105r498b3201],
2	p.	NN	O	p.	nn	4	SENT_84	[p6l540t3106r835b3201],
3	g/mL	NN	O	g/ml	nn	4	SENT_84	[p6l540t3106r835b3201],
4	ADP	NN	O	adp	_	0	SENT_84	[p6l102t3233r312b3302],
5	umol/L	NN	O	umol/l	nn	6	SENT_84	[p6l353t3229r676b3321],
6	Epinephrine	NN	O	epinephrine	dep	4	SENT_84	[p6l105t3356r655b3455],
7	p.	NN	O	p.	nn	8	SENT_84	[p6l699t3356r1022b3448],
8	mol/L	NN	O	mol/l	dep	4	SENT_84	[p6l699t3356r1022b3448],

1	4	CD	NUMBER	4	_	0	SENT_85	[p7l130t77r348b134],
2	(	CD	NUMBER	(	number	6	SENT_85	[p7l130t77r348b134],
3	-7	CD	NUMBER	-7	number	6	SENT_85	[p7l130t77r348b134],
4	to	TO	O	to	dep	6	SENT_85	[p7l130t77r348b134],
5	15	CD	NUMBER	15	number	6	SENT_85	[p7l368t77r446b134],
6	)	CD	NUMBER	)	dep	1	SENT_85	[p7l368t77r446b134],
7	-4	CD	NUMBER	-4	num	8	SENT_85	[p7l849t77r1074b134],
8	(	NN	O	(	dep	6	SENT_85	[p7l849t77r1074b134],
9	-14	CD	NUMBER	-14	num	11	SENT_85	[p7l849t77r1074b134],
10	to	TO	O	to	dep	11	SENT_85	[p7l1091t83r1144b124],
11	5	CD	NUMBER	5	dep	1	SENT_85	[p7l1162t77r1211b134],
12	)	CD	NUMBER	)	number	13	SENT_85	[p7l1162t77r1211b134],
13	6	CD	NUMBER	6	num	14	SENT_85	[p7l1712t77r1860b134],
14	(	NN	O	(	dep	11	SENT_85	[p7l1712t77r1860b134],
15	-4	CD	NUMBER	-4	num	17	SENT_85	[p7l1712t77r1860b134],
16	to	TO	O	to	dep	17	SENT_85	[p7l1877t83r1929b124],
17	16	CD	NUMBER	16	dep	1	SENT_85	[p7l1949t77r2027b134],
18	)	CD	NUMBER	)	number	19	SENT_85	[p7l1949t77r2027b134],
19	4	CD	NUMBER	4	num	20	SENT_85	[p7l130t166r278b223],
20	(	NN	O	(	dep	17	SENT_85	[p7l130t166r278b223],
21	-8	CD	NUMBER	-8	number	24	SENT_85	[p7l130t166r278b223],
22	to	TO	O	to	dep	24	SENT_85	[p7l296t172r348b213],
23	15	CD	NUMBER	15	number	24	SENT_85	[p7l368t166r446b223],
24	)	CD	NUMBER	)	dep	1	SENT_85	[p7l368t166r446b223],
25	-2	CD	NUMBER	-2	num	26	SENT_85	[p7l849t166r1074b223],
26	(	NN	O	(	dep	24	SENT_85	[p7l849t166r1074b223],
27	-14	CD	NUMBER	-14	num	29	SENT_85	[p7l849t166r1074b223],
28	to	TO	O	to	dep	29	SENT_85	[p7l1091t172r1144b213],
29	9	CD	NUMBER	9	dep	1	SENT_85	[p7l1163t165r1211b223],
30	)	CD	NUMBER	)	number	31	SENT_85	[p7l1163t165r1211b223],
31	6	CD	NUMBER	6	num	32	SENT_85	[p7l1712t166r1859b223],
32	(	NN	O	(	dep	29	SENT_85	[p7l1712t166r1859b223],
33	.	.	O	.	_	0	SENT_85	[p7l1712t166r1859b223],

1	—	NN	O	—	_	0	SENT_86	[p7l1712t166r1859b223],
2	.	.	O	.	_	0	SENT_86	[p7l1712t166r1859b223],

1	9	CD	NUMBER	9	dep	7	SENT_87	[p7l1712t166r1859b223],
2	to	TO	O	to	_	0	SENT_87	[p7l1877t172r1929b213],
3	20	CD	NUMBER	20	number	4	SENT_87	[p7l1947t166r2027b223],
4	)	CD	NUMBER	)	prep_to	1	SENT_87	[p7l1947t166r2027b223],
5	-2	CD	NUMBER	-2	num	6	SENT_87	[p7l84t254r310b311],
6	(	NN	O	(	dep	7	SENT_87	[p7l84t254r310b311],
7	-14	CD	NUMBER	-14	dep	12	SENT_87	[p7l84t254r310b311],
8	to	TO	O	to	_	0	SENT_87	[p7l327t261r379b302],
9	10	CD	NUMBER	10	num	10	SENT_87	[p7l399t254r478b311],
10	)	CD	NUMBER	)	prep_to	7	SENT_87	[p7l399t254r478b311],
11	-7	CD	NUMBER	-7	num	12	SENT_87	[p7l849t254r1144b311],
12	(	NN	O	(	dep	13	SENT_87	[p7l849t254r1144b311],
13	-17	CD	NUMBER	-17	dep	18	SENT_87	[p7l849t254r1144b311],
14	to	TO	O	to	_	0	SENT_87	[p7l849t254r1144b311],
15	3	CD	NUMBER	3	number	16	SENT_87	[p7l1162t254r1211b311],
16	)	CD	NUMBER	)	prep_to	13	SENT_87	[p7l1162t254r1211b311],
17	3	CD	NUMBER	3	num	18	SENT_87	[p7l1710t254r1890b311],
18	(	NN	O	(	dep	19	SENT_87	[p7l1710t254r1890b311],
19	-10	CD	NUMBER	-10	_	0	SENT_87	[p7l1710t254r1890b311],
20	to	TO	O	to	_	0	SENT_87	[p7l1908t261r1960b302],
21	16	CD	NUMBER	16	num	22	SENT_87	[p7l1980t254r2058b311],
22	)	CD	NUMBER	)	prep_to	19	SENT_87	[p7l1980t254r2058b311],

1	-0.06	CD	NUMBER	-0.06	_	0	SENT_88	[p7l7t454r158b499],
2	(	CD	NUMBER	(	num	3	SENT_88	[p7l179t451r354b508],
3	-0.31	CD	NUMBER	-0.31	dep	1	SENT_88	[p7l179t451r354b508],
4	to	TO	O	to	_	0	SENT_88	[p7l374t457r426b499],
5	0.18	CD	NUMBER	0.18	num	6	SENT_88	[p7l446t451r571b508],
6	)	CD	NUMBER	)	prep_to	3	SENT_88	[p7l446t451r571b508],
7	0.04	CD	NUMBER	0.04	num	8	SENT_88	[p7l818t454r924b499],
8	(	NN	O	(	dep	15	SENT_88	[p7l943t451r1120b508],
9	-0.18	CD	NUMBER	-0.18	dep	8	SENT_88	[p7l943t451r1120b508],
10	to	TO	O	to	_	0	SENT_88	[p7l1138t457r1191b499],
11	0.28	CD	NUMBER	0.28	num	12	SENT_88	[p7l1210t451r1335b508],
12	)	CD	NUMBER	)	prep_to	9	SENT_88	[p7l1210t451r1335b508],
13	-0.16	CD	NUMBER	-0.16	num	14	SENT_88	[p7l1588t454r1740b499],
14	(	NN	O	(	dep	15	SENT_88	[p7l1759t451r1937b508],
15	-0.38	CD	NUMBER	-0.38	dep	20	SENT_88	[p7l1759t451r1937b508],
16	to	TO	O	to	_	0	SENT_88	[p7l1954t457r2007b499],
17	0.05	CD	NUMBER	0.05	num	18	SENT_88	[p7l2026t451r2152b508],
18	)	CD	NUMBER	)	prep_to	15	SENT_88	[p7l2026t451r2152b508],
19	-0.15	CD	NUMBER	-0.15	num	20	SENT_88	[p7l7t543r157b587],
20	(	NN	O	(	dep	21	SENT_88	[p7l179t540r356b597],
21	-0.38	CD	NUMBER	-0.38	dep	26	SENT_88	[p7l179t540r356b597],
22	to	TO	O	to	_	0	SENT_88	[p7l374t546r426b587],
23	0.06	CD	NUMBER	0.06	num	24	SENT_88	[p7l446t540r571b597],
24	)	CD	NUMBER	)	prep_to	21	SENT_88	[p7l446t540r571b597],
25	0.07	CD	NUMBER	0.07	num	26	SENT_88	[p7l818t543r924b587],
26	(	NN	O	(	dep	27	SENT_88	[p7l943t540r1119b597],
27	-0.15	CD	NUMBER	-0.15	dep	32	SENT_88	[p7l943t540r1119b597],
28	to	TO	O	to	_	0	SENT_88	[p7l1138t546r1191b587],
29	0.31	CD	NUMBER	0.31	num	30	SENT_88	[p7l1210t540r1335b597],
30	)	CD	NUMBER	)	prep_to	27	SENT_88	[p7l1210t540r1335b597],
31	-0.06	CD	NUMBER	-0.06	num	32	SENT_88	[p7l1588t543r1740b587],
32	(	NN	O	(	dep	33	SENT_88	[p7l1759t540r1937b597],
33	-0.32	CD	NUMBER	-0.32	dep	38	SENT_88	[p7l1759t540r1937b597],
34	to	TO	O	to	_	0	SENT_88	[p7l1954t546r2007b587],
35	0.19	CD	NUMBER	0.19	num	36	SENT_88	[p7l2026t540r2152b597],
36	)	CD	NUMBER	)	prep_to	33	SENT_88	[p7l2026t540r2152b597],
37	-0.26	CD	NUMBER	-0.26	num	38	SENT_88	[p7l7t632r158b675],
38	(	NN	O	(	dep	39	SENT_88	[p7l179t628r354b685],
39	-0.65	CD	NUMBER	-0.65	dep	44	SENT_88	[p7l179t628r354b685],
40	to	TO	O	to	_	0	SENT_88	[p7l374t635r426b675],
41	0.13	CD	NUMBER	0.13	num	42	SENT_88	[p7l446t628r571b685],
42	)	CD	NUMBER	)	prep_to	39	SENT_88	[p7l446t628r571b685],
43	0.46	CD	NUMBER	0.46	num	44	SENT_88	[p7l818t632r923b675],
44	(	NN	O	(	dep	45	SENT_88	[p7l943t628r1069b685],
45	0.07	CD	NUMBER	0.07	dep	49	SENT_88	[p7l943t628r1069b685],
46	to	TO	O	to	_	0	SENT_88	[p7l1086t635r1139b675],
47	0.84	CD	NUMBER	0.84	num	48	SENT_88	[p7l1158t621r1312b685],
48	)	CD	NUMBER	)	prep_to	45	SENT_88	[p7l1158t621r1312b685],
49	b	NN	O	b	dep	3	SENT_88	[p7l1158t621r1312b685],
50	0.11	CD	NUMBER	0.11	num	49	SENT_88	[p7l1634t632r1738b675],
51	(	CD	NUMBER	(	num	52	SENT_88	[p7l1759t628r1938b685],
52	-0.57	CD	NUMBER	-0.57	dep	3	SENT_88	[p7l1759t628r1938b685],
53	to	TO	O	to	_	0	SENT_88	[p7l1954t635r2007b675],
54	0.79	CD	NUMBER	0.79	num	55	SENT_88	[p7l2026t628r2152b685],
55	)	CD	NUMBER	)	prep_to	52	SENT_88	[p7l2026t628r2152b685],
56	"	''	O	"	punct	52	SENT_88	[p7l68t736r79b745],

1	‘	NN	O	‘	npadvmod	9	SENT_89	[p7l68t736r79b745],
2	In	IN	O	in	_	0	SENT_89	[p7l87t736r114b757],
3	1	CD	NUMBER	1	num	4	SENT_89	[p7l125t736r137b757],
4	patient	NN	O	patient	prep_in	9	SENT_89	[p7l149t736r248b765],
5	,	,	O	,	_	0	SENT_89	[p7l149t736r248b765],
6	it	PRP	O	it	nsubj	9	SENT_89	[p7l260t736r278b757],
7	was	VBD	O	be	cop	9	SENT_89	[p7l287t742r338b757],
8	not	RB	O	not	neg	9	SENT_89	[p7l349t738r392b757],
9	possible	JJ	O	possible	_	0	SENT_89	[p7l402t735r510b765],
10	to	TO	O	to	aux	11	SENT_89	[p7l522t737r546b757],
11	determine	VB	O	determine	xcomp	9	SENT_89	[p7l558t735r694b757],
12	the	DT	O	the	det	13	SENT_89	[p7l705t735r746b757],
13	C50T	NN	O	c50t	dobj	11	SENT_89	[p7l758t735r826b757],
14	and	CC	O	and	_	0	SENT_89	[p7l837t735r886b757],
15	C807T	NN	O	c807t	nn	17	SENT_89	[p7l897t735r980b757],
16	polymorphism	NN	O	polymorphism	nn	17	SENT_89	[p7l990t735r1185b765],
17	status	NN	O	status	conj_and	13	SENT_89	[p7l1197t737r1280b757],
18	.	.	O	.	_	0	SENT_89	[p7l1197t737r1280b757],

1	b	NN	O	b	nn	2	SENT_90	[p7l1340t731r1353b745],
2	Signiﬁcant	NN	O	signiﬁcant	nsubj	5	SENT_90	[p7l1362t735r1503b764],
3	at	IN	O	at	_	0	SENT_90	[p7l1514t737r1538b757],
4	p	NN	O	p	prep_at	2	SENT_90	[p7l1547t742r1562b765],
5	=	JJ	O	=	_	0	SENT_90	[p7l1576t743r1594b750],
6	0.05	CD	NUMBER	0.05	num	7	SENT_90	[p7l1608t736r1657b757],
7	level	NN	O	level	dobj	5	SENT_90	[p7l1668t735r1737b757],
8	.	.	O	.	_	0	SENT_90	[p7l1668t735r1737b757],

1	ADP	NN	O	adp	_	0	SENT_91	[p7l7t829r146b875],
2	=	JJ	O	=	amod	4	SENT_91	[p7l175t846r214b861],
3	adenosine	NN	O	adenosine	nn	4	SENT_91	[p7l245t827r541b876],
4	diphosphate	NN	O	diphosphate	dep	1	SENT_91	[p7l568t827r945b892],
5	;	:	O	;	_	0	SENT_91	[p7l568t827r945b892],
6	CI	NN	O	ci	dep	1	SENT_91	[p7l1078t828r1145b876],
7	=	JJ	O	=	amod	9	SENT_91	[p7l1175t846r1214b861],
8	confidence	NN	O	confidence	nn	9	SENT_91	[p7l1244t827r1558b876],
9	interval	NN	O	interval	dep	6	SENT_91	[p7l1583t827r1820b876],
10	.	.	O	.	_	0	SENT_91	[p7l1583t827r1820b876],

1	concentrations	NNS	O	concentration	_	0	SENT_92	[p7l11t1060r578b1119],
2	.	.	O	.	_	0	SENT_92	[p7l11t1060r578b1119],

1	Formal	JJ	O	formal	amod	2	SENT_93	[p7l619t1057r883b1119],
2	tests	NNS	O	test	nsubjpass	9	SENT_93	[p7l921t1065r1088b1119],
3	of	IN	O	of	_	0	SENT_93	[p7l1129t1057r1202b1119],
4	interaction	NN	O	interaction	prep_of	2	SENT_93	[p7l1236t1060r1640b1119],
5	[	CD	NUMBER	[	number	6	SENT_93	[p7l1684t1057r1765b1131],
6	5	CD	NUMBER	5	num	7	SENT_93	[p7l1684t1057r1765b1131],
7	]	NN	O	]	dep	4	SENT_93	[p7l1684t1057r1765b1131],
8	were	VBD	O	be	auxpass	9	SENT_93	[p7l1808t1078r1989b1119],
9	applied	VBN	O	apply	_	0	SENT_93	[p7l2031t1078r2150b1140, p7l9t1158r199b1241],
10	to	TO	O	to	aux	11	SENT_93	[p7l237t1166r306b1220],
11	determine	VB	O	determine	xcomp	9	SENT_93	[p7l349t1158r731b1220],
12	any	DT	O	any	det	13	SENT_93	[p7l773t1179r907b1242],
13	differences	NNS	O	difference	dobj	11	SENT_93	[p7l947t1157r1349b1220],
14	in	IN	O	in	_	0	SENT_93	[p7l1389t1160r1461b1219],
15	the	DT	O	the	det	16	SENT_93	[p7l1499t1158r1615b1220],
16	response	NN	O	response	prep_in	11	SENT_93	[p7l1656t1179r1990b1241],
17	between	IN	O	between	_	0	SENT_93	[p7l2030t1158r2150b1220, p7l8t1266r235b1321],
18	carriers	NNS	O	carrier	prep_between	16	SENT_93	[p7l271t1261r551b1321],
19	of	IN	O	of	_	0	SENT_93	[p7l588t1258r661b1321],
20	the	DT	O	the	det	22	SENT_93	[p7l690t1258r807b1321],
21	candidate	NN	O	candidate	nn	22	SENT_93	[p7l845t1258r1208b1321],
22	polymorphisms	NNS	O	polymorphism	prep_of	18	SENT_93	[p7l1244t1258r1832b1342],
23	and	CC	O	and	_	0	SENT_93	[p7l1869t1258r2009b1321],
24	aspirin	NN	O	aspirin	nn	25	SENT_93	[p7l2044t1280r2150b1321, p7l9t1363r189b1443],
25	dosage	NN	O	dosage	prep_of	18	SENT_93	[p7l247t1360r523b1443],
26	.	.	O	.	_	0	SENT_93	[p7l247t1360r523b1443],

1	Analyses	NNS	O	analysis	nsubjpass	3	SENT_94	[p7l579t1360r917b1444],
2	were	VBD	O	be	auxpass	3	SENT_94	[p7l971t1381r1152b1422],
3	performed	VBN	O	perform	_	0	SENT_94	[p7l1209t1360r1608b1443],
4	on	IN	O	on	_	0	SENT_94	[p7l1664t1381r1755b1422],
5	Stata	NNP	O	Stata	prep_on	3	SENT_94	[p7l1813t1362r1996b1422],
6	9.0	CD	NUMBER	9.0	number	7	SENT_94	[p7l2052t1364r2151b1422],
7	(	CD	NUMBER	(	num	14	SENT_94	[p7l11t1460r432b1544],
8	StataCorp	NNP	O	StataCorp	nn	14	SENT_94	[p7l11t1460r432b1544],
9	,	,	O	,	_	0	SENT_94	[p7l11t1460r432b1544],
10	College	NNP	O	College	nn	11	SENT_94	[p7l467t1461r747b1544],
11	Station	NNP	O	Station	dep	14	SENT_94	[p7l782t1462r1062b1535],
12	,	,	O	,	_	0	SENT_94	[p7l782t1462r1062b1535],
13	Texas	NNP	LOCATION	Texas	nn	14	SENT_94	[p7l1095t1460r1353b1536],
14	)	NN	O	)	dep	5	SENT_94	[p7l1095t1460r1353b1536],
15	.	.	O	.	_	0	SENT_94	[p7l1095t1460r1353b1536],

1	Results	NNS	O	result	_	0	SENT_95	[p7l11t1709r315b1776],

1	From	IN	O	from	_	0	SENT_96	[p7l9t1863r206b1923],
2	September	NNP	DATE	September	prep_from	11	SENT_96	[p7l231t1860r640b1944],
3	2002	CD	DATE	2002	num	2	SENT_96	[p7l660t1864r822b1923],
4	to	TO	O	to	_	0	SENT_96	[p7l844t1868r914b1923],
5	April	NNP	DATE	April	prep_to	2	SENT_96	[p7l936t1860r1130b1944],
6	2004	CD	DATE	2004	num	5	SENT_96	[p7l1152t1864r1333b1935],
7	,	,	O	,	_	0	SENT_96	[p7l1152t1864r1333b1935],
8	200	CD	NUMBER	200	num	9	SENT_96	[p7l1357t1864r1478b1923],
9	participants	NNS	O	participant	nsubjpass	11	SENT_96	[p7l1501t1863r1946b1944],
10	were	VBD	O	be	auxpass	11	SENT_96	[p7l1968t1882r2150b1923],
11	invited	VBN	O	invite	_	0	SENT_96	[p7l9t1962r271b2024],
12	and	CC	O	and	cc	13	SENT_96	[p7l296t1962r436b2024],
13	116	CD	NUMBER	116	dobj	11	SENT_96	[p7l461t1966r580b2024],
14	consented	VBD	O	consent	rcmod	13	SENT_96	[p7l607t1962r987b2024],
15	to	TO	O	to	aux	16	SENT_96	[p7l1011t1970r1081b2024],
16	participate	VB	O	participate	xcomp	14	SENT_96	[p7l1107t1965r1526b2045],
17	.	.	O	.	_	0	SENT_96	[p7l1107t1965r1526b2045],

1	A	DT	O	a	det	3	SENT_97	[p7l1552t1965r1614b2023],
2	further	JJ	O	further	amod	3	SENT_97	[p7l1637t1962r1902b2024],
3	26	CD	NUMBER	26	nsubj	6	SENT_97	[p7l1924t1966r2004b2024],
4	did	VBD	O	do	aux	6	SENT_97	[p7l2032t1962r2152b2024],
5	not	RB	O	not	neg	6	SENT_97	[p7l10t2070r131b2125],
6	meet	VB	O	meet	_	0	SENT_97	[p7l164t2070r350b2125],
7	the	DT	O	the	det	9	SENT_97	[p7l382t2063r499b2125],
8	inclusion	NN	O	inclusion	nn	9	SENT_97	[p7l535t2063r876b2125],
9	criteria	NNS	O	criterion	dobj	6	SENT_97	[p7l913t2065r1194b2137],
10	,	,	O	,	_	0	SENT_97	[p7l913t2065r1194b2137],
11	leaving	VBG	O	leave	partmod	6	SENT_97	[p7l1230t2063r1503b2146],
12	90	CD	NUMBER	90	num	13	SENT_97	[p7l1537t2066r1615b2125],
13	patients	NNS	O	patient	npadvmod	14	SENT_97	[p7l1650t2065r1948b2146],
14	suitable	JJ	O	suitable	acomp	11	SENT_97	[p7l1986t2065r2150b2125, p7l11t2163r163b2226],
15	for	IN	O	for	_	0	SENT_97	[p7l198t2163r303b2226],
16	randomization	NN	O	randomization	prep_for	11	SENT_97	[p7l336t2163r903b2226],
17	.	.	O	.	_	0	SENT_97	[p7l336t2163r903b2226],

1	Of	IN	O	of	_	0	SENT_98	[p7l941t2163r1036b2226],
2	90	CD	NUMBER	90	num	3	SENT_98	[p7l1067t2167r1145b2226],
3	patients	NNS	O	patient	prep_of	13	SENT_98	[p7l1179t2166r1497b2247],
4	,	,	O	,	_	0	SENT_98	[p7l1179t2166r1497b2247],
5	the	DT	O	the	det	6	SENT_98	[p7l1531t2163r1648b2226],
6	80	CD	NUMBER	80	nsubj	13	SENT_98	[p7l1684t2167r1762b2226],
7	who	WP	O	who	nsubj	8	SENT_98	[p7l1794t2163r1953b2226],
8	consented	VBD	O	consent	rcmod	6	SENT_98	[p7l1989t2185r2150b2226, p7l11t2265r257b2327],
9	to	TO	O	to	_	0	SENT_98	[p7l296t2273r366b2327],
10	further	JJ	O	further	amod	12	SENT_98	[p7l407t2265r672b2327],
11	genetic	JJ	O	genetic	amod	12	SENT_98	[p7l713t2268r979b2348],
12	testing	NN	O	testing	prep_to	8	SENT_98	[p7l1020t2268r1274b2348],
13	formed	VBD	O	form	_	0	SENT_98	[p7l1313t2265r1586b2327],
14	the	DT	O	the	det	15	SENT_98	[p7l1625t2265r1742b2327],
15	group	NN	O	group	dobj	13	SENT_98	[p7l1786t2286r2005b2348],
16	for	IN	O	for	_	0	SENT_98	[p7l2047t2265r2152b2327],
17	analysis	NN	O	analysis	prep_for	13	SENT_98	[p7l10t2366r307b2450],
18	of	IN	O	of	_	0	SENT_98	[p7l346t2365r419b2428],
19	the	DT	O	the	det	21	SENT_98	[p7l450t2366r567b2428],
20	baseline	NN	O	baseline	nn	21	SENT_98	[p7l603t2366r913b2428],
21	effects	NNS	O	effect	prep_of	17	SENT_98	[p7l953t2365r1182b2428],
22	of	IN	O	of	_	0	SENT_98	[p7l1221t2365r1294b2428],
23	the	DT	O	the	det	26	SENT_98	[p7l1326t2366r1442b2428],
24	candidate	NN	O	candidate	nn	26	SENT_98	[p7l1481t2366r1844b2428],
25	genetic	JJ	O	genetic	amod	26	SENT_98	[p7l1884t2368r2151b2449],
26	polymorphisms	NNS	O	polymorphism	prep_of	21	SENT_98	[p7l9t2467r616b2551],
27	.	.	O	.	_	0	SENT_98	[p7l9t2467r616b2551],

1	This	DT	O	this	nsubj	2	SENT_99	[p7l662t2467r822b2530],
2	included	VBD	O	include	_	0	SENT_99	[p7l867t2467r1195b2530],
3	all	DT	O	all	det	4	SENT_99	[p7l1240t2467r1327b2530],
4	patients	NNS	O	patient	dobj	2	SENT_99	[p7l1371t2470r1669b2551],
5	before	IN	O	before	_	0	SENT_99	[p7l1712t2467r1950b2530],
6	random	JJ	O	random	amod	7	SENT_99	[p7l1996t2488r2150b2530, p7l11t2568r177b2630],
7	assignment	NN	O	assignment	prep_before	2	SENT_99	[p7l206t2571r634b2651],
8	to	TO	O	to	_	0	SENT_99	[p7l659t2576r729b2630],
9	either	CC	O	either	preconj	10	SENT_99	[p7l759t2568r976b2630],
10	aspirin	NN	O	aspirin	prep_to	2	SENT_99	[p7l1004t2571r1261b2651],
11	or	CC	O	or	_	0	SENT_99	[p7l1291t2589r1366b2630],
12	clopidogrel	NN	O	clopidogrel	prep_to	2	SENT_99	[p7l1394t2568r1833b2651],
13	.	.	O	.	_	0	SENT_99	[p7l1394t2568r1833b2651],

1	In	IN	O	in	_	0	SENT_100	[p7l1863t2571r1939b2629],
2	total	NN	O	total	prep_in	8	SENT_100	[p7l1965t2568r2150b2642],
3	,	,	O	,	_	0	SENT_100	[p7l1965t2568r2150b2642],
4	63	CD	NUMBER	63	num	5	SENT_100	[p7l10t2672r87b2731],
5	patients	NNS	O	patient	nsubjpass	12	SENT_100	[p7l147t2671r448b2752],
6	were	VBD	O	be	auxpass	8	SENT_100	[p7l505t2690r688b2731],
7	randomly	RB	O	randomly	advmod	8	SENT_100	[p7l748t2669r1116b2753],
8	assigned	VBN	O	assign	_	0	SENT_100	[p7l1174t2669r1503b2752],
9	to	TO	O	to	_	0	SENT_100	[p7l1560t2676r1630b2731],
10	aspirin	NN	O	aspirin	prep_to	8	SENT_100	[p7l1691t2671r1951b2752],
11	and	CC	O	and	_	0	SENT_100	[p7l2011t2669r2151b2731],
12	formed	VBD	O	form	conj_and	8	SENT_100	[p7l9t2769r281b2832],
13	the	DT	O	the	det	14	SENT_100	[p7l332t2769r448b2832],
14	group	NN	O	group	dobj	12	SENT_100	[p7l504t2790r723b2853],
15	for	IN	O	for	_	0	SENT_100	[p7l777t2769r882b2832],
16	subsequent	JJ	O	subsequent	amod	17	SENT_100	[p7l935t2769r1368b2853],
17	analysis	NN	O	analysis	prep_for	12	SENT_100	[p7l1420t2769r1717b2853],
18	of	IN	O	of	_	0	SENT_100	[p7l1771t2769r1844b2832],
19	aspirin	NN	O	aspirin	nn	20	SENT_100	[p7l1893t2772r2151b2853],
20	resistance	NN	O	resistance	prep_of	17	SENT_100	[p7l9t2874r400b2933],
21	.	.	O	.	_	0	SENT_100	[p7l9t2874r400b2933],

1	The	DT	O	the	det	3	SENT_101	[p7l435t2871r576b2933],
2	baseline	NN	O	baseline	nn	3	SENT_101	[p7l610t2871r919b2933],
3	characteristics	NNS	O	characteristic	nsubjpass	5	SENT_101	[p7l956t2871r1488b2933],
4	are	VBP	O	be	auxpass	5	SENT_101	[p7l1524t2892r1637b2933],
5	presented	VBN	O	present	_	0	SENT_101	[p7l1672t2871r2047b2954],
6	in	IN	O	in	_	0	SENT_101	[p7l2080t2874r2151b2932],
7	Table	NNP	O	Table	prep_in	5	SENT_101	[p7l9t2972r215b3034],
8	2	CD	NUMBER	2	num	7	SENT_101	[p7l247t2975r303b3033],
9	.	.	O	.	_	0	SENT_101	[p7l247t2975r303b3033],

1	Baseline	NN	O	baseline	nn	2	SENT_102	[p7l8t3149r326b3218],
2	Aggregation	NN	O	aggregation	_	0	SENT_102	[p7l352t3151r818b3242],

1	The	DT	O	the	det	5	SENT_103	[p8l9t27r149b89],
2	heterozygote	NN	O	heterozygote	nn	5	SENT_103	[p8l177t27r660b111],
3	and	CC	O	and	_	0	SENT_103	[p8l689t27r828b89],
4	homozygote	NN	O	homozygote	conj_and	2	SENT_103	[p8l853t27r1311b111],
5	frequency	NN	O	frequency	nsubjpass	15	SENT_103	[p8l1338t26r1717b111],
6	of	IN	O	of	_	0	SENT_103	[p8l1742t26r1814b89],
7	the	DT	O	the	det	8	SENT_103	[p8l1835t26r1951b89],
8	PIAZ	NNP	O	PIAZ	prep_of	5	SENT_103	[p8l1979t17r2149b101],
9	,	,	O	,	_	0	SENT_103	[p8l1979t17r2149b101],
10	C807T	NN	O	c807t	prep_of	5	SENT_103	[p8l11t129r261b201],
11	,	,	O	,	_	0	SENT_103	[p8l11t129r261b201],
12	and	CC	O	and	_	0	SENT_103	[p8l311t127r450b190],
13	A842/C50T	NN	O	a842/c50t	prep_of	5	SENT_103	[p8l493t129r907b190],
14	are	VBP	O	be	auxpass	15	SENT_103	[p8l954t149r1066b190],
15	presented	VBN	O	present	_	0	SENT_103	[p8l1114t127r1489b211],
16	in	IN	O	in	_	0	SENT_103	[p8l1534t130r1605b189],
17	Table	NNP	O	Table	prep_in	15	SENT_103	[p8l1650t127r1857b190],
18	2	CD	NUMBER	2	num	17	SENT_103	[p8l1904t131r1961b189],
19	.	.	O	.	_	0	SENT_103	[p8l1904t131r1961b189],

1	The	DT	O	the	det	9	SENT_104	[p8l2009t127r2149b190],
2	overall	JJ	O	overall	amod	9	SENT_104	[p8l11t229r264b291],
3	mean	NN	O	mean	nn	9	SENT_104	[p8l289t250r496b291],
4	(	CD	NUMBER	(	num	9	SENT_104	[p8l523t228r686b304],
5	SD	NN	O	sd	nn	9	SENT_104	[p8l523t228r686b304],
6	)	CD	NUMBER	)	num	9	SENT_104	[p8l523t228r686b304],
7	baseline	NN	O	baseline	nn	9	SENT_104	[p8l711t229r1020b291],
8	aggregation	NN	O	aggregation	nn	9	SENT_104	[p8l1048t232r1491b312],
9	(	NN	O	(	nsubj	10	SENT_104	[p8l1517t228r1749b312],
10	using	VBG	O	use	csubj	18	SENT_104	[p8l1517t228r1749b312],
11	1.1	CD	NUMBER	1.1	num	12	SENT_104	[p8l1773t233r1868b291],
12	pug/mL	NN	O	pug/ml	dobj	10	SENT_104	[p8l1901t231r2151b312],
13	of	IN	O	of	_	0	SENT_104	[p8l11t329r83b392],
14	collagen	NN	O	collagen	nn	15	SENT_104	[p8l120t329r456b413],
15	)	NN	O	)	prep_of	12	SENT_104	[p8l120t329r456b413],
16	was	VBD	O	be	cop	18	SENT_104	[p8l495t351r637b392],
17	83	CD	PERCENT	83	num	18	SENT_104	[p8l679t331r824b394],
18	%	NN	PERCENT	%	_	0	SENT_104	[p8l679t331r824b394],
19	(	CD	PERCENT	(	num	21	SENT_104	[p8l872t329r1096b404],
20	22	CD	PERCENT	22	num	21	SENT_104	[p8l872t329r1096b404],
21	%	NN	PERCENT	%	dep	18	SENT_104	[p8l872t329r1096b404],
22	)	CD	NUMBER	)	dep	21	SENT_104	[p8l872t329r1096b404],
23	.	.	O	.	_	0	SENT_104	[p8l872t329r1096b404],

1	There	EX	O	there	expl	2	SENT_105	[p8l1137t330r1354b392],
2	was	VBD	O	be	_	0	SENT_105	[p8l1394t351r1536b392],
3	no	DT	O	no	det	4	SENT_105	[p8l1577t351r1668b392],
4	evidence	NN	O	evidence	nsubj	2	SENT_105	[p8l1711t330r2040b392],
5	to	TO	O	to	aux	6	SENT_105	[p8l2080t337r2150b392],
6	suggest	VB	O	suggest	infmod	4	SENT_105	[p8l11t438r293b513],
7	that	IN	O	that	complm	18	SENT_105	[p8l317t430r464b493],
8	either	CC	O	either	preconj	9	SENT_105	[p8l491t430r709b493],
9	heterozygous	JJ	O	heterozygous	amod	12	SENT_105	[p8l735t430r1236b514],
10	or	CC	O	or	_	0	SENT_105	[p8l1264t452r1341b493],
11	homozygous	JJ	O	homozygous	amod	12	SENT_105	[p8l1366t430r1841b514],
12	carriers	NNS	O	carrier	nsubj	18	SENT_105	[p8l1870t433r2150b493],
13	of	IN	O	of	_	0	SENT_105	[p8l11t532r83b594],
14	the	DT	O	the	det	17	SENT_105	[p8l107t532r223b594],
15	candidate	NN	O	candidate	nn	17	SENT_105	[p8l254t532r618b594],
16	genetic	JJ	O	genetic	amod	17	SENT_105	[p8l649t535r916b615],
17	polymorphisms	NNS	O	polymorphism	prep_of	12	SENT_105	[p8l945t532r1533b616],
18	had	VBD	O	have	ccomp	6	SENT_105	[p8l1563t532r1703b594],
19	any	DT	O	any	det	21	SENT_105	[p8l1732t553r1866b616],
20	important	JJ	O	important	amod	21	SENT_105	[p8l1893t535r2150b615, p8l8t641r155b695],
21	differences	NNS	O	difference	nsubj	28	SENT_105	[p8l199t632r602b695],
22	in	IN	O	in	_	0	SENT_105	[p8l646t635r718b694],
23	baseline	NN	O	baseline	nn	24	SENT_105	[p8l760t633r1069b695],
24	aggregation	NN	O	aggregation	prep_in	21	SENT_105	[p8l1116t635r1558b716],
25	(	CD	NUMBER	(	num	28	SENT_105	[p8l1604t632r1835b708],
26	Table	NNP	O	Table	nn	28	SENT_105	[p8l1604t632r1835b708],
27	3	CD	NUMBER	3	num	28	SENT_105	[p8l1879t632r1964b708],
28	)	NN	O	)	xcomp	18	SENT_105	[p8l1879t632r1964b708],
29	.	.	O	.	_	0	SENT_105	[p8l1879t632r1964b708],

1	The	DT	O	the	det	2	SENT_106	[p8l2009t633r2150b695],
2	effects	NNS	O	effect	nsubjpass	8	SENT_106	[p8l11t733r240b796],
3	of	IN	O	of	_	0	SENT_106	[p8l282t733r355b796],
4	multiple	JJ	O	multiple	amod	6	SENT_106	[p8l391t733r705b817],
5	gene	NN	O	gene	nn	6	SENT_106	[p8l747t755r922b816],
6	interaction	NN	O	interaction	prep_of	2	SENT_106	[p8l964t736r1368b796],
7	were	VBD	O	be	auxpass	8	SENT_106	[p8l1406t755r1588b796],
8	assessed	VBN	O	assess	_	0	SENT_106	[p8l1630t733r1970b808],
9	,	,	O	,	_	0	SENT_106	[p8l1630t733r1970b808],
10	and	CC	O	and	_	0	SENT_106	[p8l2012t733r2152b796],
11	after	IN	O	after	_	0	SENT_106	[p8l11t835r181b897],
12	adjusting	VBG	O	adjust	prepc_after	18	SENT_106	[p8l208t835r556b919],
13	for	IN	O	for	_	0	SENT_106	[p8l580t835r686b897],
14	aspirin	NN	O	aspirin	nn	15	SENT_106	[p8l712t838r969b918],
15	dose	NN	O	dose	prep_for	12	SENT_106	[p8l998t835r1186b909],
16	,	,	O	,	_	0	SENT_106	[p8l998t835r1186b909],
17	there	EX	O	there	expl	18	SENT_106	[p8l1214t835r1407b897],
18	was	VBD	O	be	conj_and	8	SENT_106	[p8l1433t856r1576b897],
19	no	DT	O	no	det	20	SENT_106	[p8l1603t856r1695b897],
20	evidence	NN	O	evidence	nsubj	18	SENT_106	[p8l1724t835r2053b897],
21	to	TO	O	to	aux	22	SENT_106	[p8l2080t843r2150b897],
22	suggest	VB	O	suggest	infmod	20	SENT_106	[p8l11t943r293b1019],
23	any	DT	O	any	det	25	SENT_106	[p8l329t957r464b1020],
24	additive	JJ	O	additive	amod	25	SENT_106	[p8l500t936r800b998],
25	effect	NN	O	effect	nn	33	SENT_106	[p8l841t935r1035b998],
26	of	IN	O	of	_	0	SENT_106	[p8l1072t935r1144b998],
27	two	CD	NUMBER	two	num	28	SENT_106	[p8l1176t944r1312b998],
28	polymorphisms	NNS	O	polymorphism	prep_of	25	SENT_106	[p8l1349t936r1937b1020],
29	(	CD	NUMBER	(	num	30	SENT_106	[p8l1977t935r2049b1010],
30	n	NN	O	n	dep	25	SENT_106	[p8l1977t935r2049b1010],
31	=	JJ	O	=	amod	33	SENT_106	[p8l2094t960r2143b979],
32	12	CD	NUMBER	12	tmod	31	SENT_106	[p8l10t1036r114b1112],
33	)	NN	O	)	dobj	22	SENT_106	[p8l10t1036r114b1112],
34	compared	VBN	O	compare	_	0	SENT_106	[p8l151t1037r525b1121],
35	with	IN	O	with	prepc_compared_with	22	SENT_106	[p8l557t1037r723b1100],
36	a	DT	O	a	det	40	SENT_106	[p8l758t1059r796b1100],
37	single	JJ	O	single	amod	40	SENT_106	[p8l831t1037r1049b1120],
38	polymorphism	NN	O	polymorphism	nn	40	SENT_106	[p8l1085t1037r1637b1121],
39	(	NN	O	(	nn	40	SENT_106	[p8l1673t1036r1745b1112],
40	n	NN	O	n	pobj	22	SENT_106	[p8l1673t1036r1745b1112],
41	=	JJ	O	=	amod	40	SENT_106	[p8l1787t1061r1836b1081],
42	34	CD	NUMBER	34	tmod	41	SENT_106	[p8l1877t1041r1976b1111],
43	;	:	O	;	_	0	SENT_106	[p8l1877t1041r1976b1111],
44	p	NN	O	p	nsubj	53	SENT_106	[p8l2009t1058r2051b1121],
45	=	JJ	O	=	amod	47	SENT_106	[p8l2094t1061r2143b1081],
46	0.733	CD	NUMBER	0.733	tmod	45	SENT_106	[p8l10t1137r237b1213],
47	)	NN	O	)	dep	44	SENT_106	[p8l10t1137r237b1213],
48	,	,	O	,	_	0	SENT_106	[p8l10t1137r237b1213],
49	and	CC	O	and	_	0	SENT_106	[p8l293t1138r433b1200],
50	only	RB	O	only	quantmod	51	SENT_106	[p8l485t1138r647b1222],
51	1	CD	NUMBER	1	num	52	SENT_106	[p8l699t1142r733b1199],
52	patient	NN	O	patient	conj_and	44	SENT_106	[p8l788t1141r1051b1221],
53	carried	VBD	O	carry	parataxis	8	SENT_106	[p8l1104t1138r1366b1200],
54	all	DT	O	all	det	56	SENT_106	[p8l1418t1138r1505b1200],
55	three	CD	NUMBER	three	num	56	SENT_106	[p8l1557t1138r1749b1200],
56	polymorphisms	NNS	O	polymorphism	dobj	53	SENT_106	[p8l1803t1138r2150b1222, p8l9t1239r297b1322],
57	.	.	O	.	_	0	SENT_106	[p8l1803t1138r2150b1222, p8l9t1239r297b1322],

1	Therefore	RB	O	therefore	advmod	6	SENT_107	[p8l348t1238r735b1313],
2	,	,	O	,	_	0	SENT_107	[p8l348t1238r735b1313],
3	the	DT	O	the	det	5	SENT_107	[p8l786t1239r902b1301],
4	remaining	VBG	O	remain	amod	5	SENT_107	[p8l953t1241r1340b1322],
5	analyses	NNS	O	analysis	nsubj	6	SENT_107	[p8l1389t1239r1704b1323],
6	report	VBP	O	report	_	0	SENT_107	[p8l1754t1247r1986b1322],
7	the	DT	O	the	det	8	SENT_107	[p8l2033t1239r2150b1301],
8	results	NNS	O	result	dobj	6	SENT_107	[p8l9t1340r257b1403],
9	of	IN	O	of	_	0	SENT_107	[p8l290t1340r362b1403],
10	the	DT	O	the	det	12	SENT_107	[p8l388t1340r505b1403],
11	individual	JJ	O	individual	amod	12	SENT_107	[p8l537t1340r920b1403],
12	polymorphisms	NNS	O	polymorphism	prep_of	8	SENT_107	[p8l951t1340r1558b1424],
13	.	.	O	.	_	0	SENT_107	[p8l951t1340r1558b1424],

1	Postoperative	JJ	O	postoperative	amod	2	SENT_108	[p8l7t1520r517b1609],
2	Outcomes	NNS	O	outcome	_	0	SENT_108	[p8l554t1519r921b1585],
3	After	IN	O	after	dep	2	SENT_108	[p8l7t1633r201b1696],
4	5	CD	DURATION	5	num	5	SENT_108	[p8l228t1637r265b1696],
5	days	NNS	NUMBER	day	pobj	3	SENT_108	[p8l298t1633r465b1717],
6	of	IN	O	of	_	0	SENT_108	[p8l497t1633r569b1696],
7	aspirin	NN	O	aspirin	nn	8	SENT_108	[p8l596t1636r853b1717],
8	therapy	NN	O	therapy	prep_of	5	SENT_108	[p8l882t1633r1190b1717],
9	,	,	O	,	_	0	SENT_108	[p8l882t1633r1190b1717],
10	the	DT	O	the	det	13	SENT_108	[p8l1220t1633r1336b1696],
11	mean	NN	O	mean	nn	13	SENT_108	[p8l1367t1655r1574b1696],
12	platelet	NN	O	platelet	nn	13	SENT_108	[p8l1603t1633r1884b1717],
13	aggregation	NN	O	aggregation	appos	8	SENT_108	[p8l1913t1655r2150b1716, p8l11t1761r242b1841],

1	in	IN	O	in	_	0	SENT_109	[p8l278t1761r349b1819],
2	the	DT	O	the	det	3	SENT_109	[p8l383t1758r500b1820],
3	patients	NNS	O	patient	nsubj	4	SENT_109	[p8l537t1761r834b1841],
4	receiving	VBG	O	receive	prepc_in	7	SENT_109	[p8l871t1761r1216b1841],
5	aspirin	NN	O	aspirin	dobj	4	SENT_109	[p8l1251t1761r1509b1841],
6	was	VBD	O	be	auxpass	7	SENT_109	[p8l1542t1779r1685b1820],
7	reduced	VBN	O	reduce	_	0	SENT_109	[p8l1721t1758r2027b1820],
8	by	IN	O	by	_	0	SENT_109	[p8l2060t1758r2153b1842],
9	30	CD	PERCENT	30	num	10	SENT_109	[p8l8t1859r156b1921],
10	%	NN	PERCENT	%	agent	7	SENT_109	[p8l8t1859r156b1921],
11	(	CD	PERCENT	(	number	12	SENT_109	[p8l194t1857r367b1932],
12	95	CD	PERCENT	95	num	13	SENT_109	[p8l194t1857r367b1932],
13	%	NN	PERCENT	%	nsubjpass	7	SENT_109	[p8l194t1857r367b1932],
14	conﬁdence	NN	O	conﬁdence	nn	15	SENT_109	[p8l405t1857r808b1920],
15	interval	NN	O	interval	dep	13	SENT_109	[p8l840t1858r1145b1920],
16	:	:	O	:	_	0	SENT_109	[p8l840t1858r1145b1920],
17	24	CD	PERCENT	24	number	21	SENT_109	[p8l1177t1859r1325b1921],
18	%	NN	PERCENT	%	dep	21	SENT_109	[p8l1177t1859r1325b1921],
19	to	TO	O	to	dep	21	SENT_109	[p8l1361t1865r1430b1920],
20	36	CD	PERCENT	36	number	21	SENT_109	[p8l1461t1857r1660b1932],
21	%	NN	PERCENT	%	dep	13	SENT_109	[p8l1461t1857r1660b1932],
22	)	CD	NUMBER	)	dep	21	SENT_109	[p8l1461t1857r1660b1932],
23	.	.	O	.	_	0	SENT_109	[p8l1461t1857r1660b1932],

1	PZAZ	NNP	O	PZAZ	nn	3	SENT_110	[p8l7t2021r165b2103],
2	Polymorphism	NN	O	polymorphism	nn	3	SENT_110	[p8l198t2035r755b2128],
3	Carriers	NNS	O	carrier	nsubj	7	SENT_110	[p8l11t2148r313b2208],
4	of	IN	O	of	_	0	SENT_110	[p8l354t2146r427b2208],
5	PIAZ	NN	O	piaz	nn	6	SENT_110	[p8l462t2137r614b2207],
6	polymorphism	NN	O	polymorphism	prep_of	3	SENT_110	[p8l653t2146r1205b2230],
7	had	VBD	O	have	_	0	SENT_110	[p8l1244t2146r1385b2208],
8	consistently	RB	O	consistently	advmod	9	SENT_110	[p8l1424t2147r1870b2230],
9	higher	JJR	O	higher	amod	10	SENT_110	[p8l1908t2146r2152b2229],
10	baseline	NN	O	baseline	dobj	7	SENT_110	[p8l8t2246r317b2309],
11	adjusted	VBN	O	adjust	partmod	10	SENT_110	[p8l363t2246r683b2330],
12	difference	NN	O	difference	dobj	11	SENT_110	[p8l727t2246r1092b2309],
13	in	IN	O	in	_	0	SENT_110	[p8l1136t2249r1208b2308],
14	percentage	NN	O	percentage	nn	15	SENT_110	[p8l1251t2254r1663b2330],
15	aggregation	NN	O	aggregation	prep_in	12	SENT_110	[p8l1708t2249r2151b2329],
16	for	IN	O	for	_	0	SENT_110	[p8l9t2348r114b2410],
17	all	DT	O	all	det	19	SENT_110	[p8l156t2348r244b2410],
18	three	CD	NUMBER	three	num	19	SENT_110	[p8l285t2348r478b2410],
19	agonist	NN	O	agonist	prep_for	11	SENT_110	[p8l523t2351r810b2430],
20	,	,	O	,	_	0	SENT_110	[p8l523t2351r810b2430],
21	albeit	IN	O	albeit	advmod	11	SENT_110	[p8l856t2348r1063b2410],
22	without	IN	O	without	_	0	SENT_110	[p8l1102t2348r1394b2410],
23	reaching	VBG	O	reach	prepc_without	21	SENT_110	[p8l1435t2348r1762b2430],
24	statistical	JJ	O	statistical	amod	25	SENT_110	[p8l1803t2348r2152b2410],
25	significance	NN	O	significance	dobj	23	SENT_110	[p8l11t2447r468b2531],
26	.	.	O	.	_	0	SENT_110	[p8l11t2447r468b2531],

1	The	DT	O	the	det	2	SENT_111	[p8l519t2448r660b2510],
2	results	NNS	O	result	nsubj	7	SENT_111	[p8l711t2448r959b2510],
3	of	IN	O	of	_	0	SENT_111	[p8l1010t2447r1083b2510],
4	EC50	NN	O	ec50	nn	5	SENT_111	[p8l1129t2449r1320b2510],
5	concentrations	NNS	O	concentration	prep_of	2	SENT_111	[p8l1371t2450r1919b2510],
6	were	VBD	O	be	cop	7	SENT_111	[p8l1968t2469r2150b2510],
7	uniform	JJ	O	uniform	_	0	SENT_111	[p8l10t2548r331b2623],
8	,	,	O	,	_	0	SENT_111	[p8l10t2548r331b2623],
9	with	IN	O	with	_	0	SENT_111	[p8l386t2548r553b2611],
10	lower	JJR	O	lower	amod	11	SENT_111	[p8l607t2548r818b2611],
11	amounts	NNS	O	amount	prep_with	7	SENT_111	[p8l873t2556r1195b2611],
12	of	IN	O	of	_	0	SENT_111	[p8l1253t2548r1325b2611],
13	agonist	NN	O	agonist	prep_of	11	SENT_111	[p8l1377t2551r1647b2631],
14	required	VBN	O	require	partmod	13	SENT_111	[p8l1701t2548r2027b2632],
15	to	TO	O	to	xcomp	14	SENT_111	[p8l2080t2556r2150b2611],

1	Table	NNP	O	Table	_	0	SENT_112	[p8l69t2690r154b2718],
2	4	CD	NUMBER	4	dep	1	SENT_112	[p8l166t2691r191b2718],
3	.	.	O	.	_	0	SENT_112	[p8l166t2691r191b2718],

1	Baseline	NN	O	baseline	nsubj	2	SENT_113	[p8l214t2690r344b2718],
2	Adjusted	VBD	O	adjust	_	0	SENT_113	[p8l354t2690r494b2728],
3	Differences	NNS	O	difference	dobj	2	SENT_113	[p8l507t2690r678b2728],
4	in	IN	O	in	_	0	SENT_113	[p8l693t2691r723b2718],
5	Platelet	NN	O	platelet	nn	6	SENT_113	[p8l736t2690r854b2718],
6	Aggregation	NN	O	aggregation	prep_in	2	SENT_113	[p8l863t2691r1054b2728],
7	After	IN	O	after	_	0	SENT_113	[p8l1066t2690r1147b2728],
8	5	CD	DURATION	5	num	9	SENT_113	[p8l1158t2692r1177b2718],
9	Days	NNS	DURATION	day	prep_after	2	SENT_113	[p8l1190t2691r1271b2728],
10	of	IN	O	of	_	0	SENT_113	[p8l1285t2690r1319b2728],
11	Aspirin	NN	O	aspirin	prep_of	9	SENT_113	[p8l1325t2691r1443b2728],

1	PIAZ	NN	O	piaz	_	0	SENT_114	[p8l1044t2763r1105b2791],
2	C807T	NN	O	c807t	nn	4	SENT_114	[p8l1467t2767r1573b2792],
3	"	''	O	"	punct	4	SENT_114	[p8l1467t2767r1573b2792],
4	A842G/C50T	NN	O	a842g/c50t	dep	1	SENT_114	[p8l1853t2767r2048b2792],

1	Difference	NN	O	difference	_	0	SENT_115	[p8l68t2835r223b2861],
2	in	IN	O	in	_	0	SENT_115	[p8l236t2837r265b2860],
3	percentage	NN	O	percentage	nn	4	SENT_115	[p8l277t2839r444b2869],
4	aggregation	NN	O	aggregation	prep_in	1	SENT_115	[p8l457t2837r637b2869],
5	(	CD	PERCENT	(	num	7	SENT_115	[p8l650t2835r719b2866],
6	95	CD	PERCENT	95	num	7	SENT_115	[p8l650t2835r719b2866],
7	%	NN	PERCENT	%	dep	14	SENT_115	[p8l650t2835r719b2866],
8	CI	NN	O	ci	nn	10	SENT_115	[p8l735t2835r780b2866],
9	)	CD	NUMBER	)	num	10	SENT_115	[p8l735t2835r780b2866],
10	Collagen	NNP	O	Collagen	dep	7	SENT_115	[p8l102t2878r236b2912],
11	1	CD	NUMBER	1	num	12	SENT_115	[p8l249t2880r263b2903],
12	ug/mL	NN	O	ug/ml	dep	14	SENT_115	[p8l278t2879r380b2912],
13	8	CD	NUMBER	8	num	14	SENT_115	[p8l991t2880r1006b2904],
14	(	NN	O	(	dep	20	SENT_115	[p8l1016t2878r1070b2909],
15	-4	CD	NUMBER	-4	num	17	SENT_115	[p8l1016t2878r1070b2909],
16	to	TO	O	to	dep	17	SENT_115	[p8l1079t2882r1107b2904],
17	19	CD	NUMBER	19	dep	14	SENT_115	[p8l1118t2878r1160b2909],
18	)	CD	NUMBER	)	number	19	SENT_115	[p8l1118t2878r1160b2909],
19	5	CD	NUMBER	5	dep	17	SENT_115	[p8l1436t2880r1450b2904],
20	(	NN	O	(	dep	1	SENT_115	[p8l1462t2878r1516b2909],
21	-4	CD	NUMBER	-4	num	20	SENT_115	[p8l1462t2878r1516b2909],
22	to	TO	O	to	dep	1	SENT_115	[p8l1524t2881r1553b2904],
23	13	CD	NUMBER	13	number	24	SENT_115	[p8l1563t2878r1605b2909],
24	)	CD	NUMBER	)	num	25	SENT_115	[p8l1563t2878r1605b2909],
25	o	NN	O	o	dep	1	SENT_115	[p8l1854t2880r1869b2904],
26	(	CD	NUMBER	(	number	30	SENT_115	[p8l1879t2878r1949b2909],
27	-13	CD	NUMBER	-13	number	30	SENT_115	[p8l1879t2878r1949b2909],
28	to	TO	O	to	dep	30	SENT_115	[p8l1959t2881r1987b2904],
29	14	CD	NUMBER	14	number	30	SENT_115	[p8l1997t2878r2039b2909],
30	)	CD	NUMBER	)	dep	1	SENT_115	[p8l1997t2878r2039b2909],
31	ADP	NN	ORGANIZATION	adp	nn	34	SENT_115	[p8l100t2922r172b2946],
32	5	CD	NUMBER	5	num	34	SENT_115	[p8l184t2923r199b2947],
33	p.	NN	O	p.	nn	34	SENT_115	[p8l214t2921r325b2953],
34	mol/L	NN	O	mol/l	dep	30	SENT_115	[p8l214t2921r325b2953],
35	6	CD	NUMBER	6	num	36	SENT_115	[p8l991t2921r1070b2951],
36	(	NN	O	(	dep	30	SENT_115	[p8l991t2921r1070b2951],
37	.	.	O	.	_	0	SENT_115	[p8l991t2921r1070b2951],

1	—	NN	O	—	_	0	SENT_116	[p8l991t2921r1070b2951],
2	.	.	O	.	_	0	SENT_116	[p8l991t2921r1070b2951],

1	4	CD	NUMBER	4	number	3	SENT_117	[p8l991t2921r1070b2951],
2	to	TO	O	to	dep	3	SENT_117	[p8l1079t2924r1107b2946],
3	15	CD	NUMBER	15	num	4	SENT_117	[p8l1118t2921r1160b2952],
4	)	NN	O	)	_	0	SENT_117	[p8l1118t2921r1160b2952],
5	2	CD	NUMBER	2	number	6	SENT_117	[p8l1436t2923r1451b2946],
6	(	CD	NUMBER	(	num	7	SENT_117	[p8l1462t2921r1516b2951],
7	-4	CD	NUMBER	-4	dep	4	SENT_117	[p8l1462t2921r1516b2951],
8	to	TO	O	to	_	0	SENT_117	[p8l1524t2924r1553b2946],
9	9	CD	NUMBER	9	num	10	SENT_117	[p8l1563t2921r1589b2952],
10	)	NN	O	)	prep_to	7	SENT_117	[p8l1563t2921r1589b2952],
11	.	.	O	.	_	0	SENT_117	[p8l1829t2921r1950b2952],

1	—	NN	O	—	_	0	SENT_118	[p8l1829t2921r1950b2952],
2	.	.	O	.	_	0	SENT_118	[p8l1829t2921r1950b2952],

1	7	CD	NUMBER	7	_	0	SENT_119	[p8l1829t2921r1950b2952],
2	(	NN	O	(	dep	1	SENT_119	[p8l1829t2921r1950b2952],
3	.	.	O	.	_	0	SENT_119	[p8l1829t2921r1950b2952],

1	—	NN	O	—	_	0	SENT_120	[p8l1829t2921r1950b2952],
2	.	.	O	.	_	0	SENT_120	[p8l1829t2921r1950b2952],

1	14	CD	NUMBER	14	dep	102	SENT_121	[p8l1829t2921r1950b2952],
2	to	TO	O	to	dep	102	SENT_121	[p8l1959t2924r1987b2946],
3	1	CD	NUMBER	1	dep	102	SENT_121	[p8l1997t2921r2023b2952],
4	)	CD	NUMBER	)	dep	102	SENT_121	[p8l1997t2921r2023b2952],
5	Epinephrine	NN	ORGANIZATION	epinephrine	dep	102	SENT_121	[p8l101t2964r290b2998],
6	10	CD	NUMBER	10	dep	102	SENT_121	[p8l303t2966r335b2989],
7	umol/L	NN	O	umol/l	dep	102	SENT_121	[p8l349t2964r460b2996],
8	8	CD	NUMBER	8	dep	102	SENT_121	[p8l991t2966r1006b2989],
9	(	NN	O	(	dep	102	SENT_121	[p8l1016t2964r1069b2994],
10	-3	CD	NUMBER	-3	dep	102	SENT_121	[p8l1016t2964r1069b2994],
11	to	TO	O	to	dep	102	SENT_121	[p8l1079t2967r1107b2989],
12	19	CD	NUMBER	19	dep	102	SENT_121	[p8l1118t2964r1160b2994],
13	)	CD	NUMBER	)	dep	102	SENT_121	[p8l1118t2964r1160b2994],
14	3	CD	NUMBER	3	dep	102	SENT_121	[p8l1435t2966r1451b2989],
15	(	NN	O	(	dep	102	SENT_121	[p8l1462t2964r1514b2994],
16	-5	CD	NUMBER	-5	dep	102	SENT_121	[p8l1462t2964r1514b2994],
17	to	TO	O	to	dep	102	SENT_121	[p8l1524t2967r1553b2989],
18	10	CD	NUMBER	10	dep	102	SENT_121	[p8l1563t2964r1605b2994],
19	)	CD	NUMBER	)	dep	102	SENT_121	[p8l1563t2964r1605b2994],
20	-7	CD	NUMBER	-7	dep	102	SENT_121	[p8l1829t2966r1869b2989],
21	(	NN	O	(	dep	102	SENT_121	[p8l1879t2964r1949b2994],
22	-18	CD	NUMBER	-18	dep	102	SENT_121	[p8l1879t2964r1949b2994],
23	to	TO	O	to	dep	102	SENT_121	[p8l1959t2967r1987b2989],
24	4	CD	NUMBER	4	dep	102	SENT_121	[p8l1997t2964r2023b2994],
25	)	CD	NUMBER	)	dep	102	SENT_121	[p8l1997t2964r2023b2994],
26	Diﬁerence	NN	O	diﬁerence	dep	102	SENT_121	[p8l68t3007r223b3033],
27	in	IN	O	in	dep	102	SENT_121	[p8l236t3008r265b3032],
28	EC50	NN	O	ec50	dep	102	SENT_121	[p8l277t3008r355b3033],
29	concentration	NN	O	concentration	dep	102	SENT_121	[p8l368t3008r575b3033],
30	(	CD	PERCENT	(	dep	102	SENT_121	[p8l588t3007r658b3038],
31	95	CD	PERCENT	95	dep	102	SENT_121	[p8l588t3007r658b3038],
32	%	NN	PERCENT	%	dep	102	SENT_121	[p8l588t3007r658b3038],
33	CI	NN	O	ci	dep	102	SENT_121	[p8l673t3007r718b3038],
34	)	CD	NUMBER	)	dep	102	SENT_121	[p8l673t3007r718b3038],
35	Collagen	NNP	O	Collagen	dep	102	SENT_121	[p8l102t3052r236b3085],
36	p.	NN	O	p.	dep	102	SENT_121	[p8l251t3052r352b3085],
37	g/mL	NN	O	g/ml	dep	102	SENT_121	[p8l251t3052r352b3085],
38	-0.25	CD	NUMBER	-0.25	dep	102	SENT_121	[p8l924t3053r1005b3077],
39	(	CD	NUMBER	(	dep	102	SENT_121	[p8l1016t3051r1112b3082],
40	-0.84	CD	NUMBER	-0.84	dep	102	SENT_121	[p8l1016t3051r1112b3082],
41	to	TO	O	to	dep	102	SENT_121	[p8l1121t3055r1149b3077],
42	0.34	CD	NUMBER	0.34	dep	102	SENT_121	[p8l1159t3051r1227b3082],
43	)	CD	NUMBER	)	dep	102	SENT_121	[p8l1159t3051r1227b3082],
44	-0.22	CD	NUMBER	-0.22	dep	102	SENT_121	[p8l1370t3053r1451b3077],
45	(	NN	O	(	dep	102	SENT_121	[p8l1462t3051r1557b3082],
46	-0.74	CD	NUMBER	-0.74	dep	102	SENT_121	[p8l1462t3051r1557b3082],
47	to	TO	O	to	dep	102	SENT_121	[p8l1566t3055r1594b3077],
48	0.31	CD	NUMBER	0.31	dep	102	SENT_121	[p8l1605t3051r1672b3082],
49	)	CD	NUMBER	)	dep	102	SENT_121	[p8l1605t3051r1672b3082],
50	0.19	CD	NUMBER	0.19	dep	102	SENT_121	[p8l1812t3053r1869b3077],
51	(	NN	O	(	dep	102	SENT_121	[p8l1879t3051r1974b3082],
52	-0.53	CD	NUMBER	-0.53	dep	102	SENT_121	[p8l1879t3051r1974b3082],
53	to	TO	O	to	dep	102	SENT_121	[p8l1984t3055r2012b3077],
54	0.91	CD	NUMBER	0.91	dep	102	SENT_121	[p8l2022t3051r2089b3082],
55	)	CD	NUMBER	)	dep	102	SENT_121	[p8l2022t3051r2089b3082],
56	ADP	NN	ORGANIZATION	adp	dep	102	SENT_121	[p8l100t3096r172b3119],
57	p.	NN	O	p.	dep	102	SENT_121	[p8l186t3094r297b3126],
58	mol/L	NN	O	mol/l	dep	102	SENT_121	[p8l186t3094r297b3126],
59	-0.02	CD	NUMBER	-0.02	dep	102	SENT_121	[p8l924t3096r1006b3120],
60	(	CD	NUMBER	(	dep	102	SENT_121	[p8l1016t3094r1111b3125],
61	-0.28	CD	NUMBER	-0.28	dep	102	SENT_121	[p8l1016t3094r1111b3125],
62	to	TO	O	to	dep	102	SENT_121	[p8l1121t3098r1149b3120],
63	0.24	CD	NUMBER	0.24	dep	102	SENT_121	[p8l1159t3094r1227b3125],
64	)	CD	NUMBER	)	dep	102	SENT_121	[p8l1159t3094r1227b3125],
65	-0.08	CD	NUMBER	-0.08	dep	102	SENT_121	[p8l1370t3096r1451b3120],
66	(	NN	O	(	dep	102	SENT_121	[p8l1462t3094r1556b3125],
67	-0.31	CD	NUMBER	-0.31	dep	102	SENT_121	[p8l1462t3094r1556b3125],
68	to	TO	O	to	dep	102	SENT_121	[p8l1566t3098r1594b3120],
69	0.14	CD	NUMBER	0.14	dep	102	SENT_121	[p8l1605t3094r1672b3125],
70	)	CD	NUMBER	)	dep	102	SENT_121	[p8l1605t3094r1672b3125],
71	0.11	CD	NUMBER	0.11	dep	102	SENT_121	[p8l1812t3096r1868b3120],
72	(	NN	O	(	dep	102	SENT_121	[p8l1879t3094r1974b3125],
73	-0.12	CD	NUMBER	-0.12	dep	102	SENT_121	[p8l1879t3094r1974b3125],
74	to	TO	O	to	dep	102	SENT_121	[p8l1984t3098r2012b3120],
75	0.34	CD	NUMBER	0.34	dep	102	SENT_121	[p8l2022t3094r2089b3125],
76	)	CD	NUMBER	)	dep	102	SENT_121	[p8l2022t3094r2089b3125],
77	Epinephrine	NNP	O	Epinephrine	dep	102	SENT_121	[p8l101t3137r290b3171],
78	p.	NN	O	p.	dep	102	SENT_121	[p8l305t3137r416b3169],
79	1	CD	NUMBER	1	dep	102	SENT_121	[p8l305t3137r416b3169],
80	'	''	O	'	_	0	SENT_121	[p8l305t3137r416b3169],
81	1	CD	NUMBER	1	dep	102	SENT_121	[p8l305t3137r416b3169],
82	’	CD	NUMBER	’	dep	102	SENT_121	[p8l305t3137r416b3169],
83	10l/L	NN	O	10l/l	dep	102	SENT_121	[p8l305t3137r416b3169],
84	-0.67	CD	NUMBER	-0.67	dep	102	SENT_121	[p8l925t3139r1007b3163],
85	(	CD	NUMBER	(	dep	102	SENT_121	[p8l1016t3137r1112b3168],
86	-1.74	CD	NUMBER	-1.74	dep	102	SENT_121	[p8l1016t3137r1112b3168],
87	to	TO	O	to	dep	102	SENT_121	[p8l1121t3141r1149b3163],
88	0.39	CD	NUMBER	0.39	dep	102	SENT_121	[p8l1159t3137r1227b3168],
89	)	CD	NUMBER	)	dep	102	SENT_121	[p8l1159t3137r1227b3168],
90	-0.50	CD	NUMBER	-0.50	dep	102	SENT_121	[p8l1370t3139r1451b3163],
91	(	NN	O	(	dep	102	SENT_121	[p8l1462t3137r1556b3168],
92	-1.51	CD	NUMBER	-1.51	dep	102	SENT_121	[p8l1462t3137r1556b3168],
93	to	TO	O	to	dep	102	SENT_121	[p8l1566t3141r1594b3163],
94	0.51	CD	NUMBER	0.51	dep	102	SENT_121	[p8l1605t3137r1672b3168],
95	)	CD	NUMBER	)	dep	102	SENT_121	[p8l1605t3137r1672b3168],
96	0.52	CD	NUMBER	0.52	dep	102	SENT_121	[p8l1812t3139r1869b3163],
97	(	NN	O	(	dep	102	SENT_121	[p8l1879t3137r1975b3168],
98	-0.64	CD	NUMBER	-0.64	dep	102	SENT_121	[p8l1879t3137r1975b3168],
99	to	TO	O	to	dep	102	SENT_121	[p8l1984t3140r2012b3163],
100	1.67	CD	NUMBER	1.67	dep	102	SENT_121	[p8l2022t3137r2089b3167],
101	)	CD	NUMBER	)	dep	102	SENT_121	[p8l2022t3137r2089b3167],
102	"	''	O	"	_	0	SENT_121	[p8l68t3228r79b3237],

1	’	NN	O	’	nn	2	SENT_122	[p8l68t3228r79b3237],
2	C807T	NN	O	c807t	nsubjpass	4	SENT_122	[p8l88t3227r170b3249],
3	was	VBD	O	be	auxpass	4	SENT_122	[p8l180t3234r230b3249],
4	compared	VBN	O	compare	_	0	SENT_122	[p8l242t3227r375b3257],
5	using	VBG	O	use	xcomp	4	SENT_122	[p8l385t3228r458b3257],
6	homozygotes	NNS	O	homozygote	dobj	5	SENT_122	[p8l468t3227r643b3257],
7	versus	CC	O	versus	prep	6	SENT_122	[p8l654t3234r740b3249],
8	heterozygotes	NNS	O	heterozygote	dep	7	SENT_122	[p8l751t3227r935b3257],
9	and	CC	O	and	_	0	SENT_122	[p8l947t3227r996b3249],
10	normal	JJ	O	normal	dep	7	SENT_122	[p8l1007t3227r1108b3249],
11	.	.	O	.	_	0	SENT_122	[p8l1007t3227r1108b3249],

1	ADP	NN	O	adp	_	0	SENT_123	[p8l67t3271r130b3292],
2	=	JJ	O	=	amod	4	SENT_123	[p8l143t3279r161b3286],
3	adenosine	NN	O	adenosine	nn	4	SENT_123	[p8l175t3270r310b3293],
4	diphosphate	NN	O	diphosphate	dep	1	SENT_123	[p8l322t3270r493b3300],
5	;	:	O	;	_	0	SENT_123	[p8l322t3270r493b3300],
6	CI	NN	O	ci	dep	1	SENT_123	[p8l554t3271r584b3293],
7	=	JJ	O	=	amod	9	SENT_123	[p8l598t3279r616b3286],
8	conﬁdence	NN	O	conﬁdence	nn	9	SENT_123	[p8l630t3270r772b3293],
9	interval	NN	O	interval	dep	6	SENT_123	[p8l784t3270r892b3293],
10	.	.	O	.	_	0	SENT_123	[p8l784t3270r892b3293],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_124	[p8l12t3467r137b3513],
2	Thorac	NNP	PERSON	Thorac	nn	3	SENT_124	[p8l160t3465r362b3513],
3	Surg	NNP	O	Surg	_	0	SENT_124	[p8l388t3466r524b3529],
4	2007	CD	DATE	2007	num	3	SENT_124	[p8l12t3541r327b3596],
5	;	:	O	;	_	0	SENT_124	[p8l12t3541r327b3596],
6	83:134	CD	NUMBER	83:134	number	7	SENT_124	[p8l12t3541r327b3596],
7	-9	CD	NUMBER	-9	dep	3	SENT_124	[p8l336t3541r398b3586],

1	induce	VB	O	induce	_	0	SENT_125	[p9l13t89r264b151],
2	50	CD	PERCENT	50	number	3	SENT_125	[p9l313t91r459b153],
3	%	NN	PERCENT	%	amod	4	SENT_125	[p9l313t91r459b153],
4	aggregation	NN	O	aggregation	dobj	1	SENT_125	[p9l515t92r974b171],
5	,	,	O	,	_	0	SENT_125	[p9l515t92r974b171],
6	consistent	JJ	O	consistent	amod	4	SENT_125	[p9l1026t92r1401b151],
7	with	IN	O	with	_	0	SENT_125	[p9l1445t89r1611b151],
8	less	JJR	O	less	amod	11	SENT_125	[p9l1658t89r1794b151],
9	effective	JJ	O	effective	amod	11	SENT_125	[p9l1845t89r2147b151],
10	platelet	NN	O	platelet	nn	11	SENT_125	[p9l13t188r293b270],
11	inhibition	NN	O	inhibition	prep_with	6	SENT_125	[p9l323t188r689b249],
12	by	IN	O	by	_	0	SENT_125	[p9l718t188r811b271],
13	aspirin	NN	O	aspirin	nn	15	SENT_125	[p9l841t190r1098b270],
14	(	CD	NUMBER	(	num	15	SENT_125	[p9l1131t187r1362b262],
15	Table	NNP	O	Table	prep_by	11	SENT_125	[p9l1131t187r1362b262],
16	4	CD	NUMBER	4	number	17	SENT_125	[p9l1393t187r1478b262],
17	)	CD	NUMBER	)	num	15	SENT_125	[p9l1393t187r1478b262],
18	.	.	O	.	_	0	SENT_125	[p9l1393t187r1478b262],

1	An	DT	O	a	det	3	SENT_126	[p9l94t289r205b347],
2	interaction	NN	O	interaction	nn	3	SENT_126	[p9l239t289r642b348],
3	term	NN	O	term	nsubjpass	5	SENT_126	[p9l675t294r850b348],
4	was	VBD	O	be	auxpass	5	SENT_126	[p9l882t308r1025b348],
5	identified	VBN	O	identify	_	0	SENT_126	[p9l1059t286r1419b348],
6	when	WRB	O	when	advmod	9	SENT_126	[p9l1450t286r1657b348],
7	epinephrine	NN	O	epinephrine	nsubjpass	9	SENT_126	[p9l1693t286r2147b369],
8	was	VBD	O	be	auxpass	9	SENT_126	[p9l12t408r154b449],
9	used	VBN	O	use	advcl	5	SENT_126	[p9l186t387r363b449],
10	as	IN	O	as	_	0	SENT_126	[p9l394t408r468b449],
11	an	DT	O	a	det	12	SENT_126	[p9l500t408r588b449],
12	agonist	NN	O	agonist	prep_as	9	SENT_126	[p9l621t390r907b469],
13	,	,	O	,	_	0	SENT_126	[p9l621t390r907b469],
14	both	DT	O	both	dep	9	SENT_126	[p9l939t387r1108b449],
15	on	IN	O	on	_	0	SENT_126	[p9l1141t408r1232b449],
16	percentage	NN	O	percentage	nn	17	SENT_126	[p9l1263t395r1674b469],
17	aggregation	NN	O	aggregation	prep_on	9	SENT_126	[p9l1708t390r2149b469],
18	and	CC	O	and	_	0	SENT_126	[p9l15t486r154b547],
19	EC50	NN	O	ec50	nn	20	SENT_126	[p9l178t487r369b547],
20	concentration	NN	O	concentration	prep_on	9	SENT_126	[p9l395t488r924b547],
21	.	.	O	.	_	0	SENT_126	[p9l395t488r924b547],

1	Low-dose	JJ	O	low-dose	amod	2	SENT_127	[p9l951t486r1314b547],
2	aspirin	NN	O	aspirin	nsubj	5	SENT_127	[p9l1342t488r1599b568],
3	was	VBD	O	be	cop	5	SENT_127	[p9l1621t507r1763b547],
4	less	RBR	O	less	advmod	5	SENT_127	[p9l1789t486r1924b547],
5	effective	JJ	O	effective	_	0	SENT_127	[p9l1952t485r2148b547, p9l13t588r167b647],
6	.	.	O	.	_	0	SENT_127	[p9l1952t485r2148b547, p9l13t588r167b647],

1	The	DT	O	the	det	3	SENT_128	[p9l193t585r334b647],
2	interaction	NN	O	interaction	nn	3	SENT_128	[p9l360t588r764b647],
3	coefficient	NN	O	coefficient	nsubj	4	SENT_128	[p9l790t585r1166b647],
4	described	VBD	O	describe	_	0	SENT_128	[p9l1192t585r1554b647],
5	a	DT	O	a	det	7	SENT_128	[p9l1579t607r1617b647],
6	higher	JJR	O	higher	amod	7	SENT_128	[p9l1642t585r1887b667],
7	aggregation	NN	O	aggregation	dobj	4	SENT_128	[p9l1912t607r2148b667, p9l15t688r246b767],
8	of	IN	O	of	_	0	SENT_128	[p9l276t685r348b746],
9	19	CD	PERCENT	19	num	10	SENT_128	[p9l373t687r518b748],
10	%	NN	PERCENT	%	nn	15	SENT_128	[p9l373t687r518b748],
11	(	CD	PERCENT	(	number	12	SENT_128	[p9l554t684r726b759],
12	95	CD	PERCENT	95	dep	13	SENT_128	[p9l554t684r726b759],
13	%	NN	PERCENT	%	dep	15	SENT_128	[p9l554t684r726b759],
14	confidence	NN	O	confidence	nn	15	SENT_128	[p9l761t685r1163b746],
15	interval	NN	O	interval	prep_of	7	SENT_128	[p9l1192t685r1496b746],
16	:	:	O	:	_	0	SENT_128	[p9l1192t685r1496b746],
17	2	CD	NUMBER	2	number	19	SENT_128	[p9l1527t689r1564b745],
18	to	TO	O	to	dep	19	SENT_128	[p9l1592t693r1662b746],
19	36	CD	NUMBER	36	dep	7	SENT_128	[p9l1689t689r1788b758],
20	;	:	O	;	_	0	SENT_128	[p9l1689t689r1788b758],
21	p	NN	O	p	dep	19	SENT_128	[p9l1816t706r1858b768],
22	=	JJ	O	=	amod	24	SENT_128	[p9l1895t709r1945b728],
23	0.03	CD	NUMBER	0.03	tmod	22	SENT_128	[p9l1982t684r2147b759],
24	)	NN	O	)	dep	21	SENT_128	[p9l1982t684r2147b759],
25	and	CC	O	and	_	0	SENT_128	[p9l15t784r154b846],
26	less	JJR	O	less	amod	27	SENT_128	[p9l183t784r319b846],
27	inhibition	NN	O	inhibition	dep	19	SENT_128	[p9l350t784r717b846],
28	with	IN	O	with	_	0	SENT_128	[p9l745t784r911b846],
29	an	DT	O	a	det	30	SENT_128	[p9l942t805r1030b846],
30	EC50	NN	O	ec50	prep_with	27	SENT_128	[p9l1061t785r1252b846],
31	of	IN	O	of	_	0	SENT_128	[p9l1284t783r1356b846],
32	-2.07	CD	NUMBER	-2.07	number	33	SENT_128	[p9l1390t787r1592b846],
33	(	CD	NUMBER	(	num	36	SENT_128	[p9l1623t783r1857b858],
34	-4.19	CD	NUMBER	-4.19	number	36	SENT_128	[p9l1623t783r1857b858],
35	to	TO	O	to	dep	36	SENT_128	[p9l1887t791r1957b846],
36	0.04	CD	NUMBER	0.04	prep_of	30	SENT_128	[p9l1988t787r2147b858],
37	;	:	O	;	_	0	SENT_128	[p9l1988t787r2147b858],
38	p	NN	O	p	dep	7	SENT_128	[p9l11t904r53b967],
39	=	JJ	O	=	amod	41	SENT_128	[p9l102t908r152b927],
40	0.06	CD	NUMBER	0.06	tmod	39	SENT_128	[p9l200t883r366b958],
41	)	NN	O	)	dep	38	SENT_128	[p9l200t883r366b958],
42	in	IN	O	in	_	0	SENT_128	[p9l407t887r479b945],
43	patients	NNS	O	patient	prep_in	7	SENT_128	[p9l519t887r816b967],
44	who	WP	O	who	nsubj	48	SENT_128	[p9l855t884r1014b946],
45	were	VBD	O	be	cop	48	SENT_128	[p9l1053t905r1234b946],
46	both	DT	O	both	det	47	SENT_128	[p9l1275t884r1445b946],
47	PIAZ	NN	O	piaz	npadvmod	48	SENT_128	[p9l1485t875r1637b945],
48	positive	JJ	O	positive	rcmod	43	SENT_128	[p9l1677t887r1967b967],
49	and	CC	O	and	_	0	SENT_128	[p9l2010t884r2150b946],
50	receiving	VBG	O	receive	conj_and	48	SENT_128	[p9l13t988r357b1067],
51	low-dose	JJ	O	low-dose	amod	52	SENT_128	[p9l386t985r724b1047],
52	aspirin	NN	O	aspirin	dobj	50	SENT_128	[p9l758t988r1033b1067],
53	.	.	O	.	_	0	SENT_128	[p9l758t988r1033b1067],

1	C807	NN	O	c807	nn	3	SENT_129	[p9l17t1162r210b1229],
2	T	NN	O	t	nn	3	SENT_129	[p9l213t1163r269b1228],
3	Polymorphism	NN	O	polymorphism	nsubj	20	SENT_129	[p9l293t1161r848b1253],
4	There	EX	O	there	expl	5	SENT_129	[p9l13t1274r230b1335],
5	was	VBD	O	be	rcmod	3	SENT_129	[p9l282t1295r424b1335],
6	no	DT	O	no	det	7	SENT_129	[p9l479t1295r570b1335],
7	evidence	NN	O	evidence	nsubj	5	SENT_129	[p9l626t1274r955b1335],
8	that	IN	O	that	complm	14	SENT_129	[p9l1009t1274r1155b1335],
9	heterozygote	NN	O	heterozygote	nn	10	SENT_129	[p9l1208t1274r1689b1357],
10	carriers	NNS	O	carrier	nsubj	14	SENT_129	[p9l1746t1277r2025b1335],
11	of	IN	O	of	_	0	SENT_129	[p9l2080t1274r2153b1335],
12	C807T	NN	O	c807t	nn	13	SENT_129	[p9l15t1374r247b1434],
13	polymorphism	NN	O	polymorphism	prep_of	10	SENT_129	[p9l284t1373r835b1456],
14	had	VBD	O	have	ccomp	5	SENT_129	[p9l874t1373r1014b1434],
15	any	DT	O	any	det	17	SENT_129	[p9l1053t1394r1187b1456],
16	important	JJ	O	important	amod	17	SENT_129	[p9l1224t1375r1597b1455],
17	differences	NNS	O	difference	dobj	14	SENT_129	[p9l1637t1372r2038b1434],
18	in	IN	O	in	_	0	SENT_129	[p9l2078t1375r2149b1433],
19	baseline	NN	O	baseline	prep_in	17	SENT_129	[p9l12t1471r321b1533],
20	adjusted	VBN	O	adjust	_	0	SENT_129	[p9l366t1471r685b1554],
21	difference	NN	O	difference	dobj	20	SENT_129	[p9l729t1471r1094b1533],
22	in	IN	O	in	_	0	SENT_129	[p9l1137t1474r1209b1532],
23	percentage	NN	O	percentage	nn	24	SENT_129	[p9l1251t1479r1662b1554],
24	aggregation	NN	O	aggregation	prep_in	20	SENT_129	[p9l1708t1474r2149b1553],
25	for	IN	O	for	_	0	SENT_129	[p9l13t1572r118b1634],
26	all	DT	O	all	quantmod	27	SENT_129	[p9l150t1572r237b1634],
27	three	CD	NUMBER	three	num	28	SENT_129	[p9l267t1572r459b1634],
28	agonist	NN	O	agonist	prep_for	20	SENT_129	[p9l494t1575r763b1654],
29	and	CC	O	and	_	0	SENT_129	[p9l795t1572r934b1634],
30	EC50	NN	O	ec50	nn	31	SENT_129	[p9l965t1574r1155b1634],
31	concentrations	NNS	O	concentration	prep_for	20	SENT_129	[p9l1189t1575r1755b1634],
32	.	.	O	.	_	0	SENT_129	[p9l1189t1575r1755b1634],

1	However	RB	O	however	advmod	9	SENT_130	[p9l1789t1575r2147b1646],
2	,	,	O	,	_	0	SENT_130	[p9l1789t1575r2147b1646],
3	participants	NNS	O	participant	nsubj	9	SENT_130	[p9l13t1674r457b1754],
4	who	WP	O	who	nsubj	6	SENT_130	[p9l500t1672r659b1733],
5	were	VBD	O	be	cop	6	SENT_130	[p9l703t1693r884b1733],
6	homozygous	JJ	O	homozygous	rcmod	3	SENT_130	[p9l931t1672r1404b1755],
7	for	IN	O	for	_	0	SENT_130	[p9l1450t1671r1555b1733],
8	polymorphism	NN	O	polymorphism	prep_for	6	SENT_130	[p9l1598t1672r2149b1755],
9	had	VBD	O	have	_	0	SENT_130	[p9l14t1770r154b1832],
10	consistently	RB	O	consistently	advmod	11	SENT_130	[p9l195t1770r639b1853],
11	higher	JJR	O	higher	amod	12	SENT_130	[p9l678t1770r922b1852],
12	baseline	NN	O	baseline	dobj	9	SENT_130	[p9l960t1770r1268b1832],
13	adjusted	VBN	O	adjust	partmod	12	SENT_130	[p9l1312t1770r1630b1853],
14	difference	NN	O	difference	dobj	13	SENT_130	[p9l1672t1770r2036b1832],
15	in	IN	O	in	_	0	SENT_130	[p9l2078t1773r2149b1831],
16	percentage	NN	O	percentage	nn	17	SENT_130	[p9l13t1878r424b1952],
17	aggregation	NN	O	aggregation	prep_in	14	SENT_130	[p9l456t1873r898b1952],
18	for	IN	O	for	_	0	SENT_130	[p9l927t1870r1031b1932],
19	all	DT	O	all	det	21	SENT_130	[p9l1061t1870r1148b1931],
20	three	CD	NUMBER	three	num	21	SENT_130	[p9l1176t1870r1368b1932],
21	agonist	NN	O	agonist	prep_for	13	SENT_130	[p9l1400t1873r1686b1952],
22	,	,	O	,	_	0	SENT_130	[p9l1400t1873r1686b1952],
23	albeit	IN	O	albeit	advmod	13	SENT_130	[p9l1719t1870r1925b1932],
24	without	IN	O	without	_	0	SENT_130	[p9l1951t1870r2148b1932, p9l15t1976r135b2030],
25	reaching	VBG	O	reach	prepc_without	23	SENT_130	[p9l167t1969r492b2051],
26	statistical	JJ	O	statistical	amod	27	SENT_130	[p9l525t1969r872b2030],
27	significance	NN	O	significance	dobj	25	SENT_130	[p9l907t1968r1363b2051],
28	.	.	O	.	_	0	SENT_130	[p9l907t1968r1363b2051],

1	The	DT	O	the	det	2	SENT_131	[p9l1398t1969r1539b2030],
2	results	NNS	O	result	nsubj	7	SENT_131	[p9l1573t1969r1820b2030],
3	of	IN	O	of	_	0	SENT_131	[p9l1856t1968r1928b2030],
4	EC50	NN	O	ec50	nn	5	SENT_131	[p9l1958t1970r2149b2030],
5	concentrations	NNS	O	concentration	prep_of	2	SENT_131	[p9l15t2071r562b2130],
6	were	VBD	O	be	cop	7	SENT_131	[p9l613t2089r795b2130],
7	uniform	JJ	O	uniform	_	0	SENT_131	[p9l849t2068r1170b2141],
8	,	,	O	,	_	0	SENT_131	[p9l849t2068r1170b2141],
9	with	IN	O	with	_	0	SENT_131	[p9l1223t2068r1389b2130],
10	lower	JJR	O	lower	amod	11	SENT_131	[p9l1441t2068r1651b2130],
11	amounts	NNS	O	amount	prep_with	7	SENT_131	[p9l1704t2076r2025b2130],
12	of	IN	O	of	_	0	SENT_131	[p9l2081t2068r2153b2130],
13	agonist	NN	O	agonist	prep_of	11	SENT_131	[p9l15t2171r284b2250],
14	required	VBN	O	require	partmod	13	SENT_131	[p9l321t2168r646b2250],
15	to	TO	O	to	aux	16	SENT_131	[p9l682t2176r752b2230],
16	induce	VB	O	induce	xcomp	14	SENT_131	[p9l791t2168r1042b2230],
17	50	CD	PERCENT	50	number	18	SENT_131	[p9l1081t2170r1228b2231],
18	%	NN	PERCENT	%	amod	19	SENT_131	[p9l1081t2170r1228b2231],
19	aggregation	NN	O	aggregation	dobj	16	SENT_131	[p9l1273t2171r1733b2250],
20	,	,	O	,	_	0	SENT_131	[p9l1273t2171r1733b2250],
21	consistent	JJ	O	consistent	amod	19	SENT_131	[p9l1775t2171r2150b2230],
22	with	IN	O	with	_	0	SENT_131	[p9l12t2267r177b2328],
23	less	JJR	O	less	dep	24	SENT_131	[p9l204t2267r340b2328],
24	effective	JJ	O	effective	amod	26	SENT_131	[p9l370t2266r673b2328],
25	platelet	NN	O	platelet	nn	26	SENT_131	[p9l701t2267r981b2349],
26	inhibition	NN	O	inhibition	prep_with	21	SENT_131	[p9l1007t2267r1373b2328],
27	by	IN	O	by	_	0	SENT_131	[p9l1399t2267r1491b2350],
28	aspirin	NN	O	aspirin	nn	30	SENT_131	[p9l1518t2269r1775b2349],
29	(	CD	NUMBER	(	num	30	SENT_131	[p9l1804t2266r2035b2341],
30	Table	NNP	O	Table	prep_by	16	SENT_131	[p9l1804t2266r2035b2341],
31	3	CD	NUMBER	3	num	32	SENT_131	[p9l2062t2266r2147b2341],
32	)	NN	O	)	dep	30	SENT_131	[p9l2062t2266r2147b2341],
33	.	.	O	.	_	0	SENT_131	[p9l2062t2266r2147b2341],

1	There	EX	O	there	expl	2	SENT_132	[p9l13t2366r230b2428],
2	was	VBD	O	be	_	0	SENT_132	[p9l275t2387r417b2428],
3	no	DT	O	no	det	4	SENT_132	[p9l465t2387r555b2428],
4	evidence	NN	O	evidence	nsubj	2	SENT_132	[p9l605t2366r933b2428],
5	of	IN	O	of	_	0	SENT_132	[p9l982t2366r1054b2428],
6	an	DT	O	a	det	7	SENT_132	[p9l1098t2387r1185b2428],
7	interaction	NN	O	interaction	prep_of	4	SENT_132	[p9l1231t2369r1635b2428],
8	with	IN	O	with	_	0	SENT_132	[p9l1679t2366r1844b2428],
9	aspirin	NN	O	aspirin	nn	10	SENT_132	[p9l1892t2369r2149b2449],
10	dosage	NN	O	dosage	prep_with	7	SENT_132	[p9l16t2465r292b2547],
11	.	.	O	.	_	0	SENT_132	[p9l16t2465r292b2547],

1	A842	NN	O	a842	nn	4	SENT_133	[p9l7t2643r207b2709],
2	G/C50T	NN	O	g/c50t	nn	4	SENT_133	[p9l217t2641r523b2712],
3	Polymorphism	NN	O	polymorphism	nn	4	SENT_133	[p9l547t2641r1102b2733],
4	Carriers	NNS	O	carrier	nsubj	8	SENT_133	[p9l15t2755r317b2814],
5	of	IN	O	of	_	0	SENT_133	[p9l349t2753r422b2814],
6	A842G/C50T	NN	O	a842g/c50t	nn	7	SENT_133	[p9l446t2755r925b2814],
7	polymorphism	NN	O	polymorphism	prep_of	4	SENT_133	[p9l954t2753r1505b2836],
8	had	VBD	O	have	_	0	SENT_133	[p9l1535t2753r1676b2814],
9	consistently	RB	O	consistently	advmod	10	SENT_133	[p9l1706t2753r2151b2836],
10	lower	JJR	O	lower	amod	11	SENT_133	[p9l13t2852r223b2913],
11	baseline	NN	O	baseline	dobj	8	SENT_133	[p9l255t2852r564b2913],
12	adjusted	VBN	O	adjust	partmod	11	SENT_133	[p9l601t2852r920b2935],
13	difference	NN	O	difference	dobj	12	SENT_133	[p9l957t2851r1321b2913],
14	in	IN	O	in	_	0	SENT_133	[p9l1357t2854r1428b2912],
15	percentage	NN	O	percentage	nn	16	SENT_133	[p9l1463t2859r1874b2934],
16	aggregation	NN	O	aggregation	prep_in	13	SENT_133	[p9l1912t2873r2148b2934, p9l15t2954r246b3033],
17	for	IN	O	for	_	0	SENT_133	[p9l280t2951r385b3013],
18	all	DT	O	all	det	20	SENT_133	[p9l420t2951r507b3013],
19	three	CD	NUMBER	three	num	20	SENT_133	[p9l540t2951r732b3013],
20	agonist	NN	O	agonist	prep_for	12	SENT_133	[p9l770t2954r1056b3033],
21	,	,	O	,	_	0	SENT_133	[p9l770t2954r1056b3033],
22	albeit	IN	O	albeit	advmod	12	SENT_133	[p9l1094t2951r1301b3013],
23	without	IN	O	without	_	0	SENT_133	[p9l1332t2951r1622b3013],
24	reaching	VBG	O	reach	prepc_without	22	SENT_133	[p9l1655t2951r1981b3033],
25	statistical	JJ	O	statistical	amod	26	SENT_133	[p9l2015t2959r2148b3013, p9l13t3052r256b3114],
26	signiﬁcance	NN	O	signiﬁcance	dobj	24	SENT_133	[p9l295t3052r752b3134],
27	.	.	O	.	_	0	SENT_133	[p9l295t3052r752b3134],

1	The	DT	O	the	det	2	SENT_134	[p9l793t3052r933b3114],
2	results	NNS	O	result	nsubj	7	SENT_134	[p9l974t3052r1221b3114],
3	of	IN	O	of	_	0	SENT_134	[p9l1262t3052r1334b3114],
4	EC50	NN	O	ec50	nn	5	SENT_134	[p9l1370t3054r1561b3114],
5	concentrations	NNS	O	concentration	prep_of	2	SENT_134	[p9l1601t3055r2148b3114],
6	were	VBD	O	be	cop	7	SENT_134	[p9l12t3172r193b3212],
7	consistent	JJ	O	consistent	_	0	SENT_134	[p9l246t3153r638b3212],
8	.	.	O	.	_	0	SENT_134	[p9l246t3153r638b3212],

1	Higher	JJR	O	higher	amod	2	SENT_135	[p9l690t3151r953b3233],
2	amounts	NNS	O	amount	nsubjpass	6	SENT_135	[p9l1003t3158r1324b3212],
3	of	IN	O	of	_	0	SENT_135	[p9l1376t3150r1449b3212],
4	agonist	NN	O	agonist	prep_of	2	SENT_135	[p9l1496t3153r1765b3233],
5	were	VBD	O	be	auxpass	6	SENT_135	[p9l1812t3172r1993b3212],
6	required	VBN	O	require	_	0	SENT_135	[p9l2044t3172r2148b3212, p9l16t3249r262b3332],
7	to	TO	O	to	aux	8	SENT_135	[p9l297t3257r367b3311],
8	induce	VB	O	induce	xcomp	6	SENT_135	[p9l404t3249r655b3311],
9	50	CD	PERCENT	50	number	10	SENT_135	[p9l693t3251r839b3313],
10	%	NN	PERCENT	%	amod	11	SENT_135	[p9l693t3251r839b3313],
11	aggregation	NN	O	aggregation	dobj	8	SENT_135	[p9l883t3252r1344b3331],
12	,	,	O	,	_	0	SENT_135	[p9l883t3252r1344b3331],
13	suggesting	VBG	O	suggest	xcomp	6	SENT_135	[p9l1383t3252r1785b3331],
14	more	RBR	O	more	advmod	15	SENT_135	[p9l1821t3270r2012b3311],
15	effective	JJ	O	effective	amod	16	SENT_135	[p9l2052t3249r2148b3311, p9l13t3349r255b3410],
16	inhibition	NN	O	inhibition	dobj	13	SENT_135	[p9l307t3349r674b3410],
17	by	IN	O	by	_	0	SENT_135	[p9l723t3349r816b3432],
18	aspirin	NN	O	aspirin	nn	20	SENT_135	[p9l867t3352r1124b3431],
19	(	CD	NUMBER	(	num	20	SENT_135	[p9l1176t3348r1407b3423],
20	Table	NNP	O	Table	prep_by	13	SENT_135	[p9l1176t3348r1407b3423],
21	4	CD	NUMBER	4	number	22	SENT_135	[p9l1459t3348r1542b3423],
22	)	CD	NUMBER	)	dep	20	SENT_135	[p9l1459t3348r1542b3423],
23	.	.	O	.	_	0	SENT_135	[p9l1459t3348r1542b3423],

1	There	EX	O	there	expl	2	SENT_136	[p9l1595t3349r1812b3410],
2	was	VBD	O	be	_	0	SENT_136	[p9l1862t3370r2005b3410],
3	no	DT	O	no	det	4	SENT_136	[p9l2056t3370r2148b3410],
4	evidence	NN	O	evidence	nsubj	2	SENT_136	[p9l16t3448r344b3509],
5	of	IN	O	of	_	0	SENT_136	[p9l377t3447r450b3509],
6	any	DT	O	any	det	7	SENT_136	[p9l478t3469r612b3531],
7	interaction	NN	O	interaction	prep_of	4	SENT_136	[p9l641t3450r1044b3509],
8	with	IN	O	with	_	0	SENT_136	[p9l1073t3448r1239b3509],
9	aspirin	NN	O	aspirin	nn	10	SENT_136	[p9l1271t3450r1528b3530],
10	dosage	NN	O	dosage	prep_with	7	SENT_136	[p9l1561t3448r1837b3530],
11	.	.	O	.	_	0	SENT_136	[p9l1561t3448r1837b3530],

1	Comment	NN	O	comment	_	0	SENT_137	[p9l16t3696r423b3761],

1	Our	PRP$	O	we	poss	2	SENT_138	[p10l16t56r164b116],
2	study	NN	O	study	nsubj	3	SENT_138	[p10l192t54r398b137],
3	suggests	VBZ	O	suggest	_	0	SENT_138	[p10l426t62r741b136],
4	that	IN	O	that	complm	17	SENT_138	[p10l770t54r916b116],
5	the	DT	O	the	det	8	SENT_138	[p10l942t54r1058b116],
6	heterozygous	JJ	O	heterozygous	amod	8	SENT_138	[p10l1089t54r1588b137],
7	gene	NN	O	gene	nn	8	SENT_138	[p10l1619t76r1793b136],
8	frequencies	NNS	O	frequency	nsubj	17	SENT_138	[p10l1823t54r2148b137, p10l15t158r151b216],
9	of	IN	O	of	_	0	SENT_138	[p10l175t155r247b216],
10	PIAZ	NN	O	piaz	prep_of	8	SENT_138	[p10l266t146r435b228],
11	,	,	O	,	_	0	SENT_138	[p10l266t146r435b228],
12	C807T	NN	O	c807t	conj_and	10	SENT_138	[p10l461t157r710b228],
13	,	,	O	,	_	0	SENT_138	[p10l461t157r710b228],
14	and	CC	O	and	_	0	SENT_138	[p10l736t155r875b216],
15	C50T	NN	O	c50t	conj_and	10	SENT_138	[p10l897t157r1088b216],
16	are	VBP	O	be	cop	17	SENT_138	[p10l1110t176r1223b216],
17	common	JJ	O	common	ccomp	3	SENT_138	[p10l1248t176r1590b216],
18	.	.	O	.	_	0	SENT_138	[p10l1248t176r1590b216],

1	There	EX	O	there	expl	2	SENT_139	[p10l1613t155r1830b216],
2	were	VBD	O	be	_	0	SENT_139	[p10l1851t176r2033b216],
3	no	DT	O	no	det	5	SENT_139	[p10l2056t176r2148b216],
4	important	JJ	O	important	amod	5	SENT_139	[p10l13t256r388b336],
5	differences	NNS	O	difference	nsubj	2	SENT_139	[p10l418t253r820b315],
6	in	IN	O	in	_	0	SENT_139	[p10l850t256r921b314],
7	the	DT	O	the	det	9	SENT_139	[p10l950t254r1065b315],
8	baseline	NN	O	baseline	nn	9	SENT_139	[p10l1095t254r1404b315],
9	aggregation	NN	O	aggregation	prep_in	5	SENT_139	[p10l1436t256r1878b336],
10	of	IN	O	of	_	0	SENT_139	[p10l1908t253r1981b315],
11	carriers	NNS	O	carrier	prep_of	9	SENT_139	[p10l2008t275r2148b315, p10l13t355r179b414],
12	of	IN	O	of	_	0	SENT_139	[p10l215t352r287b414],
13	these	DT	O	these	prep_of	11	SENT_139	[p10l315t352r510b414],
14	identified	VBN	O	identify	partmod	13	SENT_139	[p10l544t352r904b414],
15	genetic	JJ	O	genetic	amod	16	SENT_139	[p10l937t355r1203b434],
16	polymorphisms	NNS	O	polymorphism	dobj	14	SENT_139	[p10l1236t352r1842b435],
17	,	,	O	,	_	0	SENT_139	[p10l1236t352r1842b435],
18	but	CC	O	but	_	0	SENT_139	[p10l1875t352r2001b414],
19	the	DT	O	the	det	20	SENT_139	[p10l2031t352r2148b414],
20	responses	NNS	O	response	nsubj	28	SENT_139	[p10l13t473r383b534],
21	to	TO	O	to	_	0	SENT_139	[p10l424t459r493b513],
22	aspirin	NN	O	aspirin	prep_to	20	SENT_139	[p10l536t455r793b534],
23	after	IN	O	after	_	0	SENT_139	[p10l835t452r1005b513],
24	coronary	JJ	O	coronary	amod	25	SENT_139	[p10l1045t473r1375b535],
25	surgery	NN	O	surgery	prep_after	22	SENT_139	[p10l1415t473r1698b535],
26	were	VBD	O	be	cop	28	SENT_139	[p10l1735t473r1916b513],
27	quite	RB	O	quite	advmod	28	SENT_139	[p10l1960t455r2147b534],
28	different	JJ	O	different	conj_but	2	SENT_139	[p10l16t551r346b614],
29	.	.	O	.	_	0	SENT_139	[p10l16t551r346b614],

1	PZAZ	NNP	O	PZAZ	nn	2	SENT_140	[p10l11t714r169b795],
2	Polymorphism	NN	O	polymorphism	nsubjpass	20	SENT_140	[p10l202t728r757b820],
3	The	DT	O	the	det	5	SENT_140	[p10l13t839r153b901],
4	functional	JJ	O	functional	amod	5	SENT_140	[p10l182t839r560b901],
5	signiﬁcance	NN	O	signiﬁcance	dep	2	SENT_140	[p10l589t839r1026b922],
6	of	IN	O	of	_	0	SENT_140	[p10l1057t839r1129b901],
7	the	DT	O	the	det	9	SENT_140	[p10l1153t840r1268b901],
8	P	NN	O	p	nn	9	SENT_140	[p10l1299t842r1346b900],
9	polymorphism	NN	O	polymorphism	prep_of	2	SENT_140	[p10l1477t839r2028b923],
10	on	IN	O	on	_	0	SENT_140	[p10l2058t860r2149b901],
11	the	DT	O	the	det	15	SENT_140	[p10l13t938r129b1000],
12	platelet	NN	O	platelet	nn	15	SENT_140	[p10l178t938r458b1021],
13	IIb/IIIa	NN	O	iib/iiia	nn	15	SENT_140	[p10l504t938r768b1000],
14	receptor	NN	O	receptor	nn	15	SENT_140	[p10l816t946r1128b1021],
15	function	NN	O	function	prep_on	9	SENT_140	[p10l1173t938r1484b1000],
16	is	VBZ	O	be	auxpass	20	SENT_140	[p10l1531t941r1587b1000],
17	not	RB	O	not	neg	20	SENT_140	[p10l1637t946r1757b1000],
18	yet	RB	O	yet	advmod	20	SENT_140	[p10l1802t946r1916b1021],
19	completely	RB	O	completely	advmod	20	SENT_140	[p10l1963t960r2148b1000, p10l13t1038r268b1121],
20	elucidated	VBN	O	elucidate	_	0	SENT_140	[p10l295t1038r701b1111],
21	,	,	O	,	_	0	SENT_140	[p10l295t1038r701b1111],
22	but	CC	O	but	_	0	SENT_140	[p10l730t1038r856b1099],
23	it	PRP	O	it	nsubj	25	SENT_140	[p10l882t1041r932b1099],
24	is	VBZ	O	be	cop	25	SENT_140	[p10l958t1041r1014b1099],
25	one	CD	NUMBER	one	conj_but	20	SENT_140	[p10l1044t1059r1176b1099],
26	of	IN	O	of	_	0	SENT_140	[p10l1207t1038r1279b1099],
27	the	DT	O	the	det	33	SENT_140	[p10l1302t1038r1418b1099],
28	most	RBS	O	most	advmod	29	SENT_140	[p10l1448t1045r1630b1099],
29	common	JJ	O	common	amod	33	SENT_140	[p10l1657t1059r1981b1099],
30	and	CC	O	and	_	0	SENT_140	[p10l2010t1038r2150b1099],
31	well	RB	O	well	advmod	32	SENT_140	[p10l12t1137r167b1198],
32	known	VBN	O	know	amod	33	SENT_140	[p10l203t1137r457b1198],
33	polymorphisms	NNS	O	polymorphism	prep_of	25	SENT_140	[p10l494t1137r1080b1220],
34	associated	VBN	O	associate	partmod	33	SENT_140	[p10l1119t1137r1502b1198],
35	with	IN	O	with	_	0	SENT_140	[p10l1535t1137r1701b1198],
36	genetic	JJ	O	genetic	amod	38	SENT_140	[p10l1738t1139r2004b1219],
37	aspirin	NN	O	aspirin	nn	38	SENT_140	[p10l2042t1158r2148b1198, p10l13t1238r193b1318],
38	resistance	NN	O	resistance	prep_with	34	SENT_140	[p10l231t1238r600b1297],
39	[	CD	NUMBER	[	number	40	SENT_140	[p10l647t1236r727b1308],
40	6	CD	NUMBER	6	num	41	SENT_140	[p10l647t1236r727b1308],
41	]	NN	O	]	dep	38	SENT_140	[p10l647t1236r727b1308],
42	and	CC	O	and	_	0	SENT_140	[p10l773t1235r913b1297],
43	coronary	JJ	O	coronary	amod	45	SENT_140	[p10l951t1257r1282b1318],
44	thrombosis	NN	O	thrombosis	nn	45	SENT_140	[p10l1318t1235r1738b1297],
45	[	NN	O	[	prep_with	34	SENT_140	[p10l1783t1236r1888b1308],
46	7	CD	NUMBER	7	num	47	SENT_140	[p10l1783t1236r1888b1308],
47	]	NN	O	]	dep	45	SENT_140	[p10l1783t1236r1888b1308],
48	.	.	O	.	_	0	SENT_140	[p10l1783t1236r1888b1308],

1	These	DT	O	these	det	2	SENT_141	[p10l1928t1235r2147b1297],
2	findings	NNS	O	finding	nsubj	7	SENT_141	[p10l13t1335r316b1417],
3	have	VBP	O	have	aux	7	SENT_141	[p10l360t1335r535b1396],
4	not	RB	O	not	neg	7	SENT_141	[p10l579t1342r700b1396],
5	been	VBN	O	be	cop	7	SENT_141	[p10l740t1335r922b1396],
6	entirely	RB	O	entirely	advmod	7	SENT_141	[p10l966t1335r1252b1418],
7	consistent	JJ	O	consistent	_	0	SENT_141	[p10l1294t1338r1686b1396],
8	.	.	O	.	_	0	SENT_141	[p10l1294t1338r1686b1396],

1	The	DT	O	the	det	4	SENT_142	[p10l1731t1335r1871b1396],
2	Physicians	NNP	O	Physicians	nn	4	SENT_142	[p10l1915t1335r2148b1418, p10l15t1436r201b1495],
3	Health	NNP	O	Health	nn	4	SENT_142	[p10l250t1434r502b1495],
4	Study	NNP	O	Study	nsubj	5	SENT_142	[p10l553t1434r769b1517],
5	(	VBD	O	(	_	0	SENT_142	[p10l817t1433r882b1508],
6	a	DT	O	a	det	11	SENT_142	[p10l817t1433r882b1508],
7	large	JJ	O	large	amod	11	SENT_142	[p10l930t1434r1114b1516],
8	prospective	JJ	O	prospective	amod	11	SENT_142	[p10l1164t1436r1594b1516],
9	observational	JJ	O	observational	amod	11	SENT_142	[p10l1645t1434r2149b1495],
10	study	NN	O	study	nn	11	SENT_142	[p10l15t1532r244b1616],
11	)	NN	O	)	nsubj	12	SENT_142	[p10l15t1532r244b1616],
12	reported	VBD	O	report	ccomp	5	SENT_142	[p10l273t1533r596b1616],
13	no	DT	O	no	det	14	SENT_142	[p10l623t1554r714b1595],
14	association	NN	O	association	dobj	12	SENT_142	[p10l744t1536r1153b1595],
15	between	IN	O	between	_	0	SENT_142	[p10l1178t1533r1496b1595],
16	PIAZ	NNP	ORGANIZATION	PIAZ	prep_between	14	SENT_142	[p10l1523t1524r1675b1594],
17	and	CC	O	and	_	0	SENT_142	[p10l1703t1533r1842b1595],
18	the	DT	O	the	det	19	SENT_142	[p10l1868t1533r1983b1595],
19	risk	NN	O	risk	dobj	12	SENT_142	[p10l2012t1533r2152b1595],
20	of	IN	O	of	_	0	SENT_142	[p10l15t1633r87b1694],
21	myocardial	JJ	O	myocardial	amod	22	SENT_142	[p10l123t1633r540b1716],
22	infarction	NN	O	infarction	prep_of	19	SENT_142	[p10l579t1633r958b1706],
23	,	,	O	,	_	0	SENT_142	[p10l579t1633r958b1706],
24	stroke	NN	O	stroke	prep_of	19	SENT_142	[p10l1001t1633r1246b1706],
25	,	,	O	,	_	0	SENT_142	[p10l1001t1633r1246b1706],
26	or	CC	O	or	_	0	SENT_142	[p10l1289t1654r1365b1694],
27	venous	JJ	O	venous	amod	28	SENT_142	[p10l1402t1654r1668b1694],
28	thrombosis	NN	O	thrombosis	conj_or	22	SENT_142	[p10l1708t1633r2147b1706],
29	;	:	O	;	_	0	SENT_142	[p10l1708t1633r2147b1706],
30	neither	CC	O	neither	nsubj	31	SENT_142	[p10l14t1732r282b1793],
31	was	VBD	O	be	parataxis	5	SENT_142	[p10l303t1753r445b1793],
32	there	EX	O	there	expl	34	SENT_142	[p10l469t1732r661b1793],
33	any	DT	O	any	det	34	SENT_142	[p10l688t1753r822b1815],
34	evidence	NN	O	evidence	xcomp	31	SENT_142	[p10l846t1732r1174b1793],
35	of	IN	O	of	_	0	SENT_142	[p10l1201t1731r1273b1793],
36	a	DT	O	a	det	38	SENT_142	[p10l1294t1753r1332b1793],
37	protective	JJ	O	protective	amod	38	SENT_142	[p10l1356t1734r1727b1814],
38	effect	NN	O	effect	prep_of	34	SENT_142	[p10l1755t1731r1949b1793],
39	from	IN	O	from	_	0	SENT_142	[p10l1971t1731r2149b1793],
40	aspirin	NN	O	aspirin	nn	41	SENT_142	[p10l15t1833r272b1913],
41	administration	NN	O	administration	prep_from	38	SENT_142	[p10l296t1830r846b1892],
42	[	CD	NUMBER	[	number	43	SENT_142	[p10l875t1831r980b1903],
43	8	CD	NUMBER	8	num	44	SENT_142	[p10l875t1831r980b1903],
44	]	NN	O	]	dep	41	SENT_142	[p10l875t1831r980b1903],
45	.	.	O	.	_	0	SENT_142	[p10l875t1831r980b1903],

1	The	DT	O	the	det	2	SENT_143	[p10l1004t1830r1144b1892],
2	dose	NN	O	dose	nsubj	13	SENT_143	[p10l1172t1830r1340b1892],
3	of	IN	O	of	_	0	SENT_143	[p10l1366t1830r1438b1892],
4	aspirin	NN	O	aspirin	prep_of	2	SENT_143	[p10l1459t1833r1716b1913],
5	used	VBN	O	use	partmod	4	SENT_143	[p10l1739t1830r1916b1892],
6	in	IN	O	in	_	0	SENT_143	[p10l1938t1833r2009b1891],
7	the	DT	O	the	det	10	SENT_143	[p10l2031t1830r2148b1892],
8	Physicians	NNP	O	Physicians	nn	10	SENT_143	[p10l14t1930r406b2013],
9	Health	NNP	O	Health	nn	10	SENT_143	[p10l437t1930r689b1991],
10	Study	NNP	O	Study	prep_in	5	SENT_143	[p10l721t1930r938b2013],
11	was	VBD	O	be	cop	13	SENT_143	[p10l964t1951r1106b1991],
12	325	CD	NUMBER	325	num	13	SENT_143	[p10l1135t1933r1254b1991],
13	mg	NN	O	mg	_	0	SENT_143	[p10l1286t1951r1421b2012],
14	.	.	O	.	_	0	SENT_143	[p10l1286t1951r1421b2012],

1	The	DT	O	the	det	2	SENT_144	[p10l1452t1930r1596b1991],
2	results	NNS	O	result	nsubj	6	SENT_144	[p10l1628t1930r1885b1991],
3	of	IN	O	of	_	0	SENT_144	[p10l1918t1930r1992b1991],
4	our	PRP$	O	we	poss	5	SENT_144	[p10l2021t1951r2150b1991],
5	study	NN	O	study	prep_of	2	SENT_144	[p10l15t2030r227b2113],
6	suggest	VBP	O	suggest	_	0	SENT_144	[p10l253t2037r544b2112],
7	that	IN	O	that	complm	12	SENT_144	[p10l568t2029r720b2091],
8	carriers	NNS	O	carrier	nsubj	12	SENT_144	[p10l746t2032r1037b2091],
9	of	IN	O	of	_	0	SENT_144	[p10l1066t2029r1140b2091],
10	PIAZ	NN	O	piaz	nn	11	SENT_144	[p10l1163t2020r1319b2090],
11	polymorphism	NN	O	polymorphism	prep_of	8	SENT_144	[p10l1345t2029r1913b2113],
12	had	VBD	O	have	ccomp	6	SENT_144	[p10l1940t2029r2084b2091],
13	a	DT	O	a	det	17	SENT_144	[p10l2111t2050r2149b2091],
14	uniformly	RB	O	uniformly	advmod	15	SENT_144	[p10l14t2129r400b2212],
15	more	RBR	O	more	advmod	16	SENT_144	[p10l454t2151r651b2191],
16	impaired	JJ	O	impaired	amod	17	SENT_144	[p10l709t2129r1061b2212],
17	response	NN	O	response	dobj	12	SENT_144	[p10l1116t2151r1461b2212],
18	to	TO	O	to	_	0	SENT_144	[p10l1518t2137r1589b2191],
19	aspirin	NN	O	aspirin	prep_to	12	SENT_144	[p10l1649t2132r1915b2212],
20	after	IN	O	after	prep	12	SENT_144	[p10l1974t2129r2150b2191],

1	1A2	NN	O	1a2	_	0	SENT_145	[p10l1348t830r1450b900],

1	LIM	NN	O	lim	_	0	SENT_146	[p10l1259t2356r1358b2393],
2	ET	NNP	O	ET	nn	3	SENT_146	[p10l1378t2356r1442b2393],
3	AL	NNP	O	AL	dep	1	SENT_146	[p10l1460t2356r1530b2393],
4	137	CD	NUMBER	137	dep	1	SENT_146	[p10l1657t2346r1755b2394],

1	ASPIRIN	NN	O	aspirin	nn	2	SENT_147	[p10l143t2415r361b2453],
2	EFFICACY	NN	O	efficacy	_	0	SENT_147	[p10l381t2415r640b2453],
3	WITH	IN	O	with	dep	2	SENT_147	[p10l658t2415r806b2453],
4	GENETIC	JJ	O	genetic	amod	5	SENT_147	[p10l826t2415r1063b2453],
5	POLYMORPHISM	NN	O	polymorphism	pobj	3	SENT_147	[p10l1084t2415r1531b2453],

1	coronary	JJ	O	coronary	amod	2	SENT_148	[p10l13t2725r292b2776],
2	surgery	NN	O	surgery	_	0	SENT_148	[p10l311t2725r550b2776],
3	compared	VBN	O	compare	_	0	SENT_148	[p10l570t2708r884b2776],
4	with	IN	O	with	prepc_compared_with	2	SENT_148	[p10l902t2708r1042b2759],
5	homozygotes	NNS	O	homozygote	pobj	2	SENT_148	[p10l1062t2708r1477b2776],
6	with	IN	O	with	_	0	SENT_148	[p10l1497t2708r1636b2759],
7	the	DT	O	the	det	9	SENT_148	[p10l1655t2708r1753b2759],
8	PIA1	NN	O	pia1	nn	9	SENT_148	[p10l12t2784r138b2842],
9	genotype	NN	O	genotype	prep_with	5	SENT_148	[p10l180t2798r486b2860],
10	.	.	O	.	_	0	SENT_148	[p10l180t2798r486b2860],

1	Although	IN	O	although	mark	6	SENT_149	[p10l527t2792r825b2859],
2	the	DT	O	the	det	3	SENT_149	[p10l865t2792r962b2842],
3	ﬁndings	NNS	O	ﬁndings	nsubj	6	SENT_149	[p10l1003t2792r1259b2859],
4	did	VBD	O	do	aux	6	SENT_149	[p10l1302t2792r1402b2842],
5	not	RB	O	not	neg	6	SENT_149	[p10l1442t2798r1544b2842],
6	reach	VB	O	reach	advcl	13	SENT_149	[p10l1583t2792r1754b2842],
7	statistical	JJ	O	statistical	amod	8	SENT_149	[p10l12t2875r309b2926],
8	signiﬁcance	NN	O	signiﬁcance	dobj	6	SENT_149	[p10l343t2875r731b2943],
9	,	,	O	,	_	0	SENT_149	[p10l343t2875r731b2943],
10	the	DT	O	the	det	11	SENT_149	[p10l765t2875r862b2926],
11	results	NNS	O	result	nsubj	13	SENT_149	[p10l897t2875r1106b2926],
12	were	VBD	O	be	cop	13	SENT_149	[p10l1139t2893r1291b2926],
13	consistent	JJ	O	consistent	_	0	SENT_149	[p10l1327t2877r1645b2926],
14	on	IN	O	on	_	0	SENT_149	[p10l1679t2892r1754b2926],
15	the	DT	O	the	det	19	SENT_149	[p10l11t2959r108b3009],
16	six	CD	NUMBER	six	num	19	SENT_149	[p10l134t2961r217b3009],
17	different	JJ	O	different	amod	19	SENT_149	[p10l242t2959r509b3009],
18	aggregation	NN	O	aggregation	nn	19	SENT_149	[p10l533t2961r906b3026],
19	tests	NNS	O	test	prep_on	13	SENT_149	[p10l929t2965r1088b3009],
20	.	.	O	.	_	0	SENT_149	[p10l929t2965r1088b3009],

1	On	IN	O	on	_	0	SENT_150	[p10l1115t2960r1209b3009],
2	(	CD	NUMBER	(	num	4	SENT_150	[p10l1234t2958r1485b3020],
3	formal	JJ	O	formal	amod	4	SENT_150	[p10l1234t2958r1485b3020],
4	)	NN	O	)	prep_on	9	SENT_150	[p10l1234t2958r1485b3020],
5	interaction	NN	O	interaction	nn	6	SENT_150	[p10l1510t2961r1753b3009, p10l11t3045r133b3093],
6	testing	NN	O	testing	dep	4	SENT_150	[p10l153t3045r383b3109],
7	,	,	O	,	_	0	SENT_150	[p10l153t3045r383b3109],
8	we	PRP	O	we	nsubj	9	SENT_150	[p10l403t3060r490b3093],
9	discovered	VBD	O	discover	_	0	SENT_150	[p10l513t3042r854b3093],
10	that	IN	O	that	complm	23	SENT_150	[p10l873t3042r997b3093],
11	the	DT	O	the	det	12	SENT_150	[p10l1015t3042r1112b3093],
12	response	NN	O	response	nsubj	23	SENT_150	[p10l1134t3060r1415b3110],
13	of	IN	O	of	_	0	SENT_150	[p10l1438t3042r1498b3093],
14	carriers	NNS	O	carrier	prep_of	12	SENT_150	[p10l1516t3045r1753b3093],
15	of	IN	O	of	_	0	SENT_150	[p10l13t3126r73b3176],
16	the	DT	O	the	det	18	SENT_150	[p10l116t3126r213b3176],
17	PIAZ	NN	ORGANIZATION	piaz	nn	18	SENT_150	[p10l262t3118r390b3175],
18	polymorphism	NN	O	polymorphism	prep_of	14	SENT_150	[p10l436t3126r900b3194],
19	to	TO	O	to	_	0	SENT_150	[p10l947t3132r1005b3176],
20	aspirin	NN	O	aspirin	prep_to	18	SENT_150	[p10l1054t3128r1272b3193],
21	is	VBZ	O	be	cop	23	SENT_150	[p10l1319t3128r1366b3176],
22	potentially	RB	O	potentially	advmod	23	SENT_150	[p10l1414t3126r1756b3194],
23	modifiable	JJ	O	modifiable	ccomp	9	SENT_150	[p10l12t3208r365b3259],
24	.	.	O	.	_	0	SENT_150	[p10l12t3208r365b3259],

1	Participants	NNS	O	participant	nsubj	5	SENT_151	[p10l389t3211r765b3276],
2	with	IN	O	with	_	0	SENT_151	[p10l786t3208r926b3259],
3	PlA2	NN	O	pla2	nn	4	SENT_151	[p10l948t3201r1076b3258],
4	polymorphism	NN	O	polymorphism	prep_with	1	SENT_151	[p10l1097t3208r1561b3276],
5	had	VBD	O	have	_	0	SENT_151	[p10l1584t3208r1701b3259],
6	a	DT	O	a	det	8	SENT_151	[p10l1723t3226r1754b3259],
7	better	JJR	O	better	amod	8	SENT_151	[p10l10t3292r198b3342],
8	response	NN	O	response	dobj	5	SENT_151	[p10l241t3309r522b3359],
9	with	IN	O	with	_	0	SENT_151	[p10l566t3292r705b3342],
10	lower	JJR	O	lower	amod	11	SENT_151	[p10l749t3292r926b3342],
11	aggregation	NN	O	aggregation	prep_with	8	SENT_151	[p10l970t3294r1344b3359],
12	and	CC	O	and	_	0	SENT_151	[p10l1389t3292r1505b3342],
13	higher	JJR	O	higher	amod	14	SENT_151	[p10l1549t3292r1756b3359],
14	EC50s	NNS	O	ec50	conj_and	11	SENT_151	[p10l12t3375r202b3424],
15	when	WRB	O	when	advmod	16	SENT_151	[p10l245t3374r418b3424],
16	receiving	VBG	O	receive	dep	8	SENT_151	[p10l461t3376r753b3441],
17	a	DT	O	a	det	23	SENT_151	[p10l796t3391r827b3424],
18	medium	NN	O	medium	nn	23	SENT_151	[p10l871t3374r1133b3424],
19	dose	NN	O	dose	nn	23	SENT_151	[p10l1178t3374r1319b3424],
20	(	NN	O	(	nn	23	SENT_151	[p10l1365t3373r1486b3435],
21	325	CD	NUMBER	325	num	23	SENT_151	[p10l1365t3373r1486b3435],
22	mg	NN	O	mg	nn	23	SENT_151	[p10l1532t3373r1651b3441],
23	)	NN	O	)	dobj	16	SENT_151	[p10l1532t3373r1651b3441],
24	of	IN	O	of	_	0	SENT_151	[p10l1697t3374r1757b3424],
25	aspirin	NN	O	aspirin	prep_of	23	SENT_151	[p10l13t3457r230b3523],
26	compared	VBN	O	compare	_	0	SENT_151	[p10l269t3455r583b3523],
27	with	IN	O	with	prepc_compared_with	16	SENT_151	[p10l619t3455r758b3506],
28	a	DT	O	a	det	31	SENT_151	[p10l797t3473r828b3506],
29	low	JJ	O	low	amod	31	SENT_151	[p10l866t3455r978b3506],
30	dose	NN	O	dose	nn	31	SENT_151	[p10l1016t3455r1157b3506],
31	(	NN	O	(	pobj	16	SENT_151	[p10l1198t3455r1320b3516],
32	100	CD	NUMBER	100	num	34	SENT_151	[p10l1198t3455r1320b3516],
33	mg	NN	O	mg	nn	34	SENT_151	[p10l1359t3454r1477b3522],
34	)	NN	O	)	dep	16	SENT_151	[p10l1359t3454r1477b3522],
35	on	IN	O	on	_	0	SENT_151	[p10l1517t3473r1593b3506],
36	epinephrine-induced	JJ	O	epinephrine-induced	amod	37	SENT_151	[p10l1633t3457r1753b3523, p10l12t3539r586b3606],
37	aggregation	NN	O	aggregation	prep_on	34	SENT_151	[p10l614t3541r1004b3606],
38	.	.	O	.	_	0	SENT_151	[p10l614t3541r1004b3606],

1	M	NN	O	m	_	0	SENT_152	[p10l2006t2391r2046b2430],
2	<	JJR	O	<	amod	1	SENT_152	[p10l2005t2433r2046b2476],
3	:	:	O	:	_	0	SENT_152	[p10l2005t2433r2046b2476],
4	A	DT	O	a	det	8	SENT_152	[p10l2006t2479r2046b2511],
5	:3	CD	NUMBER	:3	num	8	SENT_152	[p10l2006t2513r2047b2557],
6	U	NNP	O	U	nn	8	SENT_152	[p10l2005t2559r2047b2598],
7	U	NNP	O	U	nn	8	SENT_152	[p10l2005t2603r2047b2632],
8	)	NNP	O	)	dep	2	SENT_152	[p10l2005t2603r2047b2632],
9	<	VBG	O	<	partmod	8	SENT_152	[p10l2005t2636r2046b2680],
10	:	:	O	:	_	0	SENT_152	[p10l2005t2636r2046b2680],
11	>	JJR	O	>	dep	8	SENT_152	[p10l2006t2681r2046b2725],
12	9	CD	NUMBER	9	num	14	SENT_152	[p10l2005t2728r2047b2794],
13	Q	NNP	O	Q	nn	14	SENT_152	[p10l2006t2799r2046b2843],
14	m	NN	O	m	dep	15	SENT_152	[p10l2006t2845r2046b2885],
15	<	JJR	O	<	dep	11	SENT_152	[p10l2005t2888r2046b2931],
16	:	:	O	:	_	0	SENT_152	[p10l2005t2888r2046b2931],
17	U	NN	O	u	dep	11	SENT_152	[p10l2005t2933r2047b2971],

1	We	PRP	O	we	nsubj	3	SENT_153	[p11l77t28r179b76],
2	are	VBP	O	be	cop	3	SENT_153	[p11l204t43r295b76],
3	unsure	JJ	O	unsure	_	0	SENT_153	[p11l319t43r529b76],
4	as	IN	O	as	_	0	SENT_153	[p11l554t43r614b76],
5	to	TO	O	to	prepc_as_to	3	SENT_153	[p11l636t32r693b76],
6	why	WRB	O	why	advmod	11	SENT_153	[p11l715t26r845b94],
7	these	DT	O	these	det	8	SENT_153	[p11l865t26r1025b76],
8	responses	NNS	O	response	nsubj	11	SENT_153	[p11l1048t43r1350b93],
9	were	VBD	O	be	cop	11	SENT_153	[p11l1372t43r1519b76],
10	preferentially	RB	O	preferentially	advmod	11	SENT_153	[p11l1543t26r1753b93, p11l13t107r239b175],
11	detectable	JJ	O	detectable	pcomp	3	SENT_153	[p11l264t107r574b158],
12	on	IN	O	on	_	0	SENT_153	[p11l602t125r676b158],
13	epinephrine-induced	JJ	O	epinephrine-induced	amod	14	SENT_153	[p11l703t107r1351b175],
14	aggregation	NN	O	aggregation	prep_on	11	SENT_153	[p11l1377t110r1752b174],
15	,	,	O	,	_	0	SENT_153	[p11l1377t110r1752b174],
16	a	DT	O	a	det	17	SENT_153	[p11l12t207r43b240],
17	finding	NN	O	finding	dep	18	SENT_153	[p11l89t190r309b257],
18	consistent	JJ	O	consistent	ccomp	3	SENT_153	[p11l355t192r661b240],
19	with	IN	O	with	_	0	SENT_153	[p11l705t190r840b240],
20	the	DT	O	the	det	23	SENT_153	[p11l886t190r980b240],
21	Framingham	NNP	O	Framingham	nn	23	SENT_153	[p11l1028t190r1420b257],
22	Offspring	NNP	O	Offspring	nn	23	SENT_153	[p11l1468t190r1756b257],
23	Study	NNP	O	Study	prep_with	18	SENT_153	[p11l13t271r204b339],
24	,	,	O	,	_	0	SENT_153	[p11l13t271r204b339],
25	where	WRB	O	where	advmod	29	SENT_153	[p11l228t271r417b322],
26	incremental	JJ	O	incremental	amod	27	SENT_153	[p11l443t271r808b322],
27	aggregation	NN	O	aggregation	nsubjpass	29	SENT_153	[p11l833t273r1194b338],
28	was	VBD	O	be	auxpass	29	SENT_153	[p11l1216t288r1332b322],
29	observed	VBN	O	observe	advcl	3	SENT_153	[p11l1359t271r1636b322],
30	using	VBG	O	use	xcomp	29	SENT_153	[p11l1660t288r1753b322, p11l11t357r108b422],
31	epinephrine	NN	O	epinephrine	dobj	30	SENT_153	[p11l131t354r502b422],
32	as	IN	O	as	_	0	SENT_153	[p11l527t372r587b405],
33	an	DT	O	a	det	34	SENT_153	[p11l612t372r684b405],
34	agonist	NN	O	agonist	prep_as	30	SENT_153	[p11l707t357r927b422],
35	on	IN	O	on	_	0	SENT_153	[p11l950t372r1024b405],
36	samples	NNS	O	sample	prep_on	34	SENT_153	[p11l1048t355r1294b422],
37	obtained	VBN	O	obtain	partmod	36	SENT_153	[p11l1319t355r1587b405],
38	from	IN	O	from	_	0	SENT_153	[p11l1609t354r1754b405],
39	subjects	NNS	O	subject	prep_from	37	SENT_153	[p11l12t462r255b530],
40	with	IN	O	with	_	0	SENT_153	[p11l274t462r409b512],
41	PIAZ	NN	ORGANIZATION	piaz	nn	42	SENT_153	[p11l429t454r553b511],
42	polymorphism	NN	O	polymorphism	prep_with	37	SENT_153	[p11l572t462r1037b530],
43	,	,	O	,	_	0	SENT_153	[p11l572t462r1037b530],
44	with	IN	O	with	_	0	SENT_153	[p11l1057t462r1192b512],
45	similar	JJ	O	similar	amod	47	SENT_153	[p11l1213t462r1423b512],
46	nonsignificant	JJ	O	nonsignificant	amod	47	SENT_153	[p11l1442t462r1753b529, p11l11t546r159b595],
47	ﬁndings	NNS	O	ﬁndings	prep_with	37	SENT_153	[p11l182t544r430b611],
48	with	IN	O	with	_	0	SENT_153	[p11l454t544r590b595],
49	ADP	NN	O	adp	nn	50	SENT_153	[p11l613t546r758b594],
50	[	NN	O	[	prep_with	47	SENT_153	[p11l788t545r873b604],
51	2	CD	NUMBER	2	num	52	SENT_153	[p11l788t545r873b604],
52	]	NN	O	]	dep	50	SENT_153	[p11l788t545r873b604],
53	.	.	O	.	_	0	SENT_153	[p11l788t545r873b604],

1	C807	NN	O	c807	nn	3	SENT_154	[p11l14t690r172b744],
2	T	NN	O	t	nn	3	SENT_154	[p11l174t691r220b743],
3	Polymorphism	NN	O	polymorphism	nsubjpass	8	SENT_154	[p11l240t688r693b764],
4	The	DT	O	the	det	6	SENT_154	[p11l11t781r128b832],
5	C807T	NN	O	c807t	nn	6	SENT_154	[p11l173t783r367b832],
6	polymorphism	NN	O	polymorphism	dep	3	SENT_154	[p11l408t781r872b849],
7	is	VBZ	O	be	auxpass	8	SENT_154	[p11l914t784r962b832],
8	associated	VBN	O	associate	_	0	SENT_154	[p11l1006t781r1330b832],
9	with	IN	O	with	_	0	SENT_154	[p11l1370t781r1509b832],
10	an	DT	O	a	det	12	SENT_154	[p11l1552t799r1625b832],
11	increased	VBN	O	increase	amod	12	SENT_154	[p11l1667t784r1753b831, p11l13t864r251b914],
12	expression	NN	O	expression	prep_with	8	SENT_154	[p11l287t866r624b931],
13	of	IN	O	of	_	0	SENT_154	[p11l660t863r720b914],
14	the	DT	O	the	det	18	SENT_154	[p11l751t864r849b914],
15	platelet	NN	O	platelet	nn	18	SENT_154	[p11l885t864r1123b931],
16	GP	NN	O	gp	nn	18	SENT_154	[p11l1158t865r1251b914],
17	la/Ila	NN	O	la/ila	nn	18	SENT_154	[p11l1286t865r1456b914],
18	receptor	NN	O	receptor	prep_of	12	SENT_154	[p11l1491t870r1755b931],
19	[	CD	NUMBER	[	number	20	SENT_154	[p11l17t946r105b1006],
20	9	CD	NUMBER	9	num	21	SENT_154	[p11l17t946r105b1006],
21	]	NN	O	]	dep	18	SENT_154	[p11l17t946r105b1006],
22	.	.	O	.	_	0	SENT_154	[p11l17t946r105b1006],

1	This	DT	O	this	nsubj	5	SENT_155	[p11l134t946r268b996],
2	was	VBD	O	be	cop	5	SENT_155	[p11l295t963r413b996],
3	a	DT	O	a	det	5	SENT_155	[p11l443t963r473b996],
4	common	JJ	O	common	amod	5	SENT_155	[p11l502t963r773b996],
5	polymorphism	NN	O	polymorphism	_	0	SENT_155	[p11l800t946r1264b1014],
6	in	IN	O	in	_	0	SENT_155	[p11l1291t948r1351b996],
7	our	PRP$	O	we	poss	8	SENT_155	[p11l1379t963r1485b996],
8	sample	NN	O	sample	prep_in	5	SENT_155	[p11l1512t946r1752b1013],
9	,	,	O	,	_	0	SENT_155	[p11l1512t946r1752b1013],
10	with	IN	O	with	_	0	SENT_155	[p11l10t1027r149b1078],
11	38	CD	PERCENT	38	num	12	SENT_155	[p11l183t1029r306b1079],
12	%	NN	PERCENT	%	prep_with	5	SENT_155	[p11l183t1029r306b1079],
13	being	VBG	O	be	cop	14	SENT_155	[p11l344t1027r522b1094],
14	heterozygous	JJ	O	heterozygous	partmod	12	SENT_155	[p11l556t1027r978b1095],
15	and	CC	O	and	_	0	SENT_155	[p11l1015t1027r1131b1078],
16	a	DT	O	a	det	19	SENT_155	[p11l1167t1044r1197b1078],
17	further	JJ	O	further	amod	19	SENT_155	[p11l1232t1027r1455b1078],
18	28	CD	PERCENT	28	num	19	SENT_155	[p11l1488t1029r1610b1079],
19	%	NN	PERCENT	%	npadvmod	20	SENT_155	[p11l1488t1029r1610b1079],
20	homozygous	JJ	O	homozygous	partmod	12	SENT_155	[p11l1650t1027r1753b1078, p11l12t1128r329b1179],
21	for	IN	O	for	_	0	SENT_155	[p11l356t1110r445b1161],
22	this	DT	O	this	det	23	SENT_155	[p11l469t1111r583b1161],
23	polymorphism	NN	O	polymorphism	prep_for	14	SENT_155	[p11l611t1110r1091b1179],
24	.	.	O	.	_	0	SENT_155	[p11l611t1110r1091b1179],

1	Analysis	NN	O	analysis	nsubj	12	SENT_156	[p11l1119t1111r1388b1179],
2	comparing	VBG	O	compare	partmod	1	SENT_156	[p11l1417t1113r1756b1178],
3	heterozygous	JJ	O	heterozygous	amod	6	SENT_156	[p11l12t1216r434b1284],
4	and	CC	O	and	_	0	SENT_156	[p11l462t1216r579b1266],
5	homozygous	JJ	O	homozygous	conj_and	3	SENT_156	[p11l605t1216r1003b1284],
6	carriers	NNS	O	carrier	dobj	2	SENT_156	[p11l1032t1218r1269b1266],
7	with	IN	O	with	_	0	SENT_156	[p11l1295t1216r1435b1266],
8	the	DT	O	the	det	9	SENT_156	[p11l1461t1216r1558b1266],
9	norm	NN	O	norm	prep_with	6	SENT_156	[p11l1586t1233r1754b1266],
10	did	VBD	O	do	aux	12	SENT_156	[p11l13t1298r114b1348],
11	not	RB	O	not	neg	12	SENT_156	[p11l155t1304r256b1348],
12	reveal	VB	O	reveal	_	0	SENT_156	[p11l296t1298r488b1348],
13	any	DT	O	any	det	15	SENT_156	[p11l530t1315r642b1366],
14	discernable	JJ	O	discernable	amod	15	SENT_156	[p11l684t1298r1045b1348],
15	pattern	NN	O	pattern	dobj	12	SENT_156	[p11l1088t1304r1317b1365],
16	despite	IN	O	despite	_	0	SENT_156	[p11l1361t1298r1586b1365],
17	heterozygous	JJ	O	heterozygous	amod	18	SENT_156	[p11l1629t1298r1753b1348, p11l13t1399r332b1449],
18	individuals	NNS	O	individual	prep_despite	12	SENT_156	[p11l368t1381r722b1432],
19	expressing	VBG	O	express	partmod	18	SENT_156	[p11l760t1384r1099b1449],
20	intermediate	JJ	O	intermediate	amod	21	SENT_156	[p11l1133t1381r1538b1432],
21	levels	NNS	O	level	dobj	19	SENT_156	[p11l1575t1381r1753b1432],
22	of	IN	O	of	_	0	SENT_156	[p11l13t1463r73b1514],
23	receptor	NN	O	receptor	nn	24	SENT_156	[p11l92t1470r356b1531],
24	density	NN	O	density	prep_of	21	SENT_156	[p11l379t1464r608b1532],
25	[	CD	NUMBER	[	number	26	SENT_156	[p11l634t1464r723b1523],
26	9	CD	NUMBER	9	num	27	SENT_156	[p11l634t1464r723b1523],
27	]	NN	O	]	dep	24	SENT_156	[p11l634t1464r723b1523],
28	.	.	O	.	_	0	SENT_156	[p11l634t1464r723b1523],

1	The	DT	O	the	det	2	SENT_157	[p11l747t1464r864b1514],
2	ﬁndings	NNS	O	ﬁndings	nsubjpass	12	SENT_157	[p11l887t1463r1143b1531],
3	of	IN	O	of	_	0	SENT_157	[p11l1167t1463r1228b1514],
4	increased	VBN	O	increase	amod	6	SENT_157	[p11l1246t1464r1550b1514],
5	platelet	NN	O	platelet	nn	6	SENT_157	[p11l1571t1464r1753b1531, p11l11t1546r89b1596],
6	aggregation	NN	O	aggregation	prep_of	2	SENT_157	[p11l125t1548r499b1613],
7	[	CD	NUMBER	[	num	9	SENT_157	[p11l540t1546r643b1606],
8	10	CD	NUMBER	10	num	9	SENT_157	[p11l540t1546r643b1606],
9	]	NN	O	]	dep	6	SENT_157	[p11l540t1546r643b1606],
10	were	VBD	O	be	auxpass	12	SENT_157	[p11l682t1563r834b1596],
11	largely	RB	O	largely	advmod	12	SENT_157	[p11l871t1546r1088b1614],
12	confined	VBN	O	confine	_	0	SENT_157	[p11l1124t1546r1396b1596],
13	to	TO	O	to	_	0	SENT_157	[p11l1430t1552r1488b1596],
14	participants	NNS	O	participant	prep_to	12	SENT_157	[p11l1525t1548r1753b1613, p11l11t1634r182b1696],
15	homozygous	JJ	O	homozygous	amod	14	SENT_157	[p11l211t1628r609b1696],
16	for	IN	O	for	_	0	SENT_157	[p11l637t1628r725b1679],
17	this	DT	O	this	det	19	SENT_157	[p11l751t1628r865b1679],
18	polymorphism	NN	O	polymorphism	nn	19	SENT_157	[p11l893t1628r1357b1696],
19	(	NN	O	(	prep_for	15	SENT_157	[p11l1386t1627r1581b1689],
20	Table	NNP	O	Table	nn	22	SENT_157	[p11l1386t1627r1581b1689],
21	3	CD	NUMBER	3	num	22	SENT_157	[p11l1609t1627r1680b1689],
22	)	NN	O	)	dep	19	SENT_157	[p11l1609t1627r1680b1689],
23	.	.	O	.	_	0	SENT_157	[p11l1609t1627r1680b1689],

1	It	PRP	O	it	nsubj	3	SENT_158	[p11l1710t1630r1755b1679],
2	is	VBZ	O	be	cop	3	SENT_158	[p11l11t1712r59b1760],
3	difficult	JJ	O	difficult	_	0	SENT_158	[p11l87t1709r325b1760],
4	to	TO	O	to	aux	5	SENT_158	[p11l349t1716r407b1760],
5	determine	VB	O	determine	xcomp	3	SENT_158	[p11l436t1709r758b1760],
6	the	DT	O	the	det	8	SENT_158	[p11l784t1709r881b1760],
7	clinical	JJ	O	clinical	amod	8	SENT_158	[p11l910t1709r1133b1760],
8	signiﬁcance	NN	O	signiﬁcance	dobj	5	SENT_158	[p11l1159t1709r1529b1776],
9	of	IN	O	of	_	0	SENT_158	[p11l1557t1709r1618b1760],
10	this	DT	O	this	det	11	SENT_158	[p11l1639t1709r1753b1760],
11	finding	NN	O	finding	prep_of	8	SENT_158	[p11l11t1792r252b1859],
12	.	.	O	.	_	0	SENT_158	[p11l11t1792r252b1859],

1	The	DT	O	the	det	2	SENT_159	[p11l292t1792r409b1842],
2	differences	NNS	O	difference	nsubj	32	SENT_159	[p11l451t1792r792b1842],
3	in	IN	O	in	_	0	SENT_159	[p11l831t1794r890b1841],
4	the	DT	O	the	det	5	SENT_159	[p11l928t1792r1025b1842],
5	point	NN	O	point	prep_in	2	SENT_159	[p11l1064t1794r1230b1859],
6	estimates	NNS	O	estimate	nsubj	9	SENT_159	[p11l1268t1794r1563b1842],
7	were	VBD	O	be	cop	9	SENT_159	[p11l1601t1809r1753b1842],
8	small	JJ	O	small	amod	9	SENT_159	[p11l12t1874r180b1924],
9	(	NN	O	(	rcmod	5	SENT_159	[p11l219t1873r328b1935],
10	2	CD	PERCENT	2	number	14	SENT_159	[p11l219t1873r328b1935],
11	%	NN	PERCENT	%	dep	14	SENT_159	[p11l219t1873r328b1935],
12	to	TO	O	to	dep	14	SENT_159	[p11l370t1880r428b1924],
13	5	CD	PERCENT	5	number	14	SENT_159	[p11l466t1873r599b1935],
14	%	NN	PERCENT	%	num	15	SENT_159	[p11l466t1873r599b1935],
15	)	CD	NUMBER	)	dep	9	SENT_159	[p11l466t1873r599b1935],
16	,	,	O	,	_	0	SENT_159	[p11l466t1873r599b1935],
17	and	CC	O	and	_	0	SENT_159	[p11l639t1874r756b1924],
18	the	DT	O	the	det	26	SENT_159	[p11l792t1874r890b1924],
19	upper	JJ	O	upper	amod	26	SENT_159	[p11l929t1891r1118b1941],
20	bound	VBN	O	bind	amod	26	SENT_159	[p11l1153t1874r1358b1924],
21	of	IN	O	of	_	0	SENT_159	[p11l1396t1874r1457b1924],
22	the	DT	O	the	det	25	SENT_159	[p11l1491t1874r1588b1924],
23	95	CD	PERCENT	95	number	24	SENT_159	[p11l1628t1875r1749b1926],
24	%	NN	PERCENT	%	amod	25	SENT_159	[p11l1628t1875r1749b1926],
25	conﬁdence	NN	O	conﬁdence	prep_of	20	SENT_159	[p11l13t1956r351b2007],
26	interval	NN	O	interval	rcmod	5	SENT_159	[p11l380t1956r623b2007],
27	was	VBD	O	be	cop	32	SENT_159	[p11l649t1973r767b2007],
28	a	DT	O	a	det	32	SENT_159	[p11l797t1973r828b2007],
29	maximum	JJ	O	maximum	amod	32	SENT_159	[p11l856t1958r1172b2007],
30	13	CD	PERCENT	13	number	31	SENT_159	[p11l1201t1958r1322b2008],
31	%	NN	PERCENT	%	amod	32	SENT_159	[p11l1201t1958r1322b2008],
32	difference	NN	O	difference	_	0	SENT_159	[p11l1356t1956r1666b2007],
33	in	IN	O	in	_	0	SENT_159	[p11l1695t1958r1754b2006],
34	aggregation	NN	O	aggregation	prep_in	32	SENT_159	[p11l13t2042r386b2107],
35	on	IN	O	on	_	0	SENT_159	[p11l420t2057r495b2090],
36	collagen	NN	O	collagen	prep_on	34	SENT_159	[p11l529t2040r807b2107],
37	,	,	O	,	_	0	SENT_159	[p11l529t2040r807b2107],
38	which	WDT	O	which	nsubj	40	SENT_159	[p11l839t2040r1029b2090],
39	is	VBZ	O	be	cop	40	SENT_159	[p11l1062t2042r1109b2090],
40	unlikely	JJ	O	unlikely	rcmod	36	SENT_159	[p11l1143t2040r1400b2108],
41	to	TO	O	to	aux	42	SENT_159	[p11l1431t2046r1488b2090],
42	contain	VB	O	contain	xcomp	40	SENT_159	[p11l1523t2042r1754b2090],
43	an	DT	O	a	det	45	SENT_159	[p11l12t2139r86b2172],
44	important	JJ	O	important	amod	45	SENT_159	[p11l113t2124r429b2189],
45	difference	NN	O	difference	dobj	42	SENT_159	[p11l458t2122r785b2172],
46	.	.	O	.	_	0	SENT_159	[p11l458t2122r785b2172],

1	A842	NN	O	a842	nn	3	SENT_160	[p11l6t2269r169b2322],
2	G/C50T	NN	O	g/c50t	nn	3	SENT_160	[p11l177t2267r427b2324],
3	Polymorphism	NN	O	polymorphism	nsubj	7	SENT_160	[p11l447t2266r900b2342],
4	The	DT	O	the	det	6	SENT_160	[p11l11t2359r125b2409],
5	842G/C50T	NN	O	842g/c50t	nn	6	SENT_160	[p11l147t2360r486b2409],
6	alleles	NNS	O	allele	dep	3	SENT_160	[p11l506t2359r695b2409],
7	exhibit	VBP	O	exhibit	_	0	SENT_160	[p11l718t2359r926b2409],
8	complete	JJ	O	complete	amod	13	SENT_160	[p11l946t2359r1223b2426],
9	linkage	NN	O	linkage	nn	13	SENT_160	[p11l1245t2359r1466b2426],
10	dysequilibrium	NN	O	dysequilibrium	nn	13	SENT_160	[p11l1489t2359r1753b2427, p11l11t2441r239b2492],
11	(	NN	O	(	nn	13	SENT_160	[p11l288t2440r671b2502],
12	nonrandom	JJ	O	nonrandom	amod	13	SENT_160	[p11l288t2440r671b2502],
13	association	NN	O	association	dobj	7	SENT_160	[p11l720t2443r1057b2492],
14	between	IN	O	between	_	0	SENT_160	[p11l1104t2441r1365b2492],
15	842G/C50T	NN	O	842g/c50t	prep_between	13	SENT_160	[p11l1413t2442r1754b2492],
16	such	JJ	O	such	amod	15	SENT_160	[p11l12t2524r151b2574],
17	that	IN	O	that	complm	20	SENT_160	[p11l179t2524r298b2574],
18	it	PRP	O	it	dep	20	SENT_160	[p11l325t2526r366b2574],
19	more	RBR	O	more	advmod	20	SENT_160	[p11l393t2541r549b2574],
20	likely	JJ	O	likely	dep	7	SENT_160	[p11l578t2524r745b2592],
21	to	TO	O	to	aux	22	SENT_160	[p11l771t2530r828b2574],
22	occur	VB	O	occur	xcomp	20	SENT_160	[p11l858t2541r1023b2574],
23	together	RB	O	together	advmod	22	SENT_160	[p11l1049t2524r1305b2591],
24	on	IN	O	on	_	0	SENT_160	[p11l1333t2541r1408b2574],
25	a	DT	O	a	det	26	SENT_160	[p11l1437t2541r1468b2574],
26	chromosome	NN	O	chromosome	prep_on	22	SENT_160	[p11l1497t2524r1753b2574, p11l12t2624r170b2657],
27	than	IN	O	than	_	0	SENT_160	[p11l216t2607r353b2657],
28	other	JJ	O	other	amod	29	SENT_160	[p11l400t2607r560b2657],
29	combinations	NNS	O	combination	prep_than	26	SENT_160	[p11l605t2607r1016b2657],
30	of	IN	O	of	_	0	SENT_160	[p11l1063t2607r1122b2657],
31	alleles	NNS	O	allele	prep_of	29	SENT_160	[p11l1166t2606r1393b2668],
32	)	CD	NUMBER	)	dep	31	SENT_160	[p11l1166t2606r1393b2668],
33	.	.	O	.	_	0	SENT_160	[p11l1166t2606r1393b2668],

1	The	DT	O	the	det	3	SENT_161	[p11l1440t2607r1555b2657],
2	842G	NN	O	842g	nn	3	SENT_161	[p11l1602t2608r1753b2657],
3	variant	NN	O	variant	nsubj	5	SENT_161	[p11l10t2691r226b2740],
4	is	VBZ	O	be	cop	5	SENT_161	[p11l248t2691r294b2740],
5	located	JJ	O	located	_	0	SENT_161	[p11l318t2689r537b2740],
6	in	IN	O	in	_	0	SENT_161	[p11l560t2691r618b2739],
7	the	DT	O	the	det	8	SENT_161	[p11l640t2689r735b2740],
8	promoter	NN	O	promoter	prep_in	5	SENT_161	[p11l759t2695r1046b2757],
9	of	IN	O	of	_	0	SENT_161	[p11l1069t2689r1128b2740],
10	COX-1	NN	O	cox-1	prep_of	8	SENT_161	[p11l1150t2691r1353b2740],
11	and	CC	O	and	_	0	SENT_161	[p11l1380t2689r1493b2740],
12	persons	NNS	O	person	conj_and	10	SENT_161	[p11l1516t2706r1753b2757],
13	heterozygous	JJ	O	heterozygous	dep	5	SENT_161	[p11l12t2770r419b2838],
14	for	IN	O	for	_	0	SENT_161	[p11l450t2770r536b2821],
15	842G/C50T	NN	O	842g/c50t	prep_for	13	SENT_161	[p11l567t2772r905b2821],
16	that	WDT	O	that	nsubjpass	18	SENT_161	[p11l934t2770r1053b2821],
17	is	VBZ	O	be	auxpass	18	SENT_161	[p11l1083t2773r1129b2821],
18	associated	VBN	O	associate	rcmod	15	SENT_161	[p11l1163t2770r1475b2821],
19	with	IN	O	with	_	0	SENT_161	[p11l1504t2770r1639b2821],
20	increased	VBN	O	increase	amod	22	SENT_161	[p11l1670t2773r1753b2820, p11l12t2853r243b2903],
21	aspirin	NN	O	aspirin	nn	22	SENT_161	[p11l268t2855r478b2920],
22	effectiveness	NN	O	effectiveness	prep_with	18	SENT_161	[p11l504t2853r902b2903],
23	.	.	O	.	_	0	SENT_161	[p11l504t2853r902b2903],

1	Unlike	IN	O	unlike	_	0	SENT_162	[p11l929t2853r1131b2903],
2	the	DT	O	the	det	5	SENT_162	[p11l1156t2853r1251b2903],
3	other	JJ	O	other	amod	5	SENT_162	[p11l1278t2853r1438b2903],
4	two	CD	NUMBER	two	num	5	SENT_162	[p11l1461t2859r1571b2903],
5	polymorphisms	NNS	O	polymorphism	prep_unlike	11	SENT_162	[p11l1596t2853r1753b2921, p11l12t2936r371b3003],
6	,	,	O	,	_	0	SENT_162	[p11l1596t2853r1753b2921, p11l12t2936r371b3003],
7	carriers	NNS	O	carrier	nsubj	11	SENT_162	[p11l419t2938r646b2986],
8	of	IN	O	of	_	0	SENT_162	[p11l692t2936r752b2986],
9	this	DT	O	this	det	10	SENT_162	[p11l792t2936r902b2986],
10	genotype	NN	O	genotype	prep_of	7	SENT_162	[p11l948t2942r1228b3004],
11	have	VBP	O	have	_	0	SENT_162	[p11l1274t2936r1416b2986],
12	a	DT	O	a	det	14	SENT_162	[p11l1463t2953r1494b2986],
13	greater	JJR	O	greater	amod	14	SENT_162	[p11l1539t2942r1755b3003],
14	sensitivity	NN	O	sensitivity	dobj	11	SENT_162	[p11l13t3019r322b3085],
15	to	TO	O	to	_	0	SENT_162	[p11l351t3023r407b3068],
16	aspirin	NN	O	aspirin	prep_to	14	SENT_162	[p11l441t3019r666b3085],
17	,	,	O	,	_	0	SENT_162	[p11l441t3019r666b3085],
18	possibly	RB	O	possibly	dep	14	SENT_162	[p11l699t3017r951b3085],
19	due	JJ	O	due	_	0	SENT_162	[p11l982t3017r1093b3068],
20	to	TO	O	to	_	0	SENT_162	[p11l1125t3023r1182b3068],
21	reduced	VBN	O	reduce	amod	22	SENT_162	[p11l1214t3017r1463b3068],
22	levels	NNS	O	level	prep_due_to	14	SENT_162	[p11l1493t3017r1665b3068],
23	of	IN	O	of	_	0	SENT_162	[p11l1698t3017r1758b3068],
24	COX-1	NN	O	cox-1	prep_of	22	SENT_162	[p11l13t3101r216b3150],
25	[	CD	NUMBER	[	number	26	SENT_162	[p11l269t3100r388b3159],
26	11	CD	NUMBER	11	num	27	SENT_162	[p11l269t3100r388b3159],
27	]	NN	O	]	dep	14	SENT_162	[p11l269t3100r388b3159],
28	.	.	O	.	_	0	SENT_162	[p11l269t3100r388b3159],

1	Our	PRP$	O	we	poss	2	SENT_163	[p11l437t3101r558b3150],
2	results	NNS	O	result	nsubj	3	SENT_163	[p11l602t3099r804b3150],
3	confirmed	VBD	O	confirm	_	0	SENT_163	[p11l851t3099r1162b3150],
4	complete	JJ	O	complete	amod	6	SENT_163	[p11l1208t3100r1485b3167],
5	linkage	NN	O	linkage	nn	6	SENT_163	[p11l1532t3099r1753b3167],
6	dysequilibrium	NN	O	dysequilibrium	dobj	3	SENT_163	[p11l13t3182r496b3250],
7	,	,	O	,	_	0	SENT_163	[p11l13t3182r496b3250],
8	as	IN	O	as	mark	17	SENT_163	[p11l528t3199r588b3232],
9	both	DT	O	both	preconj	11	SENT_163	[p11l617t3182r756b3232],
10	the	DT	O	the	det	11	SENT_163	[p11l784t3182r879b3232],
11	A842G	NN	O	a842g	nsubjpass	17	SENT_163	[p11l908t3183r1112b3232],
12	and	CC	O	and	_	0	SENT_163	[p11l1144t3182r1257b3232],
13	the	DT	O	the	det	15	SENT_163	[p11l1285t3182r1380b3232],
14	C50T	NN	O	c50t	nn	15	SENT_163	[p11l1412t3183r1568b3232],
15	polymorphisms	NNS	O	polymorphism	conj_and	11	SENT_163	[p11l1596t3182r1753b3250, p11l12t3263r355b3331],
16	were	VBD	O	be	auxpass	17	SENT_163	[p11l390t3280r538b3314],
17	sequenced	VBN	O	sequence	advcl	3	SENT_163	[p11l575t3263r915b3331],
18	.	.	O	.	_	0	SENT_163	[p11l575t3263r915b3331],

1	In	IN	O	in	_	0	SENT_164	[p11l952t3265r1013b3313],
2	our	PRP$	O	we	poss	3	SENT_164	[p11l1049t3280r1152b3314],
3	study	NN	O	study	prep_in	17	SENT_164	[p11l1186t3263r1368b3331],
4	,	,	O	,	_	0	SENT_164	[p11l1186t3263r1368b3331],
5	all	DT	O	all	det	6	SENT_164	[p11l1406t3263r1477b3314],
6	patients	NNS	O	patient	nsubj	17	SENT_164	[p11l1511t3265r1753b3331],
7	who	WP	O	who	nsubj	12	SENT_164	[p11l10t3346r141b3397],
8	were	VBD	O	be	cop	12	SENT_164	[p11l189t3364r340b3397],
9	heterozygous	JJ	O	heterozygous	amod	12	SENT_164	[p11l390t3346r807b3414],
10	or	CC	O	or	_	0	SENT_164	[p11l858t3364r920b3397],
11	homozygous	JJ	O	homozygous	amod	12	SENT_164	[p11l968t3346r1362b3414],
12	carriers	NNS	O	carrier	rcmod	6	SENT_164	[p11l1413t3349r1647b3397],
13	of	IN	O	of	_	0	SENT_164	[p11l1697t3346r1757b3397],
14	A842G	NN	O	a842g	nn	15	SENT_164	[p11l10t3430r214b3479],
15	polymorphisms	NNS	O	polymorphism	prep_of	12	SENT_164	[p11l236t3429r714b3497],
16	also	RB	O	also	advmod	17	SENT_164	[p11l737t3429r854b3479],
17	had	VBD	O	have	_	0	SENT_164	[p11l876t3429r991b3479],
18	identical	JJ	O	identical	amod	20	SENT_164	[p11l1011t3429r1273b3479],
19	C50T	NN	O	c50t	nn	20	SENT_164	[p11l1295t3430r1451b3479],
20	polymorphism	NN	O	polymorphism	dobj	17	SENT_164	[p11l1471t3429r1753b3497, p11l11t3511r216b3578],
21	.	.	O	.	_	0	SENT_164	[p11l1471t3429r1753b3497, p11l11t3511r216b3578],

1	The	DT	O	the	det	2	SENT_165	[p11l250t3511r364b3561],
2	results	NNS	O	result	nsubj	7	SENT_165	[p11l398t3511r599b3561],
3	of	IN	O	of	_	0	SENT_165	[p11l634t3511r693b3561],
4	aggregation	NN	O	aggregation	prep_of	2	SENT_165	[p11l723t3513r1083b3578],
5	were	VBD	O	be	cop	7	SENT_165	[p11l1115t3528r1262b3561],
6	also	RB	O	also	advmod	7	SENT_165	[p11l1297t3511r1414b3561],
7	consistent	JJ	O	consistent	_	0	SENT_165	[p11l1449t3513r1755b3561],
8	with	IN	O	with	_	0	SENT_165	[p11l10t3592r145b3643],
9	a	DT	O	a	det	11	SENT_165	[p11l175t3609r206b3643],
10	greater	JJR	O	greater	amod	11	SENT_165	[p11l237t3598r453b3659],
11	response	NN	O	response	prep_with	7	SENT_165	[p11l480t3609r752b3660],
12	to	TO	O	to	_	0	SENT_165	[p11l782t3598r838b3643],
13	aspirin	NN	O	aspirin	prep_to	11	SENT_165	[p11l869t3594r1094b3660],
14	,	,	O	,	_	0	SENT_165	[p11l869t3594r1094b3660],
15	with	IN	O	with	_	0	SENT_165	[p11l1124t3592r1259b3643],
16	lower	JJR	O	lower	amod	17	SENT_165	[p11l1288t3592r1459b3643],
17	aggregation	NN	O	aggregation	prep_with	7	SENT_165	[p11l1488t3609r1753b3659, p11l11t3677r129b3725],
18	and	CC	O	and	_	0	SENT_165	[p11l161t3674r275b3725],
19	a	DT	O	a	det	22	SENT_165	[p11l306t3692r337b3725],
20	greater	JJR	O	greater	amod	22	SENT_165	[p11l369t3681r585b3741],
21	platelet	NN	O	platelet	nn	22	SENT_165	[p11l615t3674r843b3742],
22	inhibition	NN	O	inhibition	prep_with	7	SENT_165	[p11l873t3674r1172b3725],
23	with	IN	O	with	_	0	SENT_165	[p11l1202t3674r1337b3725],
24	higher	JJR	O	higher	amod	26	SENT_165	[p11l1369t3674r1568b3741],
25	ECSO	NN	O	ecso	nn	26	SENT_165	[p11l1598t3676r1754b3725],
26	levels	NNS	O	level	prep_with	7	SENT_165	[p11l11t3757r199b3807],
27	.	.	O	.	_	0	SENT_165	[p11l11t3757r199b3807],

1	The	DT	O	the	det	3	SENT_166	[p11l219t3757r334b3807],
2	conﬁdence	NN	O	conﬁdence	nn	3	SENT_166	[p11l356t3757r684b3807],
3	intervals	NNS	O	interval	nsubj	5	SENT_166	[p11l704t3757r966b3807],
4	were	VBD	O	be	cop	5	SENT_166	[p11l985t3774r1133b3807],
5	wide	JJ	O	wide	_	0	SENT_166	[p11l1152t3757r1315b3817],
6	,	,	O	,	_	0	SENT_166	[p11l1152t3757r1315b3817],
7	and	CC	O	and	_	0	SENT_166	[p11l1337t3757r1451b3807],
8	the	DT	O	the	det	10	SENT_166	[p11l1469t3757r1563b3807],
9	lower	JJR	O	lower	dep	10	SENT_166	[p11l1584t3757r1755b3807],
10	bound	VBN	O	bind	nsubj	11	SENT_166	[p12l10t20r209b70],
11	contained	VBD	O	contain	conj_and	5	SENT_166	[p12l232t20r532b70],
12	up	RP	O	up	prt	11	SENT_166	[p12l555t37r632b87],
13	to	TO	O	to	_	0	SENT_166	[p12l656t26r713b70],
14	an	DT	O	a	det	17	SENT_166	[p12l738t37r810b70],
15	18	CD	PERCENT	18	number	16	SENT_166	[p12l833t22r952b72],
16	%	NN	PERCENT	%	amod	17	SENT_166	[p12l833t22r952b72],
17	reduction	NN	O	reduction	prep_to	11	SENT_166	[p12l979t20r1272b70],
18	in	IN	O	in	_	0	SENT_166	[p12l1295t22r1353b69],
19	aggregation	NN	O	aggregation	prep_in	17	SENT_166	[p12l1377t22r1752b87],
20	;	:	O	;	_	0	SENT_166	[p12l1377t22r1752b87],
21	it	PRP	O	it	nsubj	23	SENT_166	[p12l11t104r52b152],
22	is	VBZ	O	be	cop	23	SENT_166	[p12l88t104r134b152],
23	difficult	JJ	O	difficult	parataxis	5	SENT_166	[p12l175t101r404b152],
24	to	TO	O	to	aux	25	SENT_166	[p12l439t108r496b152],
25	determine	VB	O	determine	xcomp	23	SENT_166	[p12l536t101r847b152],
26	whether	IN	O	whether	complm	28	SENT_166	[p12l885t101r1139b152],
27	this	DT	O	this	nsubj	28	SENT_166	[p12l1175t101r1285b152],
28	represents	VBZ	O	represent	ccomp	25	SENT_166	[p12l1323t108r1643b169],
29	an	DT	O	a	dobj	28	SENT_166	[p12l1682t119r1754b152],

1	138	CD	NUMBER	138	num	2	SENT_167	[p12l414t303r511b350],
2	LIM	NN	O	lim	_	0	SENT_167	[p12l636t313r735b350],
3	ET	NNP	O	ET	nn	4	SENT_167	[p12l755t312r818b349],
4	AL	NNP	O	AL	dep	2	SENT_167	[p12l836t312r906b349],

1	ASPIRIN	NN	O	aspirin	nn	2	SENT_168	[p12l635t371r852b410],
2	EFFICACY	NN	O	efficacy	_	0	SENT_168	[p12l871t371r1130b410],
3	WITH	IN	O	with	dep	2	SENT_168	[p12l1148t372r1295b409],
4	GENETIC	JJ	O	genetic	amod	5	SENT_168	[p12l1315t371r1551b410],
5	POLYMORPHISM	NN	O	polymorphism	pobj	3	SENT_168	[p12l1572t371r2017b410],

1	important	JJ	O	important	amod	2	SENT_169	[p12l413t666r718b731],
2	difference	NN	O	difference	_	0	SENT_169	[p12l745t664r1041b714],
3	that	WDT	O	that	dobj	8	SENT_169	[p12l1068t664r1187b714],
4	our	PRP$	O	we	poss	5	SENT_169	[p12l1214t681r1317b714],
5	study	NN	O	study	nsubjpass	8	SENT_169	[p12l1343t664r1510b732],
6	was	VBD	O	be	auxpass	8	SENT_169	[p12l1534t681r1649b714],
7	not	RB	O	not	neg	8	SENT_169	[p12l1677t670r1775b714],
8	powered	VBN	O	power	rcmod	2	SENT_169	[p12l1800t664r2067b731],
9	to	TO	O	to	aux	10	SENT_169	[p12l2092t670r2149b714],
10	detect	VB	O	detect	xcomp	8	SENT_169	[p12l415t749r611b800],
11	.	.	O	.	_	0	SENT_169	[p12l415t749r611b800],

1	(	NN	O	(	_	0	SENT_170	[p12l122t351r164b389],
2	3	CD	NUMBER	3	num	1	SENT_170	[p12l122t351r164b389],
3	:	:	O	:	_	0	SENT_170	[p12l123t391r163b435],
4	>	JJR	O	>	amod	7	SENT_170	[p12l123t391r163b435],
5	w	NN	O	w	nn	7	SENT_170	[p12l122t437r163b477],
6	E	NN	O	e	nn	7	SENT_170	[p12l122t479r163b546],
7	o	NN	O	o	dep	1	SENT_170	[p12l122t550r164b593],
8	<	JJR	O	<	dep	7	SENT_170	[p12l122t597r163b640],
9	:	:	O	:	_	0	SENT_170	[p12l122t642r163b685],
10	>	JJR	O	>	amod	13	SENT_170	[p12l122t642r163b685],
11	U3	NN	O	u3	nn	13	SENT_170	[p12l122t689r164b718],
12	o	NN	O	o	nn	13	SENT_170	[p12l122t724r164b762],
13	c	NN	O	c	dep	7	SENT_170	[p12l122t764r163b807],
14	F	NN	O	f	dep	13	SENT_170	[p12l122t810r163b841],
15	‘	CD	NUMBER	‘	num	14	SENT_170	[p12l122t810r163b841],
16	:	:	O	:	_	0	SENT_170	[p12l122t844r163b888],
17	>	JJR	O	>	dep	7	SENT_170	[p12l122t844r163b888],
18	w	NN	O	w	dep	17	SENT_170	[p12l122t890r163b930],

1	Potential	JJ	O	potential	amod	2	SENT_171	[p12l411t896r687b951],
2	Limitations	NNPS	O	Limitations	_	0	SENT_171	[p12l714t898r1064b951],

1	Our	PRP$	O	we	poss	3	SENT_172	[p12l415t1002r536b1051],
2	original	JJ	O	original	amod	3	SENT_172	[p12l564t1001r797b1068],
3	study	NN	O	study	nsubjpass	5	SENT_172	[p12l826t1001r993b1069],
4	was	VBD	O	be	auxpass	5	SENT_172	[p12l1018t1018r1133b1051],
5	powered	VBN	O	power	_	0	SENT_172	[p12l1163t1001r1429b1068],
6	to	TO	O	to	aux	7	SENT_172	[p12l1457t1007r1513b1051],
7	detect	VB	O	detect	xcomp	5	SENT_172	[p12l1544t1001r1726b1051],
8	a	DT	O	a	det	11	SENT_172	[p12l1754t1018r1785b1051],
9	30	CD	PERCENT	30	number	10	SENT_172	[p12l1812t1003r1932b1053],
10	%	NN	PERCENT	%	amod	11	SENT_172	[p12l1812t1003r1932b1053],
11	difference	NN	O	difference	dobj	7	SENT_172	[p12l1967t1001r2149b1051, p12l415t1103r551b1136],
12	in	IN	O	in	_	0	SENT_172	[p12l598t1088r655b1136],
13	aggregation	NN	O	aggregation	prep_in	11	SENT_172	[p12l702t1088r1061b1153],
14	between	IN	O	between	_	0	SENT_172	[p12l1106t1086r1364b1136],
15	any	DT	O	any	det	17	SENT_172	[p12l1411t1103r1520b1154],
16	two	CD	NUMBER	two	num	17	SENT_172	[p12l1564t1092r1674b1136],
17	arms	NNS	O	arm	prep_between	13	SENT_172	[p12l1721t1103r1885b1136],
18	.	.	O	.	_	0	SENT_172	[p12l1721t1103r1885b1136],

1	In	IN	O	in	_	0	SENT_173	[p12l1933t1088r1994b1136],
2	this	DT	O	this	det	3	SENT_173	[p12l2039t1086r2149b1136],
3	subanalysis	NN	O	subanalysis	prep_in	7	SENT_173	[p12l415t1169r781b1237],
4	,	,	O	,	_	0	SENT_173	[p12l415t1169r781b1237],
5	we	PRP	O	we	nsubj	7	SENT_173	[p12l811t1187r897b1220],
6	were	VBD	O	be	cop	7	SENT_173	[p12l927t1187r1074b1220],
7	unable	JJ	O	unable	_	0	SENT_173	[p12l1106t1169r1312b1220],
8	to	TO	O	to	aux	9	SENT_173	[p12l1343t1175r1399b1220],
9	determine	VB	O	determine	xcomp	7	SENT_173	[p12l1432t1169r1742b1220],
10	whether	IN	O	whether	complm	16	SENT_173	[p12l1772t1169r2026b1220],
11	the	DT	O	the	det	12	SENT_173	[p12l2054t1169r2148b1220],
12	absence	NN	O	absence	nsubj	16	SENT_173	[p12l415t1254r654b1304],
13	of	IN	O	of	_	0	SENT_173	[p12l683t1254r742b1304],
14	statistical	JJ	O	statistical	amod	15	SENT_173	[p12l765t1254r1048b1304],
15	significance	NN	O	significance	prep_of	12	SENT_173	[p12l1074t1254r1429b1321],
16	implied	VBD	O	imply	ccomp	9	SENT_173	[p12l1456t1254r1691b1321],
17	no	DT	O	no	det	19	SENT_173	[p12l1717t1271r1791b1304],
18	true	JJ	O	true	amod	19	SENT_173	[p12l1817t1260r1938b1304],
19	difference	NN	O	difference	dobj	16	SENT_173	[p12l1967t1254r2149b1304, p12l415t1354r566b1388],
20	.	.	O	.	_	0	SENT_173	[p12l1967t1254r2149b1304, p12l415t1354r566b1388],

1	The	DT	O	the	det	2	SENT_174	[p12l595t1337r709b1388],
2	ﬁndings	NNS	O	ﬁndings	nsubj	15	SENT_174	[p12l737t1337r984b1404],
3	of	IN	O	of	_	0	SENT_174	[p12l1013t1337r1072b1388],
4	increased	VBN	O	increase	amod	5	SENT_174	[p12l1095t1337r1387b1388],
5	aggregation	NN	O	aggregation	prep_of	2	SENT_174	[p12l1414t1339r1773b1404],
6	with	IN	O	with	dep	5	SENT_174	[p12l1799t1337r1934b1388],
7	C807T	NN	O	c807t	pobj	6	SENT_174	[p12l1962t1339r2151b1388],
8	and	CC	O	and	_	0	SENT_174	[p12l415t1422r528b1472],
9	reduced	VBD	O	reduce	dep	5	SENT_174	[p12l569t1422r817b1472],
10	aggregation	NN	O	aggregation	dobj	9	SENT_174	[p12l860t1424r1220b1489],
11	with	IN	O	with	_	0	SENT_174	[p12l1260t1422r1395b1472],
12	A842G/C50T	NN	O	a842g/c50t	nn	13	SENT_174	[p12l1436t1423r1826b1472],
13	polymorphisms	NNS	O	polymorphism	prep_with	9	SENT_174	[p12l1867t1422r2149b1490, p12l413t1506r631b1573],
14	were	VBD	O	be	cop	15	SENT_174	[p12l664t1523r811b1556],
15	consistent	JJ	O	consistent	_	0	SENT_174	[p12l847t1508r1152b1556],
16	with	IN	O	with	_	0	SENT_174	[p12l1183t1506r1318b1556],
17	previous	JJ	O	previous	amod	18	SENT_174	[p12l1351t1508r1614b1573],
18	reports	NNS	O	report	prep_with	15	SENT_174	[p12l1647t1512r1879b1573],
19	,	,	O	,	_	0	SENT_174	[p12l1647t1512r1879b1573],
20	but	CC	O	but	_	0	SENT_174	[p12l1913t1506r2015b1556],
21	our	PRP$	O	we	poss	22	SENT_174	[p12l2048t1523r2151b1556],
22	findings	NNS	O	finding	nsubj	25	SENT_174	[p12l413t1590r660b1657],
23	did	VBD	O	do	aux	25	SENT_174	[p12l688t1590r785b1641],
24	not	RB	O	not	neg	25	SENT_174	[p12l810t1596r908b1641],
25	reach	VB	O	reach	conj_but	15	SENT_174	[p12l932t1590r1098b1641],
26	statistical	JJ	O	statistical	amod	27	SENT_174	[p12l1124t1590r1406b1641],
27	signiﬁcance	NN	O	signiﬁcance	dobj	25	SENT_174	[p12l1432t1590r1803b1657],
28	.	.	O	.	_	0	SENT_174	[p12l1432t1590r1803b1657],

1	Clinical	JJ	MISC	clinical	amod	2	SENT_175	[p12l416t1737r657b1793],
2	Implications	NNS	MISC	implication	nsubj	6	SENT_175	[p12l682t1737r1065b1812],
3	Our	PRP$	MISC	we	poss	5	SENT_175	[p12l415t1831r536b1880],
4	main	JJ	O	main	amod	5	SENT_175	[p12l571t1832r724b1880],
5	findings	NNS	O	finding	dep	2	SENT_175	[p12l759t1829r1006b1897],
6	suggest	VBP	O	suggest	_	0	SENT_175	[p12l1044t1836r1273b1897],
7	that	IN	O	that	complm	11	SENT_175	[p12l1307t1830r1426b1880],
8	it	PRP	O	it	nsubj	11	SENT_175	[p12l1461t1832r1501b1880],
9	may	MD	O	may	aux	11	SENT_175	[p12l1537t1847r1666b1898],
10	be	VB	O	be	cop	11	SENT_175	[p12l1700t1830r1771b1880],
11	possible	JJ	O	possible	ccomp	6	SENT_175	[p12l1808t1830r2056b1897],
12	to	TO	O	to	aux	13	SENT_175	[p12l2092t1836r2149b1880],
13	improve	VB	O	improve	xcomp	11	SENT_175	[p12l413t1917r666b1982],
14	the	DT	O	the	det	15	SENT_175	[p12l689t1915r783b1965],
15	response	NN	O	response	dobj	13	SENT_175	[p12l807t1932r1078b1982],
16	of	IN	O	of	_	0	SENT_175	[p12l1102t1915r1161b1965],
17	PIAZ	NN	O	piaz	nn	18	SENT_175	[p12l1181t1908r1304b1965],
18	carriers	NNS	O	carrier	prep_of	15	SENT_175	[p12l1327t1917r1554b1965],
19	to	TO	O	to	_	0	SENT_175	[p12l1577t1921r1633b1965],
20	aspirin	NN	O	aspirin	prep_to	13	SENT_175	[p12l1658t1917r1866b1982],
21	by	IN	O	by	_	0	SENT_175	[p12l1888t1915r1963b1983],
22	using	VBG	O	use	prepc_by	13	SENT_175	[p12l1984t1917r2151b1982],
23	a	DT	O	a	det	25	SENT_175	[p12l415t2016r445b2049],
24	higher	JJR	O	higher	amod	25	SENT_175	[p12l473t1998r671b2065],
25	dose	NN	O	dose	dobj	22	SENT_175	[p12l699t1998r851b2049],
26	.	.	O	.	_	0	SENT_175	[p12l699t1998r851b2049],

1	A	DT	O	a	det	4	SENT_176	[p12l879t2000r929b2048],
2	20	CD	PERCENT	20	number	3	SENT_176	[p12l955t2000r1074b2050],
3	%	NN	PERCENT	%	amod	4	SENT_176	[p12l955t2000r1074b2050],
4	improvement	NN	O	improvement	nsubj	9	SENT_176	[p12l1106t2001r1519b2066],
5	in	IN	O	in	_	0	SENT_176	[p12l1545t2001r1603b2048],
6	platelet	NN	O	platelet	nn	7	SENT_176	[p12l1630t1998r1857b2066],
7	aggregation	NN	O	aggregation	prep_in	4	SENT_176	[p12l1884t2016r2149b2065, p12l413t2085r531b2133],
8	is	VBZ	O	be	cop	9	SENT_176	[p12l558t2085r604b2133],
9	considerable	JJ	O	considerable	_	0	SENT_176	[p12l634t2083r1035b2143],
10	,	,	O	,	_	0	SENT_176	[p12l634t2083r1035b2143],
11	bearing	VBG	O	bear	parataxis	9	SENT_176	[p12l1063t2083r1297b2150],
12	in	IN	O	in	_	0	SENT_176	[p12l1323t2085r1381b2132],
13	mind	NN	O	mind	prep_in	11	SENT_176	[p12l1409t2083r1568b2133],
14	the	DT	O	the	det	16	SENT_176	[p12l1595t2083r1689b2133],
15	overall	JJ	O	overall	amod	16	SENT_176	[p12l1719t2083r1925b2133],
16	reduction	NN	O	reduction	dobj	11	SENT_176	[p12l1952t2083r2149b2133, p12l413t2169r531b2217],
17	of	IN	O	of	_	0	SENT_176	[p12l568t2167r626b2217],
18	30	CD	PERCENT	30	num	19	SENT_176	[p12l658t2168r777b2219],
19	%	NN	PERCENT	%	prep_of	16	SENT_176	[p12l658t2168r777b2219],
20	in	IN	O	in	_	0	SENT_176	[p12l818t2169r876b2216],
21	percentage	NN	O	percentage	nn	22	SENT_176	[p12l912t2173r1246b2234],
22	aggregation	NN	O	aggregation	prep_in	19	SENT_176	[p12l1284t2169r1643b2234],
23	after	IN	O	after	_	0	SENT_176	[p12l1679t2167r1818b2217],
24	5	CD	DURATION	5	num	25	SENT_176	[p12l1852t2170r1881b2217],
25	days	NNS	NUMBER	day	prep_after	9	SENT_176	[p12l1921t2167r2056b2235],
26	of	IN	O	of	_	0	SENT_176	[p12l2094t2167r2153b2217],
27	aspirin	NN	O	aspirin	nn	28	SENT_176	[p12l415t2253r623b2319],
28	therapy	NN	O	therapy	prep_of	25	SENT_176	[p12l649t2251r898b2319],
29	.	.	O	.	_	0	SENT_176	[p12l649t2251r898b2319],

1	If	IN	O	if	mark	13	SENT_177	[p12l927t2251r973b2301],
2	facilities	NNS	O	facility	nsubj	13	SENT_177	[p12l995t2251r1246b2302],
3	for	IN	O	for	_	0	SENT_177	[p12l1272t2251r1358b2302],
4	the	DT	O	the	det	5	SENT_177	[p12l1382t2251r1477b2302],
5	screening	NN	O	screening	prep_for	2	SENT_177	[p12l1505t2253r1798b2318],
6	and	CC	O	and	_	0	SENT_177	[p12l1825t2251r1937b2302],
7	detection	NN	O	detection	prep_for	2	SENT_177	[p12l1965t2251r2149b2302, p12l413t2337r531b2385],
8	of	IN	O	of	_	0	SENT_177	[p12l562t2334r621b2385],
9	PIM	NN	O	pim	nn	10	SENT_177	[p12l648t2327r771b2384],
10	polymorphism	NN	O	polymorphism	prep_of	5	SENT_177	[p12l802t2335r1249b2402],
11	are	VBP	O	be	cop	13	SENT_177	[p12l1281t2352r1372b2385],
12	not	RB	O	not	neg	13	SENT_177	[p12l1404t2341r1502b2385],
13	available	JJ	O	available	advcl	18	SENT_177	[p12l1533t2334r1818b2394],
14	,	,	O	,	_	0	SENT_177	[p12l1533t2334r1818b2394],
15	it	PRP	O	it	nsubj	18	SENT_177	[p12l1850t2337r1890b2385],
16	may	MD	O	may	aux	18	SENT_177	[p12l1919t2352r2049b2402],
17	be	VB	O	be	cop	18	SENT_177	[p12l2077t2334r2148b2385],
18	prudent	JJ	O	prudent	_	0	SENT_177	[p12l413t2419r659b2486],
19	to	TO	O	to	aux	20	SENT_177	[p12l683t2425r739b2469],
20	consider	VB	O	consider	xcomp	18	SENT_177	[p12l766t2419r1024b2469],
21	medium-dose	JJ	O	medium-dose	amod	22	SENT_177	[p12l1049t2419r1470b2469],
22	aspirin	NN	O	aspirin	dobj	20	SENT_177	[p12l1498t2421r1706b2486],
23	as	IN	O	as	_	0	SENT_177	[p12l1733t2436r1792b2469],
24	the	DT	O	the	det	25	SENT_177	[p12l1818t2419r1912b2469],
25	dosage	NN	O	dosage	prep_as	20	SENT_177	[p12l1940t2419r2149b2486],
26	of	IN	O	of	_	0	SENT_177	[p12l415t2503r473b2553],
27	choice	NN	O	choice	prep_of	25	SENT_177	[p12l496t2503r702b2553],
28	.	.	O	.	_	0	SENT_177	[p12l496t2503r702b2553],

1	Approximately	RB	O	approximately	quantmod	2	SENT_178	[p12l727t2503r1186b2571],
2	1	CD	NUMBER	1	nsubj	6	SENT_178	[p12l1210t2506r1238b2553],
3	in	IN	O	in	_	0	SENT_178	[p12l1265t2505r1323b2553],
4	3	CD	NUMBER	3	num	5	SENT_178	[p12l1348t2506r1378b2553],
5	patients	NNS	O	patient	prep_in	2	SENT_178	[p12l1404t2505r1646b2571],
6	carry	VBP	O	carry	_	0	SENT_178	[p12l1673t2520r1827b2571],
7	this	DT	O	this	det	9	SENT_178	[p12l1850t2503r1959b2553],
8	silent	JJ	O	silent	amod	9	SENT_178	[p12l1987t2503r2151b2553],
9	polymorphism	NN	O	polymorphism	dobj	6	SENT_178	[p12l413t2588r876b2656],
10	.	.	O	.	_	0	SENT_178	[p12l413t2588r876b2656],

1	Certainly	RB	O	certainly	advmod	6	SENT_179	[p12l482t2671r790b2739],
2	,	,	O	,	_	0	SENT_179	[p12l482t2671r790b2739],
3	further	JJ	O	further	amod	4	SENT_179	[p12l816t2671r1039b2722],
4	work	NN	O	work	nsubjpass	6	SENT_179	[p12l1062t2671r1222b2722],
5	is	VBZ	O	be	auxpass	6	SENT_179	[p12l1245t2674r1293b2722],
6	required	VBN	O	require	_	0	SENT_179	[p12l1320t2671r1593b2739],
7	to	TO	O	to	aux	8	SENT_179	[p12l1618t2678r1676b2722],
8	determine	VB	O	determine	ccomp	6	SENT_179	[p12l1704t2671r2025b2722],
9	the	DT	O	the	det	11	SENT_179	[p12l2051t2671r2149b2722],
10	clinical	JJ	O	clinical	amod	11	SENT_179	[p12l415t2756r637b2806],
11	utility	NN	O	utility	dobj	8	SENT_179	[p12l664t2756r851b2824],
12	of	IN	O	of	_	0	SENT_179	[p12l877t2756r938b2806],
13	preoperative	JJ	O	preoperative	amod	14	SENT_179	[p12l961t2758r1362b2823],
14	screening	NN	O	screening	prep_of	11	SENT_179	[p12l1391t2758r1695b2823],
15	for	IN	O	for	_	0	SENT_179	[p12l1720t2756r1808b2806],
16	PIAZ	NNP	ORGANIZATION	PIAZ	nn	17	SENT_179	[p12l1834t2748r1961b2805],
17	polymorphism	NN	O	polymorphism	prep_for	8	SENT_179	[p12l1987t2756r2149b2824, p12l414t2840r753b2907],
18	,	,	O	,	_	0	SENT_179	[p12l1987t2756r2149b2824, p12l414t2840r753b2907],
19	and	CC	O	and	_	0	SENT_179	[p12l784t2840r900b2890],
20	to	TO	O	to	aux	21	SENT_179	[p12l927t2846r984b2890],
21	determine	VB	O	determine	conj_and	8	SENT_179	[p12l1015t2840r1336b2890],
22	whether	IN	O	whether	complm	26	SENT_179	[p12l1364t2840r1625b2890],
23	optimum	JJ	O	optimum	amod	25	SENT_179	[p12l1653t2842r1939b2907],
24	platelet	NN	O	platelet	nn	25	SENT_179	[p12l1967t2840r2149b2907, p12l413t2924r491b2975],
25	inhibition	NN	O	inhibition	nsubj	26	SENT_179	[p12l524t2924r834b2975],
26	leads	VBZ	O	lead	ccomp	21	SENT_179	[p12l868t2924r1030b2975],
27	to	TO	O	to	_	0	SENT_179	[p12l1063t2930r1121b2975],
28	substantial	JJ	O	substantial	amod	30	SENT_179	[p12l1157t2924r1501b2975],
29	clinical	JJ	O	clinical	amod	30	SENT_179	[p12l1536t2924r1758b2975],
30	results	NNS	O	result	prep_to	26	SENT_179	[p12l1792t2924r2018b2975],
31	.	.	O	.	_	0	SENT_179	[p12l1792t2924r2018b2975],

1	Although	IN	O	although	_	0	SENT_180	[p12l2052t2924r2149b2974, p12l413t3008r642b3075],

1	our	PRP$	O	we	poss	2	SENT_181	[p12l697t3025r804b3058],
2	study	NN	O	study	nsubjpass	4	SENT_181	[p12l857t3008r1035b3076],
3	was	VBD	O	be	auxpass	4	SENT_181	[p12l1085t3025r1206b3058],
4	confined	VBN	O	confine	ccomp	12	SENT_181	[p12l1261t3007r1539b3058],
5	to	TO	O	to	_	0	SENT_181	[p12l1591t3014r1650b3058],
6	postoperative	JJ	O	postoperative	amod	7	SENT_181	[p12l1704t3010r2148b3075],
7	patients	NNS	O	patient	prep_to	4	SENT_181	[p12l413t3094r681b3159],
8	,	,	O	,	_	0	SENT_181	[p12l413t3094r681b3159],
9	the	DT	O	the	det	10	SENT_181	[p12l716t3092r813b3142],
10	results	NNS	O	result	nsubj	12	SENT_181	[p12l848t3092r1057b3142],
11	are	VBP	O	be	cop	12	SENT_181	[p12l1093t3109r1187b3142],
12	likely	JJ	O	likely	_	0	SENT_181	[p12l1222t3092r1395b3160],
13	to	TO	O	to	aux	14	SENT_181	[p12l1427t3098r1484b3142],
14	reﬂective	VB	O	reﬂective	xcomp	12	SENT_181	[p12l1519t3092r1807b3142],
15	the	DT	O	the	det	17	SENT_181	[p12l1842t3092r1939b3142],
16	genedrug	NN	O	genedrug	nn	17	SENT_181	[p12l1975t3109r2149b3159, p12l415t3176r562b3243],
17	interaction	NN	O	interaction	dobj	14	SENT_181	[p12l593t3178r950b3236],
18	,	,	O	,	_	0	SENT_181	[p12l593t3178r950b3236],
19	rather	RB	O	rather	_	0	SENT_181	[p12l984t3176r1176b3226],
20	than	IN	O	than	_	0	SENT_181	[p12l1206t3176r1347b3226],
21	any	DT	O	any	det	23	SENT_181	[p12l1380t3193r1492b3244],
22	confounding	JJ	O	confounding	amod	23	SENT_181	[p12l1523t3176r1923b3243],
23	effects	NNS	O	effect	conj_negcc	17	SENT_181	[p12l1955t3176r2149b3226],
24	of	IN	O	of	_	0	SENT_181	[p12l415t3259r475b3310],
25	surgery	NN	O	surgery	prep_of	23	SENT_181	[p12l500t3277r753b3327],
26	.	.	O	.	_	0	SENT_181	[p12l500t3277r753b3327],

1	In	IN	O	in	_	0	SENT_182	[p12l481t3347r542b3394],
2	conclusion	NN	O	conclusion	prep_in	14	SENT_182	[p12l571t3345r910b3405],
3	,	,	O	,	_	0	SENT_182	[p12l571t3345r910b3405],
4	genetic	JJ	O	genetic	amod	5	SENT_182	[p12l941t3347r1157b3412],
5	polymorphisms	NNS	O	polymorphism	nsubj	14	SENT_182	[p12l1185t3345r1662b3413],
6	of	IN	O	of	_	0	SENT_182	[p12l1692t3345r1751b3395],
7	PIAZ	NN	O	piaz	prep_of	5	SENT_182	[p12l1776t3337r1914b3405],
8	,	,	O	,	_	0	SENT_182	[p12l1776t3337r1914b3405],
9	C807T	NN	O	c807t	prep_of	5	SENT_182	[p12l1945t3346r2148b3405],
10	,	,	O	,	_	0	SENT_182	[p12l1945t3346r2148b3405],
11	and	CC	O	and	_	0	SENT_182	[p12l415t3429r528b3479],
12	C50T	NN	O	c50t	prep_of	5	SENT_182	[p12l556t3430r711b3479],
13	are	VBP	O	be	cop	14	SENT_182	[p12l738t3446r830b3479],
14	common	JJ	O	common	_	0	SENT_182	[p12l859t3446r1138b3479],
15	.	.	O	.	_	0	SENT_182	[p12l859t3446r1138b3479],

1	There	EX	O	there	expl	4	SENT_183	[p12l1166t3429r1342b3479],
2	did	VBD	O	do	aux	4	SENT_183	[p12l1372t3429r1470b3479],
3	not	RB	O	not	neg	4	SENT_183	[p12l1497t3435r1595b3479],
4	appear	VB	O	appear	_	0	SENT_183	[p12l1622t3446r1832b3496],
5	to	TO	O	to	aux	9	SENT_183	[p12l1858t3435r1914b3479],
6	be	VB	O	be	cop	9	SENT_183	[p12l1941t3429r2012b3479],
7	any	DT	O	any	det	9	SENT_183	[p12l2042t3446r2151b3497],
8	identifiable	JJ	O	identifiable	amod	9	SENT_183	[p12l413t3512r757b3563],
9	differences	NNS	O	difference	xcomp	4	SENT_183	[p12l788t3512r1114b3563],
10	in	IN	O	in	_	0	SENT_183	[p12l1143t3514r1201b3562],
11	the	DT	O	the	det	14	SENT_183	[p12l1228t3512r1322b3563],
12	baseline	NN	O	baseline	nn	14	SENT_183	[p12l1350t3512r1601b3563],
13	platelet	NN	O	platelet	nn	14	SENT_183	[p12l1629t3512r1857b3580],
14	aggregation	NN	O	aggregation	prep_in	9	SENT_183	[p12l1885t3529r2149b3579, p12l413t3599r545b3647],
15	.	.	O	.	_	0	SENT_183	[p12l1885t3529r2149b3579, p12l413t3599r545b3647],

1	The	DT	O	the	det	2	SENT_184	[p12l574t3596r688b3647],
2	responses	NNS	O	response	nsubjpass	10	SENT_184	[p12l715t3614r1016b3664],
3	to	TO	O	to	_	0	SENT_184	[p12l1043t3603r1100b3647],
4	aspirin	NN	O	aspirin	prep_to	2	SENT_184	[p12l1129t3599r1337b3664],
5	were	VBD	O	be	auxpass	10	SENT_184	[p12l1363t3614r1510b3647],
6	consistently	RB	O	consistently	advmod	10	SENT_184	[p12l1539t3596r1901b3664],
7	but	CC	O	but	_	0	SENT_184	[p12l1925t3596r2027b3647],
8	not	RB	O	not	neg	10	SENT_184	[p12l2053t3603r2151b3647],
9	significantly	RB	O	significantly	advmod	10	SENT_184	[p12l415t3680r785b3749],
10	impaired	JJ	O	impaired	_	0	SENT_184	[p12l810t3681r1087b3748],
11	with	IN	O	with	_	0	SENT_184	[p12l1111t3681r1246b3731],
12	P1	NN	O	p1	nn	13	SENT_184	[p12l1273t3673r1397b3730],
13	”	NN	O	”	prep_with	10	SENT_184	[p12l1273t3673r1397b3730],
14	and	CC	O	and	_	0	SENT_184	[p12l1425t3681r1538b3731],
15	C807T	NN	O	c807t	nn	16	SENT_184	[p12l1565t3682r1754b3731],
16	carriers	NNS	O	carrier	conj_and	13	SENT_184	[p12l1781t3683r2008b3731],
17	and	CC	O	and	_	0	SENT_184	[p12l2037t3681r2150b3731],
18	consistently	RB	O	consistently	advmod	13	SENT_184	[p12l415t3765r776b3833],
19	but	CC	O	but	_	0	SENT_184	[p12l811t3765r913b3815],
20	not	RB	O	not	neg	22	SENT_184	[p12l950t3771r1048b3815],
21	significantly	RB	O	significantly	advmod	22	SENT_184	[p12l1085t3765r1455b3833],
22	improved	VBN	O	improve	conj_but	10	SENT_184	[p12l1491t3765r1787b3832],
23	with	IN	O	with	_	0	SENT_184	[p12l1822t3765r1956b3815],
24	C50T	NN	O	c50t	prep_with	22	SENT_184	[p12l1995t3766r2151b3815],

1	carriers	NNS	O	carrier	_	0	SENT_185	[p13l415t25r657b73],
2	.	.	O	.	_	0	SENT_185	[p13l415t25r657b73],

1	The	DT	O	the	det	2	SENT_186	[p13l680t22r794b73],
2	response	NN	O	response	nsubj	13	SENT_186	[p13l818t40r1089b90],
3	of	IN	O	of	_	0	SENT_186	[p13l1113t22r1172b73],
4	persons	NNS	O	person	prep_of	2	SENT_186	[p13l1191t40r1427b90],
5	with	IN	O	with	_	0	SENT_186	[p13l1448t22r1583b73],
6	the	DT	O	the	det	8	SENT_186	[p13l1604t22r1699b73],
7	PIAZ	NN	ORGANIZATION	piaz	nn	8	SENT_186	[p13l1723t15r1846b72],
8	polymorphism	NN	O	polymorphism	prep_with	4	SENT_186	[p13l1868t22r2149b90, p13l413t105r602b173],
9	to	TO	O	to	_	0	SENT_186	[p13l635t112r691b156],
10	aspirin	NN	O	aspirin	prep_to	8	SENT_186	[p13l726t108r935b173],
11	may	MD	O	may	aux	13	SENT_186	[p13l969t123r1098b173],
12	be	VB	O	be	cop	13	SENT_186	[p13l1129t105r1201b156],
13	dose	NN	O	dose	_	0	SENT_186	[p13l1237t105r1373b156],
14	related	JJ	O	related	amod	13	SENT_186	[p13l1408t105r1634b165],
15	,	,	O	,	_	0	SENT_186	[p13l1408t105r1634b165],
16	with	IN	O	with	_	0	SENT_186	[p13l1668t105r1803b156],
17	signiﬁcant	JJ	O	signiﬁcant	amod	18	SENT_186	[p13l1837t105r2151b172],
18	improvement	NN	O	improvement	prep_with	13	SENT_186	[p13l413t192r827b257],
19	observed	VBN	O	observe	partmod	18	SENT_186	[p13l846t190r1123b240],
20	in	IN	O	in	_	0	SENT_186	[p13l1141t192r1199b239],
21	patients	NNS	O	patient	prep_in	19	SENT_186	[p13l1219t192r1460b257],
22	using	VBG	O	use	partmod	21	SENT_186	[p13l1481t192r1647b257],
23	medium	NN	O	medium	dobj	22	SENT_186	[p13l1666t190r1945b240],
24	-	:	O	-	_	0	SENT_186	[p13l1666t190r1945b240],
25	rather	RB	O	rather	_	0	SENT_186	[p13l1966t190r2151b240],
26	than	IN	O	than	_	0	SENT_186	[p13l413t274r549b324],
27	low-dose	JJ	O	low-dose	amod	28	SENT_186	[p13l574t274r849b324],
28	aspirin	NN	O	aspirin	conj_negcc	13	SENT_186	[p13l876t276r1100b341],
29	.	.	O	.	_	0	SENT_186	[p13l876t276r1100b341],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_187	[p13l1639t352r1765b398],
2	Thorac	NNP	PERSON	Thorac	nn	3	SENT_187	[p13l1789t350r1990b398],
3	Surg	NNP	O	Surg	_	0	SENT_187	[p13l2017t351r2153b414],
4	2007	CD	DATE	2007	num	3	SENT_187	[p13l1765t426r2151b481],
5	;	:	O	;	_	0	SENT_187	[p13l1765t426r2151b481],
6	83:134	CD	NUMBER	83:134	number	7	SENT_187	[p13l1765t426r2151b481],
7	—	CD	NUMBER	—	num	8	SENT_187	[p13l1765t426r2151b481],
8	9	CD	NUMBER	9	dep	3	SENT_187	[p13l1765t426r2151b481],

1	The	DT	O	the	det	2	SENT_188	[p13l8t689r134b744],
2	authors	NNS	O	author	nsubj	4	SENT_188	[p13l157t689r407b744],
3	would	MD	O	would	aux	4	SENT_188	[p13l427t689r636b744],
4	like	VB	O	like	_	0	SENT_188	[p13l656t689r774b744],
5	to	TO	O	to	aux	7	SENT_188	[p13l796t695r857b744],
6	gratefully	RB	O	gratefully	advmod	7	SENT_188	[p13l880t689r1201b763],
7	acknowledge	VB	O	acknowledge	xcomp	4	SENT_188	[p13l1221t689r1656b762],
8	Kate	NNP	PERSON	Kate	nn	9	SENT_188	[p13l1678t691r1827b744],
9	Sheridan	NNP	PERSON	Sheridan	dobj	7	SENT_188	[p13l1851t689r2151b744],
10	for	IN	O	for	_	0	SENT_188	[p13l8t771r102b826],
11	laboratory	NN	O	laboratory	nn	14	SENT_188	[p13l129t771r474b845],
12	and	CC	O	and	_	0	SENT_188	[p13l502t771r626b826],
13	database	NN	O	database	conj_and	11	SENT_188	[p13l655t771r946b826],
14	assistance	NN	O	assistance	prep_for	9	SENT_188	[p13l977t773r1326b836],
15	,	,	O	,	_	0	SENT_188	[p13l977t773r1326b836],
16	Emma	NNP	PERSON	Emma	nn	17	SENT_188	[p13l1356t773r1569b826],
17	Kadri	NNP	PERSON	Kadri	conj_and	14	SENT_188	[p13l1598t771r1783b826],
18	and	CC	O	and	_	0	SENT_188	[p13l1812t771r1936b826],
19	Elizabeth	NNP	PERSON	Elizabeth	nn	20	SENT_188	[p13l1963t771r2151b826, p13l8t853r157b908],
20	Bligh	NNP	PERSON	Bligh	conj_and	14	SENT_188	[p13l199t853r372b926],
21	from	IN	O	from	_	0	SENT_188	[p13l415t853r574b908],
22	the	DT	O	the	det	24	SENT_188	[p13l616t853r720b908],
23	Hospital	NNP	O	Hospital	nn	24	SENT_188	[p13l765t853r1047b927],
24	Pharmacy	NNP	O	Pharmacy	prep_from	7	SENT_188	[p13l1090t853r1424b927],
25	for	IN	O	for	_	0	SENT_188	[p13l1464t853r1558b908],
26	their	PRP$	O	they	poss	27	SENT_188	[p13l1600t853r1757b908],
27	assistance	NN	O	assistance	prep_for	24	SENT_188	[p13l1801t855r2150b919],
28	,	,	O	,	_	0	SENT_188	[p13l1801t855r2150b919],
29	Papworth	NNP	ORGANIZATION	Papworth	nn	31	SENT_188	[p13l9t935r332b1009],
30	Hospital	NNP	ORGANIZATION	Hospital	nn	31	SENT_188	[p13l359t935r642b1009],
31	Research	NNP	ORGANIZATION	Research	prep_from	7	SENT_188	[p13l668t935r971b990],
32	and	CC	ORGANIZATION	and	_	0	SENT_188	[p13l999t935r1123b990],
33	Development	NNP	ORGANIZATION	Development	nn	34	SENT_188	[p13l1150t935r1602b1009],
34	Department	NNP	ORGANIZATION	Department	conj_and	31	SENT_188	[p13l1628t937r2033b1009],
35	for	IN	O	for	_	0	SENT_188	[p13l2059t935r2153b990],
36	project	NN	O	project	nn	37	SENT_188	[p13l9t1019r239b1091],
37	management	NN	O	management	prep_for	31	SENT_188	[p13l279t1024r732b1090],
38	,	,	O	,	_	0	SENT_188	[p13l279t1024r732b1090],
39	and	CC	O	and	_	0	SENT_188	[p13l775t1017r899b1072],
40	the	DT	O	the	det	41	SENT_188	[p13l938t1017r1041b1072],
41	nurses	NNS	O	nurse	conj_and	24	SENT_188	[p13l1084t1036r1302b1072],
42	of	IN	O	of	_	0	SENT_188	[p13l1344t1017r1409b1072],
43	the	DT	O	the	det	45	SENT_188	[p13l1445t1017r1548b1072],
44	Surgical	NNP	O	Surgical	nn	45	SENT_188	[p13l1592t1017r1862b1090],
45	Unit	NNP	O	Unit	prep_of	41	SENT_188	[p13l1901t1019r2049b1072],
46	in	IN	O	in	_	0	SENT_188	[p13l2088t1019r2151b1071],
47	Papworth	NNP	LOCATION	Papworth	nn	48	SENT_188	[p13l9t1099r332b1173],
48	Hospital	NNP	LOCATION	Hospital	prep_in	7	SENT_188	[p13l353t1099r651b1173],
49	.	.	O	.	_	0	SENT_188	[p13l353t1099r651b1173],

1	We	PRP	O	we	nsubj	3	SENT_189	[p13l673t1101r785b1154],
2	especially	RB	O	especially	advmod	3	SENT_189	[p13l809t1099r1136b1173],
3	acknowledge	VBP	O	acknowledge	_	0	SENT_189	[p13l1157t1099r1591b1172],
4	the	DT	O	the	det	5	SENT_189	[p13l1613t1099r1716b1154],
5	contribution	NN	O	contribution	dobj	3	SENT_189	[p13l1740t1099r2151b1154],
6	of	IN	O	of	_	0	SENT_189	[p13l10t1181r75b1236],
7	the	DT	O	the	det	10	SENT_189	[p13l97t1181r200b1236],
8	late	JJ	O	late	amod	10	SENT_189	[p13l228t1181r346b1236],
9	Andrew	NNP	PERSON	Andrew	nn	10	SENT_189	[p13l372t1181r644b1236],
10	Trull	NNP	PERSON	Trull	prep_of	5	SENT_189	[p13l668t1181r830b1236],
11	for	IN	O	for	_	0	SENT_189	[p13l856t1181r950b1236],
12	project	NN	O	project	nn	14	SENT_189	[p13l975t1183r1205b1255],
13	team	NN	O	team	nn	14	SENT_189	[p13l1230t1188r1395b1236],
14	assistance	NN	O	assistance	prep_for	10	SENT_189	[p13l1423t1183r1771b1236],
15	.	.	O	.	_	0	SENT_189	[p13l1423t1183r1771b1236],

1	This	DT	O	this	det	2	SENT_190	[p13l1799t1181r1941b1236],
2	study	NN	O	study	nsubjpass	4	SENT_190	[p13l1970t1181r2153b1255],
3	was	VBD	O	be	auxpass	4	SENT_190	[p13l7t1282r134b1318],
4	funded	VBN	O	fund	_	0	SENT_190	[p13l157t1263r397b1318],
5	by	IN	O	by	_	0	SENT_190	[p13l418t1263r500b1337],
6	Papworth	NNP	ORGANIZATION	Papworth	nn	9	SENT_190	[p13l522t1263r844b1337],
7	Hospital	NNP	ORGANIZATION	Hospital	nn	9	SENT_190	[p13l867t1263r1149b1337],
8	NHS	NNP	ORGANIZATION	NHS	nn	9	SENT_190	[p13l1172t1264r1333b1318],
9	Trust	NNP	ORGANIZATION	Trust	agent	4	SENT_190	[p13l1357t1265r1533b1318],
10	and	CC	O	and	_	0	SENT_190	[p13l1556t1263r1680b1318],
11	the	DT	O	the	det	16	SENT_190	[p13l1701t1263r1804b1318],
12	Papworth	NNP	ORGANIZATION	Papworth	nn	16	SENT_190	[p13l1829t1263r2151b1337],
13	Hospital	NNP	ORGANIZATION	Hospital	nn	16	SENT_190	[p13l9t1345r291b1419],
14	Surgeons	NNP	ORGANIZATION	Surgeons	nn	16	SENT_190	[p13l326t1346r635b1418],
15	Research	NNP	ORGANIZATION	Research	nn	16	SENT_190	[p13l670t1345r972b1400],
16	Fund	NNP	ORGANIZATION	Fund	agent	4	SENT_190	[p13l1006t1345r1193b1400],
17	.	.	O	.	_	0	SENT_190	[p13l1006t1345r1193b1400],

1	Doctor	NNP	O	Doctor	nn	2	SENT_191	[p13l1229t1347r1455b1400],
2	Lim	NNP	PERSON	Lim	nsubjpass	4	SENT_191	[p13l1487t1347r1617b1399],
3	was	VBD	O	be	auxpass	4	SENT_191	[p13l1649t1364r1775b1400],
4	supported	VBN	O	support	_	0	SENT_191	[p13l1811t1345r2152b1419],
5	by	IN	O	by	_	0	SENT_191	[p13l8t1427r90b1501],
6	the	DT	O	the	det	9	SENT_191	[p13l116t1427r219b1482],
7	Medical	NNP	ORGANIZATION	Medical	nn	9	SENT_191	[p13l248t1427r515b1482],
8	Research	NNP	ORGANIZATION	Research	nn	9	SENT_191	[p13l543t1427r845b1482],
9	Council	NNP	ORGANIZATION	Council	agent	4	SENT_191	[p13l874t1427r1148b1492],
10	,	,	O	,	_	0	SENT_191	[p13l874t1427r1148b1492],
11	United	NNP	LOCATION	United	nn	12	SENT_191	[p13l1177t1427r1407b1482],
12	Kingdom	NNP	LOCATION	Kingdom	appos	9	SENT_191	[p13l1434t1427r1759b1500],
13	.	.	O	.	_	0	SENT_191	[p13l1434t1427r1759b1500],

1	References	NNS	O	reference	_	0	SENT_192	[p13l11t1696r463b1764],

1	Undas	NNP	O	Undas	nn	2	SENT_193	[p13l137t1850r352b1905],
2	A	NNP	O	A	dep	19	SENT_193	[p13l393t1852r464b1916],
3	,	,	O	,	_	0	SENT_193	[p13l393t1852r464b1916],
4	Brummel	NNP	PERSON	Brummel	nn	5	SENT_193	[p13l506t1850r818b1905],
5	K	NNP	PERSON	K	appos	2	SENT_193	[p13l860t1852r927b1916],
6	,	,	O	,	_	0	SENT_193	[p13l860t1852r927b1916],
7	Musial	NNP	PERSON	Musial	nn	8	SENT_193	[p13l970t1850r1198b1905],
8	]	NNP	O	]	appos	2	SENT_193	[p13l1236t1852r1279b1918],
9	,	,	O	,	_	0	SENT_193	[p13l1236t1852r1279b1918],
10	Mann	NNP	PERSON	Mann	nn	11	SENT_193	[p13l1322t1852r1519b1905],
11	KG	NNP	O	KG	appos	2	SENT_193	[p13l1561t1852r1687b1916],
12	,	,	O	,	_	0	SENT_193	[p13l1561t1852r1687b1916],
13	Szczeklik	NNP	PERSON	Szczeklik	nn	15	SENT_193	[p13l1733t1850r2041b1905],
14	A.	NNP	PERSON	A.	nn	15	SENT_193	[p13l2078t1852r2149b1905],
15	Pl	NNP	PERSON	Pl	appos	2	SENT_193	[p13l138t1931r340b1999],
16	(	CD	NUMBER	(	num	17	SENT_193	[p13l138t1931r340b1999],
17	A2	NN	O	a2	dep	19	SENT_193	[p13l138t1931r340b1999],
18	)	CD	NUMBER	)	num	19	SENT_193	[p13l138t1931r340b1999],
19	polymorphism	NN	O	polymorphism	dep	27	SENT_193	[p13l370t1932r861b2007],
20	of	IN	O	of	_	0	SENT_193	[p13l890t1932r954b1987],
21	beta	NN	O	beta	prep_of	19	SENT_193	[p13l977t1931r1204b1999],
22	(	CD	NUMBER	(	number	23	SENT_193	[p13l977t1931r1204b1999],
23	3	CD	NUMBER	3	num	25	SENT_193	[p13l977t1931r1204b1999],
24	)	NN	O	)	nn	25	SENT_193	[p13l977t1931r1204b1999],
25	integrins	NNS	O	integrin	nsubjpass	27	SENT_193	[p13l1233t1934r1527b2006],
26	is	VBZ	O	be	auxpass	27	SENT_193	[p13l1556t1934r1607b1987],
27	associated	VBN	O	associate	_	0	SENT_193	[p13l1637t1932r1978b1987],
28	with	IN	O	with	_	0	SENT_193	[p13l2003t1932r2151b1987],
29	enhanced	VBN	O	enhance	amod	31	SENT_193	[p13l139t2014r462b2069],
30	thrombin	NN	O	thrombin	nn	31	SENT_193	[p13l507t2014r821b2069],
31	generation	NN	O	generation	prep_with	27	SENT_193	[p13l868t2016r1225b2088],
32	and	CC	O	and	_	0	SENT_193	[p13l1272t2014r1396b2069],
33	impaired	JJ	O	impaired	amod	34	SENT_193	[p13l1442t2014r1745b2088],
34	antithrombotic	JJ	O	antithrombotic	amod	35	SENT_193	[p13l1792t2014r2150b2069, p13l136t2096r298b2151],
35	action	NN	O	action	prep_with	27	SENT_193	[p13l337t2098r536b2151],
36	of	IN	O	of	_	0	SENT_193	[p13l575t2096r640b2151],
37	aspirin	NN	O	aspirin	prep_of	35	SENT_193	[p13l675t2098r904b2170],
38	at	IN	O	at	_	0	SENT_193	[p13l942t2103r1002b2151],
39	the	DT	O	the	det	40	SENT_193	[p13l1037t2096r1141b2151],
40	site	NN	O	site	prep_at	37	SENT_193	[p13l1181t2098r1292b2151],
41	of	IN	O	of	_	0	SENT_193	[p13l1331t2096r1396b2151],
42	microvascular	JJ	O	microvascular	amod	43	SENT_193	[p13l1430t2096r1899b2151],
43	injury	NN	O	injury	prep_of	40	SENT_193	[p13l1935t2098r2149b2171],
44	.	.	O	.	_	0	SENT_193	[p13l1935t2098r2149b2171],

1	Circulation	NN	O	circulation	_	0	SENT_194	[p13l139t2178r510b2233],
2	2001	CD	DATE	2001	num	1	SENT_194	[p13l537t2181r977b2244],
3	;	:	O	;	_	0	SENT_194	[p13l537t2181r977b2244],
4	104:2666	CD	NUMBER	104:2666	number	5	SENT_194	[p13l537t2181r977b2244],
5	-72	CD	NUMBER	-72	dep	1	SENT_194	[p13l988t2181r1113b2233],
6	.	.	O	.	_	0	SENT_194	[p13l988t2181r1113b2233],

1	.	.	O	.	_	0	SENT_195	[p13l85t2304r95b2315],

1	Feng	NN	O	feng	nn	2	SENT_196	[p13l138t2262r300b2334],
2	D	NN	O	d	_	0	SENT_196	[p13l320t2262r392b2326],
3	,	,	O	,	_	0	SENT_196	[p13l320t2262r392b2326],
4	Lindpaintner	NNP	PERSON	Lindpaintner	nn	5	SENT_196	[p13l415t2260r855b2334],
5	K	NNP	PERSON	K	appos	2	SENT_196	[p13l876t2262r942b2326],
6	,	,	O	,	_	0	SENT_196	[p13l876t2262r942b2326],
7	Larson	NNP	PERSON	Larson	nn	8	SENT_196	[p13l965t2262r1193b2315],
8	MG	NN	O	mg	appos	2	SENT_196	[p13l1214t2262r1359b2326],
9	,	,	O	,	_	0	SENT_196	[p13l1214t2262r1359b2326],
10	et	FW	O	et	nn	11	SENT_196	[p13l1384t2267r1443b2315],
11	al.	FW	O	al.	appos	2	SENT_196	[p13l1464t2260r1535b2315],
12	.	.	O	.	_	0	SENT_196	[p13l1464t2260r1535b2315],

1	Increased	VBN	O	increase	amod	3	SENT_197	[p13l1559t2260r1883b2315],
2	platelet	NN	O	platelet	nn	3	SENT_197	[p13l1903t2260r2153b2334],
3	aggregability	NN	O	aggregability	_	0	SENT_197	[p13l139t2342r575b2417],
4	associated	VBN	O	associate	partmod	3	SENT_197	[p13l601t2342r942b2397],
5	with	IN	O	with	_	0	SENT_197	[p13l966t2342r1115b2397],
6	platelet	NN	O	platelet	nn	9	SENT_197	[p13l1141t2342r1391b2416],
7	GPIIIa	NN	O	gpiium	nn	9	SENT_197	[p13l1418t2344r1633b2397],
8	PlA2	NN	O	pla2	nn	9	SENT_197	[p13l1660t2342r1815b2396],
9	polymorphism	NN	O	polymorphism	prep_with	4	SENT_197	[p13l1842t2342r2150b2417, p13l137t2424r369b2498],
10	:	:	O	:	_	0	SENT_197	[p13l1842t2342r2150b2417, p13l137t2424r369b2498],
11	the	DT	O	the	det	12	SENT_197	[p13l425t2424r531b2479],
12	Framingham	NNP	O	Framingham	dep	3	SENT_197	[p13l587t2424r1030b2498],
13	Offspring	NNP	O	Offspring	nn	14	SENT_197	[p13l1086t2424r1413b2498],
14	Study	NNP	O	Study	dep	12	SENT_197	[p13l1468t2424r1683b2499],
15	.	.	O	.	_	0	SENT_197	[p13l1468t2424r1683b2499],

1	Arterioscler	NNP	O	Arterioscler	nn	4	SENT_198	[p13l1738t2424r2152b2479],
2	Thromb	NNP	O	Thromb	nn	4	SENT_198	[p13l137t2506r404b2561],
3	Vasc	NNP	O	Vasc	nn	4	SENT_198	[p13l430t2508r587b2561],
4	Biol	NNP	O	Biol	_	0	SENT_198	[p13l614t2506r743b2561],
5	1999	CD	DATE	1999	num	4	SENT_198	[p13l771t2509r1262b2572],
6	;	:	O	;	_	0	SENT_198	[p13l771t2509r1262b2572],
7	19:1142	CD	NUMBER	19:1142	num	8	SENT_198	[p13l771t2509r1262b2572],
8	—	NN	O	—	dep	4	SENT_198	[p13l771t2509r1262b2572],
9	7	CD	NUMBER	7	dep	8	SENT_198	[p13l771t2509r1262b2572],
10	.	.	O	.	_	0	SENT_198	[p13l771t2509r1262b2572],

1	.	.	O	.	_	0	SENT_199	[p13l85t2632r95b2643],

1	Lim	NNP	PERSON	Lim	nn	2	SENT_200	[p13l138t2590r267b2642],
2	E	NNP	PERSON	E	_	0	SENT_200	[p13l292t2590r351b2654],
3	,	,	O	,	_	0	SENT_200	[p13l292t2590r351b2654],
4	Cornelissen	NNP	PERSON	Cornelissen	nn	5	SENT_200	[p13l378t2588r772b2643],
5	]	NNP	O	]	appos	2	SENT_200	[p13l792t2590r835b2657],
6	,	,	O	,	_	0	SENT_200	[p13l792t2590r835b2657],
7	Routledge	NNP	PERSON	Routledge	nn	8	SENT_200	[p13l861t2588r1200b2662],
8	T	NN	O	t	appos	2	SENT_200	[p13l1225t2590r1285b2654],
9	,	,	O	,	_	0	SENT_200	[p13l1225t2590r1285b2654],
10	et	FW	O	et	nn	11	SENT_200	[p13l1312t2595r1371b2643],
11	al.	FW	O	al.	appos	2	SENT_200	[p13l1395t2588r1467b2643],
12	.	.	O	.	_	0	SENT_200	[p13l1395t2588r1467b2643],

1	Clopidogrel	NNP	O	Clopidogrel	nsubj	4	SENT_201	[p13l1494t2588r1889b2662],
2	did	VBD	O	do	aux	4	SENT_201	[p13l1914t2588r2021b2643],
3	not	RB	O	not	neg	4	SENT_201	[p13l2045t2595r2152b2643],
4	inhibit	VB	O	inhibit	_	0	SENT_201	[p13l137t2671r358b2726],
5	platelet	NN	O	platelet	nn	6	SENT_201	[p13l380t2671r629b2745],
6	function	NN	O	function	dobj	4	SENT_201	[p13l650t2671r928b2726],
7	early	RB	O	early	advmod	6	SENT_201	[p13l952t2671r1116b2746],
8	after	IN	O	after	prep	7	SENT_201	[p13l1139t2671r1291b2726],
9	coronary	JJ	O	coronary	amod	11	SENT_201	[p13l1314t2690r1609b2746],
10	bypass	NN	O	bypass	nn	11	SENT_201	[p13l1628t2671r1857b2746],
11	surgery	NN	O	surgery	dep	8	SENT_201	[p13l1882t2690r2149b2746],
12	:	:	O	:	_	0	SENT_201	[p13l1882t2690r2149b2746],
13	a	DT	O	a	det	16	SENT_201	[p13l139t2772r172b2808],
14	prospective	JJ	O	prospective	amod	16	SENT_201	[p13l209t2755r593b2827],
15	randomized	JJ	O	randomized	amod	16	SENT_201	[p13l633t2753r1035b2808],
16	trial	NN	O	trial	dep	11	SENT_201	[p13l1071t2753r1220b2808],
17	.	.	O	.	_	0	SENT_201	[p13l1071t2753r1220b2808],
18	]	SYM	O	]	dep	6	SENT_201	[p13l1256t2755r1282b2822],

1	Thorac	NNP	MISC	Thorac	nn	3	SENT_202	[p13l1319t2753r1550b2808],
2	Cardiovasc	NNP	MISC	Cardiovasc	nn	3	SENT_202	[p13l1589t2753r1958b2808],
3	Surg	NNP	MISC	Surg	_	0	SENT_202	[p13l1998t2755r2153b2827],
4	2004	CD	DATE	2004	num	3	SENT_202	[p13l137t2838r630b2901],
5	;	:	O	;	_	0	SENT_202	[p13l137t2838r630b2901],
6	128:432	CD	NUMBER	128:432	number	7	SENT_202	[p13l137t2838r630b2901],
7	—	CD	NUMBER	—	dep	3	SENT_202	[p13l137t2838r630b2901],
8	5	CD	NUMBER	5	dep	7	SENT_202	[p13l137t2838r630b2901],
9	.	.	O	.	_	0	SENT_202	[p13l137t2838r630b2901],

1	.	.	O	.	_	0	SENT_203	[p13l85t2961r95b2972],

1	Born	VBN	O	bear	_	0	SENT_204	[p13l137t2919r296b2972],
2	GVR	NN	O	gvr	dobj	1	SENT_204	[p13l342t2919r517b2972],
3	.	.	O	.	_	0	SENT_204	[p13l342t2919r517b2972],

1	Aggregation	NN	O	aggregation	_	0	SENT_205	[p13l561t2919r976b2991],
2	of	IN	O	of	_	0	SENT_205	[p13l1022t2917r1086b2972],
3	blood	NN	O	blood	nn	4	SENT_205	[p13l1127t2917r1317b2972],
4	platelets	NNS	O	platelet	prep_of	1	SENT_205	[p13l1361t2917r1641b2991],
5	by	IN	O	by	_	0	SENT_205	[p13l1685t2917r1768b2992],
6	adenosine	NN	O	adenosine	nn	7	SENT_205	[p13l1812t2917r2150b2972],
7	diphosphate	NN	O	diphosphate	prep_by	1	SENT_205	[p13l139t2999r553b3073],
8	and	CC	O	and	_	0	SENT_205	[p13l582t2999r707b3054],
9	its	PRP$	O	its	poss	10	SENT_205	[p13l733t3001r808b3054],
10	reversal	NN	O	reversal	prep_by	1	SENT_205	[p13l836t2999r1117b3054],
11	.	.	O	.	_	0	SENT_205	[p13l836t2999r1117b3054],

1	Nature	NNP	O	Nature	_	0	SENT_206	[p13l1146t3001r1378b3055],
2	1962	CD	DATE	1962	num	1	SENT_206	[p13l1408t3002r1900b3065],
3	;	:	O	;	_	0	SENT_206	[p13l1408t3002r1900b3065],
4	164:927	CD	NUMBER	164:927	number	5	SENT_206	[p13l1408t3002r1900b3065],
5	—	CD	NUMBER	—	dep	1	SENT_206	[p13l1408t3002r1900b3065],
6	9	CD	NUMBER	9	dep	5	SENT_206	[p13l1408t3002r1900b3065],
7	.	.	O	.	_	0	SENT_206	[p13l1408t3002r1900b3065],

1	.	.	O	.	_	0	SENT_207	[p13l85t3124r95b3135],

1	Altman	NNP	PERSON	Altman	nn	2	SENT_208	[p13l135t3080r385b3135],
2	DG	NNS	O	dg	_	0	SENT_208	[p13l418t3082r549b3146],
3	,	,	O	,	_	0	SENT_208	[p13l418t3082r549b3146],
4	Bland	NNP	O	Bland	nn	6	SENT_208	[p13l582t3080r776b3135],
5	]	NNP	O	]	nn	6	SENT_208	[p13l804t3082r919b3148],
6	M.	NNP	O	M.	appos	2	SENT_208	[p13l804t3082r919b3148],
7	Interaction	NN	O	interaction	nsubj	8	SENT_208	[p13l953t3082r1316b3135],
8	revisited	VBD	O	revisit	rcmod	6	SENT_208	[p13l1349t3080r1652b3135],
9	:	:	O	:	_	0	SENT_208	[p13l1349t3080r1652b3135],
10	the	DT	O	the	det	11	SENT_208	[p13l1686t3080r1789b3135],
11	difference	NN	O	difference	dep	2	SENT_208	[p13l1825t3080r2150b3135],
12	between	IN	O	between	_	0	SENT_208	[p13l136t3161r420b3216],
13	two	CD	NUMBER	two	num	14	SENT_208	[p13l446t3168r567b3216],
14	estimates	NNS	O	estimate	prep_between	11	SENT_208	[p13l596t3163r924b3216],
15	.	.	O	.	_	0	SENT_208	[p13l596t3163r924b3216],

1	Br	NNP	O	Br	nsubj	2	SENT_209	[p13l953t3163r1028b3215],
2	Med	VBD	O	med	_	0	SENT_209	[p13l1055t3161r1207b3216],
3	]	CD	NUMBER	]	num	4	SENT_209	[p13l1230t3163r1256b3229],
4	2003	CD	DATE	2003	dobj	2	SENT_209	[p13l1283t3164r1703b3227],
5	;	:	O	;	_	0	SENT_209	[p13l1283t3164r1703b3227],
6	326:219	CD	NUMBER	326:219	dep	4	SENT_209	[p13l1283t3164r1703b3227],
7	.	.	O	.	_	0	SENT_209	[p13l1283t3164r1703b3227],

1	.	.	O	.	_	0	SENT_210	[p13l85t3287r95b3298],

1	O'Donnell	NNP	PERSON	O'Donnell	nn	3	SENT_211	[p13l139t3243r475b3298],
2	C	NNP	O	C	nn	3	SENT_211	[p13l497t3245r587b3312],
3	]	NN	O	]	_	0	SENT_211	[p13l497t3245r587b3312],
4	,	,	O	,	_	0	SENT_211	[p13l497t3245r587b3312],
5	Larson	NNP	PERSON	Larson	nn	6	SENT_211	[p13l610t3245r830b3298],
6	MG	NN	O	mg	appos	3	SENT_211	[p13l852t3244r994b3309],
7	,	,	O	,	_	0	SENT_211	[p13l852t3244r994b3309],
8	Feng	NN	O	feng	nn	9	SENT_211	[p13l1018t3245r1176b3317],
9	D	NN	O	d	appos	3	SENT_211	[p13l1196t3245r1267b3309],
10	,	,	O	,	_	0	SENT_211	[p13l1196t3245r1267b3309],
11	et	FW	O	et	nn	12	SENT_211	[p13l1292t3250r1349b3298],
12	al.	FW	O	al.	appos	3	SENT_211	[p13l1371t3243r1439b3298],
13	.	.	O	.	_	0	SENT_211	[p13l1371t3243r1439b3298],

1	Genetic	JJ	O	genetic	amod	4	SENT_212	[p13l1464t3245r1711b3298],
2	and	CC	O	and	_	0	SENT_212	[p13l1735t3243r1856b3298],
3	environmental	JJ	O	environmental	conj_and	1	SENT_212	[p13l1878t3245r2150b3298, p13l138t3325r361b3380],
4	contributions	NNS	O	contribution	_	0	SENT_212	[p13l379t3325r805b3380],
5	to	TO	O	to	_	0	SENT_212	[p13l822t3332r883b3380],
6	platelet	NN	O	platelet	nn	7	SENT_212	[p13l901t3325r1150b3399],
7	aggregation	NN	O	aggregation	prep_to	4	SENT_212	[p13l1169t3327r1579b3399],
8	:	:	O	:	_	0	SENT_212	[p13l1169t3327r1579b3399],
9	the	DT	O	the	det	12	SENT_212	[p13l1599t3325r1702b3380],
10	Framingham	NNP	O	Framingham	nn	12	SENT_212	[p13l1723t3325r2151b3399],
11	Heart	NNP	O	Heart	nn	12	SENT_212	[p13l138t3409r327b3462],
12	Study	NNP	O	Study	dep	4	SENT_212	[p13l355t3407r563b3482],
13	.	.	O	.	_	0	SENT_212	[p13l355t3407r563b3482],

1	Circulation	NN	O	circulation	_	0	SENT_213	[p13l594t3407r965b3462],
2	2001	CD	DATE	2001	num	1	SENT_213	[p13l992t3410r1531b3473],
3	;	:	O	;	_	0	SENT_213	[p13l992t3410r1531b3473],
4	103:3051	CD	NUMBER	103:3051	number	5	SENT_213	[p13l992t3410r1531b3473],
5	—	CD	NUMBER	—	dep	1	SENT_213	[p13l992t3410r1531b3473],
6	6	CD	NUMBER	6	dep	5	SENT_213	[p13l992t3410r1531b3473],
7	.	.	O	.	_	0	SENT_213	[p13l992t3410r1531b3473],

1	.	.	O	.	_	0	SENT_214	[p13l85t3533r95b3544],

1	Weiss	NNP	PERSON	Weiss	nn	3	SENT_215	[p13l136t3491r334b3544],
2	E	NNP	O	E	nn	3	SENT_215	[p13l366t3491r452b3558],
3	]	NN	O	]	_	0	SENT_215	[p13l366t3491r452b3558],
4	,	,	O	,	_	0	SENT_215	[p13l366t3491r452b3558],
5	Bray	NNP	ORGANIZATION	Bray	nn	6	SENT_215	[p13l483t3491r636b3564],
6	PF	NNP	ORGANIZATION	PF	appos	3	SENT_215	[p13l665t3491r764b3555],
7	,	,	O	,	_	0	SENT_215	[p13l665t3491r764b3555],
8	Tayback	NNP	PERSON	Tayback	nn	9	SENT_215	[p13l796t3489r1076b3564],
9	M	NNP	O	M	appos	3	SENT_215	[p13l1105t3491r1190b3555],
10	,	,	O	,	_	0	SENT_215	[p13l1105t3491r1190b3555],
11	et	FW	O	et	nn	12	SENT_215	[p13l1224t3496r1283b3544],
12	al.	FW	O	al.	appos	3	SENT_215	[p13l1314t3489r1385b3544],
13	.	.	O	.	_	0	SENT_215	[p13l1314t3489r1385b3544],

1	A	DT	O	a	det	2	SENT_216	[p13l1416t3491r1471b3543],
2	polymorphism	NN	O	polymorphism	_	0	SENT_216	[p13l1502t3489r1993b3564],
3	of	IN	O	of	_	0	SENT_216	[p13l2024t3489r2089b3544],
4	a	DT	O	a	det	7	SENT_216	[p13l2117t3508r2151b3544],
5	platelet	NN	O	platelet	nn	7	SENT_216	[p13l137t3571r387b3645],
6	glycoprotein	NN	O	glycoprotein	nn	7	SENT_216	[p13l414t3571r830b3646],
7	receptor	NN	O	receptor	prep_of	2	SENT_216	[p13l857t3578r1136b3645],
8	as	IN	O	as	_	0	SENT_216	[p13l1163t3590r1228b3626],
9	an	DT	O	a	det	12	SENT_216	[p13l1257t3590r1336b3626],
10	inherited	VBN	O	inherit	amod	12	SENT_216	[p13l1363t3571r1669b3626],
11	risk	NN	O	risk	nn	12	SENT_216	[p13l1695t3571r1819b3626],
12	factor	NN	O	factor	prep_as	7	SENT_216	[p13l1844t3571r2034b3626],
13	for	IN	O	for	_	0	SENT_216	[p13l2059t3571r2153b3626],
14	coronary	JJ	O	coronary	amod	15	SENT_216	[p13l139t3672r433b3728],
15	thrombosis	NN	O	thrombosis	prep_for	12	SENT_216	[p13l459t3653r850b3708],
16	.	.	O	.	_	0	SENT_216	[p13l459t3653r850b3708],

1	N	NN	O	n	nn	3	SENT_217	[p13l879t3655r938b3709],
2	Engl	NNP	O	Engl	nn	3	SENT_217	[p13l965t3653r1115b3727],
3	]	NNP	O	]	nsubj	4	SENT_217	[p13l1139t3655r1165b3722],
4	Med	VBD	O	med	_	0	SENT_217	[p13l1193t3653r1345b3708],
5	1996	CD	DATE	1996	dobj	4	SENT_217	[p13l1373t3656r1919b3719],
6	;	:	O	;	_	0	SENT_217	[p13l1373t3656r1919b3719],
7	334:1090	CD	NUMBER	334:1090	number	8	SENT_217	[p13l1373t3656r1919b3719],
8	—	CD	NUMBER	—	dep	5	SENT_217	[p13l1373t3656r1919b3719],
9	4	CD	NUMBER	4	dep	8	SENT_217	[p13l1373t3656r1919b3719],
10	.	.	O	.	_	0	SENT_217	[p13l1373t3656r1919b3719],

1	.	.	O	.	_	0	SENT_218	[p13l86t3779r96b3790],

1	Ridker	NNP	PERSON	Ridker	nn	2	SENT_219	[p13l140t3735r367b3790],
2	PM	NNP	O	PM	_	0	SENT_219	[p13l418t3737r550b3801],
3	,	,	O	,	_	0	SENT_219	[p13l418t3737r550b3801],
4	Hennekens	NNP	PERSON	Hennekens	nn	5	SENT_219	[p13l604t3735r988b3790],
5	CH	NN	O	ch	appos	2	SENT_219	[p13l1043t3737r1172b3801],
6	,	,	O	,	_	0	SENT_219	[p13l1043t3737r1172b3801],
7	Schmitz	NNP	PERSON	Schmitz	nn	8	SENT_219	[p13l1229t3735r1498b3790],
8	C	NNP	O	C	appos	2	SENT_219	[p13l1552t3736r1619b3801],
9	,	,	O	,	_	0	SENT_219	[p13l1552t3736r1619b3801],
10	Stampfer	NNP	O	Stampfer	nn	12	SENT_219	[p13l1675t3735r1986b3809],
11	M	NNP	O	M	nn	12	SENT_219	[p13l2037t3737r2150b3804],
12	]	NN	O	]	appos	8	SENT_219	[p13l2037t3737r2150b3804],
13	,	,	O	,	_	0	SENT_219	[p13l2037t3737r2150b3804],

1	Lindpaintner	NNP	PERSON	Lindpaintner	nn	3	SENT_220	[p14l138t11r578b85],
2	K.	NNP	O	K.	nn	3	SENT_220	[p14l606t13r672b66],
3	PIA1/A2	NNP	O	PIA1/A2	_	0	SENT_220	[p14l704t12r985b66],
4	polymorphism	NN	O	polymorphism	dep	3	SENT_220	[p14l1014t11r1505b86],
5	of	IN	O	of	_	0	SENT_220	[p14l1537t11r1601b66],
6	platelet	NN	O	platelet	nn	8	SENT_220	[p14l1626t11r1876b85],
7	glycoprotein	NN	O	glycoprotein	nn	8	SENT_220	[p14l1906t11r2150b86, p14l137t95r334b148],
8	IIIa	NN	O	iium	prep_of	4	SENT_220	[p14l372t95r484b148],
9	and	CC	O	and	_	0	SENT_220	[p14l524t93r648b148],
10	risks	NNS	O	risk	dep	3	SENT_220	[p14l685t93r839b148],
11	of	IN	O	of	_	0	SENT_220	[p14l879t93r944b148],
12	myocardial	JJ	O	myocardial	amod	13	SENT_220	[p14l979t93r1351b168],
13	infarction	NN	O	infarction	prep_of	10	SENT_220	[p14l1388t93r1726b159],
14	,	,	O	,	_	0	SENT_220	[p14l1388t93r1726b159],
15	stroke	NN	O	stroke	prep_of	10	SENT_220	[p14l1768t93r1987b159],
16	,	,	O	,	_	0	SENT_220	[p14l1768t93r1987b159],
17	and	CC	O	and	_	0	SENT_220	[p14l2028t93r2152b148],
18	venous	JJ	O	venous	amod	19	SENT_220	[p14l136t194r373b230],
19	thrombosis	NN	O	thrombosis	conj_and	13	SENT_220	[p14l401t175r792b230],
20	.	.	O	.	_	0	SENT_220	[p14l401t175r792b230],

1	Lancet	NNP	O	Lancet	_	0	SENT_221	[p14l822t177r1044b230],
2	1997	CD	DATE	1997	num	1	SENT_221	[p14l1071t178r1568b241],
3	;	:	O	;	_	0	SENT_221	[p14l1071t178r1568b241],
4	349:385	CD	NUMBER	349:385	number	5	SENT_221	[p14l1071t178r1568b241],
5	—	CD	NUMBER	—	dep	1	SENT_221	[p14l1071t178r1568b241],
6	8	CD	NUMBER	8	dep	5	SENT_221	[p14l1071t178r1568b241],
7	.	.	O	.	_	0	SENT_221	[p14l1071t178r1568b241],

1	9	CD	NUMBER	9	_	0	SENT_222	[p14l46t260r95b312],
2	.	.	O	.	_	0	SENT_222	[p14l46t260r95b312],

1	Kritzik	NNP	O	Kritzik	nn	2	SENT_223	[p14l138t257r364b312],
2	M	NN	O	m	_	0	SENT_223	[p14l398t259r484b323],
3	,	,	O	,	_	0	SENT_223	[p14l398t259r484b323],
4	Savage	NN	PERSON	savage	nn	5	SENT_223	[p14l525t258r757b331],
5	B	NN	PERSON	b	appos	2	SENT_223	[p14l795t259r855b323],
6	,	,	O	,	_	0	SENT_223	[p14l795t259r855b323],
7	Nugent	NNP	PERSON	Nugent	nn	9	SENT_223	[p14l894t259r1147b331],
8	D	NNP	O	D	nn	9	SENT_223	[p14l1184t259r1281b326],
9	]	NN	O	]	appos	5	SENT_223	[p14l1184t259r1281b326],
10	,	,	O	,	_	0	SENT_223	[p14l1184t259r1281b326],
11	Santoso	NNP	PERSON	Santoso	nn	12	SENT_223	[p14l1322t259r1581b312],
12	S	NNP	PERSON	S	appos	5	SENT_223	[p14l1622t259r1677b323],
13	,	,	O	,	_	0	SENT_223	[p14l1622t259r1677b323],
14	Ruggeri	NNP	ORGANIZATION	Ruggeri	nn	15	SENT_223	[p14l1716t259r1979b331],
15	ZM	NNP	ORGANIZATION	ZM	appos	5	SENT_223	[p14l2017t259r2150b323],
16	,	,	O	,	_	0	SENT_223	[p14l2017t259r2150b323],
17	Kunicki	NNP	PERSON	Kunicki	nn	19	SENT_223	[p14l138t339r395b394],
18	T	NN	O	t	nn	19	SENT_223	[p14l424t341r509b408],
19	]	NN	O	]	appos	5	SENT_223	[p14l424t341r509b408],
20	.	.	O	.	_	0	SENT_223	[p14l424t341r509b408],

1	Nucleotide	NN	MISC	nucleotide	nn	2	SENT_224	[p14l541t339r906b395],
2	polymorphisms	NNS	O	polymorphism	nsubj	8	SENT_224	[p14l936t339r1459b414],
3	in	IN	O	in	_	0	SENT_224	[p14l1489t341r1553b393],
4	the	DT	O	the	det	7	SENT_224	[p14l1582t339r1685b394],
5	alpha	NN	O	alpha	amod	7	SENT_224	[p14l1717t339r1900b413],
6	2	CD	NUMBER	2	number	5	SENT_224	[p14l1929t342r1963b393],
7	gene	NN	O	gene	prep_in	2	SENT_224	[p14l1994t358r2150b413],
8	define	VBP	O	define	_	0	SENT_224	[p14l139t421r344b476],
9	multiple	JJ	O	multiple	amod	10	SENT_224	[p14l367t421r646b495],
10	alleles	NNS	O	allele	dobj	8	SENT_224	[p14l670t421r876b476],
11	that	WDT	O	that	nsubjpass	13	SENT_224	[p14l899t421r1029b476],
12	are	VBP	O	be	auxpass	13	SENT_224	[p14l1051t440r1151b476],
13	associated	VBN	O	associate	rcmod	10	SENT_224	[p14l1175t421r1517b476],
14	with	IN	O	with	_	0	SENT_224	[p14l1536t421r1684b476],
15	differences	NNS	O	difference	prep_with	13	SENT_224	[p14l1707t421r2065b476],
16	in	IN	O	in	_	0	SENT_224	[p14l2088t423r2151b475],
17	platelet	NN	O	platelet	nn	19	SENT_224	[p14l137t503r387b577],
18	alpha	NN	O	alpha	nn	19	SENT_224	[p14l414t503r597b577],
19	2beta	NN	O	2beta	prep_in	15	SENT_224	[p14l624t503r802b558],
20	1	CD	NUMBER	1	num	21	SENT_224	[p14l831t506r861b557],
21	density	NN	O	density	dep	19	SENT_224	[p14l893t503r1150b578],
22	.	.	O	.	_	0	SENT_224	[p14l893t503r1150b578],

1	Blood	NN	O	blood	_	0	SENT_225	[p14l1178t503r1371b558],
2	1998	CD	DATE	1998	num	1	SENT_225	[p14l1399t506r1899b569],
3	;	:	O	;	_	0	SENT_225	[p14l1399t506r1899b569],
4	92:2382	CD	NUMBER	92:2382	number	5	SENT_225	[p14l1399t506r1899b569],
5	—	CD	NUMBER	—	dep	1	SENT_225	[p14l1399t506r1899b569],
6	8	CD	NUMBER	8	dep	5	SENT_225	[p14l1399t506r1899b569],
7	.	.	O	.	_	0	SENT_225	[p14l1399t506r1899b569],

1	10	CD	NUMBER	10	_	0	SENT_226	[p14l10t588r95b640],
2	.	.	O	.	_	0	SENT_226	[p14l10t588r95b640],

1	Kunicki	JJ	PERSON	kunicki	amod	3	SENT_227	[p14l138t585r395b640],
2	T	NN	O	t	nn	3	SENT_227	[p14l436t587r522b654],
3	]	NN	O	]	_	0	SENT_227	[p14l436t587r522b654],
4	,	,	O	,	_	0	SENT_227	[p14l436t587r522b654],
5	Kritzik	NNP	PERSON	Kritzik	nn	6	SENT_227	[p14l565t585r791b640],
6	M	NNP	PERSON	M	appos	3	SENT_227	[p14l831t587r916b651],
7	,	,	O	,	_	0	SENT_227	[p14l831t587r916b651],
8	Annis	NNP	PERSON	Annis	nn	9	SENT_227	[p14l957t587r1154b640],
9	DS	NN	O	d	appos	3	SENT_227	[p14l1197t587r1312b651],
10	,	,	O	,	_	0	SENT_227	[p14l1197t587r1312b651],
11	Nugent	NNP	PERSON	Nugent	nn	12	SENT_227	[p14l1355t587r1608b659],
12	D	NNP	O	D	appos	3	SENT_227	[p14l1648t587r1745b654],
13	]	NN	O	]	dep	12	SENT_227	[p14l1648t587r1745b654],
14	.	.	O	.	_	0	SENT_227	[p14l1648t587r1745b654],

1	Hereditary	JJ	O	hereditary	amod	2	SENT_228	[p14l1789t585r2153b660],
2	variation	NN	O	variation	nsubjpass	11	SENT_228	[p14l136t669r433b722],
3	in	IN	O	in	_	0	SENT_228	[p14l458t669r522b721],
4	platelet	NN	O	platelet	nn	7	SENT_228	[p14l547t667r797b741],
5	integrin	NN	O	integrin	nn	7	SENT_228	[p14l821t669r1084b741],
6	alpha	NN	O	alpha	nn	7	SENT_228	[p14l1111t667r1293b741],
7	2beta	NN	O	2beta	prep_in	2	SENT_228	[p14l1318t667r1497b722],
8	1	CD	NUMBER	1	num	9	SENT_228	[p14l1523t670r1554b721],
9	density	NN	O	density	dep	7	SENT_228	[p14l1584t667r1825b742],
10	is	VBZ	O	be	auxpass	11	SENT_228	[p14l1849t669r1900b722],
11	associated	VBN	O	associate	_	0	SENT_228	[p14l1927t669r2150b722, p14l139t749r280b804],
12	with	IN	O	with	_	0	SENT_228	[p14l317t749r466b804],
13	two	CD	NUMBER	two	num	15	SENT_228	[p14l504t756r624b804],
14	silent	JJ	O	silent	amod	15	SENT_228	[p14l667t749r847b804],
15	polymorphisms	NNS	O	polymorphism	prep_with	11	SENT_228	[p14l885t749r1408b824],
16	in	IN	O	in	_	0	SENT_228	[p14l1448t751r1512b803],
17	the	DT	O	the	det	22	SENT_228	[p14l1551t749r1654b804],
18	alpha	NN	O	alpha	amod	22	SENT_228	[p14l1696t749r1879b823],
19	2	CD	NUMBER	2	number	18	SENT_228	[p14l1919t752r1953b803],
20	gene	NN	O	gene	nn	22	SENT_228	[p14l1994t768r2150b823],
21	coding	NN	O	coding	nn	22	SENT_228	[p14l139t831r363b905],
22	sequence	NN	O	sequence	prep_in	15	SENT_228	[p14l390t850r717b905],
23	.	.	O	.	_	0	SENT_228	[p14l390t850r717b905],

1	Blood	NN	O	blood	_	0	SENT_229	[p14l745t831r938b886],
2	1997	CD	DATE	1997	num	1	SENT_229	[p14l966t834r1507b897],
3	;	:	O	;	_	0	SENT_229	[p14l966t834r1507b897],
4	89:1939	CD	NUMBER	89:1939	number	5	SENT_229	[p14l966t834r1507b897],
5	—	CD	NUMBER	—	dep	1	SENT_229	[p14l966t834r1507b897],
6	43	CD	NUMBER	43	dep	5	SENT_229	[p14l966t834r1507b897],
7	.	.	O	.	_	0	SENT_229	[p14l966t834r1507b897],

1	11	CD	NUMBER	11	_	0	SENT_230	[p14l10t916r95b968],
2	.	.	O	.	_	0	SENT_230	[p14l10t916r95b968],

1	Halushka	NNP	PERSON	Halushka	nn	2	SENT_231	[p14l138t913r456b968],
2	MK	NNP	O	MK	_	0	SENT_231	[p14l476t915r614b979],
3	,	,	O	,	_	0	SENT_231	[p14l476t915r614b979],
4	Walker	NNP	ORGANIZATION	Walker	nn	5	SENT_231	[p14l635t913r879b968],
5	LP	NN	ORGANIZATION	lp	appos	2	SENT_231	[p14l898t915r1001b979],
6	,	,	O	,	_	0	SENT_231	[p14l898t915r1001b979],
7	Halushka	NNP	PERSON	Halushka	nn	8	SENT_231	[p14l1023t913r1341b968],
8	PV	NNP	O	PV	appos	5	SENT_231	[p14l1362t915r1472b968],
9	.	.	O	.	_	0	SENT_231	[p14l1362t915r1472b968],

1	Genetic	JJ	O	genetic	amod	2	SENT_232	[p14l1496t915r1752b968],
2	variation	NN	O	variation	_	0	SENT_232	[p14l1771t915r2068b968],
3	in	IN	O	in	_	0	SENT_232	[p14l2088t915r2151b967],
4	cyclooxygenase	NN	O	cyclooxygenase	prep_in	2	SENT_232	[p14l139t995r652b1070],
5	1	CD	NUMBER	1	num	4	SENT_232	[p14l682t998r731b1050],
6	:	:	O	:	_	0	SENT_232	[p14l682t998r731b1050],
7	effects	NNS	O	effect	dep	2	SENT_232	[p14l763t995r967b1050],
8	on	IN	O	on	_	0	SENT_232	[p14l997t1014r1079b1050],
9	response	NN	O	response	prep_on	7	SENT_232	[p14l1107t1014r1404b1069],
10	to	TO	O	to	_	0	SENT_232	[p14l1432t1002r1494b1050],
11	aspirin	NN	O	aspirin	prep_to	9	SENT_232	[p14l1525t997r1770b1069],
12	.	.	O	.	_	0	SENT_232	[p14l1525t997r1770b1069],

1	Clin	NNP	O	Clin	nn	3	SENT_233	[p14l1802t995r1940b1050],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_233	[p14l1968t995r2150b1050, p14l138t1077r336b1132],
3	Ther	NNP	O	Ther	_	0	SENT_233	[p14l362t1077r520b1132],
4	2003	CD	DATE	2003	num	3	SENT_233	[p14l545t1080r1039b1142],
5	;	:	O	;	_	0	SENT_233	[p14l545t1080r1039b1142],
6	73:122	CD	NUMBER	73:122	number	7	SENT_233	[p14l545t1080r1039b1142],
7	—	CD	NUMBER	—	dep	3	SENT_233	[p14l545t1080r1039b1142],
8	30	CD	NUMBER	30	dep	7	SENT_233	[p14l545t1080r1039b1142],
9	.	.	O	.	_	0	SENT_233	[p14l545t1080r1039b1142],

1	INVITED	VBN	O	invite	_	0	SENT_234	[p14l11t1314r416b1378],
2	COMMENTARY	NN	O	commentary	dobj	1	SENT_234	[p14l454t1313r1168b1378],

1	Aspirin	NN	O	aspirin	nsubjpass	4	SENT_235	[p14l7t1488r288b1569],
2	is	VBZ	O	be	auxpass	4	SENT_235	[p14l324t1488r381b1548],
3	widely	RB	O	widely	advmod	4	SENT_235	[p14l416t1485r668b1569],
4	used	VBN	O	use	_	0	SENT_235	[p14l703t1485r881b1548],
5	to	TO	O	to	aux	6	SENT_235	[p14l915t1493r985b1548],
6	reduce	VB	O	reduce	xcomp	4	SENT_235	[p14l1022t1485r1275b1548],
7	graft	NN	O	graft	nn	8	SENT_235	[p14l1315t1485r1488b1568],
8	thrombosis	NN	O	thrombosis	dobj	6	SENT_235	[p14l1523t1485r1943b1548],
9	after	IN	O	after	_	0	SENT_235	[p14l1982t1485r2153b1548],
10	coronary	JJ	O	coronary	amod	13	SENT_235	[p14l11t1612r342b1675],
11	artery	NN	O	artery	nn	13	SENT_235	[p14l381t1599r602b1675],
12	bypass	NN	O	bypass	nn	13	SENT_235	[p14l639t1591r896b1675],
13	grafting	NN	O	grafting	prep_after	6	SENT_235	[p14l937t1591r1249b1674],
14	.	.	O	.	_	0	SENT_235	[p14l937t1591r1249b1674],

1	However	RB	O	however	advmod	5	SENT_236	[p14l1291t1594r1649b1665],
2	,	,	O	,	_	0	SENT_236	[p14l1291t1594r1649b1665],
3	aspirin	NN	O	aspirin	nsubj	5	SENT_236	[p14l1692t1594r1950b1674],
4	only	RB	O	only	advmod	5	SENT_236	[p14l1991t1591r2153b1675],
5	prevents	VBZ	O	prevent	_	0	SENT_236	[p14l9t1704r333b1779],
6	approximately	RB	O	approximately	quantmod	7	SENT_236	[p14l390t1696r932b1780],
7	25	CD	PERCENT	25	num	8	SENT_236	[p14l985t1698r1132b1760],
8	%	NN	PERCENT	%	dobj	5	SENT_236	[p14l985t1698r1132b1760],
9	of	IN	O	of	_	0	SENT_236	[p14l1194t1696r1267b1758],
10	all	DT	O	all	det	13	SENT_236	[p14l1319t1696r1406b1758],
11	ischemic	JJ	O	ischemic	amod	13	SENT_236	[p14l1460t1696r1786b1758],
12	vascular	JJ	O	vascular	amod	13	SENT_236	[p14l1840t1696r2152b1758],
13	events	NNS	O	event	prep_of	8	SENT_236	[p14l11t1808r249b1863],
14	and	CC	O	and	_	0	SENT_236	[p14l304t1801r443b1863],
15	there	EX	O	there	expl	16	SENT_236	[p14l494t1801r687b1863],
16	are	VBP	O	be	conj_and	5	SENT_236	[p14l742t1822r854b1863],
17	many	JJ	O	many	amod	18	SENT_236	[p14l909t1822r1119b1885],
18	causes	NNS	O	cause	nsubj	16	SENT_236	[p14l1171t1822r1432b1875],
19	,	,	O	,	_	0	SENT_236	[p14l1171t1822r1432b1875],
20	including	VBG	O	include	_	0	SENT_236	[p14l1486t1801r1843b1884],
21	all	PDT	O	all	predet	23	SENT_236	[p14l1895t1801r1982b1863],
22	the	DT	O	the	det	23	SENT_236	[p14l2033t1801r2150b1863],
23	causes	NNS	O	cause	prep_including	18	SENT_236	[p14l11t1927r252b1968],
24	of	IN	O	of	_	0	SENT_236	[p14l284t1905r357b1968],
25	aspirin	NN	O	aspirin	nn	26	SENT_236	[p14l384t1908r642b1989],
26	resistance	NN	O	resistance	prep_of	23	SENT_236	[p14l672t1908r1042b1968],
27	for	IN	O	for	_	0	SENT_236	[p14l1074t1905r1179b1968],
28	the	DT	O	the	det	30	SENT_236	[p14l1207t1905r1323b1968],
29	other	JJ	O	other	amod	30	SENT_236	[p14l1355t1905r1552b1968],
30	events	NNS	O	event	prep_for	26	SENT_236	[p14l1583t1913r1840b1968],
31	.	.	O	.	_	0	SENT_236	[p14l1583t1913r1840b1968],

1	Aspirin	NN	O	aspirin	nn	2	SENT_237	[p14l1870t1908r2151b1989],
2	resistance	NN	O	resistance	nsubj	5	SENT_237	[p14l9t2013r380b2073],
3	is	VBZ	O	be	cop	5	SENT_237	[p14l432t2013r489b2073],
4	the	DT	O	the	det	5	SENT_237	[p14l540t2010r657b2073],
5	inability	NN	O	inability	_	0	SENT_237	[p14l710t2010r1019b2094],
6	of	IN	O	of	_	0	SENT_237	[p14l1070t2010r1143b2073],
7	aspirin	NN	O	aspirin	prep_of	5	SENT_237	[p14l1191t2013r1449b2094],
8	to	TO	O	to	aux	9	SENT_237	[p14l1499t2018r1569b2073],
9	block	VB	O	block	infmod	5	SENT_237	[p14l1620t2010r1823b2073],
10	platelet	NN	O	platelet	nn	11	SENT_237	[p14l1872t2010r2152b2094],
11	production	NN	O	production	dobj	9	SENT_237	[p14l9t2116r423b2199],
12	of	IN	O	of	_	0	SENT_237	[p14l460t2116r532b2178],
13	thromboxane	NN	O	thromboxane	nn	14	SENT_237	[p14l563t2116r1063b2178],
14	A2	NN	O	a2	prep_of	11	SENT_237	[p14l1098t2107r1192b2177],
15	and	CC	O	and	_	0	SENT_237	[p14l1229t2116r1368b2178],
16	subsequent	JJ	O	subsequent	amod	18	SENT_237	[p14l1405t2116r1838b2199],
17	platelet	NN	O	platelet	nn	18	SENT_237	[p14l1872t2116r2152b2199],
18	activation	NN	O	activation	prep_of	11	SENT_237	[p14l11t2251r374b2310],
19	and	CC	O	and	_	0	SENT_237	[p14l402t2248r542b2310],
20	aggregation	NN	O	aggregation	prep_of	11	SENT_237	[p14l569t2251r1030b2330],
21	.	.	O	.	_	0	SENT_237	[p14l569t2251r1030b2330],

1	Increasing	VBG	O	increase	amod	2	SENT_238	[p14l1060t2251r1452b2330],
2	degrees	NNS	O	degree	nsubj	7	SENT_238	[p14l1479t2248r1767b2330],
3	of	IN	O	of	_	0	SENT_238	[p14l1797t2248r1869b2309],
4	aspirin	NN	O	aspirin	nn	5	SENT_238	[p14l1893t2251r2151b2330],
5	resistance	NN	O	resistance	prep_of	2	SENT_238	[p14l9t2354r380b2414],
6	may	MD	O	may	aux	7	SENT_238	[p14l419t2373r579b2436],
7	correlate	VB	O	correlate	_	0	SENT_238	[p14l615t2352r940b2414],
8	independently	RB	O	independently	advmod	7	SENT_238	[p14l979t2352r1528b2436],
9	with	IN	O	with	_	0	SENT_238	[p14l1562t2352r1728b2414],
10	increasing	VBG	O	increase	amod	11	SENT_238	[p14l1765t2354r2153b2435],
11	risk	NN	O	risk	prep_with	7	SENT_238	[p14l9t2457r149b2519],
12	of	IN	O	of	_	0	SENT_238	[p14l178t2456r251b2519],
13	cardiovascular	JJ	O	cardiovascular	amod	14	SENT_238	[p14l279t2457r824b2519],
14	events	NNS	O	event	prep_of	11	SENT_238	[p14l856t2465r1113b2519],
15	.	.	O	.	_	0	SENT_238	[p14l856t2465r1113b2519],

1	The	DT	O	the	det	2	SENT_239	[p14l91t2561r228b2624],
2	study	NN	O	study	nsubj	7	SENT_239	[p14l261t2561r461b2645],
3	by	IN	O	by	_	0	SENT_239	[p14l487t2561r578b2645],
4	Lim	NNP	PERSON	Lim	prep_by	2	SENT_239	[p14l607t2564r749b2623],
5	and	CC	O	and	_	0	SENT_239	[p14l780t2561r917b2624],
6	colleagues	NNS	O	colleague	prep_by	2	SENT_239	[p14l947t2561r1321b2644],
7	[	VBP	O	[	_	0	SENT_239	[p14l1358t2562r1435b2635],
8	1	CD	NUMBER	1	number	9	SENT_239	[p14l1358t2562r1435b2635],
9	]	CD	NUMBER	]	nsubj	10	SENT_239	[p14l1358t2562r1435b2635],
10	analyzed	VBD	O	analyze	ccomp	7	SENT_239	[p14l1472t2561r1794b2645],
11	a	DT	O	a	det	13	SENT_239	[p14l1824t2583r1862b2624],
12	genetic	JJ	O	genetic	amod	13	SENT_239	[p14l1893t2564r2150b2644],
13	polymorphism	NN	O	polymorphism	dobj	10	SENT_239	[p14l9t2667r544b2751],
14	within	IN	O	within	_	0	SENT_239	[p14l563t2667r796b2730],
15	a	DT	O	a	det	16	SENT_239	[p14l819t2689r856b2730],
16	subgroup	NN	O	subgroup	prep_within	10	SENT_239	[p14l879t2667r1223b2751],
17	of	IN	O	of	_	0	SENT_239	[p14l1248t2667r1318b2730],
18	a	DT	O	a	det	21	SENT_239	[p14l1337t2689r1374b2730],
19	prospective	JJ	O	prospective	amod	21	SENT_239	[p14l1396t2670r1811b2751],
20	random	JJ	O	random	amod	21	SENT_239	[p14l1834t2667r2150b2730, p14l10t2896r64b2950],
21	©	NN	O	©	prep_of	16	SENT_239	[p14l1834t2667r2150b2730, p14l10t2896r64b2950],

1	2007	CD	DATE	2007	nsubj	12	SENT_240	[p14l91t2898r237b2950],
2	by	IN	O	by	_	0	SENT_240	[p14l262t2895r345b2969],
3	The	DT	O	the	det	4	SENT_240	[p14l370t2895r495b2950],
4	Society	NNP	O	Society	prep_by	1	SENT_240	[p14l526t2896r764b2969],
5	of	IN	O	of	_	0	SENT_240	[p14l791t2894r856b2950],
6	Thoracic	NNP	O	Thoracic	nn	7	SENT_240	[p14l879t2895r1165b2950],
7	Surgeons	NNPS	O	Surgeons	prep_of	4	SENT_240	[p14l1195t2896r1504b2968],
8	Published	VBN	O	publish	partmod	7	SENT_240	[p14l9t2976r343b3032],
9	by	IN	O	by	_	0	SENT_240	[p14l369t2976r451b3050],
10	Elsevier	NNP	ORGANIZATION	Elsevier	nn	11	SENT_240	[p14l478t2976r743b3032],
11	Inc	NNP	ORGANIZATION	Inc	agent	8	SENT_240	[p14l769t2979r870b3032],
12	ized	VBD	O	ize	_	0	SENT_240	[p14l8t3074r158b3137],
13	trial	NN	O	trial	dobj	12	SENT_240	[p14l193t3074r353b3137],
14	.	.	O	.	_	0	SENT_240	[p14l193t3074r353b3137],

1	They	PRP	O	they	nsubj	2	SENT_241	[p14l391t3074r575b3158],
2	attempted	VBD	O	attempt	_	0	SENT_241	[p14l611t3074r981b3158],
3	to	TO	O	to	aux	4	SENT_241	[p14l1016t3082r1084b3137],
4	evaluate	VB	O	evaluate	xcomp	2	SENT_241	[p14l1123t3074r1423b3137],
5	the	DT	O	the	det	6	SENT_241	[p14l1460t3074r1573b3137],
6	role	NN	O	role	dobj	4	SENT_241	[p14l1611t3074r1748b3137],
7	of	IN	O	of	_	0	SENT_241	[p14l1788t3074r1859b3137],
8	genetic	JJ	O	genetic	amod	9	SENT_241	[p14l1892t3077r2149b3157],
9	polymorphism	NN	O	polymorphism	prep_of	6	SENT_241	[p14l8t3180r543b3264],
10	on	IN	O	on	_	0	SENT_241	[p14l588t3201r677b3242],
11	the	DT	O	the	det	13	SENT_241	[p14l721t3180r834b3242],
12	aspirin	NN	O	aspirin	nn	13	SENT_241	[p14l881t3183r1129b3263],
13	response	NN	O	response	prep_on	4	SENT_241	[p14l1173t3201r1495b3263],
14	in	IN	O	in	_	0	SENT_241	[p14l1541t3183r1611b3241],
15	patients	NNS	O	patient	prep_in	13	SENT_241	[p14l1654t3183r1941b3263],
16	after	IN	O	after	_	0	SENT_241	[p14l1987t3180r2151b3242],
17	coronary	JJ	O	coronary	amod	20	SENT_241	[p14l9t3306r329b3369],
18	artery	NN	O	artery	nn	20	SENT_241	[p14l374t3292r587b3369],
19	bypass	NN	O	bypass	nn	20	SENT_241	[p14l628t3285r877b3369],
20	grafting	NN	O	grafting	prep_after	4	SENT_241	[p14l923t3285r1222b3368],
21	.	.	O	.	_	0	SENT_241	[p14l923t3285r1222b3368],

1	The	DT	O	the	det	2	SENT_242	[p14l1268t3285r1405b3347],
2	authors	NNS	O	author	nsubj	3	SENT_242	[p14l1452t3285r1724b3347],
3	postulated	VBN	O	postulate	_	0	SENT_242	[p14l1769t3285r2151b3368],
4	that	IN	O	that	complm	9	SENT_242	[p14l7t3390r149b3452],
5	several	JJ	O	several	amod	7	SENT_242	[p14l172t3390r425b3452],
6	genetic	JJ	O	genetic	amod	7	SENT_242	[p14l449t3392r706b3473],
7	polymorphisms	NNS	O	polymorphism	nsubj	9	SENT_242	[p14l729t3390r1298b3474],
8	are	VBP	O	be	cop	9	SENT_242	[p14l1323t3411r1433b3452],
9	common	JJ	O	common	ccomp	3	SENT_242	[p14l1459t3411r1776b3452],
10	and	CC	O	and	_	0	SENT_242	[p14l1800t3390r1936b3452],
11	some	DT	O	some	nsubj	13	SENT_242	[p14l1959t3411r2149b3452],
12	may	MD	O	may	aux	13	SENT_242	[p14l8t3515r165b3577],
13	affect	VB	O	affect	conj_and	3	SENT_242	[p14l186t3494r373b3556],
14	responses	NNS	O	response	dobj	13	SENT_242	[p14l393t3515r752b3577],
15	to	TO	O	to	_	0	SENT_242	[p14l773t3502r841b3556],
16	aspirin	NN	O	aspirin	prep_to	13	SENT_242	[p14l865t3497r1129b3577],
17	.	.	O	.	_	0	SENT_242	[p14l865t3497r1129b3577],

1	In	IN	O	in	_	0	SENT_243	[p14l1154t3497r1227b3555],
2	particular	JJ	O	particular	prep_in	6	SENT_243	[p14l1249t3494r1616b3577],
3	,	,	O	,	_	0	SENT_243	[p14l1249t3494r1616b3577],
4	PIA2	NN	O	pia2	nn	5	SENT_243	[p14l1640t3485r1792b3555],
5	polymorphism	NN	O	polymorphism	nsubj	6	SENT_243	[p14l1813t3494r2149b3577, p14l8t3598r235b3682],
6	seems	VBZ	O	seem	_	0	SENT_243	[p14l264t3620r485b3661],
7	to	TO	O	to	aux	8	SENT_243	[p14l513t3606r581b3661],
8	cause	VB	O	cause	xcomp	6	SENT_243	[p14l611t3620r809b3661],
9	aspirin	NN	O	aspirin	nn	10	SENT_243	[p14l840t3601r1088b3682],
10	resistance	NN	O	resistance	dobj	8	SENT_243	[p14l1115t3601r1490b3661],
11	.	.	O	.	_	0	SENT_243	[p14l1115t3601r1490b3661],

1	As	IN	O	as	prep	11	SENT_244	[p14l89t3706r185b3766],
2	with	IN	O	with	pcomp	1	SENT_244	[p14l234t3703r400b3766],
3	most	JJS	O	most	amod	5	SENT_244	[p14l450t3711r633b3766],
4	genetic	JJ	O	genetic	amod	5	SENT_244	[p14l682t3706r949b3786],
5	studies	NNS	O	study	pobj	2	SENT_244	[p14l1000t3703r1283b3777],
6	,	,	O	,	_	0	SENT_244	[p14l1000t3703r1283b3777],
7	the	DT	O	the	det	8	SENT_244	[p14l1333t3703r1450b3766],
8	results	NNS	O	result	nsubj	11	SENT_244	[p14l1501t3703r1748b3766],
9	were	VBD	O	be	cop	11	SENT_244	[p14l1797t3724r1979b3766],
10	not	RB	O	not	neg	11	SENT_244	[p14l2030t3711r2151b3766],
11	clear-cut	JJ	O	clear-cut	_	0	SENT_244	[p15l9t18r336b80],
12	and	CC	O	and	_	0	SENT_244	[p15l381t18r521b80],
13	statistical	JJ	O	statistical	amod	14	SENT_244	[p15l566t18r915b80],
14	signiﬁcance	NN	O	signiﬁcance	nsubjpass	17	SENT_244	[p15l960t18r1399b101],
15	was	VBD	O	be	auxpass	17	SENT_244	[p15l1443t39r1586b80],
16	not	RB	O	not	neg	17	SENT_244	[p15l1632t26r1753b80],
17	achieved	VBN	O	achieve	conj_and	11	SENT_244	[p15l1799t18r2148b92],
18	,	,	O	,	_	0	SENT_244	[p15l1799t18r2148b92],
19	although	IN	O	although	mark	22	SENT_244	[p15l9t123r342b206],
20	trends	NNS	O	trend	nsubj	22	SENT_244	[p15l381t123r618b185],
21	were	VBD	O	be	cop	22	SENT_244	[p15l657t144r838b185],
22	similar	JJ	O	similar	advcl	17	SENT_244	[p15l881t123r1138b185],
23	to	TO	O	to	_	0	SENT_244	[p15l1175t131r1245b185],
24	published	VBN	O	publish	amod	25	SENT_244	[p15l1285t123r1662b206],
25	results	NNS	O	result	prep_to	22	SENT_244	[p15l1700t123r1966b185],
26	.	.	O	.	_	0	SENT_244	[p15l1700t123r1966b185],

1	The	DT	O	the	det	2	SENT_245	[p15l2008t123r2149b185],
2	design	NN	O	design	nsubj	9	SENT_245	[p15l10t228r255b311],
3	of	IN	O	of	_	0	SENT_245	[p15l283t227r356b290],
4	this	DT	O	this	det	5	SENT_245	[p15l378t228r513b290],
5	study	NN	O	study	prep_of	2	SENT_245	[p15l543t228r749b312],
6	is	VBZ	O	be	cop	9	SENT_245	[p15l774t230r831b290],
7	a	DT	O	a	det	9	SENT_245	[p15l860t249r898b290],
8	major	JJ	O	major	amod	9	SENT_245	[p15l925t230r1143b312],
9	weakness	NN	O	weakness	_	0	SENT_245	[p15l1167t228r1527b290],
10	for	IN	O	for	_	0	SENT_245	[p15l1555t227r1661b290],
11	determining	VBG	O	determine	prepc_for	9	SENT_245	[p15l1689t228r2152b311],
12	correlation	NN	O	correlation	dobj	11	SENT_245	[p15l9t332r414b395],
13	between	IN	O	between	_	0	SENT_245	[p15l454t332r773b395],
14	clinical	JJ	O	clinical	amod	15	SENT_245	[p15l815t332r1078b395],
15	ﬁndings	NNS	O	ﬁndings	prep_between	12	SENT_245	[p15l1119t332r1423b415],
16	and	CC	O	and	_	0	SENT_245	[p15l1467t332r1606b395],
17	genetic	JJ	O	genetic	amod	18	SENT_245	[p15l1648t335r1915b415],
18	polymorphisms	NNS	O	polymorphism	prep_between	12	SENT_245	[p15l1956t332r2149b416, p15l8t437r450b521],
19	.	.	O	.	_	0	SENT_245	[p15l1956t332r2149b416, p15l8t437r450b521],

1	Basically	RB	O	basically	_	0	SENT_246	[p15l488t437r817b521],
2	most	RBS	O	most	pobj	1	SENT_246	[p15l851t445r1033b500],
3	studies	NNS	O	study	dep	2	SENT_246	[p15l1069t437r1332b500],
4	on	IN	O	on	_	0	SENT_246	[p15l1371t459r1462b500],
5	genetic	JJ	O	genetic	amod	6	SENT_246	[p15l1499t440r1766b520],
6	polymor0003-4975	NN	O	polymor0003-4975	prep_on	1	SENT_246	[p15l1802t437r2149b521, p15l1500t665r1844b719],
7	/	:	O	/	punct	1	SENT_246	[p15l1802t437r2149b521, p15l1500t665r1844b719],

1	07	CD	NUMBER	07	_	0	SENT_247	[p15l1850t665r1946b719],
2	/	:	O	/	punct	3	SENT_247	[p15l1850t665r1946b719],
3	$	$	MONEY	$	dep	1	SENT_247	[p15l1952t663r2150b726],
4	32.00	CD	MONEY	32.00	num	3	SENT_247	[p15l1952t663r2150b726],
5	doi	FW	O	doi	dep	3	SENT_247	[p15l982t745r2149b820],
6	:10.1016	CD	NUMBER	:10.1016	dep	5	SENT_247	[p15l982t745r2149b820],
7	/	:	O	/	punct	3	SENT_247	[p15l982t745r2149b820],
8	j.	NN	O	j.	nn	9	SENT_247	[p15l982t745r2149b820],
9	athoracsur	NN	O	athoracsur	dep	1	SENT_247	[p15l982t745r2149b820],
10	.2006.09.083	CD	NUMBER	.2006.09.083	dep	1	SENT_247	[p15l982t745r2149b820],

